Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
YAF2		ENSG00000015153	YY1 associated factor 2	Q8IY57	12	42157104-42238349	Predicted intracellular proteins	Transcription, Transcription regulation			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in all	8	Cardiomyocytes: 1091.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		U-937: 45.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA026867	Supported		Supported	Nucleoplasm						Nucleoplasm		HPA026867: AB_1858911	unprognostic (1.41e-1)	unprognostic (2.24e-1)	unprognostic (9.30e-2)	unprognostic (3.06e-1)	unprognostic (2.06e-2)	unprognostic (4.12e-1)	unprognostic (7.10e-3)	unprognostic (2.70e-1)	unprognostic (2.86e-3)	unprognostic (2.44e-2)	unprognostic (3.58e-2)	unprognostic (5.57e-2)	unprognostic (4.57e-2)	unprognostic (3.42e-1)	unprognostic (2.33e-1)	unprognostic (5.76e-2)	unprognostic (1.20e-2)	11.2	11.4	15.6	7.6	14.2	9.7	10	16.3	19.7	11	7.9	8.4	6.9	7.2	10.9	11.1	8.5	7.8	10.1	39.4	12.9	13.3	10.5	19.2	8.4	12.4	13.2	11.3	11	7.6	7.4	14.6	10.2	14.5	9.3	8.3	8.1	7.1	10	43.9	6.5	8.9	11.6	10.8	11.3	7	7.8	9.1	12.7	11.9	8.3	10.5	11.2	9.1	13.6	10.8	32.6	9.8	14.2	14.1	5.2	7	5.3	8.2	6	10.4	9.5	4.7	9.1	9.3	8.7	8	7.4	5.5	4.5	7.6	8.3	3.4	5.5	8	5.9	11.9	10.6	8.8	9.7	2.9	3.8	6.2	9.1	6.1	6.7	8.6	6.7	13.7	8.6	8.6	4.7	9.5	10.2	10.8	3.4	9.8	12.1	1.8	8.2	5.8	6.8	9.5	6.4	10.8	4.7	5.9	8.3	7.6	9.3	7.9	3.9	6	7.4	8.1	7.8	6.1	8.9	4.7	9.4	11.9	14.8	8.2	45.4	2.9	17.9	9.3	15.1	10.9	9.8	11.1	11.2	10.3	12.4	6.9	13.6	8.3	8.6	32.6	14.2	8.9	10.8	14.1	5.2	15.6	14.2	16.3	16.7	12.9	13.3	13.2	11.3	14.5	9.1	20.8	12	51.1	37.6	51.6	71.2	1091.6	33.1	21.4	30.7	19.2	80.5	35.9	53	28.7	25.4	49	20.6	23.3	39.3	18.5	47.4	31.2	70.3	92.4	24.5	136.7	37.3	53.4	36.4	11.8	53.8	38.8	40.5	40.5	25.8	71.4	31.6	23	72.2	37.2	98.7	103.5	54.7	30.7	29.6	44.7	37.9	58.6	23	27.3	Cardiomyocytes
NDUFS1	CI-75k	ENSG00000023228	NADH:ubiquinone oxidoreductase core subunit S1	P28331	2	206114817-206159603	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Electron transport, Respiratory chain, Transport	Oxidoreductase, Translocase	Disease mutation, Primary mitochondrial disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 99.5	Cell type enriched	Detected in many	5	Cardiomyocytes: 534.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA064605, CAB070844	Enhanced		Supported	Mitochondria						Mitochondria		CAB070844: , HPA064605: AB_2685297	prognostic unfavorable (3.85e-4)	unprognostic (1.76e-1)	unprognostic (9.22e-3)	unprognostic (5.01e-2)	unprognostic (8.63e-3)	unprognostic (3.75e-1)	unprognostic (3.72e-2)	unprognostic (6.18e-2)	unprognostic (2.30e-2)	unprognostic (3.28e-1)	unprognostic (2.00e-2)	unprognostic (1.28e-1)	prognostic favorable (1.47e-12)	unprognostic (1.17e-1)	unprognostic (1.29e-1)	unprognostic (4.76e-2)	unprognostic (4.73e-2)	13.9	29	12.1	8.3	22.1	7.6	10.3	11.6	26.4	9.1	17.4	16.4	9.2	18.3	9.1	7.7	15.7	7.7	7.3	62.6	11.3	11.7	29.5	30.7	8.3	7.7	13.3	13.8	8.2	9.3	22.1	11.6	10.8	24.2	10.7	18.9	13.5	12.8	10.9	99.5	11	19.9	11.1	10.8	8.4	14.9	8.8	11.1	11.2	10.8	34.7	10.5	11.6	9.4	10.7	15.3	15.7	21.4	12.5	16.1	8.9	12.9	12.9	18.8	13.6	17.6	14.3	21.9	19.1	20.6	31.9	23.2	33.5	15.2	14.7	16.9	23.8	31.7	18.2	25.1	18.5	28.4	6.7	11.8	29.3	32.1	30	18.3	21.1	13.3	17.4	10.9	25	19.7	14.3	24.8	18.6	31.7	14.9	20.7	16.2	17.4	14	17.4	21.9	23.1	17.6	26.3	25.4	26.4	23.7	18.4	14.4	22	21.6	31.2	26.9	19	20.5	18.9	17.6	15.7	17.2	18.1	14.4	17.3	21.9	17.6	17.5	17.9	12	13.3	15.7	13.6	15.4	10.8	10.7	12.2	13	15.3	9.5	10.9	12.4	9.6	12.5	21.4	8.2	16.1	8.9	12.1	22.1	11.6	26.4	11.3	11.7	13.3	13.8	24.2	11.1	56.6	24.1	13.7	19.6	14.3	94.7	534.9	63.7	60.2	35.2	36.6	113.9	40.2	79.6	36.7	9.9	33.7	63.8	0	24.5	26.7	24.7	17.4	35.9	83.9	29.8	111.2	49	33.7	34.6	5.2	31.1	25.2	28.7	27.1	47.3	60.7	29.2	35.1	42.1	80.9	78.2	32.3	27.8	28.6	37.3	14.4	43.8	18.7	52.8	23.9	Cardiomyocytes
MYOM2		ENSG00000036448	Myomesin 2	P54296	8	2045040-2165552	Predicted intracellular proteins		Muscle protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	14	heart muscle: 170.7;skeletal muscle: 75.9	Cell type enriched	Detected in many	15	Cardiomyocytes: 554.8	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enhanced	Detected in single		naive B-cell: 1.9	Low lineage specificity	Detected in single			Group enriched	Detected in some	8	HEK 293: 10.1;SCLC-21H: 4.3;U-266/84: 5.3	Not detected	Not detected							HPA001765, HPA005953	Enhanced		Approved	Mitochondria					120000	Mitochondria		HPA001765: AB_1079443, HPA005953: AB_1854258	unprognostic (2.81e-2)	unprognostic (1.11e-3)	unprognostic (8.19e-2)	unprognostic (1.35e-3)	unprognostic (2.11e-1)	unprognostic (1.86e-2)	unprognostic (2.30e-5)	unprognostic (1.10e-1)	unprognostic (5.17e-2)	unprognostic (1.34e-2)	unprognostic (9.56e-2)	unprognostic (2.54e-2)	unprognostic (3.89e-2)	unprognostic (2.71e-2)	unprognostic (9.01e-2)	unprognostic (3.22e-1)	unprognostic (1.14e-1)	2	0	0.3	0.1	0.4	0	1.7	0.9	0.9	0.2	0.2	0	0.2	0	0.5	2.7	1.2	0.1	0.1	170.7	0.3	0.1	0.7	0	0.1	0	0.2	0	0.2	0	0	0	0.1	0.1	0.9	0	0.2	1.2	1	75.9	0.2	0.1	0.3	0.1	0.4	0	0.2	0	0	0.6	8.9	1.2	0.3	0.1	1.9	0	0	0	0	0.8	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	10.1	0.3	0	0	0	0	0	0.4	0	0	0	0	0	0.3	0	0.6	0	0	0.6	0	0	0	0	0.4	0	0	0	0	4.3	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	5.3	0	0	0	0	0	0	0	0.3	0	0	0.5	0.4	0.2	0	1.9	0.8	0	0	0	0	0	0.5	0.5	0.3	0.4	0.9	0.9	0.3	0.1	0.2	0	0.1	0	6	4	0	2.3	3.2	2.8	554.8	17.8	6.7	0	3.5	0	0	11.6	3.4	5.4	2.3	1	0	1.5	0	1.4	1	5.7	6.4	1.4	6.4	0	5.5	2.8	6.2	0.6	2.3	3.3	3.6	2.5	7	2.5	0	1.4	21.4	4.1	0	17	36.9	22.7	2.5	0.1	8.7	1.1	1.4	Cardiomyocytes
USP28	KIAA1515	ENSG00000048028	Ubiquitin specific peptidase 28	Q96RU2	11	113797874-113875570	Enzymes, Predicted intracellular proteins	DNA damage, DNA repair, Ubl conjugation pathway	Hydrolase, Protease, Thiol protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 40.1;skeletal muscle: 50.2	Cell type enriched	Detected in many	5	Cardiomyocytes: 130.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		SuSa: 42.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA006778, HPA006779	Enhanced		Supported	Nucleoplasm,Nuclear bodies						Nucleoplasm	Nuclear bodies	HPA006778: AB_1080520, HPA006779: AB_1080517	unprognostic (2.54e-1)	unprognostic (2.72e-1)	unprognostic (2.99e-2)	unprognostic (3.72e-2)	unprognostic (5.51e-2)	unprognostic (2.30e-1)	unprognostic (9.73e-3)	unprognostic (3.00e-1)	unprognostic (2.04e-3)	unprognostic (1.82e-3)	unprognostic (3.17e-2)	unprognostic (1.19e-1)	unprognostic (5.11e-2)	unprognostic (2.06e-2)	unprognostic (9.03e-2)	unprognostic (1.35e-3)	unprognostic (5.03e-2)	3.9	3.4	4.8	8.6	5.7	2.4	5.7	26.4	8.6	11.6	5.1	4.9	14	4.7	6	6	5.7	5	4	40.1	5	4.8	5.1	5.6	5.1	7.2	6.8	4.5	7.5	4.1	10.6	9.7	3.9	4.8	8.9	6	5.7	5.7	12.2	50.2	3.5	5.1	11.6	6.4	6.9	4.4	5.5	3.8	3.6	5.1	10.1	7.7	7.1	4.6	10.3	4.1	2.1	3.7	17.9	16.2	6	8.6	9.7	13.1	17.3	10.8	10.7	9.3	6.4	8.8	8.6	14.8	14.4	12.5	11.5	14.6	8.6	19.9	17	18.5	12	12	12.8	8.4	6.1	6.8	7.7	6.6	7.8	6.1	6.4	9.1	10	11.9	12.6	15.5	5.7	10.5	7.5	9	4.4	5.9	12.8	15.7	16	7	14.7	18.3	13.9	9.5	8.5	5.7	6.2	15.2	5.2	4.9	42.9	12.6	2.7	8.2	9.6	14.4	8.7	6.5	5.1	7.3	9.7	0.9	15.3	6.2	0.1	3.2	2.1	16.2	2.4	8.4	10.3	4.1	11.4	4.1	8.4	2.7	9.4	0.9	17.9	3.7	1.2	5.6	6	4.8	5.7	26.4	8.6	5	4.8	6.8	4.5	4.8	3.8	8.9	9.1	10	6.9	1.4	16.1	130.6	5.1	14.7	10.3	5.2	17.7	3.5	5	5.7	1.4	4.3	5.1	0	3.4	3.7	4.7	6.2	1.1	6.7	3.9	4.8	4.7	6.2	4.1	1.4	6.4	6.5	1.7	5.4	10.3	10.1	4.4	3.5	13.1	6.3	20.2	6.5	5.2	10.8	10	1.8	0.9	24.5	9.2	4.9	Cardiomyocytes
USP13	IsoT-3	ENSG00000058056	Ubiquitin specific peptidase 13	Q92995	3	179652755-179789401	Enzymes, Plasma proteins, Predicted intracellular proteins	Autophagy, Ubl conjugation pathway	Hydrolase, Protease, Thiol protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 34.8;skeletal muscle: 90.3	Cell type enriched	Detected in many	6	Cardiomyocytes: 182.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	5	MAIT T-cell: 15.4	Lineage enriched	Detected in many	8	T-cells: 15.4	Cell line enhanced	Detected in many		HDLM-2: 36.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol						Nucleoplasm, Cytosol		HPA004827: AB_1080497	unprognostic (1.00e-2)	unprognostic (2.09e-1)	unprognostic (5.82e-2)	unprognostic (7.14e-2)	unprognostic (9.94e-2)	unprognostic (3.96e-2)	prognostic unfavorable (2.40e-5)	unprognostic (1.76e-1)	unprognostic (4.55e-2)	unprognostic (7.79e-2)	unprognostic (1.69e-3)	unprognostic (2.22e-2)	prognostic unfavorable (3.46e-6)	unprognostic (4.93e-2)	unprognostic (9.79e-2)	unprognostic (3.38e-2)	prognostic unfavorable (3.06e-4)	6.4	7.5	2	2.3	2.8	0.8	3.5	2.9	4.1	2.7	2.1	4.6	1.5	0.7	3.2	3.8	2.6	2.5	2.5	34.8	2	2.3	2.3	3.4	6	2.5	2.1	2.1	7.2	3	3.3	9.8	1.9	3	3	1.8	3.1	3.3	2.1	90.3	1.8	1.7	3.7	2.5	1.6	1.6	5.6	1.3	1.7	5.5	17.1	3.2	2.6	1.9	2	1.9	0	0.4	0	15.4	0.7	12.5	5.4	10.2	7.8	4.6	6.4	4.9	7.4	8.5	10.9	9.2	7.9	4.4	15.5	8.3	8.9	12.3	0.9	11.4	4.5	13	36.6	4.9	4.1	8.1	7.4	3.3	11.4	0	6.9	1.6	8.5	10.8	5.3	8.7	6.1	2	20	9	8.2	6.9	2.1	7.9	1.1	4.9	11.9	10.1	12.7	7.4	3.5	5.8	7.5	7.1	9.5	4.3	3	16.4	8.2	9.4	13.2	10.5	11.3	28.4	9.7	8.1	31.7	6.1	7.7	12.2	0	0.2	0	1.3	0.4	15.4	2	1.3	2.9	1.5	0.6	1	1	0	0	0.4	1.9	0.6	0.7	2	2.8	2.9	4.1	2	2.3	2.1	2.1	3	1.3	8.9	31	4.3	1.7	2.3	12.7	182.3	5.1	2.7	9.1	1.8	5.9	8.7	13.3	1	2.1	9.7	0.3	0	3.7	1.6	7.1	3.4	2.3	6.8	3.7	15.9	9.2	27.6	3.1	2	8.6	4.7	13.5	0	1.6	6.3	1.6	5.8	8.9	2.7	9.7	12.9	5.3	5.1	2.1	1.4	4.2	3.2	3.8	1.6	Cardiomyocytes
NMRK2	ITGB1BP3, MIBP, NRK2	ENSG00000077009	Nicotinamide riboside kinase 2	Q9NPI5	19	3933103-3942416	Enzymes, Predicted intracellular proteins	Pyridine nucleotide biosynthesis	Kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	heart muscle: 271.6;skeletal muscle: 103.2	Cell type enriched	Detected in single	1346	Cardiomyocytes: 751.9	Cancer enhanced	Detected in some		renal cancer: 32.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	BEWO: 22.8;NTERA-2: 18.9	Not detected	Not detected			Low region specificity	Detected in many			HPA049909, HPA054792, HPA072450	Approved		Enhanced	Nucleoplasm,Vesicles						Nucleoplasm	Vesicles	HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522				unprognostic (3.61e-1)	unprognostic (5.92e-2)	unprognostic (1.18e-2)		unprognostic (2.54e-1)	unprognostic (1.03e-1)	unprognostic (7.61e-2)		unprognostic (3.30e-2)	prognostic favorable (1.19e-4)	unprognostic (1.72e-1)	unprognostic (3.29e-2)	unprognostic (5.38e-1)		0.2	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	5.5	1	0	0	271.6	0	0.1	0.2	0	0	0	0	0	0	0.1	0	0.2	0	0	0.4	0	1	1.9	0.1	103.2	0	0	0	0.1	0	0	0	0	0	1.4	18	0.8	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	22.8	0	0	0	0	0.6	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.9	0	0	0	0.2	0	0	0	0.1	0	0	0	2.8	5.1	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	751.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	Cardiomyocytes
PPP1R12B	MGC131980, MGC87886, MYPT2, PP1bp55	ENSG00000077157	Protein phosphatase 1 regulatory subunit 12B	O60237	1	202348699-202592706	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		endometrium 1: 105.2	Cell type enriched	Detected in many	7	Cardiomyocytes: 719.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	7	neutrophil: 15.9	Lineage enriched	Detected in many	7	granulocytes: 15.9	Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA024171, HPA024640	Enhanced		Approved	Plasma membrane,Actin filaments						Plasma membrane, Actin filaments		HPA024171: AB_1854266, HPA024640: AB_1854265	unprognostic (5.24e-2)	unprognostic (8.59e-2)	unprognostic (1.38e-1)	unprognostic (2.75e-2)	unprognostic (3.04e-1)	unprognostic (5.45e-3)	unprognostic (3.12e-2)	unprognostic (9.13e-3)	unprognostic (4.05e-2)	unprognostic (3.74e-2)	unprognostic (2.79e-2)	unprognostic (1.80e-1)	unprognostic (3.60e-3)	unprognostic (6.98e-3)	unprognostic (1.27e-1)	unprognostic (1.28e-1)	unprognostic (1.19e-1)	10.6	2.8	6.9	8.1	9	1.8	7.7	13.9	10.5	55.3	62	15	31	5.8	105.2	9.4	37.4	21.9	17.4	83.1	5.8	4.5	5	2.9	8.1	4.2	10.1	9.2	18.7	2.3	2	4.5	8.4	9.5	36.4	16.3	13.7	5.7	50.3	17.6	5.3	14.1	59.5	7.3	6.9	20.8	3.4	11.1	1.3	5	11.2	3.5	35.1	11.4	2.3	1.7	15.9	1.8	0.7	1.7	0.5	2.6	5.3	4.1	3.9	5.8	4.2	6.7	2.1	2.1	2.2	2.1	2.2	4.7	3	1	3.9	5.3	8.4	6	3.2	2.4	3.8	3.7	3	7.7	1.4	1.4	6.3	3.4	3.3	3.7	3.1	3.3	11.3	1.8	3.4	4.4	3.5	3.8	2	4.7	4	2.8	2.9	1.1	3.1	10.5	4.3	1.8	9.6	5	3.8	4	4.8	2.4	5.6	4.2	2.9	2.3	3.1	1.9	2.3	1.8	5.2	4.8	3.2	2.9	5.2	12.3	1.8	1.8	1.3	1.7	0.9	1.4	1.7	1.1	1	1.4	2.3	1.4	1	15.9	0.7	1.4	1.7	1.6	0.5	6.9	9	13.9	10.5	5.8	4.5	10.1	9.2	9.5	11.1	11.9	17.5	3.7	31.2	15.3	56.6	719.4	12.7	16	18.2	12.2	70.7	12.7	10	7.2	30.9	9.2	21.3	0	11.3	7.2	19	16.4	17.4	6.8	7.8	25.4	23.1	20.9	18.5	10.9	11.2	6	8.5	1.8	14	11.8	6.3	11.5	48.1	4.5	32.3	32.3	105.4	11.9	13.7	9.5	21.3	11.5	30.2	28.9	Cardiomyocytes
ACTN2		ENSG00000077522	Actinin alpha 2	P35609	1	236686454-236764631	Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters		Actin-binding	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 141.3;skeletal muscle: 320.9;tongue: 75.4	Cell type enriched	Detected in some	88	Cardiomyocytes: 1655.8	Cancer enhanced	Detected in many		head and neck cancer: 10.4	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 3.1;HSkMC: 12.2;hTEC/SVTERT24-B: 7.6;WM-115: 2.4	Region enhanced	Detected in many		basal ganglia: 59.7	Low region specificity	Detected in many			HPA006035, HPA008315	Enhanced		Uncertain	Actin filaments					69000000	Actin filaments		HPA006035: AB_1078095, HPA008315: AB_1844543	unprognostic (1.75e-1)	unprognostic (1.50e-1)	unprognostic (2.41e-2)	unprognostic (1.69e-3)	unprognostic (2.91e-1)	unprognostic (4.32e-3)	unprognostic (7.85e-2)	unprognostic (2.97e-3)	unprognostic (2.17e-2)	unprognostic (2.80e-1)	unprognostic (2.97e-1)	unprognostic (2.66e-1)	unprognostic (2.71e-11)	unprognostic (1.30e-2)	unprognostic (1.10e-2)	unprognostic (4.98e-2)	unprognostic (1.22e-1)	3.5	0.6	1.6	0.6	10.7	0.6	0.7	0.3	2.5	0.6	0.6	5.1	0	0.6	0.7	4.4	3.7	0.7	0.7	141.3	2.5	1.4	0.6	0.6	0.9	0.6	4.7	1.4	0.7	0.7	0.6	0.1	0.6	2.7	2.8	0.6	0	4.9	0.6	320.9	0.6	0.7	1.5	3.9	0.6	0.7	0.9	4.3	0	3.5	75.4	4.8	0.9	0.1	0	0	0	0.4	0	0.1	0.1	0	0	0	0	0	0	0.4	0	0	0.7	1.9	0	0	0	0	0	0.4	0	1	0	0	0.1	3.1	0	0	0.1	0	0	0.7	12.2	0	7.6	0	0	0.3	0	0.6	0	0	0	0.1	0	1.3	0	0	0	1.6	0	0	0	0	2	0	0	0.7	0.5	0.5	0	0	0	0.2	0	0	0	0	0	0	0	2.4	0	0	0	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	1.6	10.7	0.3	2.5	2.5	1.4	4.7	1.4	2.7	4.3	0	1.1	0	0.3	0.2	0.7	1655.8	0	0	0	0	0	0	0	0	6.7	0	0	0	0.6	0	0.7	0.3	0	0	0.1	0	0	1.3	0	18.7	0.6	0	0	0	0	0	0.3	0	0.4	0.6	1.1	0	1.4	1.9	2	0.1	0	0	0	0.1	Cardiomyocytes
NEBL	LASP2, LNEBL	ENSG00000078114	Nebulette	O76041	10	20779973-21174187	Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	heart muscle: 123.6	Cell type enriched	Detected in many	10	Cardiomyocytes: 2193.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in single		neutrophil: 1.4	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		HSkMC: 13.9;hTCEpi: 12.9;SCLC-21H: 28.1;SH-SY5Y: 17.0;SK-BR-3: 26.5					Low region specificity	Detected in all			HPA013994, HPA013995	Approved											HPA013994: AB_1854359, HPA013995: AB_1854360	unprognostic (3.79e-2)	unprognostic (1.92e-3)	unprognostic (3.44e-2)	unprognostic (3.57e-3)	unprognostic (1.50e-1)	unprognostic (2.43e-1)	unprognostic (1.20e-1)	unprognostic (6.25e-2)	unprognostic (1.05e-1)	unprognostic (6.20e-3)	unprognostic (2.36e-2)	unprognostic (8.42e-2)	prognostic favorable (2.77e-8)	unprognostic (3.51e-1)	unprognostic (8.11e-2)	unprognostic (4.46e-2)	prognostic unfavorable (5.56e-4)	1.3	6.9	16.4	1	17.2	0.7	13.2	21.1	16.1	2.6	2.9	9.8	0.1	1	1.3	1	10.8	1.1	1.7	123.6	16.5	12.7	12	1.7	14.1	0.9	12.7	13.3	1.5	6	6.6	16	5.1	12.6	7.3	4	2.2	18.8	8.1	0.8	16.2	1.3	1.4	10.6	0.8	4	2.8	12.5	0.5	30.8	3.9	3.8	2.1	4.4	0	0	1.4	0.8	0	0.5	0.2	0.6	5.2	8	0.3	0	0.1	11.1	0	0	0	0	0.6	0.7	1.6	8.2	0	0.4	4.8	0.5	0	0	0	3.3	0	2.5	0	12.5	0	0	13.9	12.9	0	1.3	0	0.3	0.2	0.3	2.2	0	12.2	0.1	0	5.8	5.3	3.1	0	0.1	0	2	1.1	28.1	17	1.5	26.5	0	2.8	8.9	0	11	0	1	0	0.3	0	0	0	0	0	0	0	0.5	0	0	0.7	0	0	0.2	0	0	0	0	0	1.4	0	0.8	0	0.5	0.2	16.4	17.2	21.1	14.1	16.5	12.7	12.7	13.3	12.6	12.5	202.5	60	0	11.7	16.4	72.9	2193.2	7.6	18.7	13.6	31.4	37.3	11	24.9	2.6	229.1	5.5	3.9	0	6.5	9.5	13.9	18.2	0	0	1.9	138.2	17.2	0	0.3	35.8	3.4	0.9	11.8	0	23.7	3.1	9.9	27.7	4.6	4.4	10.2	0	4.1	1.7	0.9	40.4	30.8	1.3	10.2	24.3	Cardiomyocytes
RBFOX1	A2BP1, FOX-1, HRNBP1	ENSG00000078328	RNA binding fox-1 homolog 1	Q9NWB1	16	5239802-7713338	Predicted intracellular proteins	mRNA processing, mRNA splicing	RNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 57.2;heart muscle: 17.6;skeletal muscle: 67.6	Cell type enriched	Detected in some	11	Cardiomyocytes: 81.4	Cancer enhanced	Detected in single		glioma: 0.7	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	15	RH-30: 25.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040809, HPA066746, HPA075862	Enhanced		Approved	Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol		No	No			Nucleoplasm	Nucleoli fibrillar center, Golgi apparatus, Cytosol	HPA040809: AB_10796228, HPA066746: , HPA075862: 	unprognostic (3.75e-3)		unprognostic (2.11e-1)	unprognostic (1.59e-1)	unprognostic (1.76e-2)	unprognostic (5.19e-3)		unprognostic (8.82e-5)	unprognostic (5.02e-1)	unprognostic (3.08e-1)	unprognostic (1.47e-1)	unprognostic (1.43e-2)	unprognostic (3.24e-2)	unprognostic (2.23e-1)	unprognostic (5.00e-2)	unprognostic (2.28e-1)		1.2	2.4	19.9	1.5	33	1.6	1.3	31.5	57.2	1.4	1.9	1.9	0	1.3	1.3	5	2	2.2	1.3	17.6	16.4	6.7	1.5	1.3	1.2	1.2	3.7	21.7	1.4	1.3	1.2	0.5	1.3	13.5	2.6	1.7	0	1.7	4.9	67.6	1.5	1.4	1.2	3.5	1.2	1.4	1.7	5.6	0	1.3	9.7	1.2	1.5	0.3	1.7	0.7	3.1	0.7	1.2	1.4	0	0.1	0.2	0.4	0.1	0	0	0.1	0	0	0	0	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0.2	1.6	0	0	0	0	0	0.1	0	0.1	1.6	0	0	0	1.4	0	0	0	25.1	0.1	0	0.1	0.2	0	0.1	0.1	0	0.2	0.1	0.1	0	0.1	0.4	0.1	0	0.1	0	0.1	0.2	0.2	0	2.4	0.6	2	1.1	0.3	0.7	1	0.9	0.8	0.3	1.7	1.4	1	3.1	1.2	0.7	0.7	1	0	19.9	33	31.5	34.3	16.4	6.7	3.7	21.7	13.5	5.6	0	0.3	0	0	0	2.3	81.4	0	1.4	0	0	0	0	0	0	5.7	0	0	0	0.2	0	0.2	0	0	0	0.1	0	0	0	0	3.1	1.1	0	1.7	1	0.4	7.1	0	0	0	0.2	2.8	0	0	0.2	0.1	0	0	0	0.8	0	Cardiomyocytes
TBX5	HOS	ENSG00000089225	T-box 5	Q99593	12	114353931-114408442	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Developmental protein, DNA-binding	Atrial fibrillation, Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 44.5;lung: 14.0;placenta: 19.7	Cell type enriched	Detected in some	11	Cardiomyocytes: 62.0	Low cancer specificity	Detected in some			Region enhanced	Detected in single		hippocampal formation: 2.2	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ: 13.1;BJ hTERT+: 29.2;BJ hTERT+ SV40 Large T+: 6.8;BJ hTERT+ SV40 Large T+ RasG12V: 8.3;HAP1: 11.5	Not detected	Not detected			Not detected	Not detected			HPA008786, HPA064683	Uncertain		Approved	Nucleoplasm						Nucleoplasm		HPA008786: AB_10601720, HPA064683: AB_2685320	unprognostic (3.09e-2)	unprognostic (1.53e-1)			unprognostic (3.79e-2)	unprognostic (2.75e-1)		unprognostic (1.62e-1)	unprognostic (1.42e-1)	unprognostic (1.66e-1)	unprognostic (1.09e-1)	unprognostic (8.67e-2)	unprognostic (3.36e-7)	unprognostic (2.29e-2)	unprognostic (1.68e-2)	unprognostic (7.34e-2)	unprognostic (4.38e-3)	2.2	0.1	0.1	0	0.1	0	3.8	0.8	0.2	0.2	0.1	0.1	0	0	0.1	0.1	6.4	0.1	0	44.5	2.2	0.1	0.1	0.1	14	1.6	0.1	0.1	0.1	0.1	0	0.1	19.7	0.5	5.4	0	1.4	0.1	0	0.1	0.5	0.1	6.6	0.2	0.1	0.1	0.1	0	0	1	0	0	6.5	1.3	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0.1	0	13.1	29.2	6.8	8.3	0	0	0	0	0.7	0	0	11.5	0	3.9	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0.1	0.1	0.8	0.2	2.2	0.1	0.1	0.1	0.5	0	0	1.1	0	0	0.1	3.6	62	0	0	0	0	0	0.1	0	0	1.3	0	0	0	0	0	4.7	0	0	0	0.2	1.6	0	0	0	0	0	0	0	0	0	5.8	0	0	0	0	0.3	0	0.1	0	0	0.1	0.1	0	0	0	Cardiomyocytes
SMPX	DFN6, DFNX4	ENSG00000091482	Small muscle protein, X-linked	Q9UHP9	X	21705972-21758163	Disease related genes, Predicted intracellular proteins			Deafness, Non-syndromic deafness	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	23	heart muscle: 108.8;skeletal muscle: 155.8;tongue: 74.5	Cell type enriched	Detected in single	2069	Cardiomyocytes: 810.3	Cancer enhanced	Detected in many		head and neck cancer: 7.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	GAMG: 22.6	Low region specificity	Detected in some			Low region specificity	Detected in some			HPA077360			Approved	Plasma membrane					45000	Plasma membrane		HPA077360: AB_2732342	unprognostic (7.29e-2)	unprognostic (1.78e-1)	unprognostic (2.63e-1)	unprognostic (1.28e-1)	unprognostic (1.45e-1)	prognostic unfavorable (3.04e-5)	unprognostic (1.39e-2)	unprognostic (7.46e-2)	unprognostic (5.27e-1)	unprognostic (1.96e-2)	unprognostic (3.97e-2)	unprognostic (3.58e-2)		unprognostic (2.67e-2)	unprognostic (2.82e-1)		unprognostic (8.38e-2)	1.4	0	0.1	0.6	0.1	0	0.2	0.6	0.9	0.1	4	0	0	0.1	0.1	4.7	4	0.1	0.1	108.8	0.1	0.2	0	0.2	0	0.1	0.7	0.3	0.2	0.1	0	0	0	0	1.6	0.5	0	3.6	0.1	155.8	0	0.9	1.8	0.1	0	1.5	0.1	0	0	1	74.5	4.9	1.1	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	1.5	0	0	0	0	22.6	0	0	0	0	0	0	0	0.1	4	0	0	0	4.3	0	0	0	0	0	0	0	2.9	0.2	0	0	0	0.4	3	0	0	0.7	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0.2	0	0	4.4	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0.1	0.6	0.9	0.1	0.2	0.7	0.3	0	0	0	0	0	0	0	0	810.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.2	0	0.2	0	0	0	Cardiomyocytes
MYH7	CMD1S, CMH1, MPD1	ENSG00000092054	Myosin heavy chain 7	P12883	14	23412738-23435718	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	heart muscle: 644.7;skeletal muscle: 596.4	Cell type enriched	Detected in some	2697	Cardiomyocytes: 8327.1	Group enriched	Detected in some	9	head and neck cancer: 12.2;prostate cancer: 15.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	32	HSkMC: 16.4	Low region specificity	Detected in many							HPA001239, HPA001349, CAB015384	Enhanced								31000000			CAB015384: AB_2147279, HPA001239: AB_1079438, HPA001349: AB_1079437	unprognostic (6.49e-2)	unprognostic (8.27e-5)	unprognostic (1.56e-1)	unprognostic (3.04e-3)	unprognostic (4.30e-1)	unprognostic (7.33e-3)		unprognostic (8.60e-2)	unprognostic (1.55e-1)	unprognostic (1.31e-1)	unprognostic (1.22e-1)	unprognostic (3.79e-1)	unprognostic (5.38e-3)	unprognostic (2.32e-1)	unprognostic (1.20e-1)	unprognostic (1.41e-1)	unprognostic (2.28e-2)	5.4	0.1	0.2	0	0.2	0	0.2	0.1	0.1	0	0.1	0	0	0	0	11.7	7.2	0	0.1	644.7	0.2	0.3	0.1	0.1	0.1	0.1	0.2	0	0.1	0.4	0	0.1	0	0	3.3	0	0	11.8	0	596.4	0.1	0.1	0	0.2	0	0.1	0.1	0	0	2.9	109.6	16.9	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	16.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.1	0.1	0.2	0.3	0.2	0	0	0	0	0	0	0	0	0	8327.1	0	0	0	0	0	0	0	0	0.5	0	0	0	2.7	0	0	0	0	0	0	0	0	3.1	0.3	0.4	0.3	0	0	0	0	0	0.7	0	2.8	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
SORBS1	CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12	ENSG00000095637	Sorbin and SH3 domain containing 1	Q9BX66	10	95311771-95561414	Predicted intracellular proteins	Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		smooth muscle: 126.5	Cell type enriched	Detected in many	7	Cardiomyocytes: 479.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	4	basophil: 7.6;eosinophil: 2.2	Lineage enriched	Detected in many	6	granulocytes: 7.6	Cell line enhanced	Detected in many		CACO-2: 15.2;HMC-1: 26.6;SK-MEL-30: 22.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA027559, CAB032850, HPA043084	Enhanced		Supported	Plasma membrane,Focal adhesion sites,Centrosome						Focal adhesion sites	Plasma membrane, Centrosome	CAB032850: AB_2286335, HPA027559: AB_10600812, HPA043084: AB_2678307	prognostic favorable (2.84e-4)	unprognostic (3.53e-1)	unprognostic (1.89e-1)	unprognostic (7.85e-2)	unprognostic (3.43e-1)	unprognostic (1.41e-1)	unprognostic (2.98e-2)	unprognostic (5.30e-2)	unprognostic (1.95e-2)	unprognostic (1.65e-2)	unprognostic (3.17e-2)	unprognostic (1.27e-1)	unprognostic (3.40e-2)	unprognostic (3.13e-2)	unprognostic (1.80e-1)	unprognostic (2.55e-2)	unprognostic (5.01e-3)	95	6.4	23	16.4	21.6	1.8	23.5	16.8	22.5	14.9	70.2	18.7	22.1	8.1	41.8	12.5	45	25.1	28.9	83.7	20.9	8.3	5.9	14.7	8.7	1.4	13.4	14.1	9.8	7.3	17.5	3.5	9.9	19.2	42	20	6.4	7.2	65.7	46.4	6.3	15.5	126.5	20.6	2.9	40	5.5	19.3	0	4	12.7	1.2	63.9	31.4	0.1	0	7.6	1.2	0.6	1	0.2	0.7	0.7	6.4	1.6	2.4	0.1	0.9	0.2	0.1	0.2	0	15.2	5.7	0	1.2	0.1	2.4	0.3	1.2	0.3	0.1	1.8	2.3	3.7	0.2	9.1	0.8	0	26.6	0.4	0.2	0.3	0.1	0.1	2.6	0.9	6	1.2	0.6	0.4	0	0.3	3	2.8	1.4	0.5	2.2	0.2	7.2	10	2.8	2	0.9	0.3	22.8	4.6	1.2	0.2	0.2	0	2.3	0.1	1.2	0.8	0.2	0.1	2.8	0.2	6.4	7.6	0.2	2.2	0.7	1.2	1	0.1	0.3	0.4	0	0.1	0.3	0.1	0.2	0.6	0.2	0	0.5	0.2	23	21.6	16.8	20.7	20.9	8.3	13.4	14.1	19.2	19.3	20.8	18.1	0.5	5.1	10.3	5.9	479	12.7	0	2.3	1.8	2	17.9	3.3	4.4	61.7	19	1	0	2.6	1.9	15.3	5.3	15.1	42.9	2.7	6.4	5.8	38.6	4.9	26.4	6.9	1.1	13.5	1	14	18.2	2.8	3.5	72.2	4.3	5.4	0	64.3	2.8	4.7	10.9	24.7	0	5.2	3.3	Cardiomyocytes
CABP7	MGC57793	ENSG00000100314	Calcium binding protein 7	Q86V35	22	29720084-29731839	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 30.3;pancreas: 9.6	Cell type enriched	Detected in some	24	Cardiomyocytes: 24.3	Cancer enhanced	Detected in some		pancreatic cancer: 3.9	Region enhanced	Detected in all		hippocampal formation: 30.3	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Group enriched	Detected in some	12	HEL: 12.7;SCLC-21H: 12.6;SH-SY5Y: 4.0;U-2 OS: 4.2	Group enriched	Detected in many	5	cerebellum: 83.4;hippocampal formation: 224.8;midbrain: 72.1;pons and medulla: 115.1	Region enhanced	Detected in all		hippocampal formation: 65.6	HPA016439	Uncertain											HPA016439: AB_2669357	unprognostic (1.88e-1)	unprognostic (4.75e-2)	unprognostic (1.18e-1)	unprognostic (5.37e-2)	unprognostic (4.55e-1)	unprognostic (2.29e-4)	unprognostic (2.05e-3)	unprognostic (7.96e-2)	unprognostic (8.69e-3)	unprognostic (3.32e-2)	unprognostic (2.61e-1)	unprognostic (1.22e-1)	unprognostic (7.44e-7)	unprognostic (1.25e-4)	unprognostic (3.60e-2)	unprognostic (2.71e-1)	unprognostic (4.72e-3)	0.4	6	2.7	0.5	2.6	0.8	0.3	7.2	6.5	0.3	0.5	1.2	0	1.5	0.3	1.8	0.7	0.4	0.5	0.3	30.3	2	0.3	0.3	0.4	0.5	3.9	1.2	0.4	9.6	0.3	0.1	0.3	16.9	0.4	0.5	2.4	0.8	0.4	0.6	1	3.8	0.4	4.1	0.5	0.4	1.2	2.8	0	0.7	0	0.3	0.4	0	0.6	0.6	1.8	1.6	0.5	1.4	0.6	0.1	0.6	0.2	0.1	0	0	0	0.1	0	0	0	0.1	0.2	0.1	0.2	0	0.4	0.1	0	0	0	0	0.7	12.7	0.4	0.2	0	0.1	0.2	0	0	0	0	0	0	0	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.4	0	0	12.6	4	0.1	0.2	0.1	0.1	0.5	0	0.1	0.2	4.2	0.1	0.2	0.3	0.2	0.1	0.1	0	0	0	0.8	1.8	0.8	1.3	0.5	0.6	1.1	0.5	0.6	0.4	1	1.4	1.3	0.5	1.6	0.6	0.5	0.6	2.7	2.6	7.2	3	30.3	2	3.9	1.2	16.9	2.8	0	0	0	0	0	0.2	24.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.8	0.1	0	0	0	1	0	0	0	0	0	0.2	0	0	0	Cardiomyocytes
GALNT16	GalNAc-T16, GALNTL1, KIAA1130	ENSG00000100626	Polypeptide N-acetylgalactosaminyltransferase 16	Q8N428	14	69259277-69357033	Enzymes, Predicted intracellular proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in some	4	Cardiomyocytes: 38.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		AF22: 7.4;ASC diff: 9.8;hTEC/SVTERT24-B: 13.9;hTERT-RPE1: 14.2;SCLC-21H: 7.3;U-2 OS: 16.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA059136, HPA075325	Approved		Approved	Vesicles,Cytosol					250000	Vesicles, Cytosol		HPA059136: AB_2683919, HPA075325: 	unprognostic (9.71e-3)	unprognostic (7.47e-2)	unprognostic (4.02e-1)	unprognostic (2.30e-2)	unprognostic (6.71e-2)	unprognostic (5.72e-3)	unprognostic (3.18e-3)	unprognostic (1.22e-1)	unprognostic (1.02e-1)	unprognostic (1.28e-2)	unprognostic (3.62e-4)	unprognostic (1.31e-2)	prognostic favorable (5.23e-6)	unprognostic (5.38e-3)	unprognostic (3.34e-2)	unprognostic (3.93e-2)	unprognostic (7.96e-5)	13.6	15.5	20	2.9	17.9	0.8	14.5	16.1	21.7	7.8	4.1	5	4	3.2	6.4	6	5.1	6.5	4.8	27.6	18.3	27.2	5.6	3	4.2	4.2	6.6	25.2	2.8	5.6	4	4.1	1.2	13	4.6	3.4	1.7	28.9	6.6	5.3	7	5	11.3	8.7	14.3	2.4	3.3	3.3	0	3.5	6.3	2.2	5	3.8	0.5	0.2	1.3	0.5	0.3	0.3	0.2	0	0.6	7.4	0.2	9.8	4.5	0	1	0	1.3	1.9	0.4	0	0	0.2	1.2	0.6	0	2.4	0	0.2	0.1	5.1	0	0.1	0.3	0.1	0	0.5	0.4	0	13.9	0	14.2	0.8	0	0	0	2.3	0.3	0	0	1.4	0	0.1	0	3.9	0	0.5	0	7.3	2.4	1.6	0.3	0	0.3	0.2	0	0.1	1.5	16.7	1.9	1.5	0	0	0	1.5	0	0	0.9	0.5	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0	0.5	0.3	0.2	1.3	0.3	0.1	0.2	0.1	0.2	20	17.9	16.1	16.2	18.3	27.2	6.6	25.2	13	3.3	0	0	0	0.5	3.7	1.9	38.2	0	0	0	0	2	0.1	3.3	0	6.4	0.1	0	0	0	0	5.2	0.4	0	0	0.2	0	0	0	0	8.4	0.9	0	3.3	0	0	0.2	0	0	3.5	0	0.6	6.5	9.2	0.7	1.9	2.9	0	0	0	0.4	Cardiomyocytes
MYOM1		ENSG00000101605	Myomesin 1	P52179	18	3066807-3220108	Predicted intracellular proteins		Muscle protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	heart muscle: 111.4;skeletal muscle: 153.1;tongue: 51.6	Cell type enriched	Detected in many	17	Cardiomyocytes: 1033.7	Cancer enhanced	Detected in many		liver cancer: 6.5	Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Group enriched	Detected in some	9	HAP1: 16.6;HMC-1: 4.5;HSkMC: 8.1	Low region specificity	Detected in single			Not detected	Not detected			HPA014305, HPA049193	Enhanced								32000			HPA014305: AB_1854257, HPA049193: AB_2680670	unprognostic (2.51e-1)	unprognostic (2.08e-3)	unprognostic (2.19e-3)	unprognostic (8.01e-3)	unprognostic (8.94e-2)	unprognostic (4.31e-2)	unprognostic (9.10e-2)	unprognostic (1.59e-1)	unprognostic (9.27e-2)	unprognostic (1.87e-1)	unprognostic (2.38e-1)	unprognostic (1.63e-2)	unprognostic (2.01e-1)	unprognostic (9.15e-2)	unprognostic (4.90e-2)	unprognostic (1.73e-1)	unprognostic (2.62e-1)	6.2	0.6	1.3	0.9	1.2	0.3	0.8	0.6	0.7	1	2.4	0.3	0.4	0.5	2.9	10.1	6	1.3	3	111.4	1.1	1.3	0.4	16.6	0.4	0.4	2.2	0.1	0.9	6.4	0.3	0.3	0.5	0.9	2.6	0.7	3.4	4.6	1.1	153.1	0.3	0.9	9.3	2	0.3	0.7	1.2	0.1	0	1.6	51.6	4.6	5	0.5	0.7	3	0.6	0.4	0.8	2.1	1.1	0	0.1	0.3	0	0.9	1	0.4	0.5	0.6	0	0	0.1	0.1	0.5	0.1	0.2	0.2	0	16.6	0.1	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0	4.5	8.1	0.4	0.3	0.1	0.4	0.1	0.3	0	0.5	0.3	0	0.2	0.4	0.1	0.3	0	0	0	0.1	0	0.1	0.2	0.2	0.6	0	0.1	0.4	0	0.2	0.3	0	0.7	0.3	0	0.5	0	0	0	0.1	0.7	0	0.4	0.6	0.9	0.4	0.5	0.7	0.6	0.5	0.5	0.6	1	2.1	0.5	0.8	0	3	0.2	1.1	1.3	1.2	0.6	0.7	1.1	1.3	2.2	0.1	0.9	0.1	0	0.3	4.6	2.1	1.4	1.7	1033.7	30.6	1.4	1.2	0	2	0.4	0	0.7	10.2	0.9	0.6	0	5.6	0	0.9	0.7	0	6	0.2	1.6	0	3.7	0.6	8.9	2	1	0	1	0.9	0	2	62.6	3.9	0	1.3	6.5	6.6	2.3	1.9	1.1	1.8	1.3	0.6	0.6	Cardiomyocytes
ATP1B4		ENSG00000101892	ATPase Na+/K+ transporting family member beta 4	Q9UN42	X	120362085-120383249	Predicted intracellular proteins, Predicted membrane proteins	Transcription, Transcription regulation			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	skeletal muscle: 47.3;tongue: 26.1	Cell type enriched	Detected in single	16	Cardiomyocytes: 1.6	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enriched	Detected in single	4	HSkMC: 3.1	Not detected	Not detected			Not detected	Not detected																				unprognostic (2.59e-2)	unprognostic (6.02e-4)						unprognostic (5.78e-1)		unprognostic (5.29e-2)				1.3	0	0.1	0	0.1	0	0	0	0.1	0.1	0	0	0	0	0	4.2	1.7	0.1	0	2.4	0.1	0.1	0	0.2	0	0	0.1	0	0	0	0	0.1	0	0	1	0	0	0.4	0	47.3	0.1	0	0	0.1	0	0	0.1	0	0	0.4	26.1	2.5	0	0	0.7	0.2	1.4	0.3	0.7	0.3	1	0.1	0.1	0.1	0.4	0	0.1	0.1	0.5	0	0	0.1	0	0.2	0	0.1	0.2	0.2	0.1	0	0	0.2	0.1	0.7	0.3	0.3	0.5	0.1	0.2	0.3	3.1	0	0.2	0	0.4	0	0	0.1	0.1	0	0.4	0.2	0.1	0.2	0.2	0	0.2	0.2	0.1	0	0.1	0.3	0.2	0.1	0.1	0	0.2	0.7	0	0.6	0.5	0.4	0.3	0.2	0	0	0.3	0.4	0.4	0.1	1.3	0.3	0.3	0.3	0.1	0.2	0.3	0.1	0.2	0.1	0.7	0.3	0.3	1.4	0.7	0.3	0.2	0.2	1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
SGCG	A4, DAGA4, DMDA, DMDA1, LGMD2C, MAM, MGC130048, SCARMD2, SCG3, TYPE	ENSG00000102683	Sarcoglycan gamma	Q13326	13	23180952-23325165	Disease related genes, Plasma proteins, Predicted membrane proteins			Disease mutation, Limb-girdle muscular dystrophy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	heart muscle: 40.9;skeletal muscle: 53.3;tongue: 44.3	Cell type enriched	Detected in some	10	Cardiomyocytes: 116.6	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	fHDF/TERT166: 38.1	Low region specificity	Detected in some			Not detected	Not detected			HPA007476	Enhanced											HPA007476: AB_1079946	unprognostic (5.19e-2)	unprognostic (8.28e-2)	unprognostic (5.15e-3)	unprognostic (1.64e-4)	unprognostic (3.00e-3)	unprognostic (3.61e-2)		unprognostic (8.14e-3)	unprognostic (1.46e-1)	unprognostic (2.29e-1)	unprognostic (4.49e-1)	unprognostic (6.05e-2)	unprognostic (2.23e-2)	unprognostic (2.85e-2)	unprognostic (3.10e-1)	unprognostic (2.98e-3)	unprognostic (1.07e-1)	8.6	0.1	0.1	0.2	0.1	0	2.9	0.2	0.6	0.1	0.4	0.1	0.1	0	0.1	3.8	2.6	0.3	0.3	40.9	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.1	0.1	0.1	1.6	0.1	0.1	0.1	1.2	0.1	0.5	2.1	0.1	53.3	1.3	0.2	0.1	0.1	0.1	0.4	0.6	0.1	0.1	0.7	44.3	3.3	0.7	0.7	0	0	0	0	0	0.7	0	0	0	0.7	0	0.1	0	0	0	0	0	0	0	0	0	1.1	38.1	0	0	0.1	0	0	0	0.1	0	0	0	7.4	0	0.1	0.4	0.4	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	1.5	0	0.3	0.2	0	0.1	0	0.1	0.2	0	0	2	0	0	0	0	0	0.7	0	0.4	0	0.2	0.5	0	0	0	0.4	0	0	0	0	0	0	0.1	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.1	0	0	0	0	3	0	116.6	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	2.6	0	0	0	1.2	0	0	0	0	1.4	6.9	0.2	5	0	0	0	0	0	1.1	0	0	0	1.4	1.4	12.1	0.9	0	0	0	0	Cardiomyocytes
ZNF106	SH3BP3, ZFP106, ZNF474	ENSG00000103994	Zinc finger protein 106	Q9H2Y7	15	42412823-42491123	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 64.8;skeletal muscle: 111.1	Cell type enriched	Detected in all	9	Cardiomyocytes: 1626.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 48.5	Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA054267	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol						Nucleoli	Nucleoplasm, Cytosol	HPA054267: AB_2682431	unprognostic (2.15e-2)	unprognostic (3.31e-1)	unprognostic (7.10e-2)	unprognostic (2.61e-2)	unprognostic (4.01e-2)	unprognostic (1.34e-1)	unprognostic (9.32e-2)	unprognostic (2.49e-1)	unprognostic (3.96e-1)	unprognostic (1.33e-2)	unprognostic (2.27e-1)	unprognostic (2.07e-1)	unprognostic (1.76e-3)	unprognostic (8.71e-2)	unprognostic (1.78e-1)	unprognostic (4.36e-1)	unprognostic (4.09e-3)	14.9	5.4	8.8	6.6	10.4	9	10.3	6.3	9.1	7.1	7.8	4.5	4.5	3.9	7.4	6.3	12.7	5.4	6.1	64.8	9.2	6.3	6.4	3.7	7.8	6	7.6	6.4	6.6	4.4	8.4	7.1	5	11.9	7.8	5.6	11.3	6	5.7	111.1	4.3	5.9	10.9	8	6.3	6	5.7	7.2	3.4	5.7	46.9	6.8	7	17.7	8.3	10.8	48.5	19.6	3.9	5.1	4.5	14.4	8.4	14.7	16.2	37.2	32.8	9	11.8	11.2	10.3	11	19.7	4.2	9.7	10.5	14.4	11.8	16.6	15.2	12	15.8	15.7	7.3	18.6	19.6	7	10.7	22.2	11.1	24.7	8.1	15.7	17.5	9.2	16.5	12.2	22	1.3	16.7	5.7	8.5	5.4	6.2	11.4	8.6	8.1	26.7	5.3	5.4	16.3	9.4	5	23.8	11.2	13.2	12	10.3	14.5	24.9	11.1	17.1	14.7	17.2	8.1	15.6	36.4	9.9	17.8	19.2	19.9	19.6	7.6	5.1	15.9	4.5	6.7	4.2	4.2	10.5	8.3	3.8	3.4	48.5	3.9	18.5	10.8	3.8	4.5	8.8	10.4	6.3	9.1	9.2	6.3	7.6	6.4	11.9	7.2	125	90.2	37.8	49.6	34.2	58	1626.8	56	188.7	61.4	27.9	90.3	31.5	34.9	37	133.3	49.8	30.9	23.3	36.8	30.7	62.9	79.6	42.8	32.7	46.8	33.4	38.7	57.1	104.1	80	34.8	64.4	62.4	28.9	28.5	43.3	51.2	23	87	34.8	75.4	45.3	46.4	55.4	37.4	26.1	25.6	29.4	33.7	64.4	Cardiomyocytes
CKM	CKMM	ENSG00000104879	Creatine kinase, M-type	P06732	19	45306414-45322977	Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Kinase, Transferase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	skeletal muscle: 1374.7;tongue: 354.9	Cell type enriched	Detected in some	137	Cardiomyocytes: 5083.5	Group enriched	Detected in many	33	head and neck cancer: 64.4;prostate cancer: 14.3	Not detected	Not detected			Group enriched	Detected in some	9	classical monocyte: 2.8;intermediate monocyte: 1.1;myeloid DC: 2.1	Group enriched	Detected in many	25	dendritic cells: 2.1;monocytes: 2.8	Cell line enriched	Detected in some	4	SCLC-21H: 37.6	Not detected	Not detected			Not detected	Not detected			HPA047859	Enhanced								190000000			HPA047859: AB_2680186	unprognostic (3.51e-1)	unprognostic (7.63e-2)	unprognostic (2.61e-2)	unprognostic (4.14e-1)	unprognostic (7.68e-3)	unprognostic (4.04e-3)	unprognostic (1.85e-2)	unprognostic (4.23e-2)	unprognostic (5.19e-2)	unprognostic (1.81e-1)	unprognostic (5.00e-1)	unprognostic (9.46e-3)	unprognostic (9.67e-8)	unprognostic (3.23e-1)	unprognostic (1.73e-1)	unprognostic (2.33e-1)	unprognostic (1.95e-1)	13.9	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.1	0.1	0.2	0	0	0.1	0.1	23.5	21.1	0.1	0.1	187.9	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0	0.1	0.2	0.1	0.1	0.1	0	2.8	0.1	0.8	17.6	0.2	1374.7	0.2	0.2	0.2	0.3	0.1	0.5	0.3	0	0	11.1	354.9	24.8	0.2	0.1	0	2.1	0	2.8	0	0	1	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1.2	0	3	0	0.1	8.9	6.8	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	3.3	0.1	0.1	0	0	37.6	0	0	0	0	0	0	8.6	0	0	0	0	0	0.2	0.1	0	0	0	0	0	2.8	0	0	1.1	0	0	0	0	2.1	0	0	0	0	0	0.2	0	0	1	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0	0	0	0	0	0	0	0	0	5083.5	0	0	0	0	0	0.3	10	0	12.4	0	0	0	0	0.7	0	0	1.1	0	5.5	0	0	0.6	1.9	37	1.4	0.1	0	0	0	0	0	0	0.7	0	0	0	0.3	15.2	1.8	0.1	0.2	0	0	0.1	Cardiomyocytes
ICAM5	TLCN, TLN	ENSG00000105376	Intercellular adhesion molecule 5	Q9UMF0	19	10289981-10296778	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	brain: 32.6	Cell type enriched	Detected in some	6	Cardiomyocytes: 33.3	Cancer enhanced	Detected in many		thyroid cancer: 4.8	Group enriched	Detected in many	15	amygdala: 22.5;basal ganglia: 24.3;cerebral cortex: 32.6;hippocampal formation: 23.0;olfactory region: 15.9	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 13.5;K-562: 10.8;RPMI-8226: 12.3;U-266/70: 14.8;U-87 MG: 8.8	Group enriched	Detected in many	9	amygdala: 111.1;basal ganglia: 75.7;cerebral cortex: 76.7;hippocampal formation: 105.7;olfactory region: 63.4	Group enriched	Detected in many	13	amygdala: 58.8;basal ganglia: 55.2;cerebral cortex: 67.5;hippocampal formation: 103.7;olfactory region: 57.5	HPA008943, HPA009083, CAB025178	Enhanced								2400000			CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094	unprognostic (7.76e-2)	unprognostic (1.91e-1)	unprognostic (1.66e-2)	unprognostic (4.24e-2)	unprognostic (8.23e-3)	unprognostic (2.58e-1)	unprognostic (8.12e-2)	unprognostic (9.99e-3)	unprognostic (2.58e-1)	unprognostic (2.44e-2)	unprognostic (3.90e-3)	unprognostic (9.89e-3)	unprognostic (5.29e-5)	unprognostic (6.47e-2)	unprognostic (4.86e-2)	unprognostic (5.44e-3)	unprognostic (6.28e-3)	0.8	0.9	22.5	0.8	24.3	2	0.9	0	32.6	0.8	0.8	1	0	0.8	0.8	0.8	0.8	0.9	0.8	1	23	1.4	1.1	0.8	3.6	1.2	0.9	15.9	1.4	0.8	0.8	0.1	1.1	0	0.9	0.8	0	0.8	0.9	0.8	0.8	1	0.8	0.1	1	1	1.9	1.6	0	0.8	0	0.9	0.8	0.3	0	0	0.4	0	0	0.4	0	2.9	0	0	6.2	0	0	0.1	4.4	0.7	0.1	0.4	0	0.1	4.7	2	0	0	5.4	0.2	0	0	0.1	0.9	13.5	4.3	0.4	0.1	0	2.7	0	0.5	0.1	0	0	0	1.7	10.8	0.1	0	0.6	0	1.9	0	0.2	4.4	0.1	0	12.3	0.2	0	0.8	0.1	2	0.1	0.3	0	2.2	0	0	1.3	0	0.6	0	14.8	2.4	2.7	8.8	0	1.3	0	0	0.4	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22.5	24.3	0	32.6	23	1.4	0.9	15.9	0	1.6	6	3.2	0	0.2	0.2	0	33.3	0	0	2.3	0	0	0	0	0	0.4	0	0	0	0	0.1	0.4	0.4	2.3	0	0.1	0	0	0	0	0	0	1.5	0	0	0	0	0.1	0	0	0	0	0	0.5	1.1	1.6	0.1	0.1	0	0	0.1	Cardiomyocytes
FGF21		ENSG00000105550	Fibroblast growth factor 21	Q9NSA1	19	48755559-48758333	Predicted secreted proteins, RAS pathway related proteins		Growth factor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	113	liver: 37.8	Cell type enriched	Detected in some	12	Cardiomyocytes: 67.7	Cancer enriched	Detected in single	315	liver cancer: 33.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	HHSteC: 3.1;U-2 OS: 10.5	Not detected	Not detected			Low region specificity	Detected in all			HPA061286	Supported				Secreted to blood			254000				HPA061286: AB_2684466				unprognostic (1.64e-2)		unprognostic (3.62e-1)	unprognostic (3.21e-2)			unprognostic (3.42e-1)				unprognostic (1.54e-1)	unprognostic (1.85e-2)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	37.8	0	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0.4	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0.2	0	3.1	0	0	0	0.3	0	0.2	0	0	1.5	0	0.4	0	0	0	0	0	0.2	0	0	0	0	0	0	0.6	0	0	0	0.2	0	0.1	0	0	0	10.5	0	0	0.1	0.7	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	67.7	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
MYL7	MYL2A, MYLC2A	ENSG00000106631	Myosin light chain 7	Q01449	7	44138864-44141332	Predicted intracellular proteins		Motor protein, Muscle protein, Myosin		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	822	heart muscle: 639.9	Cell type enriched	Detected in single	8987	Cardiomyocytes: 8328.0	Cancer enriched	Detected in some	7	testis cancer: 3.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	19	BEWO: 14.8;CACO-2: 50.4;SuSa: 20.8	Not detected	Not detected							HPA013331, CAB033884, HPA039262	Enhanced											CAB033884: AB_2266773, HPA013331: AB_1854245, HPA039262: AB_2676418	unprognostic (1.00e-2)	unprognostic (7.99e-2)		unprognostic (4.36e-3)	unprognostic (2.31e-1)	unprognostic (2.51e-1)				unprognostic (1.28e-1)	unprognostic (7.85e-2)				unprognostic (1.67e-1)		unprognostic (7.28e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	639.9	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0	0.1	0.1	0.1	0.1	0	0.1	0.4	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	14.8	0	0	0.1	0	50.4	0	0	0.7	0	0	0.2	0	0	0.2	0	0	0	0.1	1.5	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.8	0.1	0.4	0.1	0	20.8	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	8328	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0.9	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
KCNT1	KCa4.1, KIAA1422, SLACK, Slo2.2	ENSG00000107147	Potassium sodium-activated channel subfamily T member 1	Q5JUK3	9	135702185-135795508	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel	Disease mutation, Epilepsy	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 29.7;skeletal muscle: 19.5	Cell type enriched	Detected in single	5	Cardiomyocytes: 4.5	Cancer enhanced	Detected in single		ovarian cancer: 0.8	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		OE19: 5.6;RH-30: 1.9;RPMI-8226: 4.2;SCLC-21H: 6.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA059880	Uncertain											HPA059880: AB_2684149	unprognostic (1.50e-3)	unprognostic (1.72e-2)	unprognostic (2.07e-3)	unprognostic (2.98e-13)	unprognostic (9.26e-2)	unprognostic (7.73e-2)	unprognostic (9.60e-2)	unprognostic (1.67e-1)	unprognostic (1.15e-1)	unprognostic (1.30e-3)	unprognostic (9.89e-2)	unprognostic (6.20e-2)	unprognostic (4.89e-7)	unprognostic (9.15e-2)	unprognostic (2.70e-1)	unprognostic (2.26e-1)	unprognostic (1.66e-2)	1.4	0.8	7.3	1	12.4	1	0.7	29.7	29.3	0.7	0.9	0.2	0	1	0.8	0.9	1.2	0.9	1.1	1.8	5.3	4.2	0.7	0.7	0.9	0.8	1.8	12	7.3	0.8	0.7	4.7	1.2	6.1	0.8	0.8	0	0.7	0.8	19.5	0.8	0.8	0.8	2.1	9.6	1.4	1.9	3.1	0	0.8	0	0.7	1.1	0.1	0	0	0.7	0	0	0.9	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0.1	0	0	0.2	0.1	0	0	0	0	0	0	0.1	0	0.1	0	0.2	0	0	0.1	5.6	0	0	1.9	4.2	0	0	6.3	1.3	0	0	0	0	0.3	0.1	0	0	0.3	0	0	0.1	0.4	0	0.1	0	0	0.2	0	0	0.9	0	0	0	0	0.1	0	0	0	0.1	0.7	0	0	0	0	0	7.3	12.4	29.7	29.3	5.3	4.2	1.8	12	6.1	3.1	0	0	0	0	0	0.6	4.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.7	0	0.7	0	0.5	0	0.9	0	0	0	0	0	Cardiomyocytes
LHX3		ENSG00000107187	LIM homeobox 3	Q9UBR4	9	136196250-136205128	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding	Disease mutation, Dwarfism	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	pituitary gland: 33.4	Cell type enriched	Detected in some	7	Cardiomyocytes: 13.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		RPMI-8226: 1.7;U-266/70: 5.2;U-698: 1.6	Not detected	Not detected			Not detected	Not detected																	unprognostic (4.17e-2)			unprognostic (4.72e-1)	unprognostic (1.33e-1)	unprognostic (2.57e-1)							unprognostic (3.31e-2)	unprognostic (6.18e-2)			0	0	0	0.4	0	1.2	0	0	2.5	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0.6	0	0.1	0	0	0	0	0	33.4	0	0.1	0	0	0.3	0	0	0	0.1	0	0	0	0.1	0	0.7	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0.9	0	0.3	0	0	0	0.1	0	0	0	0.3	0.2	0.1	0	0	0	0	0	0	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	1.7	0	0	0.4	0	0	0	0	0	0	0.5	0	0.2	0	0	0	5.2	0.6	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	1.8	13.4	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	1	0	0	0	0.1	0	0	0	0	0	Cardiomyocytes
NKX3-2	BAPX1, NKX3.2, NKX3B	ENSG00000109705	NK3 homeobox 2	P78367	4	13540830-13545050	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding, Repressor	Dwarfism	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 18.3;lymphoid tissue: 6.5	Cell type enriched	Detected in single	31	Cardiomyocytes: 3.1	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 4.6;NB-4: 12.7;NTERA-2: 7.2;THP-1: 7.6	Not detected	Not detected			Not detected	Not detected			HPA027564	Approved		Approved	Nucleoplasm						Nucleoplasm		HPA027564: AB_10601973	unprognostic (3.26e-2)	unprognostic (1.26e-1)	unprognostic (7.42e-3)	unprognostic (5.97e-2)	unprognostic (9.15e-3)	unprognostic (5.72e-2)	unprognostic (2.24e-5)	unprognostic (3.49e-2)	unprognostic (1.12e-1)	unprognostic (4.06e-2)	unprognostic (9.95e-2)	unprognostic (1.80e-1)	unprognostic (1.93e-8)	unprognostic (5.81e-2)	unprognostic (2.14e-1)	unprognostic (3.08e-2)	unprognostic (2.15e-1)	1.7	0	0.1	6.5	0.1	0	0.1	0.1	0.1	1.1	18.3	0.1	0.1	1.6	0.9	0.1	2.3	0.2	0.4	1.8	0.1	0	0.4	0.1	0.1	2	0.1	0.1	2.9	0.2	0	0.9	0.1	0.1	0.6	2.4	0.1	1.5	0.6	0.1	0.1	2	3.2	0.1	5.3	2.8	0.9	0.1	0.1	0.3	0.9	0.1	0.8	1.7	0	0	0	0	0	0	0	0	0.5	2.3	1.9	0.1	0	1.4	0	0	0	0.1	0.8	0.8	0	0	0	1	0	4.6	0	0	0	2.6	0.6	1.7	0	0.1	0	0.9	0	0.1	0	0	1.9	0	0.7	1.7	0	0.7	0	0.4	12.7	7.2	0	0.5	0	0.7	0.1	0.1	0	0.1	0	0	0	0.1	2.3	1	7.6	0	0.5	3	0.1	0.5	2.2	0	0	0.4	0.2	2.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	3.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
MYL2	CMH10	ENSG00000111245	Myosin light chain 2	P10916	12	110910819-110920722	Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins		Motor protein, Muscle protein, Myosin	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	11	heart muscle: 656.7;skeletal muscle: 672.9	Cell type enriched	Detected in some	10238	Cardiomyocytes: 17552.7	Group enriched	Detected in some	46	head and neck cancer: 31.5;prostate cancer: 25.5	Not detected	Not detected			Group enriched	Detected in some	31	memory B-cell: 3.8;naive B-cell: 2.4	Lineage enriched	Detected in single	38	B-cells: 3.8	Cell line enhanced	Detected in some		EFO-21: 4.3;HSkMC: 9.4;U-2 OS: 18.9	Not detected	Not detected			Not detected	Not detected			HPA019763, HPA039262	Supported		Uncertain	Microtubules					190000	Microtubules		HPA019763: AB_1854243, HPA039262: AB_2676418	unprognostic (2.07e-2)	unprognostic (1.37e-1)		unprognostic (1.39e-1)		prognostic unfavorable (2.60e-4)		unprognostic (1.32e-1)	unprognostic (4.05e-2)	unprognostic (4.82e-2)	unprognostic (2.05e-2)	unprognostic (2.20e-1)		unprognostic (1.76e-1)	unprognostic (2.84e-1)	unprognostic (3.55e-1)		3.6	0	0.1	0.1	0.1	0	0.8	0	0.1	0	0.1	0	0	0	0	6.4	8.9	0	0.2	656.7	0.1	0.1	0	0.1	0.1	0.2	0.1	0	0	0.1	0	0	0	0.1	6.1	0	0	7.7	0	672.9	0.1	0	0.1	0.2	0	0	0.4	0	0	2.4	59.4	10.5	0.3	0	3.8	0	0	0	0	0	0	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0.3	0.2	4.3	0	0.1	0.2	0	0.3	0	0	0	0	0	0	0.1	0	0	9.4	0	0.1	0.3	0	0.2	0	0	0	0.1	0	0	0.1	0	0	0	0	0.1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	18.9	0	0.1	0	0	1.7	0	1.9	0	0	0	0	0	0	0	3.8	0	0	0	2.4	0	0	0	0	0	0	0	0	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0	0	0	0.8	0	0.1	0	17552.7	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0.1	0	0	0	0	0	0.1	0.1	0.1	0	0	0	0	0	Cardiomyocytes
RBM24	dJ259A10.1, FLJ30829, RNPC6	ENSG00000112183	RNA binding motif protein 24	Q9BX46	6	17281346-17293875	Predicted intracellular proteins	Differentiation, mRNA processing, mRNA splicing, Translation regulation	RNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 41.0;skeletal muscle: 153.8;tongue: 37.3	Cell type enriched	Detected in some	8	Cardiomyocytes: 165.8	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		MAIT T-cell: 2.4	Lineage enriched	Detected in single	25	T-cells: 2.4	Cell line enhanced	Detected in many		LHCN-M2: 29.0;RH-30: 29.8;T-47d: 13.9	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA066927, HPA067231	Enhanced		Enhanced	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA066927: AB_2685750, HPA067231: AB_2685808	unprognostic (9.05e-3)	unprognostic (2.57e-1)	unprognostic (2.24e-1)	unprognostic (1.67e-3)	unprognostic (1.53e-1)	unprognostic (4.54e-4)	unprognostic (3.34e-2)	unprognostic (1.33e-2)	unprognostic (2.97e-3)	unprognostic (3.38e-2)	unprognostic (2.98e-2)	unprognostic (1.43e-1)	unprognostic (1.45e-1)	unprognostic (1.16e-2)	unprognostic (3.06e-2)	unprognostic (1.08e-2)	unprognostic (2.33e-4)	3.4	0.2	1.4	0.9	2.2	0.1	1.1	0.3	1.9	7	2.7	0.1	3	0.5	9.7	7.3	3.4	7.8	1.7	41	1.5	1.7	0.3	0.4	0.4	0.2	0.5	1.1	2.1	0.2	0.1	1.8	0.2	0.3	3.6	2.4	1.6	2.5	2.2	153.8	0.4	1.2	9.3	0.5	0.4	0.8	1.3	0.1	0.1	1.4	37.3	1.9	5.1	2.9	0	0	0	0	0	2.4	0	0.7	4.5	6	0	0	0	0	9.1	3.3	6.2	6.6	0	0.5	0	2.9	6.5	9.8	0	5.6	0.2	11.3	0	0.2	0	0.5	3.1	0.2	0	0.5	3.3	0	1.2	0.2	8	0.7	0	0	0	29	1.3	0	0	2	0	0.7	0	29.8	0	0	0	3.9	0.4	0	0	0.1	4.9	13.9	0.2	0	2.1	5	0	7.8	0	0	0	0.1	0	1.9	0	0	0	0	0	2.4	0	0	0.6	0	0	0	0	0	0	0	0	0	0	1.4	2.2	0.3	1.9	1.5	1.7	0.5	1.1	0.3	0.1	0	0	0	0.2	1	1.6	165.8	0	20.1	2.3	0	0	0.1	0	0	0.5	0.5	0	0	0	9.2	0.8	0.2	1.1	0	0.2	1.6	4.6	0	0	1	0	0	1.7	0	3.9	0.6	0.2	0	0.7	0.1	0	6.5	16.2	0.3	7.7	0.9	0.7	0	1.5	0.1	Cardiomyocytes
HAND1	bHLHa27, eHand, Hxt, Thing1	ENSG00000113196	Heart and neural crest derivatives expressed 1	O96004	5	154474972-154478264	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level		Tissue enhanced	Detected in some		heart muscle: 25.9;intestine: 35.1;smooth muscle: 14.2	Cell type enriched	Detected in some	8	Cardiomyocytes: 13.6	Group enriched	Detected in some	5	colorectal cancer: 0.6;testis cancer: 2.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	11	SH-SY5Y: 36.0;SuSa: 67.0	Not detected	Not detected			Not detected	Not detected			HPA040925	Uncertain		Uncertain	Nucleoplasm,Nuclear membrane						Nucleoplasm	Nuclear membrane	HPA040925: AB_10796563			unprognostic (2.37e-2)					unprognostic (8.29e-2)		unprognostic (2.46e-3)	unprognostic (7.23e-2)				unprognostic (5.21e-2)		unprognostic (6.38e-3)	0.2	6	0.1	9.7	0.1	0	0.1	0.1	0.1	0.1	35.1	0	0	4.4	0.1	0	0.1	0.1	5.3	25.9	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0.1	0.1	0	0.2	3.6	0	5.4	2.6	0.1	0.1	0	0.1	0.1	20.8	14.2	0.1	0.1	0.1	0.2	0	0.7	0.1	0	0	9.1	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	4.8	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	36	0	0	0	67	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0.1	0	13.6	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0.4	1.1	0	0	0	0.1	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.9	0	0	0	Cardiomyocytes
FGF12	FGF12B, FHF1	ENSG00000114279	Fibroblast growth factor 12	P61328	3	192139395-192767764	Disease related genes, Predicted intracellular proteins		Growth factor	Disease mutation, Epilepsy	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	adrenal gland: 21.5;brain: 31.9;heart muscle: 75.7	Cell type enriched	Detected in many	5	Cardiomyocytes: 381.1	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		AF22: 11.8;NTERA-2: 8.1;SCLC-21H: 18.9;U-251 MG: 11.3;WM-115: 13.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA071557			Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA071557: AB_2686417	unprognostic (1.67e-3)	unprognostic (1.29e-1)	unprognostic (2.26e-2)	unprognostic (2.50e-5)	unprognostic (1.75e-1)	unprognostic (5.66e-2)	unprognostic (1.04e-1)	unprognostic (1.80e-1)	unprognostic (8.03e-2)	unprognostic (2.11e-2)	unprognostic (4.00e-2)	unprognostic (9.19e-2)	unprognostic (1.87e-7)	unprognostic (2.41e-2)	unprognostic (5.36e-2)	unprognostic (5.59e-2)	unprognostic (5.99e-2)	1.2	21.5	8.8	0.7	15.8	0.6	1	17.7	31.9	0.9	0.9	1.9	0	1	1.2	0.7	1.5	1.5	0.9	75.7	6.8	4.1	2	0.9	1.2	0.7	5.1	15.8	1.1	4.9	0.7	2.9	0.8	22.3	1.3	0.8	1.1	3.6	4.2	1.1	0.7	0.7	1	2.7	6.8	0.9	1.7	2.8	0	1.4	0	0.7	0.8	0.8	1.1	0.3	1.2	0.4	0.5	0.4	0.1	0	0.8	11.8	0	0	0	0.1	0	0.1	1.1	1.4	0	0.1	0.6	5.7	0.2	0.2	0.1	0	0	1.3	0.1	0.1	2.4	5	0	0	0	0.7	0	0.2	0	0	2.9	0.1	0	0	0.1	0	3.3	0	0	8.1	5.4	0.2	0	0.1	0	3.7	1.4	18.9	0	0	0.4	0	1.4	0.9	0.2	0.3	4.9	2.5	0	11.3	0.1	1.8	0	1	0	13.7	1.2	0.2	0.5	0.2	0.3	0.4	1.1	0.2	0.2	0.1	0.5	0.4	0.3	0.6	0.5	0.4	0.3	0.3	0.1	8.8	15.8	17.7	31.9	6.8	4.1	5.1	15.8	22.3	2.8	0	0	0	4.3	0.6	77.1	381.1	0	1.4	3.4	5.2	3.9	0.1	6.6	0.7	15.9	4.9	0	0	11.4	0.2	0.8	1	0	0	0.1	31.8	0	8.6	0.3	21.4	6.4	0	1.7	0	0	2.9	4	0.2	1.1	0.2	13	0	0.5	2.1	6.1	0.1	0	0	0	1.4	Cardiomyocytes
TNNC1	TNNC	ENSG00000114854	Troponin C1, slow skeletal and cardiac type	P63316	3	52451102-52454070	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Muscle protein	Cardiomyopathy, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	heart muscle: 431.6;skeletal muscle: 765.7	Cell type enriched	Detected in many	8	Cardiomyocytes: 2506.5	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enhanced	Detected in some		MAIT T-cell: 4.0	Lineage enriched	Detected in single	7	T-cells: 4.0	Cell line enhanced	Detected in some		CACO-2: 24.3;CAPAN-2: 12.2;EFO-21: 24.4;HeLa: 16.0;Hep G2: 16.2;HSkMC: 25.3;U-2 OS: 37.5	Region enriched	Detected in many	4	cerebral cortex: 88.3	Not detected	Not detected			CAB002450, HPA044848, HPA056897	Enhanced		Approved	Nucleoplasm,Actin filaments,Mitochondria					260000	Nucleoplasm, Actin filaments, Mitochondria		CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269	unprognostic (2.18e-2)	unprognostic (1.70e-1)	unprognostic (8.66e-2)	unprognostic (3.43e-1)	unprognostic (4.00e-2)	unprognostic (1.88e-2)	unprognostic (1.11e-1)	unprognostic (1.43e-1)	unprognostic (1.53e-1)	unprognostic (3.92e-1)	unprognostic (1.03e-1)	unprognostic (1.07e-1)	unprognostic (2.15e-2)	unprognostic (4.95e-2)	unprognostic (2.31e-1)	unprognostic (4.15e-2)	unprognostic (4.86e-1)	2	0.3	0.1	0	0.1	0	0.7	0.2	0.1	0.2	0.1	0	0	0	0.1	17.8	12.8	0.1	0	431.6	0.1	0.1	0.6	0.1	2.6	0	0.1	0	0.1	0.2	0	0.6	0.2	0.5	5.5	0.1	0.7	10.4	0	765.7	0.4	0.1	0.1	0.7	0.1	0.1	0.7	0	0	3	86.9	8.7	0.4	0.2	0.2	0.6	0	0	0	4	0.5	0.2	1.8	1.3	0.2	0	0.2	2.9	0.1	0.1	0.1	0.1	24.3	12.2	0.2	24.4	3.5	0	0.1	0	0.1	0	0.4	0.6	0.1	16	16.2	0.1	0.1	0	25.3	0.4	0	0.2	0.2	0	0.7	0	1.9	0.7	0	0	0.2	0.2	5.4	0.2	0	1	0.8	1.2	4.6	0	0	0.1	2.5	0	1.5	9.8	0.2	0	0	37.5	0.3	0	1	0.4	0.3	0.1	0.2	0	0	0	0	0.7	0	4	0.2	0.9	0.5	0	0.1	1.4	0.5	0	0	0	0.6	2.5	0.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.5	0	116.1	13	0	0.6	1.3	0.2	2506.5	0	0	7.9	3.5	2	44.2	23.2	6.6	0.6	0	0.7	0	11.8	4	14	0.6	0	0.6	4.1	0	318.5	0.6	0	3.6	20.8	1	5	0	0.3	1.5	4.4	0	166.9	0.5	0	0	15.5	1.2	0.4	0.6	26	0.8	1.5	4.1	Cardiomyocytes
SMYD1	BOP, KMT3D, ZMYND22	ENSG00000115593	SET and MYND domain containing 1	Q8NB12	2	88067780-88113387	Enzymes, Predicted intracellular proteins	Transcription, Transcription regulation	DNA-binding, Methyltransferase, Repressor, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	10	heart muscle: 45.9;skeletal muscle: 103.7;tongue: 36.4	Cell type enriched	Detected in single	1107	Cardiomyocytes: 207.9	Cancer enhanced	Detected in some		stomach cancer: 1.6	Region enriched	Detected in single	4	cerebral cortex: 1.4	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	HSkMC: 5.6	Low region specificity	Detected in many			Not detected	Not detected			HPA062282	Enhanced											HPA062282: AB_2684736	unprognostic (1.93e-2)		unprognostic (2.49e-1)		unprognostic (4.09e-2)	unprognostic (8.51e-3)			unprognostic (2.74e-1)		unprognostic (3.91e-1)			unprognostic (8.81e-3)	unprognostic (1.40e-1)			2.7	0	0.1	0.1	0.3	0	1.2	0	1.4	0	4.6	0	0	0.4	0	3.4	2.5	0	0.2	45.9	0.1	0	0	0	0	0	0.1	0.1	0	0	1.8	0	0	0	0.9	0.4	0	1.5	0	103.7	0	4.4	6.3	0.1	0	2.6	0.1	0	0	0.2	36.4	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.6	0	0	0	0	0	0	0	0	1.1	0	0	0	0.5	0	0	0	0.2	0.2	0	0	0	0	0	0	0.4	0.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0	1.4	0.1	0	0.1	0.1	0	0	0	0	0	0	0	0	207.9	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
MFN2	CMT2A2, CPRP1, KIAA0214, MARF	ENSG00000116688	Mitofusin 2	O95140	1	11980181-12013514	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Apoptosis, Autophagy, Unfolded protein response	Hydrolase	Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 100.9;skeletal muscle: 111.1	Cell type enriched	Detected in all	8	Cardiomyocytes: 308.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA030554, CAB079902	Uncertain		Supported	Mitochondria						Mitochondria		CAB079902: AB_2724683, HPA030554: AB_10603018	unprognostic (9.52e-2)	unprognostic (1.80e-1)	unprognostic (1.42e-1)	unprognostic (4.38e-2)	unprognostic (8.36e-2)	unprognostic (9.71e-2)	unprognostic (1.89e-1)	unprognostic (2.44e-1)	unprognostic (3.45e-1)	unprognostic (2.19e-2)	unprognostic (1.43e-1)	unprognostic (3.55e-1)	prognostic favorable (2.36e-8)	unprognostic (4.69e-2)	unprognostic (2.76e-1)	unprognostic (8.84e-3)	unprognostic (2.12e-1)	12.8	10.1	16.4	8.9	20.3	17.2	10.1	15.9	32.1	8.7	17	17	11.2	16.5	12.1	8.7	20.1	9	9	100.9	17.9	16	14.8	20.4	10.6	8	18.8	19.3	10.2	9	22	9.3	12.9	20.8	14.1	13.2	16.5	10.7	23.7	111.1	18.8	25.7	22.9	15.7	10.2	14	11.3	10.9	7.3	18.7	28.5	12.1	16.3	10.6	7.3	8.9	18.5	16.9	5.8	10.2	13.4	26	15.9	18.1	23.8	18.3	13.8	21	20.6	19.1	28.3	22.1	26.3	17.4	19.1	22.4	24.9	18.6	27.9	29.9	47.8	25.4	69.2	22.7	27.3	25.6	20.4	19	27.7	17.2	17.4	36.9	39.8	36.9	12.2	19.9	10.3	28.2	16.8	20.9	13.1	16.8	12.7	12.5	17.5	23.5	19.7	26.4	17.8	17	17.4	21.1	13.8	24.2	25.8	23.9	14.2	13.9	16.7	19.9	19	19	28.8	21.5	20.1	21.1	31.3	22.5	31.2	20.5	8.5	10.3	7.1	9.6	13.5	10.2	7.3	7.2	8.6	8.9	6.6	6.3	8	18.5	5.8	16.9	4.6	8	13.4	16.4	20.3	15.9	32.1	17.9	16	18.8	19.3	20.8	10.9	20.8	18.6	11.5	8.2	20.3	24.8	308.6	12.7	12	14.8	14	11.8	12.2	18.3	12.7	3.6	12	31.1	23.3	17.3	13.2	9.3	12.5	10.4	39.2	14.2	28.6	17.3	13.5	18.1	4.4	6.6	11.8	16.9	10	20.9	11.6	13.9	14	14.2	13.3	18.6	12.9	14.4	27.7	16.8	26.3	21.1	9.6	22.1	12.9	Cardiomyocytes
TNNT2	CMD1D, CMH2, CMPD2	ENSG00000118194	Troponin T2, cardiac type	P45379	1	201359008-201377762	Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins		Muscle protein	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	241	heart muscle: 679.2	Cell type enriched	Detected in many	289	Cardiomyocytes: 11884.8	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	18	RH-30: 189.8	Low region specificity	Detected in many			Not detected	Not detected			CAB015371, HPA015774, HPA017888	Enhanced		Uncertain	Nucleoplasm,Nucleoli,Focal adhesion sites		No	No		50000	Nucleoplasm, Nucleoli	Focal adhesion sites	CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355	unprognostic (1.45e-1)	unprognostic (2.74e-1)	unprognostic (2.33e-4)	unprognostic (1.85e-1)	unprognostic (7.29e-2)	unprognostic (1.79e-1)	unprognostic (1.80e-1)	unprognostic (1.24e-1)	unprognostic (1.42e-1)	unprognostic (2.91e-2)	unprognostic (1.38e-1)	unprognostic (8.63e-2)	unprognostic (5.50e-3)	unprognostic (2.94e-1)	unprognostic (1.61e-1)	unprognostic (4.76e-2)	unprognostic (9.98e-2)	0.1	0.3	0.1	0.1	0.7	0	0.8	0	2.1	0	0	0	0	0	0.1	0.1	0.3	0	1.2	679.2	0.9	0	1.9	0	0.7	0.3	0.1	1.1	0.1	0.3	0	0.2	0.7	0.1	0.7	0	0	0.2	0.1	2	1.3	0	2.8	0.3	0	0	0	0	0	0.2	0.4	0	2.7	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0.2	0	0	0	0	0	0.9	0	0	0	0	0	0	0.1	0.1	0	0.1	0	7.2	0	0	0	0	0	0	0	0	4	0.1	0	0	0.4	0.5	0	0	189.8	0	0	0	0.2	0.1	0	0.2	0	10.5	0	0	0	0	5.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.7	0	2.1	0.9	0	0.1	1.1	0.1	0	3	4	0	1.1	3.1	1	11884.8	0	0	1.2	1.8	0	2.3	0	0.5	9.4	0	1.6	0	0.3	0.9	41.1	0.5	0	0	2.7	0	0	0	0	13.6	0.6	0	0	4.6	0.5	0	0.7	0.8	1.1	0.8	0.5	0	0.4	0	0.2	6.4	3.5	0	2.8	1.4	Cardiomyocytes
FILIP1	FILIP, KIAA1275	ENSG00000118407	Filamin A interacting protein 1	Q7Z7B0	6	75291859-75493738	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 37.6;smooth muscle: 44.7	Cell type enriched	Detected in many	5	Cardiomyocytes: 542.5	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		EFO-21: 10.7;HUVEC TERT2: 2.7;RPTEC TERT1: 3.0;U-266/70: 10.7	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA053564	Enhanced		Approved	Plasma membrane,Actin filaments		No				Plasma membrane, Actin filaments		HPA053564: AB_2682192	unprognostic (4.90e-2)	unprognostic (3.77e-2)	unprognostic (9.77e-3)	unprognostic (3.83e-1)	unprognostic (1.52e-1)	unprognostic (4.98e-1)	unprognostic (2.27e-2)	unprognostic (1.51e-1)	unprognostic (1.06e-1)	unprognostic (5.17e-3)	unprognostic (3.29e-2)	unprognostic (2.23e-1)	unprognostic (1.30e-3)	unprognostic (3.97e-3)	unprognostic (2.34e-1)	unprognostic (4.65e-2)	unprognostic (7.66e-3)	11	1.3	2	6.3	3	0.2	2.5	0.6	2.5	8.2	10.9	0	4.1	1.3	8.8	4.1	10.5	4.5	5.9	37.6	3.7	1.2	2.7	2.4	7.5	1.2	1.1	0.7	4.4	1.4	5.4	5.1	3.7	0.8	14.9	2.6	4.3	1.5	2.8	29.4	0.9	4.1	44.7	1.4	0.6	3.9	2.8	0	0	2.3	10.8	0.7	30.7	6	1.4	0.9	1.8	0.8	0.6	0.9	0	0.1	1.9	0.3	0.1	0.1	0.3	0.2	0.3	0.1	0.1	0	0	0.2	0.2	10.7	0	0.1	0.1	0.1	0	0.1	0.3	0.2	0.2	0.2	0.1	0	0.3	0.2	1.4	0.1	0.2	0.1	0.1	2.7	0.4	0.1	0.4	0	0.1	0	0.1	0.2	0	0	0.1	0	0.1	3	0.6	0.2	0.2	0	0.1	0.1	2.5	0.1	0.4	0	0.1	0	0.1	0.1	10.7	1	0.1	0.1	0.5	0.1	1.2	0.6	0.6	0.6	0.6	0.5	0.6	0.5	0.4	0.2	1.4	0.9	0.6	1.8	0.6	0.8	0.9	0.3	0	2	3	0.6	1.9	3.7	1.2	1.1	0.7	0.8	0	119.1	78.3	0	0.6	0.6	3.3	542.5	0	83	14.8	0	0	0.7	1.7	0	36.1	36.8	0	0	0.3	0.3	26.7	0.6	1.1	0.6	1.2	0	0	58.3	1.9	16.2	2.3	2	1.7	0	0	4.5	0	0	4.2	0	3.8	90.5	88.2	4.5	6.4	0.6	0.7	0	0	0.4	Cardiomyocytes
GHRH	GHRF	ENSG00000118702	Growth hormone releasing hormone	P01286	20	37251082-37261835	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	5	brain: 37.3	Cell type enriched	Detected in single	4	Cardiomyocytes: 1.1	Cancer enriched	Detected in some	7	urothelial cancer: 8.5	Region enriched	Detected in some	15	hypothalamus: 37.3	Cell type enhanced	Detected in single		eosinophil: 2.7	Low lineage specificity	Detected in single			Group enriched	Detected in some	7	NTERA-2: 3.6;U-266/84: 12.7	Region enriched	Detected in some	9	hypothalamus: 38.7	Low region specificity	Detected in all								Secreted in other tissues								unprognostic (4.78e-2)				unprognostic (2.57e-2)									unprognostic (1.58e-1)	unprognostic (3.10e-1)			0.1	2.7	0.3	0.1	2.4	0	0.6	0.1	1	0.1	4	0.1	0.1	8.1	0.1	0.1	0.7	0	0.1	6.5	0.1	37.3	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	7.7	0.1	0.1	0.1	1.9	0.1	0.1	7.5	0.4	0.1	0.1	0.1	0.1	0	0.7	2.7	0.6	0	0	0	0	0	0.7	0	0	0	0.7	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.3	0	0	0	0	3.6	0	0	0.1	0.1	0	0	0	1.2	0	0	0.2	0	0.1	0	0	0	0	0	0	0.1	0	12.7	0	0	0	0	0	0.6	2.7	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0.3	2.4	0.1	1	0.1	37.3	0.1	0.8	0.1	0.1	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	Cardiomyocytes
CASQ2	PDIB2	ENSG00000118729	Calsequestrin 2	O14958	1	115700007-115768781	Disease related genes, Predicted intracellular proteins		Muscle protein	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 172.4;skeletal muscle: 46.5;smooth muscle: 45.9	Cell type enriched	Detected in some	8	Cardiomyocytes: 697.0	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Cell type enhanced	Detected in single		neutrophil: 1.7	Lineage enriched	Detected in single	12	granulocytes: 1.7	Cell line enriched	Detected in single	19	HSkMC: 17.7	Region enriched	Detected in many	5	cerebellum: 48.4	Low region specificity	Detected in single			HPA027285, HPA055298	Enhanced				Intracellular and membrane							HPA027285: AB_1845933, HPA055298: AB_2682777	unprognostic (1.13e-1)	unprognostic (1.52e-1)	unprognostic (9.70e-3)	unprognostic (1.28e-1)	unprognostic (3.41e-2)	prognostic unfavorable (2.30e-4)	unprognostic (1.03e-4)	unprognostic (1.78e-1)	unprognostic (2.37e-1)	unprognostic (1.92e-1)	unprognostic (1.34e-1)	unprognostic (8.92e-2)	unprognostic (7.20e-3)	unprognostic (1.82e-2)	unprognostic (1.80e-1)	unprognostic (2.83e-1)	prognostic unfavorable (2.25e-5)	4.9	0.6	0.4	1.8	0.7	0.1	1.6	0.7	0.5	4.3	11.1	0.6	1.1	0.6	6.2	6.3	13.6	3	1.9	172.4	0.4	0.5	0.7	0.2	1.1	0.2	0.6	0.5	5	0.3	0.5	0.2	0.3	1	12.1	3.1	4.6	1.8	3.6	46.5	1	3.2	45.9	0.5	0.2	3.5	1.9	0	0	1.4	17.2	1.8	36.4	1.8	0	0.1	1.7	0	0	0.1	0	0	0	0.1	0	0.2	0.1	0.3	0	0	0	0	0.1	0.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	17.7	0.3	0	0.1	0.1	0	0.1	0	0.2	0	0.7	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0.9	0.4	0	0	0.1	0	0	0	0.1	0	0	0	0	0.8	0.7	0	0.1	0	0	0	0	0	0.1	0	0	0	0	1.7	0	0	0.1	0	0	0.4	0.7	0.7	0.5	0.4	0.5	0.6	0.5	1	0	0	0	0	0.1	0.6	0	697	0	0	0	1.8	0	0.1	0	0	15.5	0	0	0	0	0.1	0.4	0.1	0	0	0	0	0	0	0	16.5	0	0	0	0	0	0	0	0	0.7	0	0	90.5	23.9	0.1	0.2	0.3	0	0	0	0	Cardiomyocytes
MYOT	LGMD1, LGMD1A, TTID	ENSG00000120729	Myotilin	Q9UBF9	5	137867791-137887851	Disease related genes, Predicted intracellular proteins		Actin-binding, Muscle protein	Disease mutation, Limb-girdle muscular dystrophy, Myofibrillar myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	30	skeletal muscle: 297.3;tongue: 85.1	Cell type enriched	Detected in some	8	Cardiomyocytes: 25.7	Cancer enhanced	Detected in some		head and neck cancer: 3.7	Low region specificity	Detected in single			Cell type enhanced	Detected in single		plasmacytoid DC: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HEK 293: 1.6;HeLa: 2.4;U-266/70: 1.7	Not detected	Not detected			Not detected	Not detected			HPA037733, HPA037734	Enhanced											HPA037733: AB_10697082, HPA037734: AB_2675638	unprognostic (5.85e-2)	unprognostic (2.38e-2)	unprognostic (6.93e-2)	unprognostic (3.08e-1)	unprognostic (1.27e-1)	prognostic unfavorable (8.85e-4)	unprognostic (8.03e-2)	unprognostic (1.17e-2)	unprognostic (1.54e-2)	unprognostic (2.02e-2)	unprognostic (6.44e-2)	unprognostic (1.14e-1)	unprognostic (7.56e-4)	unprognostic (1.72e-2)	unprognostic (2.42e-1)	unprognostic (2.10e-1)	unprognostic (1.40e-1)	2.8	0.3	0.6	0.2	1.4	0.1	0.1	0.1	0.4	0.3	1	0	0	0.3	0.1	6	6.2	0.1	0.2	6.2	0.7	0.4	0.2	0.1	0.1	0.1	0.9	0	0.1	0.1	0.1	0	0.1	0.1	2.4	0.3	0	3.6	0.6	297.3	0.1	0.4	0.2	0.7	0.1	0.2	0.1	0.6	0	2.2	85.1	6	0.2	0.4	0.8	1	0	0.1	0.4	0.6	0	0.5	0.3	0	0	0.3	0.2	0.1	0.1	0	0	0	0	1.2	1.1	1.1	0	0	0.1	0	0.3	0	0.5	1.6	0.4	2.4	0	0	0	0.3	1.4	0.4	0	0	0.4	0	1.1	0.2	1.1	1.2	0	0.5	0.1	0	0	0	0	0.1	0.1	0	0.3	0	0.1	0.7	0	0.8	0	0	0.2	0.6	0.1	0.5	0	0	1.7	0.7	0	0.7	0.3	0.3	0	0	0	0.2	0	0	0	0.6	0.1	0	0.8	0.5	0.2	0	0.4	0.1	1	0	0	0.6	1.4	0.1	0.4	0.7	0.4	0.9	0	0.1	0.6	0	0	0	0.5	0.2	0	25.7	0	0	0	0	2	0	0	0	0.7	0	0	0	0	0	0	0.3	0	0.2	0	0	0	1.3	0	0	0.9	0	3.3	0	0	0	0	0	0	0	0.5	0	0	0.2	0.1	0	0	0	0.1	0	Cardiomyocytes
POPDC2	POP2	ENSG00000121577	Popeye domain containing 2	Q9HBU9	3	119636457-119665324	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	heart muscle: 90.5	Cell type enriched	Detected in many	4	Cardiomyocytes: 250.7	Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	10	SH-SY5Y: 26.1	Not detected	Not detected			Not detected	Not detected			HPA024255	Enhanced											HPA024255: AB_1855545	unprognostic (1.13e-1)	unprognostic (1.17e-3)	unprognostic (8.91e-3)	unprognostic (9.48e-2)	unprognostic (5.56e-2)	unprognostic (7.64e-2)	unprognostic (2.73e-2)	unprognostic (2.43e-1)	unprognostic (3.18e-2)	unprognostic (1.72e-2)	unprognostic (5.86e-3)	unprognostic (1.80e-1)	unprognostic (1.24e-2)	unprognostic (6.26e-3)	unprognostic (1.66e-2)	unprognostic (2.12e-1)	unprognostic (2.06e-2)	1.3	0.3	0.2	1	0.2	0	0.6	0.3	0.2	1.8	16	0.2	7.6	0.6	2	1.3	3.3	1.8	6.1	90.5	0.2	0	0.5	0.3	0.3	1.4	0.2	0.3	0.8	0.7	0.1	0.2	0.3	0.3	5	1.5	0.3	0.6	13.4	12.1	0.4	2.2	12.6	0.2	0.5	2.4	0.5	0.2	0.3	0.5	3.8	0.8	10.2	1.1	0.9	0.7	2.1	3	0.3	2.2	0.4	0	0.1	0.4	0	0.2	0.1	0	0.2	0.1	0	0	0	0	0	0.2	0	0	0	0.2	0	0.3	0.9	0	0.1	0.1	0.1	0.1	0	0.5	0.2	0.1	0	0.1	0	0	0.1	0	0.9	0	0	0	0.2	0.2	0	0.1	0.1	0	0	0.1	0	0.2	26.1	0	0	0.4	2.5	0	0.2	0.1	0.1	0	0.2	0.1	0.7	0	0.1	0.1	0.2	0.5	2.1	0.1	1.3	0.9	0.1	1.1	0.3	1.1	1	0.1	0.9	2.2	0.7	0.1	0.3	3	0.7	1.6	0.4	0.2	0.2	0.3	0.2	0.2	0	0.2	0.3	0.3	0.2	0	0.3	0	0.2	0.3	2.4	250.7	0	2.7	1.2	0	0	0.4	0	0.4	0.2	3.6	0.3	0	0.2	0.1	1.4	0.7	1.1	0	1.3	1.6	2.9	1.3	1.2	0.4	1.1	2.2	0	2.8	0.6	1.2	0.7	0	1.8	0.3	2.8	58.2	8.5	0.5	0.4	0.5	1	1	0.4	0.2	Cardiomyocytes
GJA3	CX46, CZP3	ENSG00000121743	Gap junction protein alpha 3	Q9Y6H8	13	20138255-20161049	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters			Cataract, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 23.1;parathyroid gland: 6.2	Cell type enriched	Detected in some	10	Cardiomyocytes: 12.5	Cancer enhanced	Detected in some		melanoma: 3.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		A-431: 5.6;CAPAN-2: 10.2;HL-60: 8.4;U-266/84: 5.9	Not detected	Not detected			Not detected	Not detected			HPA014821	Supported											HPA014821: AB_2669097	unprognostic (2.32e-1)	unprognostic (1.01e-1)	unprognostic (4.37e-2)	unprognostic (2.58e-3)	unprognostic (2.98e-2)	unprognostic (1.04e-2)	unprognostic (6.87e-3)	unprognostic (1.84e-1)	unprognostic (1.73e-1)	unprognostic (7.52e-2)	unprognostic (7.70e-2)	unprognostic (4.02e-2)	unprognostic (9.65e-8)	unprognostic (2.87e-1)	unprognostic (1.91e-1)	unprognostic (2.55e-2)	unprognostic (8.04e-3)	0.2	0	0.1	0.1	0.9	0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0	0.3	0.1	0.8	0.1	0.5	23.1	0.1	0	1.2	0.1	0.2	0.1	0.1	0.1	0.1	0.3	6.2	0.1	3.9	0.2	0.4	0	0.2	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.2	0	4.2	0.1	0.2	0.1	1	1.6	0.1	0.4	0.6	0	0	0	0	0.4	0	5.6	0.3	0	5	0.2	1.5	0	0.7	4.7	0.8	1	0.5	10.2	0	0.2	1.7	1.7	0.1	3.3	2.8	0.7	0.2	2.6	2.4	0	0	0.1	8.4	0	0.3	1.6	0.2	0.5	0	0	3.8	0.6	0	0.2	0	0	0	0.7	0.1	2	0.4	0	0	0	0.7	0	0	0.4	0	5	0.2	1.1	1.9	0	0	0	2	0.3	2.3	5.9	0	0	0.1	4	0	0	0	0.4	0	0	0.6	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0.9	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0	0	0	0	0.1	0	12.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	1.3	0	0	0	0	0	Cardiomyocytes
FABP3	FABP11, H-FABP, MDGI, O-FABP	ENSG00000121769	Fatty acid binding protein 3	P05413	1	31365625-31376850	Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins	Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	9	heart muscle: 420.9;skeletal muscle: 129.4	Cell type enriched	Detected in many	6	Cardiomyocytes: 2447.6	Cancer enhanced	Detected in all		renal cancer: 92.9	Low region specificity	Detected in all			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enriched	Detected in some	5	ASC TERT1: 120.7	Low region specificity	Detected in all							CAB017830, HPA055754	Enhanced		Uncertain	Golgi apparatus,Plasma membrane,Focal adhesion sites				1640000	4400000	Focal adhesion sites	Golgi apparatus, Plasma membrane	CAB017830: , HPA055754: AB_2682909	unprognostic (2.07e-2)	unprognostic (2.50e-2)	unprognostic (1.32e-3)	unprognostic (1.73e-2)	unprognostic (2.05e-1)	unprognostic (1.62e-1)	unprognostic (6.07e-3)	unprognostic (1.04e-1)	unprognostic (6.86e-2)	unprognostic (1.18e-1)	unprognostic (2.85e-1)	unprognostic (1.67e-1)	prognostic favorable (1.54e-7)	unprognostic (5.80e-3)	unprognostic (3.45e-1)	unprognostic (7.38e-3)	unprognostic (9.76e-3)	2.3	5.2	8.1	0.7	6	0.5	22.7	1.4	14.6	3.9	1.3	0.8	3.4	0.7	6.8	5.3	3.1	2.8	1.1	420.9	11	5.3	21.3	1.9	4.3	1.3	9.8	6	2.2	0.4	0.3	0.7	1.1	13.7	5	1.5	3	4.4	14	129.4	0.9	0.6	13	3.4	3.9	3.6	2	1.3	0.1	1.7	31.6	2.2	2.5	2.5	1.4	0.5	0	0.9	0.2	0.9	0.6	0.1	0	3.3	0.2	23.1	120.7	1.1	0.9	8.9	0.1	3.2	0.2	0.9	0.2	12.8	2.5	0	0.3	0.9	0	0.1	0.1	0.5	0.4	1.1	2.4	1.5	0.2	0	10.7	0	2.4	0	0.3	0	0.1	0.2	0	1.1	0	0	0.2	6.1	0	0.4	0.1	1.2	0	2.9	0	0.3	0	0.5	0	13.9	7.1	0.1	1.4	0.3	0.2	0.1	2.1	0.2	0.1	0.4	0.1	0.5	0.1	0.3	0	0.4	0	0.9	0.9	0.6	0.2	0.5	0.5	0.5	1.4	0	0.9	0	0.2	0.1	0.4	0.6	0.6	8.1	6	1.4	13.3	11	5.3	9.8	6	13.7	1.3	0	1.7	0.8	1	3.2	3.1	2447.6	5.1	2.7	2.3	26.2	2	2.1	383	0.3	2.1	0.8	0	0	0.3	1.3	14.9	3.8	1.1	0	96.1	7.9	0	3.7	20	4.2	6.4	17.6	8.5	0	0	2.7	0.5	3.6	7.4	399.5	8.1	0	32.3	0.3	0.1	2.6	1.4	1	0.1	5.2	Cardiomyocytes
LDB3	CMD1C, KIAA0613, PDLIM6, ZASP	ENSG00000122367	LIM domain binding 3	O75112	10	86668449-86736068	Disease related genes, Plasma proteins, Predicted intracellular proteins			Cardiomyopathy, Disease mutation, Myofibrillar myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	21	heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3	Cell type enriched	Detected in some	41	Cardiomyocytes: 1579.0	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HSkMC: 5.9;hTERT-RPE1: 5.8;SCLC-21H: 9.6;SK-MEL-30: 4.6	Low region specificity	Detected in all							HPA048955	Enhanced		Supported	Nucleoplasm,Focal adhesion sites,Cytosol					450000	Focal adhesion sites, Cytosol	Nucleoplasm	HPA048955: AB_2680568	unprognostic (1.60e-1)	unprognostic (9.01e-2)	unprognostic (4.87e-2)	unprognostic (6.92e-2)	unprognostic (5.55e-2)	unprognostic (1.50e-2)	unprognostic (2.57e-2)	unprognostic (1.36e-1)	unprognostic (2.79e-2)	unprognostic (7.61e-2)	unprognostic (2.54e-3)	unprognostic (3.55e-2)	unprognostic (4.72e-4)	unprognostic (3.07e-2)	unprognostic (1.60e-1)	unprognostic (1.62e-2)	unprognostic (3.16e-1)	6.4	0.4	0.9	1.3	1.6	0.2	0.5	0.1	1.3	2.8	2.3	0	4.9	0.4	4.2	9.9	9.9	1.3	1	213.9	1.7	1	0.3	0.2	0.4	0.2	2.6	0	1.5	0.3	0.3	0.1	0.5	0	4.4	0.8	4.7	7.6	3.1	329.7	0.3	1.2	3.6	6.7	0.2	0.7	0.5	0	0	2.8	110.3	10.2	1.9	0.9	0.9	0.6	1.8	0.4	0.6	0.6	0	0.3	0.2	0.4	3.1	0.4	0.1	0.3	0.4	0.3	0.1	0.2	0.3	0.3	0.2	0.6	0	0.7	0.4	0.2	0	0.1	0.9	0.7	0.7	0.9	0.1	0.1	0.1	1.6	5.9	0.5	0.1	0	5.8	0	0.7	0.2	1.8	0.3	1.5	0.4	0.2	0.4	0.4	0.3	0	2	0.1	0	1.1	9.6	1.8	0.3	0.2	4.6	1.4	0.3	0.2	0	0.3	0.5	0.4	0.1	0.2	0.6	0.4	0.7	0.3	0.5	1.8	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.3	0.2	0.9	0.5	0.6	1.4	0.6	0.4	0.6	0.3	0	0.9	1.6	0.1	0.6	1.7	1	2.6	0	0	0	0	0	0	0.5	0.9	1.7	1579	0	0	0	1.8	0	0.1	0	0	18.3	0.7	0	0	1	0	0.7	0.3	0	0	0.1	0	0	0	0	13.2	10.3	0.4	1.7	0	0	1	0.1	0	6.3	0	3.4	38.8	33	0.6	1	0	0	0	0	0.1	Cardiomyocytes
OPN4	melanopsin, MOP	ENSG00000122375	Opsin 4	Q9UHM6	10	86654557-86666848	G-protein coupled receptors, Predicted membrane proteins, Transporters	Biological rhythms, Sensory transduction	G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	5	brain: 21.2;skeletal muscle: 14.6	Cell type enriched	Detected in single	34	Cardiomyocytes: 3.4	Not detected	Not detected			Region enhanced	Detected in many		basal ganglia: 21.2	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		PC-3: 1.1	Not detected	Not detected			Not detected	Not detected			HPA039147	Approved											HPA039147: AB_10673304	unprognostic (3.67e-3)	unprognostic (1.40e-2)	unprognostic (3.02e-2)	unprognostic (1.62e-1)	unprognostic (7.03e-3)	unprognostic (2.89e-2)		unprognostic (3.26e-1)	unprognostic (9.54e-2)	unprognostic (5.68e-2)	unprognostic (8.88e-3)		unprognostic (1.93e-6)	unprognostic (4.10e-2)		unprognostic (5.58e-2)	unprognostic (6.76e-2)	3.5	0.3	5.4	0.4	21.2	0.2	1.1	0	5.1	0.6	0.9	0	0	0.5	0.4	0.4	0.6	0.4	0.5	3.1	3	0.1	0.3	0.2	0.3	0.2	0.2	3.3	0.3	0.4	3.6	0.6	0.5	0	0.2	0.7	1.2	1.6	0.2	14.6	1.2	1.1	0.5	0	0.3	0.5	0.5	2	0	1.4	2.7	0.3	0.5	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.2	0	0	0	0	0	0.9	0.1	0	0	0	0	0	0.5	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	1.1	0	0	0.3	0	0	0.7	0	0	0	0	0	0	0	0	0.7	0.4	0	0	0	0	0	0.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.4	21.2	0	3.5	3	0.1	0.2	3.3	0	2	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
APOBEC2	ARCD1, ARP1	ENSG00000124701	Apolipoprotein B mRNA editing enzyme catalytic subunit 2	Q9Y235	6	41053304-41064511	Enzymes, Predicted intracellular proteins	mRNA processing	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	13	heart muscle: 58.4;skeletal muscle: 163.0;tongue: 53.9	Cell type enriched	Detected in many	5	Cardiomyocytes: 89.6	Cancer enhanced	Detected in some		pancreatic cancer: 4.9	Not detected	Not detected			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		BEWO: 2.2;CACO-2: 9.0;HSkMC: 3.1;SuSa: 2.4	Not detected	Not detected			Low region specificity	Detected in all			HPA014252, HPA017957	Enhanced											HPA014252: AB_1844932, HPA017957: AB_1844933	unprognostic (5.05e-2)	unprognostic (5.55e-2)	unprognostic (1.87e-1)	unprognostic (2.77e-1)	unprognostic (2.51e-2)	unprognostic (8.16e-3)	unprognostic (1.43e-1)	unprognostic (7.22e-2)	unprognostic (1.24e-1)	unprognostic (2.50e-2)	unprognostic (1.21e-1)	unprognostic (3.87e-1)	unprognostic (2.01e-2)	unprognostic (7.02e-2)	unprognostic (3.69e-1)	unprognostic (1.31e-3)	unprognostic (2.19e-2)	1.1	0.2	0	0	0	0.2	0.1	0	0	0	0.1	0	0	0.3	0	6.1	2.8	0	0	58.4	0	0	0	0	0.1	0	0	0	0	6.8	0	0	0.1	0	1.6	0	0.1	3.2	0	163	0.2	0.2	0.4	0	0	2.2	0.5	0	1.3	0.5	53.9	4.2	0.1	0	5.5	5.5	3.6	2.4	1.5	4.8	0.4	0.1	0	0.5	0.3	0	0	2.2	0	0	0	0	9	0	0.4	0.2	0	0	0	0	0	0	0.4	0.8	0.1	0	0.6	0	1	0.1	3.1	0	0	0	0.1	0	1.4	0.5	0.4	0	0	0.2	1	0.1	1.3	0.1	0.5	0.5	0.1	0.1	0	1.2	0.3	0	0	0.1	2.4	0.2	0.1	0	0	0.3	0.4	0.1	1.7	0.3	0.8	0.2	0.5	0	1.3	2	3.6	4.4	1.3	3.5	4.3	4	4.8	1.1	5.5	4.2	4.6	1.6	1.5	2.4	5.5	3.3	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.2	2.3	89.6	0	0	0	0	2	1.4	0	2.5	9.7	0	0	0	18.9	5	0	0	0	0	0.3	1.6	0	0	0	19	0.3	0	1.7	0	0	1	3.5	0	0	1.1	2.6	0	0.1	0.2	0.2	0	1.1	0	0	0	Cardiomyocytes
KLHL31	bA345L23.2, BKLHD6, KBTBD1	ENSG00000124743	Kelch like family member 31	Q9H511	6	53647901-53665708	Predicted intracellular proteins	Transcription, Transcription regulation	Repressor		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	heart muscle: 77.7;skeletal muscle: 57.7;tongue: 40.9	Cell type enriched	Detected in single	284	Cardiomyocytes: 217.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		RH-30: 2.8;SCLC-21H: 3.7	Not detected	Not detected			Not detected	Not detected																unprognostic (7.27e-2)	unprognostic (6.18e-2)	unprognostic (2.31e-1)	unprognostic (1.10e-1)	unprognostic (1.67e-1)	unprognostic (7.67e-4)	unprognostic (2.23e-2)	unprognostic (1.25e-1)	unprognostic (2.55e-1)	unprognostic (3.98e-2)	unprognostic (5.50e-2)	unprognostic (4.24e-1)	unprognostic (1.09e-4)	unprognostic (8.73e-2)	unprognostic (2.88e-1)	unprognostic (1.23e-1)	unprognostic (1.40e-1)	13.1	0.5	0.1	0.3	0.3	0	2	0	0	0.1	0.2	0	0	0.2	0.2	1.2	1.3	0.6	0.1	77.7	0.2	0.1	0.1	0.2	0.1	0.4	0.1	0	0.1	0.2	0	0.2	0	0.1	0.6	0.1	0	1.6	0	57.7	0.6	0.2	0	0.1	0	0.1	0.4	0	0	0.5	40.9	2.2	0.3	0.2	0.7	0	0	0.1	0.9	0.6	0	1	0.7	0.2	0.2	0	0	0.5	0	0.2	0.2	0.1	1.2	2.5	0	0.2	0	0.7	1.9	0.8	0.4	0.1	0.1	1.3	0.4	1.7	1.6	0.1	0.6	0	2.1	2.6	0	0.5	0.5	0	1.4	0	0.2	0	0.8	0.9	0	0.3	1.3	0.8	0.1	2.8	0.1	0.8	0.9	3.7	0.4	0.2	0.6	0	0.3	1.2	0	0	0.1	0.5	0	0.2	0.5	0.1	0	0.3	2.1	0.1	0	0	0	0.4	0	0.6	0.7	0	0.2	0	0.3	0.2	0.2	0	0.9	0.1	0	0	0	0.1	0.3	0	0	0.2	0.1	0.1	0	0.1	0	0	0	0	0.8	0.6	0.3	217.1	0	0	0	0	0	0.7	0	0.1	0.2	0	0	0	0.3	0.2	0.2	0.5	0	0.4	0.2	0	0	0	0	0	0.3	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.1	0.4	0.7	0	0	0.4	Cardiomyocytes
WNT1	INT1	ENSG00000125084	Wnt family member 1	P04628	12	48978453-48981676	Cancer-related genes, Disease related genes, Predicted secreted proteins	Wnt signaling pathway	Developmental protein	Cancer-related genes, Disease mutation, Osteogenesis imperfecta, Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 7.7;brain: 6.5;placenta: 17.5	Cell type enriched	Detected in single	36	Cardiomyocytes: 3.6	Not detected	Not detected			Group enriched	Detected in some	7	basal ganglia: 6.5;cerebral cortex: 1.8	Group enriched	Detected in some	8	gdT-cell: 5.3;MAIT T-cell: 7.7;memory CD4 T-cell: 3.0;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.2	Lineage enriched	Detected in single	24	T-cells: 7.7	Cell line enhanced	Detected in some		CACO-2: 1.7;JURKAT: 2.9	Not detected	Not detected			Group enriched	Detected in many	4	cerebral cortex: 1.3;hippocampal formation: 1.5;midbrain: 3.5;olfactory region: 2.1						Secreted to extracellular matrix								unprognostic (2.02e-2)	unprognostic (5.80e-3)	unprognostic (1.23e-1)	unprognostic (1.64e-2)	unprognostic (1.03e-1)	unprognostic (7.65e-3)	unprognostic (5.29e-3)	unprognostic (5.68e-2)	unprognostic (1.63e-1)	unprognostic (1.20e-1)	unprognostic (4.08e-2)	unprognostic (4.97e-2)	unprognostic (1.32e-2)	unprognostic (1.67e-2)	unprognostic (1.70e-1)	unprognostic (7.35e-3)	unprognostic (2.76e-2)	0.3	0.1	0.4	1.5	6.5	2.3	0.3	0.3	2.9	0.3	0.3	0.3	0.3	1.5	0.3	0.3	0.5	0.1	0.7	0.3	0.6	0.5	0.3	0.3	0.7	2.9	0.3	0.3	0.3	0.3	0	0.3	17.5	0.3	0.3	0	0.3	1.2	0.3	0.3	0	1.8	0.3	0.3	1.9	1.2	1.4	0.3	0.3	0.3	0.3	0.3	0.6	0.3	0.3	0	0	0	0	7.7	0.8	0	0	0	0	0	0	0.7	0	0	0	0	1.7	0	0	0.1	0	0	0.2	0	0	0	0	0	0.4	0.3	0	0	0	0.6	0	0	0	0	0	0	2.9	0	0	0	0.3	0.2	0	0	0	0.5	0.1	0	0.4	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	5.3	0	7.7	0.3	3	4.8	0	0	0.5	3.2	0	0	0	0	0.4	0.8	0.4	6.5	0.3	1.8	0.6	0.5	0.3	0.3	0.3	0.3	0	0	0	0	0	0	3.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
MYH2	IBM3, MYH2A, MYHas8, MyHC-2A, MyHC-IIa, MYHSA2	ENSG00000125414	Myosin heavy chain 2	Q9UKX2	17	10521148-10549957	Disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	34	skeletal muscle: 559.4;tongue: 232.5	Cell type enriched	Detected in single	38	Cardiomyocytes: 3.8	Cancer enriched	Detected in single	60	head and neck cancer: 27.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		fHDF/TERT166: 6.1;HSkMC: 3.0;NTERA-2: 13.0;SuSa: 2.8	Not detected	Not detected			Not detected	Not detected			HPA001349, CAB010760	Enhanced								42000000			CAB010760: AB_477190, HPA001349: AB_1079437	unprognostic (6.50e-2)					unprognostic (1.86e-2)		unprognostic (4.76e-2)	unprognostic (1.92e-2)	unprognostic (1.05e-4)	unprognostic (2.89e-1)	unprognostic (9.51e-2)	unprognostic (2.03e-2)	unprognostic (1.09e-2)	unprognostic (4.30e-2)			10	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	2	8	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1	0	0	11.6	0.1	559.4	0.1	0	0.1	0.1	0	0	0.1	0	0	1.1	232.5	11.4	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0.1	0.2	0	0	0.2	0	6.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	3	0	0	0.1	0	0	0	0.1	0	0.6	0	0	0.1	13	0	0	0	0.5	0	0	0	0	0	0	0	0	2.8	0	0	0.1	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
BHLHE23	bA305P22.3, Beta4, BHLHB4, bHLHe23	ENSG00000125533	Basic helix-loop-helix family member e23	Q8NDY6	20	63005927-63007035	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	brain: 1.0;lymphoid tissue: 4.1;retina: 1.3;testis: 1.8	Cell type enriched	Detected in single	34	Cardiomyocytes: 3.4	Cancer enriched	Detected in single	11	testis cancer: 0.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	20	MOLT-4: 16.8	Not detected	Not detected			Region enhanced	Detected in some		midbrain: 3.0	HPA030575	Uncertain											HPA030575: AB_10601459															unprognostic (1.74e-1)			0.1	0	0.1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0.1	0	0	0	0	0.2	1.8	0	4.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	16.8	0.7	0.6	0	0	0.2	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
CSN1S1	CASA, CSN1	ENSG00000126545	Casein alpha s1	P47710	4	69931081-69946574	Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins		Milk protein	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	breast: 184.8	Cell type enriched	Detected in single	11	Cardiomyocytes: 1.6	Cancer enriched	Detected in some	10	breast cancer: 17.1	Low region specificity	Detected in single			Group enriched	Detected in some	6	NK-cell: 1.6;plasmacytoid DC: 3.2	Group enriched	Detected in many	11	dendritic cells: 3.2;NK-cells: 1.6	Cell line enhanced	Detected in some		ASC diff: 2.4;HL-60: 1.4;U-266/70: 1.5									HPA035659, HPA057031	Enhanced				Secreted in female reproductive system							HPA035659: AB_10696356, HPA057031: AB_2683315					unprognostic (1.52e-2)										unprognostic (1.01e-1)			44.7	0	0	0	0.1	0	184.8	0	0.9	0	0.1	0	0	0	0	0	0.1	0	0.4	0	0.1	1.2	0	0	0	0.5	0.6	0	0	0.1	0	0	0	0.1	0.1	0	0	0.1	0.1	0	0.1	0	0	0.2	0	0	0.1	0	0.2	0	0	0	0.1	0	0	3.2	0.2	0.1	1.6	0	0.2	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	1.5	0.5	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0.2	1.6	0	3.2	0	0.2	0	0.1	0	0.9	0.1	1.2	0.6	0	0.1	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	Cardiomyocytes
FLNC	ABP-280, ABPL, FLN2	ENSG00000128591	Filamin C	Q14315	7	128830377-128859274	Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters		Actin-binding	Cardiomyopathy, Disease mutation, Myofibrillar myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	8	skeletal muscle: 546.8	Cell type enriched	Detected in many	40	Cardiomyocytes: 1815.4	Low cancer specificity	Detected in all			Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		BJ: 80.1;fHDF/TERT166: 36.4;hTEC/SVTERT24-B: 39.6;U-2 OS: 34.2	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA006135, HPA071007	Enhanced		Supported	Plasma membrane,Cytosol					54000000	Plasma membrane, Cytosol		HPA006135: AB_1848602, HPA071007: 	unprognostic (1.25e-1)	unprognostic (7.38e-2)	unprognostic (4.47e-2)	unprognostic (1.40e-2)	prognostic unfavorable (2.80e-4)	unprognostic (1.64e-3)	unprognostic (4.42e-3)	prognostic unfavorable (2.17e-5)	unprognostic (1.03e-3)	unprognostic (2.35e-2)	unprognostic (1.35e-3)	unprognostic (6.37e-2)	prognostic unfavorable (5.69e-4)	unprognostic (5.68e-3)	unprognostic (1.15e-1)	unprognostic (1.52e-3)	prognostic unfavorable (3.73e-5)	2.6	0.8	0.5	7.1	0.7	0.2	0.7	0.3	1	5.2	24.4	1.4	18.4	1.9	14	10.1	16	4.8	13.3	70	0.8	0.5	0.4	0.3	1.4	0.3	1.4	0.5	3.1	0.6	1	0.3	0.6	1.9	11.9	2.1	1.7	3.1	20.2	546.8	1	5.2	69	4.7	0.3	10	1.3	0.6	0	4.7	40	2.2	39.6	20.5	0	0	0	0	0	0	0	0	0.1	0.8	0	7.3	8.8	0.8	80.1	15.2	22.8	11	24.9	0.2	0	13.5	36.4	9.3	0	4.8	0.1	13.6	0	2.7	0	4.1	0	9.2	0	0	16.6	0	39.6	0	9.3	14.2	0	9.6	0	15.5	0	0	0.3	13.3	0	4.6	0	26.5	0.2	0	0	0.4	1.4	0.1	0	0	19.2	0.1	0.3	29.3	8	34.2	2	0	0	0	0	27.1	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.7	0.3	0.6	0.8	0.5	1.4	0.5	1.9	0.6	3	0.3	0	0.1	3.3	0.4	1815.4	0	0	3.4	1.8	0	0.3	0	0.6	0.2	6.2	0	0	0.2	0.7	11.9	1.4	0	0	0.8	0	0	1.8	0	0	4.9	0.8	5	0	0	0.1	1.8	0	9.9	1	0.1	0	45.3	0.2	0.4	4	1.6	0	0	0.4	Cardiomyocytes
CSRP3	CLP, CMD1M, MLP	ENSG00000129170	Cysteine and glycine rich protein 3	P50461	11	19182030-19210573	Disease related genes, Plasma proteins, Predicted intracellular proteins	Differentiation, Myogenesis, Transcription, Transcription regulation	Actin-binding, Developmental protein	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	heart muscle: 223.9;skeletal muscle: 156.7	Cell type enriched	Detected in some	655	Cardiomyocytes: 3256.5	Cancer enriched	Detected in some	6	head and neck cancer: 18.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HSkMC: 3.6;RH-30: 1.5;U-2 OS: 2.8	Not detected	Not detected			Not detected	Not detected			HPA042581	Enhanced								240000			HPA042581: AB_2678061				unprognostic (1.62e-2)	unprognostic (1.10e-1)	unprognostic (1.55e-2)				unprognostic (4.72e-2)				unprognostic (5.99e-2)	unprognostic (1.08e-1)			0.4	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	7.9	3.4	0	0	223.9	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	2.5	0	0	4.5	0	156.7	0	0	0	0	0	0	0.1	0	0	0.8	46.9	2.3	0	0	0.4	0	0.3	0.2	0.2	0.2	0	0	0	0	0.1	0	0	0.1	0.1	0	0	0	0.6	0.2	0	0.3	0	0.2	0	0	0	0	0.1	0.2	0.2	0.2	0.2	0	0.1	0.6	3.6	0	0	0	0.1	0	0.3	0.2	0.8	0	0.8	0	0	0	0	0	0.3	1.5	0	0	0.3	0	0	0	0.1	0	0.1	0	0.9	0	0.2	2.8	0.6	0.7	0	0.2	0.4	0.9	0.9	0.1	0.2	0.1	0.3	0.1	0	0	0	0.1	0	0	0.4	0.1	0.2	0.3	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3256.5	0	0	0	0	0	0	0	0	1.1	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
TNNI3	CMD2A, CMH7, TNNC1	ENSG00000129991	Troponin I3, cardiac type	P19429	19	55151767-55157773	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Muscle protein	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	367	heart muscle: 419.3	Cell type enriched	Detected in many	56	Cardiomyocytes: 9185.5	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 7.1;HMC-1: 11.9;K-562: 21.6;OE19: 30.9	Low region specificity	Detected in many			Not detected	Not detected			CAB009349, HPA046428	Enhanced		Approved	Vesicles,Cytosol					1700000	Cytosol	Vesicles	CAB009349: AB_793465, HPA046428: AB_2679661	unprognostic (2.12e-2)	unprognostic (3.05e-2)	unprognostic (2.44e-2)	unprognostic (1.36e-1)	unprognostic (2.08e-2)	unprognostic (2.81e-2)	unprognostic (1.37e-3)	unprognostic (2.13e-1)	unprognostic (9.62e-3)	unprognostic (9.40e-2)	unprognostic (3.34e-2)	unprognostic (2.17e-3)	unprognostic (4.02e-3)	unprognostic (8.89e-2)	unprognostic (8.54e-2)	unprognostic (1.05e-1)	unprognostic (9.82e-2)	0.1	0	0.1	0.1	0.1	0	1.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.2	0.1	419.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.6	0	0.1	0.1	0.1	0.1	0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.4	0.4	0	0	0.7	0.7	0.3	0	0	0	0	2.4	0	0	0	0.2	0	0.1	0.9	3.7	0	0.6	0.5	0.7	0.1	0	0	7.1	1.7	0	1	0.3	0	11.9	0	0.3	0	0.1	0	0	0.4	21.6	0.4	0	0.3	0.1	0	0.4	30.9	0.2	0.9	0.2	0	1.1	0	0	1.2	0	0	0.1	0	1.6	5.4	0.2	0	0.6	0	0	0	0	0	0.3	2	0	0	0.4	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.7	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0	0	0	0	6.2	0	9185.5	10.2	6.7	2.3	5.2	0	0.9	0	0.6	46.9	0.1	0	0	0.2	0.4	3.1	0	0	0	1.9	1.6	1.7	0	0	164.8	0.3	0.2	1.7	0	0.2	1.8	1.1	0	1.8	0	0.2	0	0	4.2	10.3	2.5	2.1	0	0.4	0	Cardiomyocytes
FAM155B	CXorf63, TED, TMEM28	ENSG00000130054	Family with sequence similarity 155 member B	O75949	X	69505241-69532508	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		heart muscle: 25.0;seminal vesicle: 6.7;thyroid gland: 10.4	Cell type enriched	Detected in some	10	Cardiomyocytes: 18.2	Low cancer specificity	Detected in many							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 6.9;HAP1: 15.4;Hep G2: 5.6;NTERA-2: 21.3;OE19: 6.0;SCLC-21H: 10.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA036093	Uncertain											HPA036093: AB_10673613	prognostic unfavorable (4.61e-5)	unprognostic (1.17e-1)	unprognostic (2.14e-1)	unprognostic (5.14e-3)	unprognostic (1.45e-1)	unprognostic (2.49e-2)	unprognostic (3.09e-4)	unprognostic (7.07e-2)	unprognostic (1.19e-2)	unprognostic (4.67e-2)	unprognostic (4.94e-3)	prognostic unfavorable (1.83e-4)	prognostic favorable (6.63e-4)	unprognostic (1.46e-2)	unprognostic (3.50e-2)	unprognostic (2.21e-1)	unprognostic (8.21e-2)	0	0.5	1.4	0	1.1	0	0.1	3.5	1.4	0.1	0			0	0.2	0.3	0	0.7	0.1	25	1.1	2.1	0.5	0	0	0	1.3		0	1.8	0.9	1.1	0		0.9	0		1.1	6.7	0	0	0	0	0.4	0.6	0.5	0.8			10.4		0	0	0	0	0	0	0	0	0	0	0	2.5	0.1	6.9	0	0	0	0	0	0	0	3	0.6	0	4.3	0	0	0	15.4	0.6	0	0	4.2	0	0	5.6	0	0	0.1	0	0	0	0	0	0	0	0.7	0	0	4.8	0	0	21.3	6	0	0	0	0	0.2	0	10.2	0.7	0.1	0	0	0.7	1.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0.2	0	0.4	18.2	0	0	0	1.8	0	0	0	0.4	0	0	0	0	1	0	0	1.2	0	0	0.1	0	1.2	0.6	0	0	0	0	0	0	0.6	0	0.8	0	0	0.4	0.8	0	0	0.1	1.3	0	0	0	0	0.2	Cardiomyocytes
HRC	MGC133236	ENSG00000130528	Histidine rich calcium binding protein	P23327	19	49151198-49155424	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	heart muscle: 155.8;skeletal muscle: 82.1	Cell type enriched	Detected in some	18	Cardiomyocytes: 1159.6	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	Hep G2: 6.4;HSkMC: 6.6;K-562: 8.7;THP-1: 15.6;U-266/84: 4.7	Not detected	Not detected			Not detected	Not detected			HPA004833	Enhanced				Intracellular and membrane				23000			HPA004833: AB_1079083	unprognostic (1.06e-1)	unprognostic (1.04e-3)	unprognostic (1.46e-2)	unprognostic (4.94e-2)	unprognostic (5.66e-2)	unprognostic (9.75e-3)	unprognostic (3.44e-1)	unprognostic (1.74e-1)	unprognostic (4.09e-1)	unprognostic (1.62e-1)	unprognostic (7.41e-3)	unprognostic (5.85e-3)	unprognostic (4.04e-2)	unprognostic (6.68e-2)	unprognostic (1.07e-1)	unprognostic (1.86e-1)	unprognostic (1.46e-1)	2.4	0.8	0.2	0.1	0.5	0	0.8	0	0.6	1.6	0.3	0.3	0.3	0.2	1.8	4.3	1.3	1	0.5	155.8	0.2	0.2	0.7	0.4	0.3	0.4	0.4	0.3	0.7	0.3	0.4	0.2	0.4	0.3	1.4	0.2	1.3	1.4	0.6	82.1	0.3	0.3	0.5	0.2	0.1	0.2	0.7	0.1	0	1.7	25.9	2	0.4	0.6	0.5	0.1	0.9	0.5	0.2	0.3	0	0.1	0	0.5	0	0	0	0.1	0	0	0	0	1.1	0	0.1	0	0	0.1	0.1	0	0	0	0	0.8	0.1	0.5	6.4	0	0	1.3	6.6	0	0	0	0	0	0	8.7	0	0	0.1	0	0	0.3	0.7	0.1	0.2	0.1	0	0	0	0	0	0	0.1	0	0	0.3	15.6	0.2	0	0	0.3	0	0.1	4.7	0	0	0	0.3	0.9	0	0.3	0	0.5	0.3	0	0	0	0	0.5	0	0.2	0.2	0.2	0.4	0.1	0.2	0	0.2	0.5	0	0.6	0.2	0.2	0.4	0.3	0.3	0.1	0	0	0	0.2	0.2	0	1159.6	0	0	0	0	0	0.1	0	0	0	0.6	1.3	0	0.2	0	0.7	0.1	0	0.4	0.1	3.2	1.2	0.6	0	0	7.8	0	3.3	0	2.8	1	0.1	0	7.8	0	0.1	64.7	36.8	0	0.1	0.1	0.1	0	1.2	0.1	Cardiomyocytes
CKMT2	SMTCK	ENSG00000131730	Creatine kinase, mitochondrial 2	P17540	5	81233285-81266397	Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Kinase, Transferase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	13	heart muscle: 153.2;skeletal muscle: 182.4;tongue: 103.6	Cell type enriched	Detected in some	25	Cardiomyocytes: 792.8	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in single	9	NK-cell: 3.8	Lineage enriched	Detected in single	9	NK-cells: 3.8	Cell line enhanced	Detected in some		ASC diff: 3.7;BEWO: 6.0;Hep G2: 5.2;HHSteC: 4.0;T-47d: 9.7	Not detected	Not detected			Low region specificity	Detected in many			HPA051880	Enhanced								3200000			HPA051880: AB_2681650	unprognostic (3.64e-3)	unprognostic (1.15e-1)	unprognostic (2.82e-3)	unprognostic (1.88e-2)	unprognostic (1.21e-2)	unprognostic (2.41e-2)	unprognostic (1.73e-2)	unprognostic (3.57e-2)	unprognostic (2.12e-1)	unprognostic (1.03e-1)	unprognostic (2.82e-1)	unprognostic (1.84e-1)	unprognostic (1.60e-2)	unprognostic (5.34e-2)	unprognostic (2.28e-1)	unprognostic (1.76e-1)	unprognostic (2.75e-3)	2.5	5	1.3	0.3	1.9	0.2	0.8	0.4	1.2	1.2	0.5	1.2	2.5	0.3	1.3	11.5	3	1.2	1.5	153.2	1.5	0.9	2.7	0.3	0.4	0.3	2.3	1.4	1.6	1.3	1.1	0.7	0.3	4.1	2	0.3	2.5	9.1	2.1	182.4	0.5	0.6	1.4	2.8	0.4	2.1	0.9	1.5	0	3.3	103.6	2.9	1	0.6	0.4	0.1	0	0.4	3.8	0.3	0	0.1	0.9	0	0.9	3.7	0.8	6	0.1	0	0	0	0.3	0.3	0.7	0.4	0	0.9	0.1	0	0	0	0.5	3.2	0	0.7	5.2	4	0.5	0.2	1.4	0	0	0	0.5	0	0.8	0	0.6	0	0.7	0.2	0.1	0.8	0	0.4	0.8	0.9	0	0	0.1	0.7	0.7	0.5	0.4	0.9	2.3	9.7	0.4	0.8	0.5	0.9	0.5	0.3	0.1	0.1	0.8	0.4	0.5	0.9	0	0.2	0	0.1	0.4	0	0.1	0.3	0	0	0.4	0.1	0.2	0	3.8	0	0.1	0.2	0	1.3	1.9	0.4	1.2	1.5	0.9	2.3	1.4	4.1	1.5	0	0.3	0	0.4	0.1	0.7	792.8	7.6	1.4	1.2	12.2	0	0.1	31.5	1.6	16.2	5.3	0	0	0.5	0.4	0.6	0.3	0	0	0.1	0	0	0	0	0.8	6.6	0	3.3	0	0	1.3	0.2	0	14.2	0.6	0.9	0	5.9	0.2	0.4	0.1	0.2	0	0.2	0.1	Cardiomyocytes
MTUS2	CAZIP, ICIS, KIAA0774, TIP150	ENSG00000132938	Microtubule associated scaffold protein 2	Q5JR59	13	28820348-29505947	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 46.8;pituitary gland: 19.3	Cell type enriched	Detected in some	18	Cardiomyocytes: 122.0	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Cell type enhanced	Detected in some		eosinophil: 1.9;intermediate monocyte: 1.7	Group enriched	Detected in many	4	dendritic cells: 1.3;granulocytes: 1.9;monocytes: 1.7	Group enriched	Detected in some	4	HaCaT: 16.7;HeLa: 7.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA031473, HPA031474, HPA031475	Enhanced		Supported	Microtubules,Cytokinetic bridge		Yes				Microtubules, Cytokinetic bridge		HPA031473: AB_2673901, HPA031474: AB_10600109, HPA031475: AB_10600442	unprognostic (1.67e-1)	unprognostic (3.07e-1)	unprognostic (1.96e-1)	unprognostic (3.33e-3)	unprognostic (1.00e-1)	unprognostic (1.22e-2)	unprognostic (2.79e-1)	unprognostic (1.35e-1)	unprognostic (2.87e-1)	unprognostic (4.97e-2)	unprognostic (1.30e-3)	unprognostic (3.45e-2)	unprognostic (3.91e-5)	unprognostic (2.51e-2)	unprognostic (5.46e-2)	unprognostic (5.93e-2)	unprognostic (9.62e-2)	0.6	0.8	2.3	0.7	6.1	0.7	0.6	12.2	8.8	1.1	0.8	0.1	0	0.7	2.1	0.6	0.8	1.4	0.7	46.8	3.4	1.9	0.6	1.1	0.7	1	1.2	4.6	8.2	4.7	0.5	19.3	0.5	2.3	0.8	0.8	2	1	0.7	0.6	0.7	0.9	1.7	0.7	1	1.5	1.6	0.9	0	1.1	0	0.6	2.6	0.7	0	1.3	1.9	1.7	0	0.4	0	0	0	1	0	0	0.5	0	0	0	0	0	0	0	2	0	0.2	0.3	16.7	0.5	0	0	0.1	0.7	0	7	0	0	0	0	0.3	0	0.1	0	0	0	0	0	0.5	0	0.1	0	0.7	0.1	0	0	0	0	1.2	0	2.9	2.1	0.1	0.6	0	0.3	0.3	0.1	0	0	0.1	0.3	0	0	0.9	0.3	0.1	0.4	0	0	0	0.2	1.9	0	1.7	0.1	0	0.4	0	1.3	0	0	0	0	0	0.9	0.3	0	0	2.3	6.1	12.2	8.8	3.4	1.9	1.2	4.6	2.3	0.9	0	0.3	0	0.5	0.5	0	122	0	6.7	2.3	0	0	0	0	0	5.5	0	0	0	0.5	0	1	0.2	0	0.6	0.1	0	0	0.6	0	2.5	0.9	0	1.7	0	0	0	0.7	0	0	0	0	0	0.1	0	1.9	0.1	0.2	0	0	0.9	Cardiomyocytes
MYBPC3	CMH4, FHC, MYBP-C	ENSG00000134571	Myosin binding protein C, cardiac	Q14896	11	47331397-47352702	Disease related genes, Plasma proteins, Predicted intracellular proteins	Cell adhesion	Actin-binding, Muscle protein	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	108	heart muscle: 199.6	Cell type enriched	Detected in some	61	Cardiomyocytes: 1683.6	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.8	Lineage enhanced	Detected in single		granulocytes: 1.8	Cell line enriched	Detected in single	17	U-937: 12.0	Region enriched	Detected in single	33	cerebellum: 38.5	Not detected	Not detected			HPA040147, HPA043898	Enhanced								44000			HPA040147: AB_2676861, HPA043898: AB_2678720	unprognostic (1.06e-1)	unprognostic (1.47e-6)	unprognostic (2.17e-1)	unprognostic (6.16e-2)	unprognostic (3.00e-3)	unprognostic (1.40e-4)	unprognostic (7.47e-2)	unprognostic (2.72e-2)	unprognostic (2.53e-1)	unprognostic (1.62e-1)	unprognostic (9.53e-2)	unprognostic (4.22e-2)	unprognostic (1.11e-3)	unprognostic (2.11e-1)	unprognostic (1.96e-1)	unprognostic (4.15e-1)	unprognostic (3.21e-2)	0	0.2	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	199.6	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.3	0.2	0	0	0	0	0	0	0	0	0	0.1	1.8	0.6	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.1	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0	12	0	0	0.4	0	0	0.2	0	0	0	0	0.1	0	0	0	1.8	0	0.6	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	2.2	0	0	0	0	1683.6	0	0	0	0	0	0	0	0	27.7	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.3	14.7	0.3	0.8	0	1.8	1	0	0	0	0.7	0	0	0	0	0.1	0.2	0	0.2	0	0.6	0	Cardiomyocytes
MYPN	MYOP	ENSG00000138347	Myopalladin	Q86TC9	10	68106117-68212017	Disease related genes, Predicted intracellular proteins		Actin-binding	Cardiomyopathy, Disease mutation, Nemaline myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 23.6;skeletal muscle: 114.9;tongue: 46.3	Cell type enriched	Detected in some	4	Cardiomyocytes: 94.6	Cancer enriched	Detected in single	7	head and neck cancer: 0.9	Not detected	Not detected			Cell type enhanced	Detected in single		basophil: 3.8	Lineage enriched	Detected in single	12	granulocytes: 3.8	Cell line enhanced	Detected in some		BJ: 16.6;fHDF/TERT166: 46.6;GAMG: 9.2;HBF TERT88: 11.0;LHCN-M2: 20.1	Low region specificity	Detected in many			Not detected	Not detected			HPA036299, HPA061494	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			Nucleoplasm, Vesicles	Cytosol	HPA036299: , HPA061494: AB_2684539	unprognostic (4.75e-2)	unprognostic (2.20e-1)	unprognostic (8.14e-3)	unprognostic (8.62e-3)	unprognostic (3.91e-1)	unprognostic (3.36e-3)	unprognostic (4.62e-2)	unprognostic (3.86e-2)	unprognostic (2.82e-1)	unprognostic (2.26e-3)	unprognostic (3.94e-3)	unprognostic (3.10e-1)	unprognostic (2.88e-8)	unprognostic (4.63e-5)	unprognostic (9.94e-2)	unprognostic (2.01e-1)	unprognostic (3.47e-1)	4.5	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0	0.1	0	0	0	0	3.1	2.1	0	0	23.6	0.4	0.1	0	0.1	0.1	0	0.1	0	0.1	0.2	0	0.1	0	0.2	0.5	0	0.1	2.1	0	114.9	0.1	0	0	0.1	0	0.2	0.3	0	0	0.9	46.3	3.4	0	0	0.3	0.1	3.8	0.1	0.2	0.1	0	1.2	0.5	0	0	0.3	1.8	0	16.6	8.3	6.3	2.3	0	0	0	0	46.6	9.2	0.3	0	0.1	11	0.1	0	0	5.9	0	0.1	0	0	0.8	0	3.3	0.4	1.5	0.1	0	0	0.1	20.1	3.5	0	0	0	0	0.5	0	0.9	0	0	0	0	0	2.3	0.4	0	0	0	0	0.4	0.3	0	1.7	0	0	0	0	2	0	1.8	3.8	0.1	0.5	0.1	0	0.1	0.2	0.1	0	0	0.3	0.1	0.1	0.9	0.2	0.1	0.1	0	0	0.1	0.1	0.1	0	0.4	0.1	0.1	0	0.2	0	0	0	0	0.1	0	1.5	94.6	0	0	0	0	23.6	0	0	0	0.7	0	0.7	0	0.2	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0.3	0.2	0	0	0	0	0	0	0	0	0	0	0	0.1	Cardiomyocytes
ANP32D	PP32R2	ENSG00000139223	Acidic nuclear phosphoprotein 32 family member D	O95626	12	48472665-48473624	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Low tissue specificity	Detected in single			Cell type enriched	Detected in single	6	Cardiomyocytes: 1.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NB-4: 1.3;REH: 1.2									HPA063133, HPA067561	Uncertain		Enhanced	Nucleoplasm,Centrosome,Cytosol						Nucleoplasm, Centrosome	Cytosol	HPA063133: AB_2684947, HPA067561: AB_2685861		unprognostic (2.20e-1)	unprognostic (3.75e-1)	unprognostic (3.18e-1)	unprognostic (3.23e-2)	unprognostic (5.11e-2)		unprognostic (1.72e-3)		unprognostic (2.30e-2)		unprognostic (3.62e-3)		unprognostic (2.76e-2)		unprognostic (3.48e-1)		0.1	0.9	0.3	0	0.2	0.1	0.2	0.2	0.6	0	0.5			0	0.6	0.8	0.2	0.1	0.2	0	0.1	0.2	0.1	0.1	0.7	0	0.2		1.1	0.1	0	0.2	0.5		0.3	0.2		0.4	0.3	0.2	0	0.1	0.2	0.2	0.5	0.2	0.9			0.8		0	0.4	0.1	0.1	0.1	0.6	0.3	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.1	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0.8	0	0	0	0	0	0	0	0.4	1.3	0	0	0	1.2	0	0	0	0.5	0.2	0.2	0	0	0.3	0	0	0.9	0	0	0	0	0.2	0	0.1	0.7	0.4	0.4	0	0	0	0.2	0.1	0.3	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.6	0.2	0	0	0.3	0											0	0	0	0	0	0	1.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	Cardiomyocytes
FITM1	FIT1	ENSG00000139914	Fat storage inducing transmembrane protein 1	A5D6W6	14	24131275-24132849	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	heart muscle: 56.1;skeletal muscle: 94.7;tongue: 79.9	Cell type enriched	Detected in some	9	Cardiomyocytes: 228.0	Low cancer specificity	Detected in some			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	17	RH-30: 27.1	Not detected	Not detected			Low region specificity	Detected in some			HPA019842	Uncertain											HPA019842: AB_1853025	unprognostic (1.81e-2)	unprognostic (4.29e-7)	unprognostic (2.77e-1)	unprognostic (2.02e-3)	unprognostic (2.24e-2)	unprognostic (6.68e-2)	prognostic favorable (1.00e-3)	unprognostic (1.20e-4)	unprognostic (4.57e-1)	unprognostic (2.12e-2)	unprognostic (2.84e-2)	unprognostic (3.68e-2)	unprognostic (2.47e-1)	unprognostic (2.86e-2)	unprognostic (5.62e-1)	unprognostic (1.96e-1)	unprognostic (2.12e-3)	0.8	1.7	0	0.2	0	0.6	0.3	0.4	0.2	0.2	0.3	0	0	0.5	0.2	2.2	1.2	0.2	0.2	56.1	0	0	0.2	13.1	0.2	0.3	0	0	0.2	11.9	0.2	0.2	0.2	0	0.7	0.2	0.1	2.9	0.3	94.7	0.5	0.4	0.2	0	2.5	0.3	0.3	0	0	0.5	79.9	3.6	0.3	0	0.8	0.3	0	1.1	0.4	1.5	0.3	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0.3	0	0	1.6	0.1	0	0.7	0.7	0.2	0	0.1	0	0	0.4	0	0.3	0.3	0	0.2	0.3	0	0	0.3	0.2	27.1	0.1	0	0	0	0.2	0	0.1	0	0	0	0.1	0.2	0	0	0.1	0	0.2	0.1	0	0.1	0.1	0	0	0.5	0	0.5	1.1	0.3	0.2	1.1	1.5	0.3	0.8	0.6	0.6	0	0.4	0.4	0	0.1	0.3	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.2	0.1	1.4	228	0	0	0	0	0	0.2	0	0.8	1.9	0.3	2	0	2.6	0.1	0.5	0.4	0	26.1	0.2	0	1.2	0.6	1.5	2.7	0	0.1	0	1	1	0.8	1.1	0	0.7	0.1	0.3	0	0.4	1.2	0.2	0.5	0.6	0.8	0.8	0.1	Cardiomyocytes
TPM1	C15orf13, CMH3	ENSG00000140416	Tropomyosin 1	P09493	15	63042632-63071915	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins		Actin-binding, Muscle protein	Cancer-related genes, Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 544.2;skeletal muscle: 589.5	Cell type enriched	Detected in many	5	Cardiomyocytes: 12627.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		basophil: 23.8	Group enriched	Detected in all	4	dendritic cells: 8.4;granulocytes: 23.8;monocytes: 11.6	Cell line enhanced	Detected in many		hTERT-RPE1: 206.7;SuSa: 259.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA000261, HPA009066, CAB017698, HPA047089, HPA053624	Supported		Approved	Actin filaments,Cytosol					280000000	Actin filaments	Cytosol	CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210	unprognostic (1.07e-1)	unprognostic (4.20e-2)	unprognostic (1.00e-2)	unprognostic (6.20e-2)	unprognostic (1.28e-1)	unprognostic (1.45e-2)	unprognostic (1.18e-1)	unprognostic (1.08e-1)	unprognostic (1.35e-2)	unprognostic (3.27e-1)	unprognostic (1.27e-2)	unprognostic (1.20e-1)	unprognostic (1.66e-3)	unprognostic (3.38e-2)	unprognostic (1.78e-1)	unprognostic (5.53e-2)	prognostic unfavorable (7.30e-4)	17.9	5.7	5.5	32.4	5.2	1.2	15.2	5.6	5.1	48.1	119.7	2.4	84.2	14.6	72.4	38.3	121.6	36.2	75.3	544.2	4.1	2.6	14.5	4.4	10.5	3.3	3.3	7	27	29.3	1.9	3.2	17.7	4.1	72.5	28	19.1	12.9	81.3	589.5	6.5	39.5	245.2	2.7	6.5	51.7	9.6	2.3	0.4	7.7	121.7	5.9	193.8	38.7	2.7	8.4	23.8	11.6	1.2	3.4	9.9	33.8	22.3	27	1.3	9.4	5.9	88.9	95.4	35.1	58.7	43.6	15.7	6.7	0.1	43.8	95.3	39.4	18.8	22.9	15.3	39.1	0.8	3.2	5	24.1	7.6	26.5	0.2	1.1	8.3	8.8	48.2	12.8	206.7	15.3	0.8	0.5	1.2	44.8	17.5	1.5	0.4	32.1	8	3.8	0.5	9.5	0.9	83.8	18.7	6.4	4.4	11.4	18.1	4	259	13.2	0.9	70.7	77.6	38.1	11.5	67.6	0.3	0.2	0.4	21.9	1.3	53.7	23.8	6.1	2.9	2.5	11.6	2	2.7	2.4	2.7	8.4	2.6	2.6	2.3	6.7	1.2	7.9	1.7	3.4	9.9	5.5	5.2	5.6	5.1	4.1	2.6	3.3	7	4.1	2.3	53.6	87.9	11.7	166.6	63.8	52.3	12627.3	392.4	116.4	116	301.8	361.3	128.4	159.2	2265.1	4.5	128.8	537.1	0	1464	2646.2	335.9	214.6	50.8	122.9	165.5	49.3	257.1	251.7	29.3	13.2	189.8	54.2	77.6	57.7	811.2	43.7	1740.7	585.7	1062.5	207.5	461.5	1021.9	1520.7	21.6	75.4	44.2	86.2	21.9	280.4	186.5	Cardiomyocytes
MYLK3	caMLCK, MLCK	ENSG00000140795	Myosin light chain kinase 3	Q32MK0	16	46703369-46790407	Enzymes, Predicted membrane proteins		Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1	Cell type enriched	Detected in some	10	Cardiomyocytes: 162.4	Not detected	Not detected			Region enhanced	Detected in many		pons and medulla: 6.6	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		BEWO: 9.7;HEL: 29.1;K-562: 4.5;SK-BR-3: 6.1	Group enriched	Detected in some	7	cerebral cortex: 9.8;hippocampal formation: 5.7	Region enriched	Detected in single	5	hippocampal formation: 5.2	HPA073447	Enhanced		Approved	Nucleoplasm,Vesicles						Nucleoplasm	Vesicles	HPA073447: AB_2732225	unprognostic (6.01e-4)	unprognostic (2.19e-1)	unprognostic (2.64e-1)	unprognostic (1.77e-2)	unprognostic (1.84e-1)	unprognostic (2.94e-3)	unprognostic (2.60e-1)	unprognostic (4.73e-2)	unprognostic (3.33e-2)	unprognostic (2.41e-2)	unprognostic (6.58e-3)	unprognostic (1.83e-1)	unprognostic (4.16e-2)	unprognostic (2.57e-2)	unprognostic (2.52e-1)	unprognostic (1.08e-2)	unprognostic (2.97e-1)	0	0.1	0.7	0	1.7	0.1	0	0.1	0.2	0.2	0	3.8	0	0	0.1	3.4	2	0.8	0.1	62.2	1.5	1.4	0.4	0	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.2	6.6	1	0	0	1.3	0	20.8	0	0	0	0.3	0	0	2.9	0.3	0	0.1	31.1	1.1	0.1	0	1.2	0.9	2.6	0.7	1.2	0.7	0.2	0	0.1	0.1	0.1	0	0	9.7	0	0	0	0	0.7	0.1	0.2	0.1	0	0	0	0	0	0	0	0	29.1	1.6	0.1	0.1	0.1	0.2	0	0	0	0	0	0	0	4.5	0.2	0	0	0	0.2	0	0	0	0.1	0.1	0	0	0	0.3	0.3	0	6.1	0.2	2.9	0.1	0.1	0.1	0.1	0.1	0.1	0	0.4	0	0.3	0	0.1	0	2.5	0.7	0.6	0.6	0.4	0.4	0.7	0.5	0.5	0.3	1.2	0.7	0.7	2.6	1.2	0.5	0.9	0.3	0.2	0.7	1.7	0.1	0.2	1.5	1.4	0.1	0.4	6.6	0.3	0	3.5	0	0.7	0	0.5	162.4	0	16	6.8	0	2	1.4	0	0	7.4	0	0	0	0.2	0.4	1.4	0.6	1.1	0	0.4	0	0	0.6	0	3.2	0.6	0.5	0	0	0	0.5	0.1	0	0	0	1.4	0	0	0.9	0.2	0	0.2	0	0	0.2	Cardiomyocytes
RPL3L		ENSG00000140986	Ribosomal protein L3 like	Q92901	16	1943974-1957606	Predicted intracellular proteins, Ribosomal proteins		Ribonucleoprotein, Ribosomal protein		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 49.0;skeletal muscle: 148.3;tongue: 36.7	Cell type enriched	Detected in some	18	Cardiomyocytes: 115.5	Low cancer specificity	Detected in some			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		CACO-2: 7.8;Karpas-707: 5.8	Not detected	Not detected			Not detected	Not detected			HPA049136	Enhanced		Approved	Nuclear speckles						Nuclear speckles		HPA049136: AB_2680648	unprognostic (2.53e-1)	unprognostic (2.63e-2)	unprognostic (9.27e-4)	unprognostic (6.38e-4)	unprognostic (4.36e-2)	unprognostic (3.48e-3)	unprognostic (3.46e-2)	unprognostic (2.14e-1)	unprognostic (1.17e-1)	unprognostic (1.19e-2)	unprognostic (2.00e-1)	unprognostic (2.46e-2)	unprognostic (4.53e-3)	unprognostic (3.32e-1)	unprognostic (4.24e-1)	unprognostic (8.32e-3)	unprognostic (4.60e-2)	1.1	0.1	0	0	0	0.3	0.3	0	0	0	0	0	0	0.1	0	4.5	1.4	0	0.1	49	0	0	0	0	0	0	0	0	0	7	0	0	0	0	0.7	0	0.4	2.8	0	148.3	0.1	0.1	0	0	0	0	1.2	0	0	1.4	36.7	2.1	0	0	1.8	1.7	4.9	1.5	0.9	1.4	0.5	2.1	2.5	0.6	2.3	0.1	0.1	1.5	1	0	0.1	0	7.8	4.2	1.3	1.4	0	1.9	2.1	0.2	0.2	0	1	1.3	0.8	1.7	2.7	0	0.5	0.9	0.2	0.3	0.2	0.2	1.5	0	1.4	0.8	5.8	0.1	1.3	1.6	1.9	1.3	2.3	5	0.7	0.7	1.8	0.3	0.8	3.4	1	1	2.8	1.2	1.5	1.4	1.1	1.2	1.2	2.9	1.6	0.8	2.5	1.2	1.2	1.7	0.6	0.4	1.6	1.5	1.3	1.4	1.1	0.9	1.4	1.1	1.2	0.5	1.8	1.2	1.4	4.9	0.9	1	1.7	0.7	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0.6	0	115.5	0	0	0	0	0	0.1	0	0	6.6	0	0	0	0	0.2	0.2	0.9	0	0	0	0	0	0	0	4.6	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.5	1.3	0.4	0	0	0	0.4	Cardiomyocytes
UNC45B	CMYA4, UNC45	ENSG00000141161	Unc-45 myosin chaperone B	Q8IWX7	17	35147817-35189345	Disease related genes, Predicted intracellular proteins	Differentiation, Myogenesis	Chaperone, Developmental protein	Cataract, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	13	heart muscle: 48.8;skeletal muscle: 62.5;tongue: 23.2	Cell type enriched	Detected in some	4	Cardiomyocytes: 181.6	Group enriched	Detected in some	5	head and neck cancer: 0.9;testis cancer: 1.0	Not detected	Not detected			Cell type enhanced	Detected in some		gdT-cell: 3.5	Lineage enriched	Detected in single	10	T-cells: 3.5	Group enriched	Detected in some	11	BEWO: 4.7;HSkMC: 7.1	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA017861			Approved	Cytosol						Cytosol		HPA017861: AB_1847012	unprognostic (7.17e-2)	unprognostic (6.47e-3)	unprognostic (9.36e-3)	unprognostic (2.93e-1)	unprognostic (1.49e-3)	unprognostic (5.30e-2)	unprognostic (3.07e-1)	unprognostic (1.09e-2)	unprognostic (5.46e-2)	unprognostic (2.40e-2)	unprognostic (8.46e-2)	unprognostic (6.73e-2)	unprognostic (1.13e-6)	unprognostic (6.77e-2)	unprognostic (5.05e-3)	unprognostic (2.20e-1)	unprognostic (2.21e-1)	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.7	0.9	0	0.3	48.8	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.7	0	0	1.9	0.2	62.5	0	0	0	0	0.4	0.2	0.2	0	0	0.2	23.2	1	0	0	0	0	0.2	0.3	0.3	3.5	0.5	0	0	0	0	0	0	4.7	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.1	7.1	0	0	0	0	0	0.2	0	0.1	0	0	0	0.2	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	3.5	0.2	2.9	0	0.7	1.8	0	0	0.4	2	0.2	0.3	0.3	0	0.4	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	181.6	0	0	0	0	0	0	1.7	0	25	0	0	0	0	0.4	0	0	0	0	0.1	0	0	0	0	42	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.6	0.1	0	0	0	0	Cardiomyocytes
MYOM3	FLJ35961	ENSG00000142661	Myomesin 3	Q5VTT5	1	24056035-24112175	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	7	heart muscle: 59.5;skeletal muscle: 104.6;tongue: 39.7	Cell type enriched	Detected in some	6	Cardiomyocytes: 168.2	Cancer enhanced	Detected in some		renal cancer: 6.8	Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 2.3	Low lineage specificity	Detected in single			Group enriched	Detected in some	6	A549: 5.2;Hep G2: 19.8	Not detected	Not detected			Not detected	Not detected			HPA028132, HPA028340			Approved	Golgi apparatus,Vesicles,Cytokinetic bridge		Yes	No		680000	Vesicles	Golgi apparatus, Cytokinetic bridge	HPA028132: AB_10599293, HPA028340: 	unprognostic (8.59e-2)	unprognostic (2.85e-2)	unprognostic (2.39e-1)	unprognostic (8.60e-3)	unprognostic (1.52e-2)	unprognostic (7.31e-2)	unprognostic (3.00e-2)	unprognostic (1.40e-2)	unprognostic (4.66e-1)	unprognostic (2.21e-1)	unprognostic (2.73e-4)	unprognostic (2.09e-1)	prognostic favorable (4.28e-6)	unprognostic (2.77e-2)	unprognostic (1.60e-3)	unprognostic (7.75e-2)	unprognostic (1.68e-1)	1.5	0	0	0	0	0	0.1	0	0.1	0	0.1	0	0	0.3	0.1	6.3	2.7	0.2	0	59.5	0	0	9.7	0	0	0	0	0	0	0.2	0	0	0	0	1.3	0.1	0	2.7	0	104.6	0.4	1.5	0	0	0	0	1.9	0.1	0	2.7	39.7	2.8	0.2	0.1	0.8	0.4	2.3	0.4	0.2	0.4	0	0.1	5.2	0	0.1	0	0	0.5	0	0	0	0	0.6	1.5	0	2.2	0.6	0.2	0.1	0	0	0	0.1	0.1	0.1	0.8	19.8	0	0.1	0.1	0.6	0	0.2	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0.1	0.8	0.4	0	0.2	0	0	0.1	0	0.1	0	0.3	0	0.2	0.2	0.1	1.1	0.2	0.6	0.7	0.1	0.2	0	0	0.4	0	0	0.8	0.4	0.1	0.3	0.4	0.1	0.4	0.2	0.2	0	0.8	0.3	0.4	2.3	0.2	0.3	0.4	0.2	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0.2	0.6	0	168.2	0	0	0	3.5	0	0	1.7	0.1	15.5	0.1	4.3	0	0.4	0	0	0.2	0	0	0	0	1.2	0	0	6.6	0.6	0	0	0	0	0	1.4	2.9	0	25.9	2.8	6.5	0	0	0	0.5	0	0	0.4	0.3	Cardiomyocytes
ACTA1	ACTA, NEM3	ENSG00000143632	Actin, alpha 1, skeletal muscle	P68133	1	229431245-229434098	Disease related genes, Plasma proteins, Predicted intracellular proteins		Muscle protein	Disease mutation, Nemaline myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	skeletal muscle: 1935.3;tongue: 523.6	Cell type enriched	Detected in some	448	Cardiomyocytes: 1758.3	Group enriched	Detected in many	18	head and neck cancer: 133.1;prostate cancer: 34.7	Not detected	Not detected			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enriched	Detected in some	22	BEWO: 104.7	Low region specificity	Detected in many			Not detected	Not detected			CAB000045, HPA041264, HPA041271	Enhanced								6100000000			CAB000045: AB_2242301, HPA041264: AB_2677383, HPA041271: AB_2677386	unprognostic (5.59e-2)	unprognostic (1.60e-2)	unprognostic (1.77e-1)	unprognostic (3.07e-4)	unprognostic (5.75e-3)	unprognostic (3.84e-3)	unprognostic (1.86e-1)	unprognostic (7.61e-2)	unprognostic (1.32e-1)	unprognostic (2.24e-1)	unprognostic (2.64e-3)	unprognostic (2.50e-1)	unprognostic (1.56e-3)	unprognostic (9.40e-4)	unprognostic (2.61e-1)	unprognostic (1.58e-2)	unprognostic (1.01e-1)	29.6	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.3	0.2	0.2	0	0.8	0.2	0.2	48.6	30	0.2	0.2	122.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.1	0.2	0	2.7	0.2	0	40.4	0.2	1935.3	0.5	0.2	1.2	0.4	0.2	0.2	0.2	0	0	5.3	523.6	39.9	0.2	0.1	4.4	14.7	20.5	15.5	5.1	9.7	20.8	0	0	0	0	0	0	104.7	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.3	0	0	4.5	0	0.1	0.1	4.7	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0.9	0	0	0	0	0.1	0	0	0.1	0.1	0.1	0.2	0	0	0.1	0	8.9	9.3	20.5	7.6	15.5	5.7	4.4	6.4	7.4	14.7	4.3	5	7.7	12.1	5.1	14	4.7	9.7	20.8	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0	0	0	0	0	0	0.4	0.5	0.7	1758.3	0	0	0	0	3.9	0.2	0	0.3	0.3	0	0	0	0	1.1	0.4	0.1	0	0	0.1	0	0	0	0	0	0	0.6	0	0	0	0.4	0.5	0	0.4	0	0	0	1	0.7	0	0.4	0.2	0	0	0	Cardiomyocytes
PPFIA4		ENSG00000143847	PTPRF interacting protein alpha 4	O75335	1	203026498-203078740	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	10	brain: 72.6;heart muscle: 26.2;skeletal muscle: 20.4	Cell type enriched	Detected in some	5	Cardiomyocytes: 32.2	Low cancer specificity	Detected in many			Group enriched	Detected in all	4	cerebellum: 72.6;cerebral cortex: 21.1	Cell type enhanced	Detected in some		myeloid DC: 1.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		A-431: 7.4;hTERT-RPE1: 12.8;RH-30: 13.2;U-266/70: 8.3;U-87 MG: 12.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA053419, HPA054132	Enhanced											HPA053419: AB_2682143, HPA054132: AB_2682393	unprognostic (2.83e-1)	unprognostic (2.34e-3)	unprognostic (3.38e-5)	unprognostic (3.19e-1)	unprognostic (6.58e-2)	unprognostic (5.36e-2)	unprognostic (7.49e-8)	unprognostic (4.65e-1)	unprognostic (6.01e-4)	unprognostic (1.29e-1)	unprognostic (7.70e-2)	unprognostic (2.60e-2)	prognostic unfavorable (1.73e-8)	unprognostic (6.82e-3)	unprognostic (9.96e-2)	unprognostic (1.11e-1)	unprognostic (4.28e-2)	0.6	1.3	9.2	1	10.9	1.6	0.9	72.6	21.1	1.8	1	1.4	0	1.1	1.7	3.5	1.3	1.2	2.6	26.2	6.6	5	1.9	0.6	1.2	0.8	3	10.8	0.9	0.6	1.3	0.7	3.9	11.4	1.5	0.8	0.6	1.4	1.3	20.4	2.9	1.3	2	2	2.2	0.8	3.3	2.3	0	0.9	0.4	0.8	0.9	0.9	0	1.4	1.3	0.9	0	0.6	0	7.4	0	0.1	1.9	0	0.3	0.3	0.4	0.9	0.7	3.1	0.3	0.3	0.3	1.6	1.7	0.2	0.8	0.6	1.4	1.5	0	0.6	0.1	0	0	0.1	0	1	2.4	0.1	0.4	0	12.8	0	1.5	0.1	0.3	6.2	1	0.5	0.9	0.9	0	0.3	1.3	13.2	2.1	0	0	2.5	3.2	0.8	0.1	1	1.2	0.2	0.6	0	4.7	2.8	0.1	0	8.3	0.2	0.1	12.1	0.6	0.5	0	0.9	1.3	0	0.5	0	0	0	0	1.4	0	0	0	0.3	0	0.9	0	0.6	0	9.2	10.9	72.6	21.1	6.6	5	3	10.8	11.4	2.3	0	0	0	0.1	0	2.4	32.2	0	0	0	0	5.9	0	0	0.9	1.6	0	0	0	0	0.1	0.7	0	0	0	0.3	6.4	0	1.3	0	1.9	0.3	0	0	0	0	2.6	0.5	0	1.8	0	0.8	0	0.9	0.5	1.2	0	0.2	0	0	0	Cardiomyocytes
CCDC39	CILD14, DKFZp434A128, FAP59	ENSG00000145075	Coiled-coil domain containing 39		3	180614008-180870933	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		skeletal muscle: 12.4	Cell type enriched	Detected in single	16	Cardiomyocytes: 1.7	Low cancer specificity	Detected in some			Not detected	Not detected			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		ASC diff: 1.9;ASC TERT1: 2.7;HSkMC: 3.8;HUVEC TERT2: 1.2																						unprognostic (3.37e-1)	unprognostic (1.24e-1)	unprognostic (3.40e-2)	unprognostic (1.09e-1)	unprognostic (4.03e-2)	unprognostic (1.35e-4)	unprognostic (1.34e-1)	unprognostic (6.62e-2)	unprognostic (6.88e-2)	unprognostic (9.65e-2)	unprognostic (1.33e-1)	unprognostic (5.76e-2)	unprognostic (1.88e-4)	unprognostic (7.40e-2)	unprognostic (2.33e-1)	unprognostic (1.22e-3)	unprognostic (1.16e-4)	7.9	0.5	0.4	1	0.4	1.5	2.6	0.4	0.4	10.7	2.2	0	0.7	0.1	5.2	4.8	1.1	1	2.2	2.3	0.4	0.4	0.4	0.8	1.1	0.3	0.4	0	7.5	0.5	0	1.1	0.3	0.2	2	0.3	4.7	1.6	0.1	12.4	0.8	0.6	6	0.4	4.5	0.6	8.3	0	0	0.6	1.8	0	2.4	0.9	0.5	0.1	1.1	0.8	0.1	0.7	0	0	0	0	0.2	1.9	2.7	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0.6	0.4	3.8	0	0	0	0.4	1.2	0	0	0	0	0	0	0.9	0	0	0.6	0	0	0	0	0.6	0	0.1	0	0	0	0.6	0	0	0	0.2	0.3	0.5	0.1	0	0	0	0	0.4	0	0.3	0.8	0.4	0.7	0.1	0.6	0.4	0.6	0.2	0	0.5	0.4	0.5	1.1	0.1	0.1	0.1	0.1	0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0	0.2	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
CORIN	ATC2, CRN, Lrp4, PRSC, TMPRSS10	ENSG00000145244	Corin, serine peptidase	Q9Y5Q5	4	47593998-47838106	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins		Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	epididymis: 11.6;heart muscle: 39.5	Cell type enriched	Detected in some	5	Cardiomyocytes: 50.9	Low cancer specificity	Detected in some			Region enriched	Detected in single	5	pons and medulla: 1.6	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	ASC TERT1: 32.6	Region enhanced	Detected in some		basal ganglia: 2.7	Low region specificity	Detected in single			HPA070941			Approved	Nuclear bodies,Plasma membrane,Actin filaments	Intracellular and membrane	Yes	No			Plasma membrane	Nuclear bodies, Actin filaments	HPA070941: AB_2686324	unprognostic (1.05e-1)	unprognostic (2.52e-1)	unprognostic (1.14e-1)	unprognostic (1.93e-1)	unprognostic (2.10e-1)	unprognostic (3.18e-1)	unprognostic (3.58e-4)	unprognostic (3.19e-1)	unprognostic (3.67e-2)	unprognostic (8.22e-2)	unprognostic (9.78e-2)	unprognostic (6.53e-2)	unprognostic (1.18e-1)	unprognostic (2.86e-2)	unprognostic (5.18e-2)	unprognostic (7.22e-2)	unprognostic (1.33e-2)	0.3	0.1	0.3	0	0.1	0	0.8	0.1	0.1	3.1	0.1	0.1	2.6	0	3.4	11.6	0.7	1.2	4.5	39.5	0	0.2	2	0	1.3	0	0.2	0	0.6	0.1	0	1.5	0.6	1.6	1.7	0	0.4	0.3	4.6	0.2	5.3	0.4	0.5	0	3.5	0.3	3.7	0	0.2	0.1	1.7	0.4	0.8	3.2	0.2	0	0.5	0.5	0	0.3	0	0	0	0	0.2	7.5	32.6	0	1.4	2.6	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0.1	0	0	1.5	0.2	0	0	0.1	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0.1	0	0	0	0.6	1	0	0.2	0.1	0.7	0	0	0	0	0	0	0.4	0	0.5	0.3	0	0.1	0	0	0.2	0	0	0.5	0	0.1	0	0	0	0.3	0.1	0.1	0.1	0	0.2	0.2	0	1.6	0	0	6.9	0	0.2	3.4	0.8	50.9	0	0	0	1.8	0	0	0	0	4.5	0.3	0	0	0	0	9.3	0.6	0	0	0.1	0	0	0	0.8	0.8	4.4	0	5	0	0	0.7	0	0	2.5	0	0.1	0	4.2	3	4.6	2.4	0	0	0	0.2	Cardiomyocytes
MLIP	C6orf142, CIP, MGC18257	ENSG00000146147	Muscular LMNA interacting protein	Q5VWP3	6	53929982-54266280	Disease related genes, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	heart muscle: 61.7;liver: 47.4;skeletal muscle: 101.9;tongue: 31.6	Cell type enriched	Detected in some	10	Cardiomyocytes: 190.6	Cancer enhanced	Detected in some		liver cancer: 1.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	8	HUVEC TERT2: 18.1;SK-MEL-30: 17.4					Low region specificity	Detected in many			HPA029252, HPA046654	Approved		Approved	Nucleoplasm						Nucleoplasm		HPA029252: AB_2732446, HPA046654: 	unprognostic (7.95e-3)	unprognostic (4.39e-2)	unprognostic (2.36e-1)	unprognostic (1.06e-4)	unprognostic (2.38e-2)	unprognostic (1.26e-2)	unprognostic (5.60e-2)	unprognostic (2.74e-2)	unprognostic (1.89e-2)	unprognostic (1.78e-1)	unprognostic (1.03e-1)	unprognostic (1.32e-1)	unprognostic (1.91e-5)	unprognostic (7.49e-2)	unprognostic (2.65e-2)	unprognostic (5.27e-2)	unprognostic (3.29e-3)	5.7	1.9	4.2	0.2	5.2	0.1	1.6	0.8	11.5	0.8	0.5	0	0	0.3	0.4	3.5	4.9	0.5	0.8	61.7	1.8	0.8	0.5	47.4	0.4	0.2	7.2	8.3	0.4	0.6	0.3	0.5	0.2	1.8	0.8	0.4	1.3	2.6	0.3	101.9	6.5	1.1	0.3	2.9	0.3	0.4	0.5	0	0	2.7	31.6	2.2	0.6	1	0	0	0.1	0	0	0.3	0	0	0	0.3	0	0.1	0	0	0	0	0	0	0.5	0	0	0.1	0	0	0.4	2.1	0.1	0	0	0.1	0.2	0	0	0	0	0	0.7	2.2	0	0	0	18.1	0.1	0	0	1.8	0	0	0	0	0.3	0	0.3	1.2	0	0.1	0.6	1.3	0	0	0.5	17.4	0.2	0	0	0	0	0.1	0	0.1	1.4	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.1	0	0	0	0	0	4.2	5.2	0.8	11.5	1.8	0.8	7.2	8.3	1.8	0	0	0	0	0	0.3	0	190.6	0	0	0	0	0	0	1.7	0	11.7	0.5	0	0	0	0	0.3	0.1	0	18.3	0	12.7	0	0.6	1.5	8.2	0.3	0	6.8	0	0.3	0	0	0	0	1.1	0	0	0.3	0.2	0.1	1.8	0	0	0	0.1	Cardiomyocytes
ASB10	GLC1F	ENSG00000146926	Ankyrin repeat and SOCS box containing 10	Q8WXI3	7	151175698-151187832	Disease related genes, Predicted intracellular proteins	Ubl conjugation pathway		Disease mutation, Glaucoma	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	10	heart muscle: 12.3;skeletal muscle: 44.0;tongue: 15.3	Cell type enriched	Detected in single	122	Cardiomyocytes: 12.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			HPA079685	Enhanced											HPA079685: 						unprognostic (6.72e-3)				unprognostic (1.96e-1)								0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.3	0.3	0	0.2	12.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.2	0.5	0	44	0	0	0	0	0	0	0	0	0	0.6	15.3	1.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
ITGB1BP2	CHORDC3	ENSG00000147166	Integrin subunit beta 1 binding protein 2	Q9UKP3	X	71301734-71305371	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 43.0;skeletal muscle: 21.3;smooth muscle: 18.6;tongue: 19.6	Cell type enriched	Detected in some	9	Cardiomyocytes: 69.8	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enhanced	Detected in single		eosinophil: 1.5	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		HMC-1: 14.0	Not detected	Not detected			Not detected	Not detected			HPA040721			Approved	Cytosol						Cytosol		HPA040721: AB_10805827	unprognostic (1.87e-1)	unprognostic (2.65e-2)	unprognostic (6.91e-5)	unprognostic (1.95e-2)	unprognostic (7.92e-2)	unprognostic (1.54e-1)	unprognostic (3.81e-2)	unprognostic (9.02e-2)	unprognostic (4.69e-2)	unprognostic (2.15e-2)	unprognostic (4.85e-2)	unprognostic (3.17e-1)	unprognostic (3.08e-11)	unprognostic (4.38e-2)	unprognostic (3.63e-2)	unprognostic (2.99e-1)	unprognostic (2.64e-1)	0.7	0.3	0.2	1	0.3	0.6	0.3	0.6	0.2	2.7	2.8	0	2.3	0.4	12.8	3.4	4	1.8	4.8	43	0.2	0.2	0.4	0.6	0.5	0.5	0.3	0	2.4	0.3	0	0.3	0.2	0.2	3.2	0.9	3.5	0.7	5.8	21.3	0.3	1	18.6	0.3	0.6	1.1	1.6	0.1	0	0.4	19.6	0.7	5.6	0.8	0.2	0.2	1.5	0.2	0	0.5	0	0.7	2.1	3.2	2.8	0.1	0.1	0.7	1	1.4	0.7	0.9	1.6	1.6	3.1	0.4	1.6	0.8	1.5	2.9	0.8	1.8	1	1.3	1.9	1.9	0.6	0.4	0.7	14	1.7	1.3	0.5	0.5	0.7	1.2	3.4	1.4	0.8	1.6	0.9	1.2	3.5	4.7	2.1	1.3	2.1	2.5	1.2	1.6	2	1.5	0.5	0.7	0.1	0.8	2.2	0.9	0.4	0	1.4	2.8	0.3	0.6	2.9	3.8	4.8	0.4	2.4	0.6	0	0.2	1.5	0.2	0	0	0	0	0	0.2	0.2	0.5	0.1	0	0	0	0	0	0	0.2	0.3	0.6	0.2	0.2	0.2	0.3	0	0.2	0.1	0	0	0	0	0.2	1.5	69.8	0	0	0	0	0	0	0	0.4	0.1	0.1	0	0	0	0	0.4	0.2	0	0	0.2	0	0	1.3	0	0	0.3	0	0	0	0	0	0.2	0	8.1	0.3	0.9	0	1.7	0.3	0.3	0.3	0	0	0.3	0	Cardiomyocytes
ANKRD1	ALRP, C-193, CARP, CVARP, MCARP	ENSG00000148677	Ankyrin repeat domain 1	Q15327	10	90912096-90921276	Disease related genes, Predicted intracellular proteins			Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	81	heart muscle: 398.9;skeletal muscle: 333.3	Cell type enriched	Detected in some	15	Cardiomyocytes: 12578.5	Cancer enhanced	Detected in many		head and neck cancer: 7.5	Not detected	Not detected			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		EFO-21: 104.9;hTERT-RPE1: 57.1;LHCN-M2: 128.8;SuSa: 41.0;TIME: 179.4	Not detected	Not detected			Not detected	Not detected			HPA038736	Enhanced		Approved	Nucleoplasm,Nucleoli fibrillar center			Yes			Nucleoli fibrillar center	Nucleoplasm	HPA038736: AB_2676184	unprognostic (2.45e-1)	unprognostic (6.14e-3)	unprognostic (2.24e-1)	unprognostic (4.39e-1)	unprognostic (9.14e-3)	prognostic unfavorable (1.95e-4)	unprognostic (1.28e-2)	unprognostic (6.63e-3)	unprognostic (2.19e-1)	unprognostic (3.27e-1)	unprognostic (4.51e-2)	unprognostic (3.40e-1)	unprognostic (2.72e-5)	unprognostic (3.40e-2)	unprognostic (2.79e-1)	unprognostic (7.22e-2)	unprognostic (3.16e-3)	1.5	0.1	0	0.1	0	0.1	0.2	0	0.1	0.1	0.1	0	0	0.1	0.1	2.1	1.5	0.1	0.1	398.9	0	0	0.1	0.1	4.5	0.2	0	0	0.1	0.4	0.1	0.1	0.7	0.1	0.9	0.1	0	0.8	0.1	333.3	0.1	0.1	0.2	0	0.1	0.1	0.1	0	0	2.9	1.6	0.5	0.3	0	0.4	0.5	1.9	0.6	0.9	0.4	0.2	2.9	0.8	0.5	0	0.4	0.5	0	1.7	0.1	0.5	0.9	38	1.4	0	104.9	0.1	4	1	0.1	0.2	1.3	0.1	0.1	0	0.2	11.7	2.3	0	0	3.7	0	0.7	1.8	57.1	35.8	0	0	0	128.8	0	0	0	0.1	0.2	0	0	8.7	0	0.3	0	0	0	0	0	0.1	41	0	0.1	179.4	0.3	13.8	0.2	14.1	0	0	0.2	0	0	0	1.9	0.2	0.5	0.2	0.3	0.3	0.3	0.2	0.2	0.2	0.4	0.4	0.3	0.7	0.9	0.6	0.5	0.4	0.2	0	0	0	0	0	0	0	0	0.1	0	848.6	37.7	0	1.3	0	0	12578.5	10.2	1.4	9.1	0	0	0.1	0	19	2	0	0	0	0.2	0.2	0.2	0.4	3.5	0	0	0	0	1.3	0	0.2	0	0	0	1	0	0	3.7	0	0	0	0	0	1.4	0	0	0	0.5	0	0	0.1	Cardiomyocytes
SLC25A4	ANT1, PEO2, PEO3, T1	ENSG00000151729	Solute carrier family 25 member 4	P12235	4	185143241-185150382	Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters	Host-virus interaction, Transport		Cardiomyopathy, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	5	heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4	Cell type enriched	Detected in many	5	Cardiomyocytes: 4236.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	5	B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1	Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA046835, HPA071684	Approved		Supported	Mitochondria						Mitochondria		HPA046835: AB_2679831, HPA071684: AB_2686431	unprognostic (4.19e-2)	unprognostic (1.06e-2)	unprognostic (3.11e-1)	unprognostic (8.85e-2)	unprognostic (1.37e-1)	unprognostic (2.90e-3)	unprognostic (8.25e-2)	unprognostic (1.26e-2)	unprognostic (7.87e-2)	unprognostic (1.60e-1)	prognostic favorable (3.41e-4)	unprognostic (2.05e-1)	prognostic favorable (0.00e+0)	unprognostic (1.98e-1)	unprognostic (1.05e-1)	unprognostic (1.73e-1)	unprognostic (8.28e-3)	3	4.2	6.9	2	10.8	1.4	3.1	19.4	14.4	2.6	6.6	3.7	2.9	2.8	3	3.4	6.7	3.7	3.5	163.7	7.4	7.3	8.3	4.3	3	2	6.3	6.1	3.6	3	4.6	4.6	2.2	12.8	6.2	3.4	7.9	4.4	8.5	92.5	2.3	4.1	5.5	4.5	2.1	5.3	3.1	2.3	0	4.6	62.4	3.4	4.4	2.1	3.5	3	0.4	0	0.7	4.1	1.5	0.7	3.3	2.7	5.5	3	0.3	5	2.7	0.9	3.3	3.3	7.1	1.8	2.4	2	3.3	2.6	2.6	10.4	2.9	2.2	4	8.9	1.6	4.9	8.3	6.1	1.4	1.6	2.2	7.1	5.1	1.4	7.8	2.4	4.2	3.8	1.9	2	5.1	1.6	3.2	4.4	2.3	7.1	2.6	1.4	3.3	7.5	5.1	8.8	6.7	3.2	1.4	12.6	5.1	2.6	1.2	1.8	0.2	1.5	1.7	3.5	7.9	3.6	3.1	2.4	0.3	3	0	0	0	4.1	0	3.1	3.5	1.4	3.5	0.1	2.2	1.2	3	0.4	0.7	0	3	1.2	1.5	6.9	10.8	19.4	14.1	7.4	7.3	6.3	6.1	12.8	2.3	80.4	55.4	33.5	125.8	39.2	174.4	4236.1	140.1	112.4	42.1	68	98.2	59.7	837.3	68.4	15.8	25.9	41.2	0	65.1	47.9	24.6	55	11.5	83.9	50.1	151	51.6	24.5	7.6	7.7	43.1	7.9	180.5	15.4	35.7	473.2	51.1	24.6	106.1	140.9	178.4	103.5	194.8	24	35.3	15.8	33.9	10.7	48.8	46.9	Cardiomyocytes
ADPRHL1	ARH2	ENSG00000153531	ADP-ribosylhydrolase like 1	Q8NDY3	13	113399610-113453524	Predicted intracellular proteins		Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 89.6;skeletal muscle: 68.1	Cell type enriched	Detected in many	15	Cardiomyocytes: 122.4	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		SCLC-21H: 14.7;T-47d: 26.4	Region enhanced	Detected in single		cerebellum: 2.6	Not detected	Not detected			HPA066478, HPA072123	Enhanced		Approved	Nucleoplasm						Nucleoplasm		HPA066478: AB_2685673, HPA072123: 	unprognostic (3.03e-1)	unprognostic (1.38e-2)	unprognostic (2.31e-1)	unprognostic (8.88e-3)	unprognostic (1.50e-1)	prognostic unfavorable (4.88e-4)	prognostic unfavorable (2.55e-5)	unprognostic (1.57e-1)	unprognostic (1.63e-1)	unprognostic (2.35e-1)	unprognostic (2.56e-1)	unprognostic (1.58e-1)	unprognostic (1.62e-1)	unprognostic (2.14e-2)	unprognostic (1.53e-2)	unprognostic (4.99e-3)	unprognostic (1.02e-1)	1.8	1	0.6	0.2	1.1	0	0.8	0.5	3	0.4	1.4	0.3	0	0.9	0.4	4	2.2	1.9	0.7	89.6	0.5	0.8	0.2	0.4	0.5	0.1	0.7	1.1	0.5	1.5	0	1.8	1.4	0.3	0.9	0.5	0	1.9	0.1	68.1	0.9	3	0.2	0.5	0.3	1	1.3	0	0.1	0.7	21.8	0.6	0.3	0.5	1.9	2.8	1.7	1.6	1.1	2.5	1	4	9.6	1	3	3.1	5	2.7	1.5	0.7	0.5	0.4	2.7	9.9	1.4	5.7	1.7	2.8	2.2	3.8	0.2	0.4	1.4	1.6	4.1	2.3	0.7	1	0.3	1.7	1.7	2.3	3.2	0.4	0.4	0.1	3.6	1.2	0.4	4	8.7	0.6	2.4	2.2	10.4	5.1	6.3	2.5	3.6	1	0.4	14.7	3.4	1	4.8	1.2	1.2	26.4	0.5	0.3	0.1	1.8	4.4	0.5	1.4	1.1	4.7	2.9	0.8	2.1	0.4	1.2	0.1	0.1	1.6	1.8	1.9	0.8	2.5	2.8	0.8	1.4	1.5	1.7	1.1	1.3	0.5	1.3	1	0.6	1.1	0.5	3	0.5	0.8	0.7	1.1	0.3	0	0	5.8	0	1.9	1.1	1.3	122.4	0	8.1	4.5	0	0	3.2	0	2.8	1.1	1.6	3.8	0	2.9	2.2	1.5	2.3	0	1	0.5	1.6	4.1	1.3	0.3	1.3	0	0.5	1.7	0	5.1	2.1	1.4	5.8	1.4	0.3	1.7	0	0.5	1.8	2.6	2.3	2.1	0	3.2	2.8	Cardiomyocytes
SPHKAP	SKIP	ENSG00000153820	SPHK1 interactor, AKAP domain containing	Q2M3C7	2	227979950-228181645	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	15	brain: 64.0;heart muscle: 33.2	Cell type enriched	Detected in some	13	Cardiomyocytes: 75.1	Not detected	Not detected			Region enriched	Detected in many	4	cerebellum: 64.0	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	17	BJ hTERT+: 32.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA042499, HPA048168	Enhanced											HPA042499: AB_2678027, HPA048168: AB_2680296	unprognostic (4.91e-3)				unprognostic (6.46e-2)						unprognostic (1.33e-1)	unprognostic (2.59e-2)		unprognostic (2.95e-2)	unprognostic (2.09e-1)	unprognostic (1.01e-3)		0.5	0.6	10.7	0.5	5.1	0.4	1.4	64	14.8	0.5	0.5	2.1	0	0.5	0.5	0.4	0.5	0.5	0.5	33.2	15.1	3.7	0.5	0.4	0.6	0.5	1.6	4.5	3.2	0.5	0.4	0.1	0.5	3.8	0.5	0.5	0.5	2.7	0.5	0.4	0.5	0.5	0.5	1.1	1	0.5	0.7	0.9	0	0.5	0	0.4	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	32.5	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.7	5.1	64	8.5	15.1	3.7	1.6	4.5	3.8	0.9	0	0	0	0	0.1	5.6	75.1	0	0	0	0	2	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	Cardiomyocytes
OBSCN	ARHGEF30, KIAA1556, KIAA1639, UNC89	ENSG00000154358	Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF	Q5VST9	1	228208130-228378874	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Differentiation	Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	skeletal muscle: 180.2;tongue: 48.4	Cell type enriched	Detected in many	14	Cardiomyocytes: 136.5	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Cell type enhanced	Detected in some		naive CD4 T-cell: 3.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HeLa: 16.0	Low region specificity	Detected in single							HPA021186, HPA065801	Enhanced		Approved	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA021186: AB_1854761, HPA065801: 	unprognostic (8.47e-3)	unprognostic (1.56e-1)	unprognostic (9.99e-2)	prognostic unfavorable (1.64e-4)	unprognostic (5.30e-3)	unprognostic (6.36e-2)	unprognostic (4.54e-3)	unprognostic (1.82e-1)	unprognostic (8.81e-2)	unprognostic (1.93e-2)	unprognostic (3.38e-1)	unprognostic (1.45e-1)	unprognostic (1.57e-3)	unprognostic (1.34e-1)	unprognostic (1.77e-1)	unprognostic (3.53e-1)	unprognostic (1.16e-2)	2.5	0.9	0.5	0.9	4.4	0.6	0.7	3.1	0.6	0.6	0.8	0.5	0.5	0.6	0.8	4.4	2.4	1	0.6	21.2	0.5	0.7	1.6	0.5	1	1	0.5	0.5	1.7	1.4	0.4	2.4	0.5	0.9	1.7	0.3	5.2	2.6	1.1	180.2	1.1	0.8	0.5	0.6	1.4	0.5	0.7	0.6	0.5	2.2	48.4	3.5	0.6	0.7	1	1.1	0.1	0.4	0.6	3.2	0.7	2.9	2.8	8	4.5	0.2	0.1	5.6	1.5	0.5	1	0.9	2	2.1	5.7	8.1	0.5	0.6	1	0.4	1.1	0.2	2.2	5.1	1.9	16	0	2	1.3	6.1	3	1	0.4	0.2	5.4	0.4	9.4	5.3	1.3	0.3	5	2.1	1.6	8.8	0.8	1.8	8.1	0.1	1.3	4.6	1.5	3	9	0.2	2.9	1.1	2.4	8	3.7	0.7	0	9.3	0.2	0.1	4.7	0.9	1.4	0	0.8	2.1	0.1	0.4	0	0.9	0.1	0.9	0.5	0.9	0.7	0.9	1	3.2	0.5	0.1	0.6	0.1	1.1	0.8	0.7	0.5	4.4	3.1	0.6	0.5	0.7	0.5	0.5	0.9	0.6	0	5.6	0	5.9	1.9	3.2	136.5	2.5	1.4	4.5	5.2	9.8	0.1	10	2.9	3.8	1.6	0.4	0	0.4	0.4	1.5	1.9	6.9	0.5	0.1	0	0	1.3	0	4	2.8	0.3	1.7	0	1.7	9.7	1	0	4.2	4.2	2.8	0	1.2	0.1	2.5	1.5	1	1.8	1.1	3.4	Cardiomyocytes
PPP1R3A	GM, PPP1R3	ENSG00000154415	Protein phosphatase 1 regulatory subunit 3A	Q16821	7	113876777-114075920	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Carbohydrate metabolism, Glycogen metabolism		Diabetes mellitus, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	20	heart muscle: 24.1;skeletal muscle: 69.4;tongue: 75.4	Cell type enriched	Detected in some	13	Cardiomyocytes: 136.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	64	THP-1: 18.1	Region enriched	Detected in single	19	thalamus: 1.2	Not detected	Not detected			HPA070440, HPA073138	Enhanced											HPA070440: , HPA073138: 						unprognostic (8.96e-3)												1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.7	1.7	0	0	24.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.6	0	0	1.4	0	69.4	0	0	0	0	0	0	0.4	0	0	0.1	75.4	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	136.5	0	0	0	0	0	0	0	0	10.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	1.1	0	0	0	0	0	Cardiomyocytes
TTN	CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins		Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase	Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 136.5;skeletal muscle: 713.8;tongue: 227.0	Cell type enriched	Detected in many	134	Cardiomyocytes: 19161.7	Cancer enhanced	Detected in single		head and neck cancer: 1.3	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		RH-30: 4.9	Not detected	Not detected							HPA007042, CAB022682, HPA030048	Enhanced								25000000			CAB022682: , HPA007042: AB_1080292, HPA030048: AB_2732451	unprognostic (1.00e-2)	unprognostic (3.92e-1)	unprognostic (1.77e-1)	unprognostic (7.11e-2)	unprognostic (3.71e-2)	unprognostic (1.49e-2)	unprognostic (6.62e-2)	unprognostic (1.84e-1)	unprognostic (2.49e-2)	unprognostic (1.86e-1)	unprognostic (2.79e-1)	unprognostic (2.65e-1)	unprognostic (3.49e-4)	unprognostic (1.99e-1)	unprognostic (1.15e-1)	unprognostic (1.09e-1)	unprognostic (1.34e-2)	23.7	0.3	0.2	0.3	0.3	0.9	0.3	0.2	0.4	0.2	0.2	0	0	0.2	0.2	21.3	8.3	0.2	0.3	136.5	0.2	0.2	0.2	0.2	0.4	0.4	0.2	0	0.3	0.4	0.2	0.3	0.3	0	0.7	0.2	0	11.6	0.2	713.8	0.3	0.2	0.2	0.3	0.3	0.2	0.4	0	0	5.6	227	15.8	0.3	0.2	7	0.3	1.9	0.3	5	7.3	0.1	0.7	0.3	1.9	1	0	0	3.4	0.6	0	0	0	1.8	0.3	2.4	0.6	0	1.8	1.8	0	0	0	2.4	2	3.7	2.7	1.1	0	0.3	0.8	2.4	0	0	0	1.7	1.4	1.8	2.2	1.2	0.4	0.4	1.6	2.5	0.4	0.2	1.8	1.3	4.9	1.3	0	0.6	1.1	1.7	0.4	1.3	0	1.7	0.8	2.4	1.6	0	0	0.9	0.4	3.6	0.4	3.5	0.1	1.1	0.9	1.9	0.3	0.7	0.5	0.2	0.2	6.9	1.2	0.9	0.2	7	2.7	3.5	1.3	5	0.2	0.3	7.3	0.1	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0	0	0	14.9	142.6	2.2	0.2	0.8	28.9	19161.7	17.8	5.3	11.4	0	19.6	0.4	1.7	7.7	35.3	0.7	0	0	23.6	0.2	0.5	0.1	9.3	0.5	0.2	15.9	4.1	2.5	0	4.3	1.1	0.4	0	0	0	10.3	0.9	0	4.2	0	26.3	0	1.4	5.7	0.2	0.1	0.3	4.9	0	0	Cardiomyocytes
COX6A2		ENSG00000156885	Cytochrome c oxidase subunit 6A2	Q02221	16	31427731-31428428	Predicted intracellular proteins, Transporters		Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	28	heart muscle: 398.6;skeletal muscle: 421.1;tongue: 230.8	Cell type enriched	Detected in some	64	Cardiomyocytes: 3924.5	Group enriched	Detected in many	5	head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6	Not detected	Not detected			Cell type enriched	Detected in single	125	NK-cell: 12.5	Lineage enriched	Detected in single	125	NK-cells: 12.5	Cell line enriched	Detected in some	4	U-266/84: 14.6	Low region specificity	Detected in many			Low region specificity	Detected in all																unprognostic (1.66e-1)	unprognostic (1.73e-3)			unprognostic (2.09e-2)	unprognostic (1.25e-2)	unprognostic (1.68e-2)		unprognostic (3.88e-1)	unprognostic (5.61e-2)	unprognostic (7.20e-2)	unprognostic (8.71e-2)	unprognostic (6.20e-2)	unprognostic (1.68e-1)	unprognostic (2.65e-1)			3	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0	0	0.2	0.1	9.3	5.6	0.1	0.1	398.6	0.1	0.3	0.2	0.9	0.1	0.1	0.2	0	0.1	0.2	0.2	0.8	0.1	0	2.3	0.1	0.9	8.4	0.1	421.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0	5.5	230.8	11.4	0.1	0.1	0	0	0	0	12.5	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0.2	0	0	0	14.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.5	0	0	0	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0	0	0	0	0	0	0.1	0	0.6	3924.5	0	0	0	3.5	0	0	5	0	0	0	0	0	0.3	0	0	0.1	0	61.4	2.1	3.2	0	0.6	2.1	0.8	0.3	0	0	0	0	0.8	0.5	0	0.7	20.3	3.9	19.4	0	0.2	0.6	0	0	0	0	0	Cardiomyocytes
TRIM63	IRF, MURF-1, RNF28, SMRZ	ENSG00000158022	Tripartite motif containing 63	Q969Q1	1	26051304-26068436	Enzymes, Predicted intracellular proteins	Ubl conjugation pathway	Muscle protein, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	skeletal muscle: 271.4	Cell type enriched	Detected in some	11	Cardiomyocytes: 236.2	Cancer enriched	Detected in some	10	melanoma: 31.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	38	ASC diff: 10.7;SK-MEL-30: 34.3	Not detected	Not detected			Low region specificity	Detected in all																unprognostic (1.10e-1)	unprognostic (4.80e-4)	unprognostic (1.45e-2)	unprognostic (7.52e-3)	unprognostic (1.44e-1)	unprognostic (2.05e-2)	unprognostic (3.42e-1)	unprognostic (1.12e-1)	unprognostic (2.71e-1)	unprognostic (1.06e-1)	unprognostic (3.17e-1)	unprognostic (1.01e-1)	unprognostic (2.16e-2)	unprognostic (5.90e-2)	unprognostic (1.33e-2)	unprognostic (2.32e-1)	unprognostic (5.58e-2)	3.4	0	0	0	0.1	0	0.1	0	0	0.3	0	0	0	0	1	1.2	1.7	0	0.6	38.2	0	0	0.3	0	0.2	0	0	0	0	0.1	0	0	0.9	0.1	0.5	0	3.6	1	0	271.4	0.6	0.1	0.9	0.1	0	0.1	0.1	0	0	1.7	12.7	0.8	1.2	0.3	0	0.9	0	0	0	0	0.1	0	0	0	0	10.7	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0.6	0	0.1	0.3	0	0	0	0	0	0	0.4	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	34.3	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0.1	0	0	1.1	0	0.1	0.8	0	236.2	10.2	0	0	1.8	0	0.4	1.7	0.7	0	0	0	0	0	0.1	0.3	0	9.3	0	0.5	0	0	0	0	0	0	0	11.8	0	0	0	0.2	0	0	21.6	0	0	0	0	0	0.1	1.4	0	0	0	Cardiomyocytes
TNNI1		ENSG00000159173	Troponin I1, slow skeletal type	P19237	1	201403768-201429866	Predicted intracellular proteins		Actin-binding, Muscle protein		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	skeletal muscle: 559.6	Cell type enriched	Detected in some	10	Cardiomyocytes: 50.9	Group enriched	Detected in many	5	head and neck cancer: 9.6;prostate cancer: 3.4	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enriched	Detected in some	9	RH-30: 106.3	Low region specificity	Detected in all			Not detected	Not detected			HPA028190	Approved		Uncertain	Nucleoplasm,Nucleoli					25000	Nucleoplasm	Nucleoli	HPA028190: AB_10600831	unprognostic (2.82e-2)	unprognostic (2.27e-1)	unprognostic (2.91e-1)	unprognostic (5.39e-2)	unprognostic (2.31e-2)	prognostic unfavorable (9.27e-4)	unprognostic (1.93e-2)	unprognostic (2.37e-1)	unprognostic (4.25e-1)	unprognostic (3.81e-2)	unprognostic (1.75e-1)	unprognostic (2.92e-2)	unprognostic (1.05e-2)	unprognostic (2.59e-2)	unprognostic (3.52e-1)	unprognostic (2.11e-1)	unprognostic (1.71e-1)	1.4	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0.1	0.1	22.9	9.5	0	0.1	6.6	0.1	0	0.5	0.1	0.1	0	0	0	0	0.1	0	0	0	0	4	0	0	6.8	0	559.6	0.1	0.1	0	0.1	0	0.1	0.2	0	0	2.7	83.8	10.7	0	0.1	0.2	0.6	1.7	0.4	0.4	0.5	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0.1	0	12.4	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0.1	0	0	0	106.3	0.1	0	0.1	0	0	0	0	0	1.1	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	1.2	0.4	0.3	0.3	0.3	0.1	0.2	0.2	0.2	0.6	0.2	0.3	0.5	1.7	0.4	0.3	0.4	0.1	0.1	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	50.9	0	0	0	0	0	0.2	5	0	2.7	0	0.8	0	0	0.1	0.5	0	0	0	0.6	0	0	0	0	1.4	0	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.4	0	Cardiomyocytes
ACTC1	ACTC, CMD1R	ENSG00000159251	Actin, alpha, cardiac muscle 1	P68032	15	34788096-34796139	Disease related genes, Plasma proteins, Predicted intracellular proteins		Muscle protein	Atrial septal defect, Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	19	heart muscle: 243.9	Cell type enriched	Detected in some	285	Cardiomyocytes: 8201.7	Group enriched	Detected in many	6	head and neck cancer: 20.7;prostate cancer: 5.1;testis cancer: 6.9;urothelial cancer: 7.3					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		fHDF/TERT166: 37.2;LHCN-M2: 151.1;RH-30: 72.4	Not detected	Not detected			Not detected	Not detected			CAB037330, HPA041264, HPA041271	Enhanced								6200000000			CAB037330: , HPA041264: AB_2677383, HPA041271: AB_2677386	unprognostic (8.18e-3)	unprognostic (3.74e-2)	unprognostic (4.82e-3)	unprognostic (1.19e-2)	unprognostic (3.04e-2)	prognostic unfavorable (3.72e-5)	unprognostic (3.26e-1)	unprognostic (2.05e-3)	unprognostic (2.26e-1)	unprognostic (7.98e-2)	unprognostic (1.14e-2)	unprognostic (2.10e-3)	unprognostic (5.68e-4)	unprognostic (8.79e-2)	unprognostic (1.65e-1)	unprognostic (1.48e-2)	prognostic unfavorable (9.32e-4)	1	0	0	0.3	0	0	0.1	0	0	0.5	0			0	0.1	0	0.2	0	0	243.9	0	0	0	0	0	0	0		0	0	0	0	0		1.9	0		0.6	12.5	8.7	0	0	0	0	0	0.6	0			0		0	9.5	0.9	0	0	0.1	0.1	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	37.2	0	0	0	0	0	0	0	0	0.8	0	0	0	0	16.1	0	0	0	0	0	0	0	0	151.1	0	0	0	0.1	0	0	0	72.4	0	0	0	0	0	0.1	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.4											0	0	0	0.2	0.5	5.9	8201.7	0	0	0	0	19.6	0	1.7	0	4.3	0.3	0	0	0.2	0.9	0.7	0.1	0	0	0.1	0	0	0.6	0	1.9	0	0	0	0	0	2.3	0.1	0	0	0	6.2	0	28.8	0.5	0.1	0.4	0.2	0	0	0	Cardiomyocytes
MYL3	CMH8, MLC1SB, MLC1V, VLC1	ENSG00000160808	Myosin light chain 3	P08590	3	46857872-46882169	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins		Motor protein, Muscle protein, Myosin	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	12	heart muscle: 398.1;skeletal muscle: 319.8	Cell type enriched	Detected in some	65	Cardiomyocytes: 3031.1	Cancer enhanced	Detected in many		renal cancer: 8.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	RPTEC TERT1: 28.5	Not detected	Not detected			Not detected	Not detected			HPA016564, CAB018662, HPA046859, HPA063034	Enhanced		Approved	Nucleoli,Mitochondria					15000000	Nucleoli, Mitochondria		CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927	unprognostic (3.11e-1)	unprognostic (2.64e-2)	unprognostic (5.55e-2)	unprognostic (1.51e-1)	unprognostic (1.77e-1)	unprognostic (4.44e-2)	unprognostic (9.67e-3)	unprognostic (3.37e-2)	unprognostic (4.72e-3)	unprognostic (3.63e-2)	unprognostic (1.08e-1)	unprognostic (7.88e-2)	prognostic favorable (1.22e-8)	unprognostic (1.16e-3)	unprognostic (9.45e-3)	unprognostic (7.18e-5)	unprognostic (2.53e-3)	0.9	0.2	0.5	0.2	0.4	0	0.6	0.2	0.4	0.5	0.1	0.3	0	0	0.2	10.1	10.5	0.1	0.2	398.1	0.7	0.4	2.3	0.1	0.2	0.1	0.7	0.3	0.3	0.1	0	0	0.3	0.3	1.6	0	0.3	5.5	0	319.8	0.1	0	0.1	0.8	0.4	0	0.1	0.4	0	1.1	30.1	3.1	0.2	0.2	0	0	0.7	0	0	0	0	0	0	0	0	3.2	0.9	1.6	0.3	0.1	0	0.1	5.9	0	0	0.9	0	0	0	0.3	0	0.1	0	0	0.1	0	0	0.2	0	0	6.2	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	28.5	0	0	0	0	0	0	0.3	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0.5	0.4	0.2	0.4	0.7	0.4	0.7	0.3	0.3	0.4	0	0	0	0.1	0.7	0.1	3031.1	0	0	0	1.8	0	0.4	46.4	0	2	0.3	0	0	0	5	7.1	0	0	0	0.3	0	0	0	0	8.5	1.1	0	0	0	0	2.2	0	0	0.7	46.2	0.4	6.5	1.3	0	0.4	0.4	0.7	0	0	0	Cardiomyocytes
COX7A1	COX7A, COX7AH	ENSG00000161281	Cytochrome c oxidase subunit 7A1	P24310	19	36150922-36152869	Predicted intracellular proteins, Predicted membrane proteins, Transporters		Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	4	heart muscle: 114.9;skeletal muscle: 404.3	Cell type enriched	Detected in many	28	Cardiomyocytes: 19391.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		classical monocyte: 1.9	Group enriched	Detected in many	8	dendritic cells: 1.3;granulocytes: 1.4;monocytes: 1.9	Cell line enhanced	Detected in some		ASC diff: 24.5;ASC TERT1: 18.0;BJ: 16.5;BJ hTERT+: 13.7;fHDF/TERT166: 25.1;HHSteC: 16.3;HSkMC: 16.9	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (5.48e-2)	unprognostic (1.19e-1)	unprognostic (6.13e-3)	unprognostic (6.46e-3)	unprognostic (5.33e-2)	unprognostic (3.87e-2)	unprognostic (3.77e-2)	unprognostic (9.93e-2)	unprognostic (1.92e-1)	unprognostic (1.41e-1)	unprognostic (9.49e-2)	unprognostic (1.46e-1)	unprognostic (7.84e-3)	unprognostic (7.27e-3)	unprognostic (9.44e-2)	unprognostic (6.23e-2)	unprognostic (1.54e-2)	15.7	8.1	5.3	2.5	3.6	1.2	8.8	2.1	13.1	4.1	8	0.8	2.6	2	3.9	6.1	6.6	3.1	5	114.9	3.3	2.4	5	1.6	4	2.7	2.6	4.6	4.2	3.5	6	7.9	2.6	1.7	5.9	2.3	5.9	6.2	7.1	404.3	2	2.2	12.3	1.4	3.1	3.6	1.6	1.5	1.6	5.1	59.7	2.6	7	4.7	0	1.3	1.4	1.9	0	0.1	0.3	0.1	2.6	0.2	0	24.5	18	0.1	16.5	13.7	0.5	0	0	0.8	0.6	6.9	25.1	0	0.3	0	0	0.1	0.1	0.9	0.1	0.9	0.1	16.3	0	0.2	16.9	0	0	0	0	1.9	0	0.2	0.2	0	0.3	0	0.1	0.4	0.3	0.6	0	0	0	0	0.7	0	0.2	0	0	0	0	0.2	0.1	3.7	0	0.6	0.2	0.1	0.4	0.4	0.3	0.1	0.3	0.5	0	1.9	0	0	1.6	0	0	0	0	1.3	0	0.1	0	1.4	0	0.5	0.4	0.1	0.3	5.3	3.6	2.1	13.1	3.3	2.4	2.6	4.6	1.7	1.5	0	9	5.9	1.3	23.5	71.7	19391.7	25.5	1.4	3.4	21	43.2	1	693	10.8	13.4	160.8	0	0	12.2	0.9	86.2	2.4	43.9	4.4	18.4	63.5	0	239.4	11.6	76	207.9	6	269.9	0	0	16.2	9.2	0	264.5	128.7	56.3	181.1	233.8	1.5	3.2	16.7	1.6	2.5	0	0.6	Cardiomyocytes
NEXN	NELIN, nexilin	ENSG00000162614	Nexilin F-actin binding protein	Q0ZGT2	1	77888513-77943895	Disease related genes, Predicted intracellular proteins		Actin-binding	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 110.8;skeletal muscle: 198.5	Cell type enriched	Detected in many	6	Cardiomyocytes: 2090.8	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BJ: 43.5;LHCN-M2: 40.0;RH-30: 31.7	Low region specificity	Detected in many							HPA011185, HPA011904	Approved		Supported	Plasma membrane,Actin filaments					12000000	Plasma membrane, Actin filaments		HPA011185: AB_1854409, HPA011904: 	unprognostic (9.73e-2)	unprognostic (6.72e-2)	prognostic unfavorable (5.60e-4)	unprognostic (1.72e-2)	unprognostic (1.11e-1)	unprognostic (1.42e-2)	unprognostic (1.62e-2)	unprognostic (1.09e-1)	unprognostic (3.03e-2)	unprognostic (2.22e-1)	unprognostic (1.46e-1)	unprognostic (3.25e-1)	unprognostic (5.41e-2)	unprognostic (5.60e-2)	unprognostic (2.48e-1)	unprognostic (9.65e-3)	unprognostic (3.68e-2)	8.9	4.3	0.4	10.4	0.8	0	5	0.5	0.4	14.1	17	0.2	12.5	1.9	16.6	12.5	24.1	9.9	8.7	110.8	0.4	0.5	4	1.2	6.2	3.8	0.6	0.5	8.2	2	0.3	0.5	2.6	0.7	13.1	3.2	0.9	4.1	14.8	198.5	1.4	5.5	45.8	0.8	3.9	10.6	4.2	1.2	0	5.1	40.1	1	29.7	10.3	1.4	1.7	2.9	3.4	0.6	0.6	7	7.1	0.4	1.3	0	23.5	22.8	3.5	43.5	19.3	8.9	6	1.2	0	0	2.5	15.8	10.1	0.9	0.9	4.1	16	0.2	0.9	1.7	2.2	0.4	17.6	0.3	0	17	0.9	12.3	6.9	19	6.7	1.7	0	0	40	0	8.1	0.5	6.9	0	5.3	6.8	31.7	0	10.4	0.3	0	0.3	3.8	0	0.2	9.1	0	0.9	6.8	21.3	15.6	9	21.6	0	0	0	1.2	0.8	0	0	3.4	0	0.4	2	0.1	1.4	0.3	0.4	1.7	1.1	0.6	0.2	2.9	0.6	1.4	1.2	0	7	0.4	0.8	0.5	0.4	0.4	0.5	0.6	0.5	0.7	1.2	98.3	8.2	0	0.8	1.5	2.8	2090.8	0	0	9.1	0	3.9	0.3	1.7	15.9	15.1	11.3	0.9	0	27.4	2.8	19	0.9	1.1	0.8	1.1	1.6	0	53.4	2.6	5.4	67.9	5.3	0	0	0	0.2	23.5	0	325.3	0.5	2.6	213.4	98.6	0.7	2.1	0.6	0.2	2.2	0.3	0.2	Cardiomyocytes
XIRP2	CMYA3	ENSG00000163092	Xin actin binding repeat containing 2	A4UGR9	2	166888487-167259753	Cancer-related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	6	skeletal muscle: 292.8	Cell type enriched	Detected in some	66	Cardiomyocytes: 1858.5	Cancer enriched	Detected in some	5	head and neck cancer: 3.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 3.3;HEL: 1.5;HUVEC TERT2: 8.7;U-2197: 6.1	Not detected	Not detected			Not detected	Not detected			HPA034813, HPA074599	Enhanced		Approved	Nucleoplasm,Plasma membrane						Plasma membrane	Nucleoplasm	HPA034813: AB_10602588, HPA074599: 					unprognostic (5.27e-4)	unprognostic (5.96e-3)		unprognostic (7.42e-2)	unprognostic (2.42e-1)					unprognostic (1.74e-1)	unprognostic (2.56e-1)			7.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	3.6	3.3	0	0	24.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	4.3	0	292.8	0	0	0	0	0.1	0	0.6	0	0	2.3	51	2.9	0.1	0	0	0	0	0	0	0	0.6	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0.1	0	0	1.5	0	0.2	0.2	0	0	0.9	0	0.2	0.7	0	8.7	0	0	0	0	0	0	0	0	0	0.5	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	6.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1858.5	0	0	0	0	0	0	0	0	28	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	20.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.4	0	0	0	0	0	Cardiomyocytes
PDLIM5	Enh, LIM	ENSG00000163110	PDZ and LIM domain 5	Q96HC4	4	94451857-94668227	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 129.6;skeletal muscle: 173.0	Cell type enriched	Detected in all	8	Cardiomyocytes: 1784.7	Cancer enriched	Detected in all	8	prostate cancer: 132.0	Low region specificity	Detected in all			Cell type enriched	Detected in all	4	basophil: 51.1	Lineage enriched	Detected in all	4	granulocytes: 51.1	Cell line enhanced	Detected in all		hTERT-RPE1: 51.4	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB013511, HPA016740, HPA020026	Enhanced		Supported	Nucleoplasm,Plasma membrane,Focal adhesion sites					2200000	Nucleoplasm, Plasma membrane, Focal adhesion sites		CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154	unprognostic (6.20e-2)	unprognostic (1.94e-1)	unprognostic (2.81e-2)	unprognostic (1.08e-2)	unprognostic (6.61e-2)	unprognostic (2.24e-1)	unprognostic (1.33e-1)	unprognostic (2.46e-2)	unprognostic (7.60e-2)	unprognostic (2.65e-1)	unprognostic (1.18e-2)	unprognostic (1.47e-1)	unprognostic (1.24e-1)	unprognostic (2.11e-2)	unprognostic (3.15e-2)	unprognostic (1.91e-1)	unprognostic (1.04e-1)	11.6	4.8	6.2	4.2	6.1	8.7	9.8	3.4	5.8	12.7	11	3.7	7.1	5.6	37.5	12.9	14	10.2	11	129.6	5.3	5.2	12.9	13.9	5.6	5.3	5.4	4.5	10.3	8.1	3.4	6.8	18.9	10.2	15.3	5.4	12.6	15.3	12.5	173	5.6	15.8	22.1	4.9	7	5.6	5.5	3.7	1	5.3	52.9	9.5	17.7	7.1	3.2	5.6	51.1	12.2	2.7	3.9	3.8	8.2	24.4	9.5	3.7	21	14.4	3.7	20.1	16.7	11.5	9.3	22.5	18.3	3.3	20.6	20.1	5.9	8.5	12.9	18.8	19.3	5.8	5.4	12	15.9	8.5	30.3	3.9	10.8	19.3	16.6	27.6	21.5	51.4	25.9	3.4	5.1	3.6	24.5	8.1	4	1.3	3.2	18.1	10.2	1.9	7	2.9	12.9	26.4	4.7	6.3	11	25.1	5.6	8	2.9	1.2	32.4	30.1	4.8	13	12.2	2.5	3.2	3.3	16.4	2.8	7	51.1	6.8	5.9	3.8	11.8	3.1	3.2	3.7	3.9	5.6	2.5	2.5	3.2	6.8	2.7	12.2	1.9	3.4	3.8	6.2	6.1	3.4	3.9	5.3	5.2	5.4	4.5	10.2	3.7	41.7	23.4	12.7	232.1	172.6	4.3	1784.7	58.6	30.8	37.5	47.1	29.5	9.2	11.6	82.1	14.6	128.1	146.3	23.3	81.9	91.7	90.4	234.4	50.8	159.4	34.4	1.6	105	135.1	57.1	6.8	38.3	60.2	59.1	29.7	89.1	79.1	115.5	83.5	62.6	63.8	35.6	77.6	141.3	13.2	30.2	137.1	19.9	15	51	185.7	Cardiomyocytes
LMOD3		ENSG00000163380	Leiomodin 3	Q0VAK6	3	69106872-69123032	Disease related genes, Predicted intracellular proteins			Disease mutation, Nemaline myopathy	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 28.3;skeletal muscle: 121.1;tongue: 53.1	Cell type enriched	Detected in many	6	Cardiomyocytes: 241.3	Cancer enriched	Detected in single	6	head and neck cancer: 1.6	Not detected	Not detected			Cell type enhanced	Detected in some		basophil: 4.1	Low lineage specificity	Detected in many			Cell line enriched	Detected in some	5	HSkMC: 8.2	Not detected	Not detected			Not detected	Not detected			HPA036034	Uncertain											HPA036034: AB_10673494	unprognostic (1.66e-1)	unprognostic (2.65e-1)	unprognostic (1.04e-2)	unprognostic (1.32e-2)	unprognostic (1.93e-1)	unprognostic (2.50e-3)	unprognostic (1.96e-2)	unprognostic (2.77e-2)	unprognostic (1.39e-1)	unprognostic (6.57e-2)	unprognostic (3.63e-1)	unprognostic (4.33e-1)	unprognostic (2.98e-4)	unprognostic (3.67e-3)	unprognostic (1.29e-1)	unprognostic (8.86e-2)	unprognostic (2.96e-1)	0.8	0.1	0.1	0	0.2	0	0.1	0.1	0.3	0.1	0.1	0	0	0	0.1	4.8	1.9	0.1	0	28.3	0.1	0.1	0.1	0.1	0.1	0	0.4	0	0.1	0.1	0	0.5	0.1	0	0.9	0	0	4.4	0.1	121.1	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0	1.4	53.1	0.7	0.6	0.1	0.9	0.3	4.1	1.1	0.4	1	0.2	0.3	0.1	0.9	0.2	0.1	0	0.2	0.2	0	0	0	0.1	0.7	0.2	0.1	0	0.2	0.2	0	0	0	0.3	0.2	0	0.7	0.6	0	0.2	0.7	8.2	0	0.1	0.2	0.2	0	0.1	0.1	0.6	1.8	0.1	0	0.3	0.1	0	0.2	0.1	0.6	0.1	0	0.8	0.2	0.3	0.2	0.2	0.1	0.1	0.1	0.1	1.1	0.3	0.1	0.3	0.1	0.4	0.5	0.2	0.3	0.2	0.3	4.1	0.6	0.8	0.5	0.4	0.6	0.6	0.9	0.7	0.1	0.9	0.6	0.7	0.8	0.4	1.1	0.3	1	0.2	0.1	0.2	0.1	0.3	0.1	0.1	0.4	0	0	0.1	0	0	3.7	1.4	2.1	4.5	241.3	10.2	0	0	0	37.3	0.7	0	0.8	0.7	0.7	2.4	0	0	1.6	2.2	1.9	18.4	1	0.7	6.4	0	1.3	1	0.2	0.3	1.7	11.8	1.8	1.5	1.6	1	0	1.1	0.3	14.1	0	1.9	0.4	0.1	1.3	0.3	7.5	0.6	1.8	Cardiomyocytes
LRRC2		ENSG00000163827	Leucine rich repeat containing 2	Q9BYS8	3	46515423-46580099	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	heart muscle: 53.9;skeletal muscle: 70.3;tongue: 20.0	Cell type enriched	Detected in many	17	Cardiomyocytes: 175.7	Cancer enhanced	Detected in some		thyroid cancer: 5.6	Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		fHDF/TERT166: 10.8;HEL: 6.2;LHCN-M2: 6.2;TIME: 4.9	Low region specificity	Detected in many			Not detected	Not detected			HPA039138, HPA064844			Approved	Nucleoplasm,Nuclear bodies,Cytosol						Nucleoplasm	Nuclear bodies, Cytosol	HPA039138: AB_10795461, HPA064844: 	unprognostic (1.32e-4)	unprognostic (3.44e-3)	unprognostic (2.29e-2)	unprognostic (3.38e-2)	unprognostic (4.17e-2)	unprognostic (1.44e-1)	unprognostic (7.38e-3)	unprognostic (1.61e-1)	unprognostic (7.42e-2)	unprognostic (1.45e-1)	unprognostic (3.72e-3)	unprognostic (2.17e-1)	unprognostic (2.23e-2)	unprognostic (1.09e-1)	unprognostic (2.53e-1)	unprognostic (1.96e-2)	unprognostic (1.24e-1)	1.8	0.5	1.9	0.4	1.4	0.4	1	1.4	3	2.6	1.1	0.2	0	0.4	3.9	1.4	1.1	1.1	1.4	53.9	1.3	0.4	2.2	2.5	0.6	0.3	0.5	2.3	2.8	0.7	0.1	2.2	0.5	1	1.2	0.8	0.4	1.4	0.2	70.3	1.2	0.6	2.3	0.4	1.3	1	0.4	0	1.4	10.1	20	1.2	1.7	1.8	1.2	0.8	2.6	0.7	1.1	2.5	0.3	0.2	0.1	0.2	0.3	1	2.3	0.1	0.8	1.5	0.6	0.8	0	0.2	0.3	0.2	10.8	0.1	0.2	3.8	0	1.4	0.5	0.1	6.2	0.4	0.2	0.3	0.2	0.1	0.2	0.1	4.3	0	3.6	0.2	0.8	0.1	0.4	6.2	0.1	0.8	0.1	1.5	0.5	0.2	0.1	0.1	0.3	0.1	0.3	0.5	1.2	0.8	0.2	1.6	1.3	0.2	0.8	4.9	0.3	0.6	2.5	1.6	0.4	0.3	2.9	0.2	0.1	1.4	2.2	0.7	0.6	0.6	0.4	0.4	0.7	1.6	0.3	0.2	1.2	0.8	0.6	2.6	1.1	0.5	0.8	2.5	0.3	1.9	1.4	1.4	3	1.3	0.4	0.5	2.3	1	0	8.9	0.6	0	0.8	1.6	0	175.7	2.5	1.4	0	1.8	0	0.1	8.3	0.2	2	1.5	0	0	0.8	0	4.3	0.4	10.3	8.9	1.5	0	2.9	5.5	0	1.7	0.6	1.1	10.1	0	1.5	0.3	1.5	0	0	0.5	0.1	0	3.9	0.6	0.2	2	0.1	0.7	1.7	0.4	Cardiomyocytes
FBXO40	Fbx40, KIAA1195	ENSG00000163833	F-box protein 40	Q9UH90	3	121593119-121630295	Plasma proteins, Predicted intracellular proteins	Ubl conjugation pathway			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	12	heart muscle: 48.3;skeletal muscle: 58.2;tongue: 38.0	Cell type enriched	Detected in single	2762	Cardiomyocytes: 346.6	Not detected	Not detected			Low region specificity	Detected in single			Cell type enhanced	Detected in single		neutrophil: 2.8	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		Karpas-707: 2.5;U-266/70: 3.0;U-266/84: 1.9	Region enhanced	Detected in some		pons and medulla: 1.8	Low region specificity	Detected in single																unprognostic (1.67e-2)	unprognostic (1.23e-4)			unprognostic (9.17e-2)	unprognostic (6.65e-2)	unprognostic (2.62e-1)	unprognostic (1.43e-2)	unprognostic (1.22e-1)	unprognostic (7.01e-2)	unprognostic (2.91e-1)	unprognostic (2.50e-1)	unprognostic (3.48e-2)	unprognostic (1.01e-1)	unprognostic (4.14e-1)		unprognostic (4.30e-2)	1	0.1	0.2	0	0.1	0.3	0.1	0.1	1	0.1	0.1	0	0	0.1	0.1	0.6	1.1	0.1	0.1	48.3	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.5	0.1	0.1	0	0.1	0	0.2	0.4	0	1.3	2.3	0	58.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.9	38	3.9	0.1	0.1	0.5	0.6	2.8	0.8	0.2	0.9	0.1	0.1	0	0.1	0	0.2	0.1	0.8	0	0	0.1	0	0.1	0.1	0.2	0.1	0.1	0.4	0.1	0	0	0	0.1	0.1	0.3	0.4	0.1	0	0.4	0.6	0.1	0	0	0	0.1	0	0.1	0.1	2.5	0	0	0.1	0.2	0.2	0.1	0	0.2	0	0.6	0.1	0.3	0	0.1	0.2	0.2	0	0	0.1	0.3	0.5	0.4	0	0	0	3	1.9	0.8	0.2	0.1	0	0.2	0.8	0.8	0.9	0.6	0.3	0.2	0.8	0.2	0.2	0.5	0.4	0.6	2.8	0.2	0.4	0.6	0.9	0.1	0.2	0.1	0.1	1	0.1	0.1	0.2	0.5	0.2	0	0	0	0	0	0	0	346.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	Cardiomyocytes
CDC25A		ENSG00000164045	Cell division cycle 25A	P30304	3	48157146-48188402	Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins	Cell cycle, Cell division, Mitosis	Hydrolase, Protein phosphatase	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 13.0;lymphoid tissue: 23.0;testis: 19.4	Cell type enriched	Detected in some	5	Cardiomyocytes: 106.0	Cancer enhanced	Detected in many		testis cancer: 19.0	Low region specificity	Detected in many			Cell type enhanced	Detected in some		memory B-cell: 1.7	Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA005855, HPA008803			Approved	Nucleoplasm,Golgi apparatus						Nucleoplasm	Golgi apparatus	HPA005855: AB_1846364, HPA008803: 	unprognostic (1.49e-1)	unprognostic (8.13e-2)	unprognostic (1.20e-2)	unprognostic (1.43e-3)	unprognostic (2.14e-1)	unprognostic (9.51e-2)	unprognostic (7.05e-7)	unprognostic (1.35e-2)	unprognostic (4.32e-3)	unprognostic (8.92e-3)	unprognostic (4.41e-2)	unprognostic (9.09e-2)	unprognostic (4.41e-3)	unprognostic (1.57e-3)	unprognostic (1.07e-1)	unprognostic (1.29e-1)	unprognostic (2.72e-1)	0.8	1.2	1.1	5.5	1.1	13	0.8	0.7	1.2	1.1	3.3	0.6	1	1.8	0.6	0.9	3.9	0.4	2.2	0.7	1.3	2.4	1.2	0.9	0.7	4.1	1.4	0.2	2.1	3.6	0.4	2.3	4.2	1.2	1	4	1.5	1.8	0.5	0.7	0.8	2.1	0.8	0.7	3.6	1.3	19.4	0.2	23	1.6	8.8	7.4	0.8	1.3	1.7	0.9	0.5	0.1	0	1	0.1	7.6	3.8	18.1	9.7	0.6	1.2	12.5	10.6	4	13.4	10.9	16.4	4	22.8	4.2	2.8	8.5	5.8	30.9	7.3	14.2	7.4	16.3	29.1	6.9	8.1	0.6	20.5	8.5	0.6	1.1	16.6	7.2	1.6	5	17	23.1	12.1	7.2	4.1	25.6	16	26.4	7	8.7	11.5	11.9	12.4	3.4	7.2	8.5	10.6	6.6	7.7	3.4	12	4	14.6	2.5	6.6	10.2	7.3	14.5	6.1	18.2	35.8	4.9	22.9	5.5	0	0	0.5	0.4	0	0	1.7	0.6	0.2	0.9	0	0	1	0	0	0.1	0.5	0	0.1	1.1	1.1	0.7	1.2	1.3	2.4	1.4	0.2	1.2	0.2	0	0	0	0.4	0.3	0	106	0	0	0	0	2	1.9	0	0.5	14.7	0.1	0.3	0	0.8	5.7	0.5	0.4	0	0.2	2.5	0	1.2	1.3	0.3	22.9	1.4	0	0	0	1.5	0.5	0.9	0	1.8	0.2	0.4	0	0.4	15.8	13.7	0	0.2	0	3.2	0.3	Cardiomyocytes
CMYA5	C5orf10, DKFZp451G223, myospryn, SPRYD2, TRIM76	ENSG00000164309	Cardiomyopathy associated 5	Q8N3K9	5	79689877-79800240	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	heart muscle: 119.1;skeletal muscle: 329.3	Cell type enriched	Detected in many	15	Cardiomyocytes: 3073.8	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		MCF7: 2.6;RT4: 3.1;THP-1: 10.7	Low region specificity	Detected in many			Not detected	Not detected			HPA074081, HPA077831	Enhanced		Approved	Nuclear speckles,Vesicles,Plasma membrane,Cytosol						Nuclear speckles, Cytosol	Vesicles, Plasma membrane	HPA074081: , HPA077831: 	unprognostic (5.53e-2)	unprognostic (9.91e-3)	unprognostic (1.21e-2)	unprognostic (1.49e-2)	unprognostic (9.01e-4)	unprognostic (7.00e-2)	unprognostic (7.39e-2)	unprognostic (1.20e-1)	unprognostic (1.64e-1)	unprognostic (1.75e-1)	unprognostic (5.04e-1)	unprognostic (1.93e-1)	unprognostic (1.93e-2)	unprognostic (6.30e-3)	unprognostic (3.88e-2)	unprognostic (7.69e-2)	unprognostic (9.74e-2)	2.4	0.2	0.3	0	0.3	0	0.9	0.3	0.4	0.4	0.4	0	0	0	1.4	2.6	2	0.5	0.2	119.1	0.3	0.3	0.6	0.3	0.3	0	0.3	0	3.6	0.2	2.2	1.1	0.3	0.3	1.4	0	0	2.4	0.5	329.3	0.5	0.2	1.1	0.4	0.2	0.3	0.2	0.1	0	2.3	54	2.5	0.8	1.3	0	0	0	0	0	0	0	0.1	0	0	0.3	1	1	1.3	0.4	0.1	0.1	0.2	0.2	0.4	0.1	0	1.9	0.1	0	0.1	0	0.2	0	0.1	0.1	0.4	0	0.2	0	0.1	1.6	0.4	0.1	0	0	0	0.6	0	0.1	0	2.6	0.1	0.1	0.5	0	0	0.1	0	0	0.1	3.1	0.1	0	0.1	0	0.2	0.2	2	10.7	0	0.1	0.4	0	0.3	0.2	0.1	0.1	0	0.1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0	0.3	0.1	8.9	3.2	0	15.7	1.1	1.4	3073.8	2.5	8.1	15.9	24.4	0	14.8	14.9	0.5	0.1	0.7	0	0	0.4	2.5	3.7	5.2	1.1	2	1.8	205	1.7	0.6	0.3	1.1	13.8	1.1	0	0	0	10.8	0.4	0	12.7	11.5	2.6	0	0.9	0.2	1.1	4.6	27.5	0.5	0	12	Cardiomyocytes
TXLNB	C6orf198, dJ522B19.2, DKFZp451A175, MDP77	ENSG00000164440	Taxilin beta	Q8N3L3	6	139240061-139292139	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	14	heart muscle: 37.9;skeletal muscle: 131.5;tongue: 49.7	Cell type enriched	Detected in many	5	Cardiomyocytes: 228.7	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enhanced	Detected in some		memory B-cell: 5.3	Group enriched	Detected in many	4	B-cells: 5.3;granulocytes: 2.1	Cell line enhanced	Detected in some		Daudi: 7.3;HSkMC: 4.7;REH: 3.9;RPMI-8226: 5.4;U-698: 10.2	Low region specificity	Detected in many			Not detected	Not detected			HPA030401, HPA030402, HPA030403	Enhanced											HPA030401: AB_2673459, HPA030402: AB_10602486, HPA030403: AB_2673461	unprognostic (1.54e-1)	unprognostic (7.01e-3)	unprognostic (1.50e-1)	unprognostic (1.32e-1)	unprognostic (5.75e-3)	unprognostic (2.94e-1)	unprognostic (1.09e-2)	unprognostic (6.00e-2)	unprognostic (2.06e-1)	unprognostic (8.10e-3)	unprognostic (4.79e-1)	unprognostic (5.15e-2)	unprognostic (2.16e-4)	unprognostic (2.19e-2)	unprognostic (2.21e-1)	unprognostic (2.65e-1)	unprognostic (8.05e-4)	4.5	0.9	0.4	1.1	0.6	0.1	0.7	0.2	0.5	1	0.7	0.6	0	0.2	1.3	5.1	3.4	0.6	0.7	37.9	0.5	0.5	0.3	0.3	0.6	0.9	0.5	0.4	3.8	0.2	2.3	0.7	0.2	0.8	0.9	0.3	0.1	2.1	0.1	131.5	0.3	0.8	1.1	1.5	1	0.4	1.2	0.1	3.4	0.9	49.7	2.7	1	0.5	5.3	0.3	2.1	0.3	0.3	0.8	0.3	0	0	1.5	0	0	0	0	0.2	0.6	0	0.1	0	0	7.3	0	0.1	0.4	0	0.3	0	0	0.1	0.8	1	0.1	0	0	2	0.3	4.7	0	0	0	0	0	2.8	0	2.2	0.4	0.3	0.7	0.8	0.2	0	0.5	3.9	1.7	5.4	0	0	2.9	0	0	0	0	0.1	0.9	2.2	1.4	0.1	0.1	0	0.1	1.2	2.1	10.2	0.3	2	0	0	0.2	0	0.4	0.2	0.6	5.3	0.4	0.8	0.1	1.9	0.4	0.2	2.1	0.3	0.3	0.3	0.3	0.3	0.4	0.6	0.2	0.5	0.5	0.5	0.5	0.4	0.8	0.1	0	0	5.2	0.1	0.5	0	228.7	0	21.4	2.3	1.8	0	0.1	0	0	30.5	3.8	0	0	0	0	0.8	0	0	0	1.6	0	0	1.3	5.8	49.6	0.6	2.2	5	0	0	7.5	0	0	2.1	0	0	0	0.4	4.7	0.5	0.4	0	1.3	0	0	Cardiomyocytes
ANKRD2	ARPP	ENSG00000165887	Ankyrin repeat domain 2	Q9GZV1	10	97572499-97583884	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	skeletal muscle: 472.2	Cell type enriched	Detected in some	6	Cardiomyocytes: 151.7	Cancer enhanced	Detected in many		testis cancer: 5.3	Not detected	Not detected			Cell type enriched	Detected in single	18	neutrophil: 1.7	Lineage enriched	Detected in single	18	granulocytes: 1.7	Cell line enhanced	Detected in some		A-431: 14.8;A549: 5.1;BJ hTERT+ SV40 Large T+: 5.5;HaCaT: 11.7;RPTEC TERT1: 13.1	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA040842, HPA040884	Enhanced		Enhanced	Vesicles						Vesicles		HPA040842: AB_10963794, HPA040884: AB_10969453	unprognostic (1.27e-2)	unprognostic (9.99e-2)	unprognostic (2.86e-1)	unprognostic (1.39e-2)	unprognostic (1.37e-1)	unprognostic (1.61e-2)	unprognostic (2.53e-1)	unprognostic (5.60e-3)	unprognostic (2.17e-1)	unprognostic (3.12e-1)	unprognostic (4.91e-2)	unprognostic (2.22e-1)	unprognostic (1.05e-2)	unprognostic (3.69e-3)	unprognostic (4.56e-2)	unprognostic (1.39e-1)	unprognostic (2.13e-1)	2.3	0.2	0.1	0	0.2	0	0.1	0	0.3	0.1	0	0	0.1	0	0	1.2	2.7	0	0.1	47.2	0	0.1	1.6	0	0.1	0	0	0	0	0.3	0	0	0	0	0.8	0	0	1.1	0.3	472.2	0.4	0	0.1	0	0	0	0.1	0	0	3	1.2	1.1	0.3	0	0	0	1.7	0	0	0	0	14.8	5.1	0	0	0.2	0	0.4	0.7	0	5.5	3.6	0.2	4.6	0	0.6	0.1	0.3	11.7	0	4	3.7	0.1	0.2	0	0.2	0	0.4	0	0	0.6	1.7	3.3	0.2	0.1	0	0	0	0	0.2	0.4	0	0	0	0.3	0	0	0.3	0	13.1	0.7	0	0	0	3.8	0	0.3	1.8	0.3	0	0.1	1.3	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0.1	0.2	0	0.3	0	0.1	0	0	0	0	0	0	0	0.5	0.1	0	151.7	0	0	0	3.5	0	0.2	26.6	1.2	0.4	0	0	0	0.2	0.3	0.4	0	0	0	0.1	0	0	0.6	0	0	0	0	0	2.8	0	0	0.6	0	1.8	2.2	0	0	0	2.2	3.2	0.3	0.2	0	0	0.1	Cardiomyocytes
IL25	IL-17E, IL-25, IL17E	ENSG00000166090	Interleukin 25	Q9H293	14	23372809-23376403	Predicted intracellular proteins, Predicted secreted proteins		Cytokine		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 2.2;testis: 2.3	Cell type enriched	Detected in single	40	Cardiomyocytes: 13.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		HEL: 1.9	Low region specificity	Detected in some			Low region specificity	Detected in many			CAB024864	Uncertain				Secreted to blood			4230000				CAB024864: 	unprognostic (1.49e-1)				unprognostic (6.82e-2)													0.5	0.2	0.4	0.3	0.6	0	0.6	0.1	0.7	0.4	0			0	0	0	0	0.3	0	2.2	0.5	0.3	0	0	0	1.4	0.3		0.1	0	0.5	0	0		0.8	0		0.3	0.5	0.8	1	0.2	0.7	0.5	0.5	0	2.3			0.1		0	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	13.5	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	Cardiomyocytes
SYNPO2L	FLJ12921	ENSG00000166317	Synaptopodin 2 like	Q9H987	10	73644881-73663803	Plasma proteins, Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	15	heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3	Cell type enriched	Detected in some	220	Cardiomyocytes: 650.0	Group enriched	Detected in some	6	breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CACO-2: 7.7;HSkMC: 6.2;RH-30: 5.9;SK-BR-3: 6.3	Low region specificity	Detected in single			Low region specificity	Detected in all			HPA055192, HPA057142	Enhanced		Supported	Nuclear speckles,Cell Junctions,Cytosol						Nuclear speckles	Cell Junctions, Cytosol	HPA055192: AB_2682732, HPA057142: AB_2683348	unprognostic (2.75e-1)	unprognostic (1.58e-1)	unprognostic (1.20e-3)	unprognostic (3.65e-3)	unprognostic (1.27e-1)	unprognostic (1.05e-1)	unprognostic (1.33e-1)	unprognostic (4.54e-2)	unprognostic (3.30e-1)	unprognostic (2.49e-2)	unprognostic (4.50e-2)	unprognostic (2.32e-1)	unprognostic (7.44e-4)	unprognostic (1.09e-1)	unprognostic (1.01e-1)	unprognostic (1.72e-2)	unprognostic (1.34e-1)	3.8	0.1	0	0	0.1	0.1	1.1	0	0.2	0.1	0	0.3	0	0	0	3.2	3.3	0	0	69.3	0	0	0	0	0.3	0.1	0	0	0	0.1	0	0	0.6	0.1	0.8	0	0	1.6	0	72.8	0.1	0	0	0.2	0	0	0.2	0	0	1.3	29.3	3.4	0	0.3	0.7	1	3	0.7	0.7	0.7	0.1	0.5	0.1	0.8	0.3	0.1	0	1.1	0.9	1.2	0.2	0	7.7	0.7	0.4	0.5	0.9	0.1	0.1	0.1	0	0.4	0.2	0.2	0.3	0.6	0.4	0.6	0.2	0.3	6.2	0.1	1.2	0.1	0.3	0	0.5	0.3	0.3	0.3	0.3	0.2	1.9	0.2	0	0.7	0.2	5.9	0.3	0	0.6	0.3	0.4	0.1	6.3	0.1	0.3	0.4	0.7	0	0.6	1	0.2	0.3	1	0.3	0.3	0.2	0.6	0	2.9	0.7	0.7	0.7	0.4	0.3	0.5	0.3	0.3	0.2	0.7	0.4	0.4	3	0.7	0.4	1	0.2	0.1	0	0.1	0	0.2	0	0	0	0	0.1	0	3	0	0	1.4	1.3	1.4	650	0	1.4	1.2	0	2	0.1	0	0	1	1	0	0	0	0.1	0.9	0.7	1.1	0.2	0.2	0	0	0	0.3	1	0.9	0.8	1.7	0	0	0.8	0	0	0.4	0	1.3	0	0.5	0.7	0.6	0.4	0	0.7	0	0.9	Cardiomyocytes
RBPMS2		ENSG00000166831	RNA binding protein, mRNA processing factor 2	Q6ZRY4	15	64739892-64775587	Predicted intracellular proteins		Developmental protein, RNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 75.1;smooth muscle: 69.6;urinary bladder: 51.6	Cell type enriched	Detected in many	4	Cardiomyocytes: 203.2	Cancer enhanced	Detected in all		testis cancer: 37.2	Low region specificity	Detected in many			Cell type enhanced	Detected in some		memory B-cell: 1.6;naive B-cell: 3.0	Lineage enhanced	Detected in single		B-cells: 3.0	Cell line enhanced	Detected in many		AF22: 15.1;AN3-CA: 21.3;HEL: 32.1;NTERA-2: 29.5;SuSa: 35.3	Low region specificity	Detected in many			Low region specificity	Detected in many																unprognostic (1.68e-1)	unprognostic (2.29e-1)	unprognostic (1.07e-2)	unprognostic (6.79e-2)	unprognostic (1.08e-1)	unprognostic (1.51e-1)	unprognostic (1.61e-1)	unprognostic (4.51e-2)	unprognostic (6.41e-2)	unprognostic (5.86e-2)	unprognostic (2.21e-2)	unprognostic (4.47e-2)	prognostic favorable (1.48e-4)	unprognostic (2.05e-2)	unprognostic (1.12e-1)	unprognostic (1.23e-1)	unprognostic (4.68e-3)	6.9	1.1	0.7	5.8	0.9	0.5	8.3	0.6	1.2	7	32.2	1.2	11.5	2.2	13.5	5.7	17.4	7.2	20.5	75.1	1.5	0.6	9.5	3.8	1.7	0.3	1.1	1.1	6	1.1	5.5	1	2.8	2.1	19.8	3.1	5.9	1.8	17.9	2.4	1.2	7.3	69.6	1	1.1	14.7	3.2	0.5	0.2	3.5	2.2	0.3	51.6	12.8	3	0	0	0	0.7	0.4	1.8	0	2.4	15.1	21.3	0	0	2.2	0.4	0	2.7	0.6	1.8	0.2	0	2	0.4	2.5	0	11	0	1	0	3.5	32.1	3.6	3.6	1.5	0	0.3	0	0	1.7	0	0.5	0.2	0.7	0.1	0	0.2	1	0	0.1	29.5	0	0	0.8	0	0	0	0	0	5.2	3.2	0	0.6	35.3	3	0.1	0	0	11.3	1.5	1.3	0.1	0	0	0	0	0.1	0	0	0	0.1	0	0	1.6	0	0.4	0	3	0	0.2	0	0.7	0	0	0	1.8	0.7	0.9	0.6	1.2	1.5	0.6	1.1	1.1	2.1	0.5	0	0	0	0.2	0.7	0.2	203.2	0	0	0	3.5	0	0.4	8.3	0.3	4.1	3.6	0	0	1.4	1	3.6	1.6	0	7.3	0.3	0	0	3.1	1.2	0.4	3.4	0.5	1.7	0	0	3.2	2	0	6	22.3	0.9	45.3	49.2	0.7	12	1	2.6	0	0	0.1	Cardiomyocytes
XIRP1	CMYA1, DKFZp451D042, Xin	ENSG00000168334	Xin actin binding repeat containing 1	Q702N8	3	39183210-39192596	Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	heart muscle: 95.0;skeletal muscle: 219.0	Cell type enriched	Detected in single	1478	Cardiomyocytes: 827.4	Cancer enhanced	Detected in some		head and neck cancer: 2.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HSkMC: 9.3;LHCN-M2: 2.3;RH-30: 6.2;SuSa: 1.9									HPA016750, HPA018458, CAB026391	Enhanced		Approved	Nucleoplasm,Plasma membrane,Actin filaments						Plasma membrane, Actin filaments	Nucleoplasm	CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885	unprognostic (2.19e-1)	unprognostic (6.40e-2)	unprognostic (1.13e-1)	unprognostic (9.75e-2)	unprognostic (2.76e-1)	unprognostic (2.43e-2)	unprognostic (4.94e-2)	unprognostic (2.66e-3)	unprognostic (1.66e-3)	unprognostic (1.46e-1)	unprognostic (5.30e-2)	unprognostic (6.26e-2)	unprognostic (1.02e-5)	unprognostic (2.08e-2)	unprognostic (2.78e-2)	unprognostic (6.86e-4)	unprognostic (4.12e-2)	1	0.1	0	0.4	0	0	0	0	0.1	0	0.1	0.2	0	0	0	1.7	1.9	0	0.4	95	0	0	0	0	0.2	0	0.1	0	0	0.4	0	0.1	0.2	0.3	1.1	0	0	1.3	0	219	0	0.1	0.1	0	0.2	0	0	0	0.1	4.9	18.2	2.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0.2	0	0	0	0.1	0	0	0	0	0.3	0.6	0.1	0	0	0	0	0	1.1	9.3	0	0	0	0	0	0	0.1	0	2.3	0	0	0	0	0	0	0	6.2	0.2	0	0	0	0	0	0	0.1	1.9	0	0	0	0	0.7	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0.3	0	0	0	0	0	0	0	827.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0.1	0	0	0	0	Cardiomyocytes
HSPB3	HSPL27	ENSG00000169271	Heat shock protein family B (small) member 3	Q12988	5	54455601-54456384	Disease related genes, Predicted intracellular proteins	Stress response		Disease mutation, Neurodegeneration, Neuropathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 106.0;skeletal muscle: 46.1;tongue: 22.3	Cell type enriched	Detected in some	55	Cardiomyocytes: 353.4	Cancer enriched	Detected in many	6	head and neck cancer: 7.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+: 37.9;fHDF/TERT166: 17.0;HSkMC: 7.4;LHCN-M2: 5.5	Low region specificity	Detected in many			Not detected	Not detected			HPA062124			Supported	Nuclear speckles						Nuclear speckles		HPA062124: AB_2684690		unprognostic (1.44e-1)	unprognostic (2.21e-1)	unprognostic (1.78e-3)	unprognostic (3.06e-1)	unprognostic (2.25e-3)		unprognostic (1.13e-1)	unprognostic (4.41e-3)	unprognostic (6.42e-2)	unprognostic (1.85e-1)	unprognostic (2.70e-2)		unprognostic (2.73e-1)	unprognostic (2.82e-2)		unprognostic (7.15e-2)	0.7	0.1	1.1	0.1	1	0	0.5	0	2.7	0.2	1	0	0.1	0.1	1.8	4.3	3.7	0.7	0.1	106	0.5	0.4	0	0	0.5	0	0.1	1.1	0.3	0	0	0.9	0	0.2	2	0.5	0.1	2.1	0.2	46.1	0.5	0.2	2.4	0	0.2	0.2	0.3	0	0	0.1	22.3	0.9	1.1	0.1	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0.7	37.9	0	0	0.1	0	0	0.1	17	0	2.2	0	0	0	0	0	0	1	0	0.1	0	0	7.4	2.3	0	0	0	0	0	0.1	0	5.5	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0.1	0	0	0.1	0	0	0	2	0	0	0	0	0	0	1.2	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	1.1	1	0	2.7	0.5	0.4	0.1	1.1	0.2	0	0	0	0	0.2	5.7	0	353.4	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	1	0	0	0	0.1	1.6	0	0	0	0	0.6	0	3.3	0	0	0	0	0	0	0	0.1	6.5	5.7	0.5	0	4.5	0.1	0	0	0.3	Cardiomyocytes
HOXD12	HOX4H	ENSG00000170178	Homeobox D12	P35452	2	176099730-176101193	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Developmental protein, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 4.3;intestine: 3.5;seminal vesicle: 4.8;vagina: 3.7	Cell type enriched	Detected in single	17	Cardiomyocytes: 1.7	Not detected	Not detected			Region enriched	Detected in single	41	basal ganglia: 4.3	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		JURKAT: 4.0;REH: 6.9;SCLC-21H: 1.9	Not detected	Not detected			Not detected	Not detected			HPA059444	Uncertain											HPA059444: AB_2684020		unprognostic (1.00e-1)	unprognostic (2.40e-3)		unprognostic (1.32e-2)	unprognostic (3.53e-2)		unprognostic (1.71e-2)	unprognostic (1.36e-2)			unprognostic (7.11e-2)		unprognostic (4.54e-2)	unprognostic (7.29e-2)		unprognostic (1.44e-2)	0.1	0	0.1	0.1	4.3	0	0.1	0.1	0.1	1.4	3.5	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	1.8	3.4	0.1	0.1	4.8	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.4	0.2	0.1	0	0.1	0	0.4	0	0.3	0	0.5	0	0.1	0.1	0.9	0.4	0	0	0	0.6	0	0	0	0	0	0	0	4	0	0.1	0	0.9	0.1	1	0.5	0	0.1	6.9	0	0	0	0.1	1.9	0.1	0.6	0	0.9	0	0.9	0	0	0.1	0.1	0.2	0.4	0	0	0	0	0.7	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	4.3	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
TMEM182	FLJ30294	ENSG00000170417	Transmembrane protein 182	Q6ZP80	2	102736905-103019900	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	heart muscle: 40.3;skeletal muscle: 53.9;tongue: 37.8	Cell type enriched	Detected in many	6	Cardiomyocytes: 134.4	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Low region specificity	Detected in some			Low region specificity	Detected in some			HPA045861			Approved	Nucleoplasm,Vesicles						Nucleoplasm, Vesicles		HPA045861: AB_2679475	unprognostic (1.39e-1)	unprognostic (3.42e-2)	unprognostic (5.10e-2)	unprognostic (1.12e-4)	unprognostic (5.35e-2)	unprognostic (7.01e-2)	unprognostic (1.13e-2)	unprognostic (1.10e-1)	unprognostic (7.03e-3)	unprognostic (2.34e-1)	unprognostic (4.19e-2)	unprognostic (3.42e-2)	unprognostic (9.88e-2)	unprognostic (4.61e-2)	unprognostic (1.10e-1)	unprognostic (3.53e-1)	unprognostic (2.36e-2)	2.4	1.1	1.2	1	1.3	0.3	1.1	1.7	1.8	1.4	1	0.5	1.5	1	0.6	2.3	1.8	1.1	0.8	40.3	1.2	1.9	1.4	1.7	0.6	0.8	1.2	0.5	1	1.1	1.5	6.8	0.8	2.8	1.9	1	0.9	3.8	1.2	53.9	0.5	0.9	1.1	1.2	0.8	1	0.8	0.4	1.8	2	37.8	4	1.2	0.7	4.4	3.1	0.3	0.3	2.4	4.1	1.1	4.9	2.8	2.1	6.6	2.7	2.7	7.7	2.7	2.4	2.7	3.9	9.2	6.9	4.1	9.2	0.9	4.4	2.9	2.3	3.7	5.7	9.1	1.8	6.1	1.3	5.8	3.2	5.5	4.9	3.4	6.8	4.3	3.8	1.9	0.4	5.9	4.3	1.6	2.7	3.6	2.9	5.3	3.6	4.7	3	3.1	5.6	3.9	3.8	4.3	5.5	1.9	3.6	3.9	8.6	2.9	3.3	2.9	0.3	4.3	3.1	3.3	3.3	4	10	3.4	4.4	9.1	6.5	0	0	0.3	3.9	0.3	3.2	4.4	2.8	2.2	1.3	1.9	3.8	4.1	0.1	2.4	0.3	3.1	0.8	1.1	1.2	1.3	1.7	1.8	1.2	1.9	1.2	0.5	2.8	0.4	20.8	10.5	5.9	0.8	0.3	0.1	134.4	0	17.4	23.9	3.5	0	1.9	0	1.3	0.6	0	0.4	23.3	2.9	2.1	1	1	3.5	1.9	1	0	6.3	0	0.6	0.4	0.6	0.7	6.8	0	2.2	2.3	1.7	0	0.7	2.4	0.3	0	0.9	0.9	2.2	0.5	0.9	1	1.7	2.7	Cardiomyocytes
LMOD2		ENSG00000170807	Leiomodin 2	Q6P5Q4	7	123655807-123664290	Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	44	heart muscle: 117.3;skeletal muscle: 297.2;tongue: 100.1	Cell type enriched	Detected in some	1164	Cardiomyocytes: 1233.0	Group enriched	Detected in some	20	head and neck cancer: 3.5;prostate cancer: 1.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	HSkMC: 5.7;SuSa: 2.0	Not detected	Not detected			Not detected	Not detected			HPA046370, HPA051039	Enhanced		Uncertain	Plasma membrane,Actin filaments,Cytosol						Plasma membrane	Actin filaments, Cytosol	HPA046370: , HPA051039: AB_2681321	unprognostic (2.55e-1)			unprognostic (1.14e-1)	unprognostic (1.43e-1)	unprognostic (2.38e-3)	unprognostic (1.18e-1)	unprognostic (5.50e-1)	unprognostic (5.69e-2)	unprognostic (6.98e-2)		unprognostic (2.13e-2)	unprognostic (1.43e-3)	unprognostic (3.37e-2)	unprognostic (1.51e-1)		unprognostic (1.82e-3)	3.3	0	0.1	0	0.1	0	0.1	0.1	0.1	0	0.1	0	0	0	0	3.2	3.8	0	0	117.3	0.1	0.1	0	0.1	0.1	0	0.1	0	0.1	0.1	0	0	0.1	0	1.5	0	0	2.6	0	297.2	0.1	0.1	0	0.1	0	0.1	0.1	0	0	1.4	100.1	3.8	0.1	0	0	0	0	0	0	0.4	0	0	0	0.1	0.5	0.1	0	0.1	0	0.6	0	0	0.1	0	0.2	0	0.1	0	0	0	0	0	0	0.2	0	0.4	0	0	0.1	0	5.7	0	0	0	0.1	0	0	0.2	0.3	0	0	0	0	0.2	0	0.1	0	0	0	0	0.3	0.1	0.3	0	0.3	0	2	0	0.1	0	0	0	0	0	0.2	0	0	0	0.1	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	1233	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.5	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
ANO5	GDD1, LGMD2L, TMEM16E	ENSG00000171714	Anoctamin 5	Q75V66	11	22193176-22283357	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters			Disease mutation, Limb-girdle muscular dystrophy, Osteogenesis imperfecta	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 37.7;parathyroid gland: 26.9;skeletal muscle: 43.7	Cell type enriched	Detected in many	11	Cardiomyocytes: 82.0	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		classical monocyte: 1.5	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		A549: 6.6;HAP1: 7.2;HEK 293: 9.0;NTERA-2: 5.0;U-266/84: 5.2	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA058857	Uncertain											HPA058857: AB_2683835	unprognostic (5.25e-3)	unprognostic (1.36e-3)	unprognostic (2.43e-1)	unprognostic (7.67e-3)	unprognostic (3.50e-2)	unprognostic (5.85e-2)	unprognostic (8.17e-3)	unprognostic (2.30e-2)	unprognostic (1.68e-1)	unprognostic (3.89e-2)	unprognostic (2.54e-4)	unprognostic (8.55e-2)	prognostic favorable (2.50e-7)	unprognostic (3.65e-3)	unprognostic (2.84e-1)	unprognostic (2.77e-4)	unprognostic (7.94e-2)	1	3.8	3.9	0.9	3.8	0.3	0.9	0.9	7.9	1.7	2.6	1.1	1	2.9	1.5	1.6	2.4	1.1	1.6	37.7	4.5	4.2	3.1	2.3	1.4	0.6	3.4	6.3	1	3.3	26.9	5	0.4	3.5	3.8	2.9	2.7	3.4	3.7	43.7	0.5	3.1	4.1	1.9	1	3	2.3	1.7	0	3.9	14.2	0.6	3.2	1.9	0	0.9	0	1.5	0	0.1	0.1	0	6.6	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.2	0	0	0	9	0	0	0	0	0	0.2	0	0	0	0	1.3	0	1.7	2.4	4.3	0	0	0	0	5	3.5	0	0.1	0	0	4.5	0.1	4	3.7	0	0	0	3.2	3.3	2.5	0	0	2.9	0	0	2.9	5.2	0	4	0	0.9	0	1.5	0	0	0	0	0	0	0	0.9	0	0.1	0	0	0	0	0	0	0.1	3.9	3.8	0.9	7.9	4.5	4.2	3.4	6.3	3.5	1.7	0	5.1	0.5	0.3	0.2	7.2	82	0	1.4	0	1.8	0	0	1.7	0.9	4.8	2.7	2.6	0	2.4	0	0.2	1.6	0	4.9	0.5	1.6	5.2	3.7	0.8	1.9	0	1.3	1.7	0	7.5	2.4	1.1	3.5	1.1	2.4	0.4	0	0.4	4.1	0.5	0.1	0	0	3	0.1	Cardiomyocytes
SYNPO	KIAA1029	ENSG00000171992	Synaptopodin	Q8N3V7	5	150601080-150659220	Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	heart muscle: 66.1;placenta: 63.4;skeletal muscle: 222.7	Cell type enriched	Detected in many	4	Cardiomyocytes: 219.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	25	memory B-cell: 2.9;naive B-cell: 3.3	Lineage enriched	Detected in single	27	B-cells: 3.3	Cell line enhanced	Detected in many		BEWO: 26.4;EFO-21: 21.8;HUVEC TERT2: 21.3;TIME: 51.7;U-87 MG: 45.9	Group enriched	Detected in many	6	amygdala: 75.9;basal ganglia: 61.9;cerebral cortex: 93.2;hippocampal formation: 69.5;olfactory region: 42.1	Low region specificity	Detected in all			CAB033265, HPA034631, CAB037325, HPA071347	Enhanced		Approved	Nucleoplasm,Actin filaments,Cytosol						Nucleoplasm, Cytosol	Actin filaments	CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: AB_2732179	unprognostic (2.09e-2)	unprognostic (7.72e-3)	unprognostic (3.95e-2)	unprognostic (2.78e-3)	unprognostic (3.07e-2)	unprognostic (1.66e-2)	unprognostic (1.76e-1)	unprognostic (1.41e-2)	unprognostic (1.90e-1)	unprognostic (1.21e-1)	unprognostic (1.17e-1)	unprognostic (4.86e-2)	prognostic unfavorable (1.53e-6)	unprognostic (1.23e-1)	unprognostic (5.72e-2)	unprognostic (2.21e-2)	unprognostic (6.35e-2)	17.3	14.6	17.7	4.4	18.9	0.6	5.7	1.4	24.9	4.3	5.5	2.4	0.8	6.6	5.1	4.8	6.7	4.4	6.8	66.1	16.6	4	15.8	7.8	11.7	2.4	4.5	5.6	23.3	6.8	2.5	2.8	63.4	3.7	7.6	4.1	16.4	2.6	6.7	222.7	1.8	7.6	8.2	4.8	14.5	4.7	17.4	3.9	0.5	4	5.7	2.6	6.2	17	3.3	0	0.1	0	0	0	0	0.1	7	0	0.1	1	0.9	26.4	4	5.5	1.4	1.1	6.2	2.8	0	21.8	5.7	8.7	2.6	0	3.9	0.5	0	0	0	10.6	1.3	6	0	0.2	1.1	6.3	1.5	1.1	8.2	21.3	0	0	0	1.3	0.4	0	0.2	0.8	2.6	3.4	0.1	0.2	0	1	0.5	2.5	11.7	5.8	6.4	0.2	9.7	0.4	1.9	51.7	5.2	16.3	0.1	1	0.2	0	0.3	45.9	0	3.4	0	0	0	0	0	0	2.9	0	0	0	3.3	0	0	0.1	0	0	0	0	0	17.7	18.9	1.4	24.9	16.6	4	4.5	5.6	3.7	3.9	32.8	13.5	0.9	2.8	4	1.3	219.1	35.7	5.3	14.8	7	2	9.9	0	44.4	1.6	40.9	50.6	0	30.5	5.8	12.3	1.6	0	38	1.9	0	13.3	42.4	6.7	1.9	2.6	1.1	5	41.5	9.9	6.1	29.3	25.9	26.2	3.3	0.6	45.3	32	0.7	0.4	1.9	21.6	1.3	9.1	3	Cardiomyocytes
MYOZ2	C4orf5, CS-1	ENSG00000172399	Myozenin 2	Q9NPC6	4	119135784-119187789	Disease related genes, Predicted intracellular proteins			Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	15	heart muscle: 219.1;skeletal muscle: 188.6	Cell type enriched	Detected in some	343	Cardiomyocytes: 2214.4	Cancer enhanced	Detected in some		head and neck cancer: 1.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC TERT1: 3.3;HSkMC: 3.7;SK-MEL-30: 9.5;U-87 MG: 10.0	Not detected	Not detected			Not detected	Not detected			HPA035763, HPA035764	Enhanced		Approved	Nucleoplasm,Cytosol						Nucleoplasm, Cytosol		HPA035763: AB_2674770, HPA035764: AB_10696509	unprognostic (2.53e-1)	unprognostic (9.20e-2)	unprognostic (6.94e-2)	unprognostic (2.14e-1)	unprognostic (2.57e-1)	unprognostic (2.34e-2)	unprognostic (5.71e-1)	unprognostic (2.18e-1)	unprognostic (4.77e-2)	unprognostic (4.04e-1)	unprognostic (8.25e-2)	unprognostic (5.07e-2)	unprognostic (6.19e-7)	unprognostic (6.66e-4)	unprognostic (2.43e-1)	unprognostic (3.06e-1)	unprognostic (2.83e-2)	3.7	0	0.1	0	0.1	0	0.4	0	0.1	0.1	0.2	0	0	0	0.4	2.4	2.6	0.2	0.1	219.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0	0	0	0.1	0	0.9	0	0	1.9	0.1	188.6	0	0.1	0.2	0	0.1	0.1	0.6	0	0	2	13.9	3.2	0.2	0.1	0.1	0.1	0	0	0.2	0.6	0	0	0	0	0	0.2	3.3	0	0.4	0.5	0	0	0.2	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	1.1	0	0	3.7	0	0.6	0	0.1	0.7	0	0	0	0.8	0	0	0	0.2	0	0	0	2	0	0	0	0	0.6	0	0	9.5	1.7	0	0	0.2	0.1	0.2	0.5	0	0	0	0	10	0	1.3	0	0	0	0	0	0	0	0	0	0	0.1	0.6	0	0	0.2	0	0.1	0	0	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.1	0	0	2214.4	0	0	0	0	0	0	0	0.1	0.4	0	0	0	1.9	0	0.2	0.1	0	0	0.6	0	0	0	0	0.4	0.3	0	0	0	0	0	1.8	0	0.7	0.7	0	6.5	0.3	0.3	0.1	0	0	0	0	0	Cardiomyocytes
HSPB7	cvHSP	ENSG00000173641	Heat shock protein family B (small) member 7	Q9UBY9	1	16014028-16019594	Predicted intracellular proteins	Stress response	Chaperone		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	8	heart muscle: 524.6;skeletal muscle: 551.1	Cell type enriched	Detected in many	48	Cardiomyocytes: 2261.8	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	fHDF/TERT166: 83.9	Not detected	Not detected			Not detected	Not detected			HPA027639	Approved		Approved	Nucleoplasm					43000	Nucleoplasm		HPA027639: AB_10601756	unprognostic (1.11e-1)	unprognostic (1.05e-1)	unprognostic (1.28e-3)	unprognostic (7.44e-3)	unprognostic (8.35e-2)	prognostic unfavorable (5.29e-4)	unprognostic (1.02e-1)	unprognostic (5.32e-2)	unprognostic (2.47e-3)	unprognostic (3.19e-3)	unprognostic (6.94e-2)	unprognostic (1.55e-1)	unprognostic (1.20e-2)	unprognostic (1.18e-2)	unprognostic (1.51e-2)	unprognostic (9.98e-2)	prognostic unfavorable (1.26e-4)	32.3	9.6	0.1	3.3	0.1	0.1	9	0.9	0.2	7	8.4	0.3	1.3	0.7	12.6	8	15.7	4.5	8.2	524.6	0.1	0	4.1	0.2	1.2	2.7	0.2	0.3	4.8	1	1.1	0.2	0.7	0.9	4.7	0.9	1.7	4.4	2.7	551.1	1	2.1	20.1	0.4	0.3	6.1	1.3	0	0	9.6	70.1	7.2	12	4.6	0	0.3	0	0	0	0	0	0	0	0	0.4	19.6	0.8	0.4	4.9	0.3	0	0	0	0	0	0	83.9	0	0	0	0	0	0	0.1	0	0.1	0	1.2	0	0	0.5	0	0	0	2	0	0	0	0	1.1	0	0	0.1	0	0	0	0	1	0.8	0	0	0	0.4	0	3	0	0.3	0	0.3	0	3.9	0.1	0.4	0	2.6	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.1	0.1	0.9	0.2	0.1	0	0.2	0.3	0.9	0	0	0	0	0.1	2.9	0.2	2261.8	0	0	0	3.5	0	2.4	11.6	1.1	29.5	0.7	0	0	0.2	1.4	11.2	0.3	0	0	1.4	1.6	0	0	0	47.4	13.3	0.3	0	0	0	3	0	0	6.3	0	0.4	0	43.4	1.7	1	2.3	2.7	0	0	0.1	Cardiomyocytes
TCAP	CMD1N, LGMD2G, T-cap, TELE, telethonin	ENSG00000173991	Titin-cap	O15273	17	39664187-39666555	Disease related genes, Predicted intracellular proteins			Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	34	heart muscle: 298.7;skeletal muscle: 708.2;tongue: 249.2	Cell type enriched	Detected in many	230	Cardiomyocytes: 2189.2	Group enriched	Detected in many	8	head and neck cancer: 20.2;prostate cancer: 11.4	Not detected	Not detected			Cell type enriched	Detected in single	5	naive CD8 T-cell: 2.4	Lineage enriched	Detected in single	6	T-cells: 2.4	Cell line enhanced	Detected in many		NB-4: 7.0;SK-BR-3: 12.1	Region enhanced	Detected in many		cerebral cortex: 15.0	Not detected	Not detected			CAB004591, HPA026477	Enhanced								68000			CAB004591: AB_628340, HPA026477: AB_1857888	unprognostic (5.29e-2)	unprognostic (9.29e-2)	unprognostic (2.40e-3)	unprognostic (4.32e-3)	unprognostic (8.79e-2)	unprognostic (3.68e-2)	unprognostic (1.61e-1)	unprognostic (3.34e-1)	unprognostic (3.46e-1)	unprognostic (1.12e-2)	unprognostic (1.12e-4)	unprognostic (2.62e-1)	unprognostic (4.51e-2)	unprognostic (8.59e-2)	unprognostic (1.13e-1)	unprognostic (2.78e-1)	prognostic favorable (4.55e-4)	3.2	0.2	0.2	0.1	0.5	0.2	0.2	0.4	0.2	0.1	0.1	0	0.1	0.1	0.1	11.1	8.6	0.1	0.1	298.7	0.2	0.2	0.1	0.1	0.2	0.2	0.6	0	0.1	0.2	0.1	0.2	0.1	0	4.1	0.1	0	12.3	0.1	708.2	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0	0	5.8	249.2	11.5	0.2	0.1	0.3	0	0	0.2	0.3	2.4	0.1	0.2	3.2	2.5	3.6	0.5	0.5	0.8	0.5	0.2	0.5	0.8	1.2	2.1	1.3	2.6	0.3	2.7	1.3	1.1	0.1	0.2	1.1	3.2	1.4	1.6	0.4	0.7	0.7	0.4	1	0.6	1	0.3	1.4	0.2	1.7	2.4	0.8	0.2	1.4	1	7	1.7	1.3	0.8	1.1	2.5	0.8	0.5	0.4	1.6	2.5	1.7	12.1	1.4	2.4	0.9	1.4	1.2	1	1.8	2.2	0.8	5.3	3	0.7	1.1	1.8	0.9	0	0	0	0.4	0	0	0.3	0	0	0	0.2	0.4	2.4	0	0.3	0.2	0	0	0.1	0.2	0.5	0.4	0.2	0.2	0.2	0.6	0	0	0	0	0	0.5	0.5	1.4	1.3	2189.2	2.5	0	0	1.8	0	0	1.7	0.2	0	1.9	0	0	0	0	0.5	0.8	0	0	0.4	9.5	2.9	1.3	1.2	0	0.3	0.6	1.7	0	1.5	0.6	0.4	0	0.4	0	1.1	6.5	1.9	0.9	0.7	1.8	0.3	0	1.1	0.7	Cardiomyocytes
MSRB3	DFNB74, DKFZp686C1178, FLJ36866	ENSG00000174099	Methionine sulfoxide reductase B3	Q8IXL7	12	65278643-65491430	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins		Oxidoreductase	Deafness, Disease mutation, Non-syndromic deafness	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		smooth muscle: 75.9	Cell type enriched	Detected in many	16	Cardiomyocytes: 2030.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		eosinophil: 23.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		fHDF/TERT166: 37.2;hTERT-RPE1: 33.8;U-937: 31.3	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA014432	Enhanced				Intracellular and membrane							HPA014432: AB_1854146	unprognostic (1.40e-2)	prognostic unfavorable (3.84e-4)	unprognostic (2.86e-3)	unprognostic (1.94e-1)	unprognostic (2.74e-2)	unprognostic (1.74e-2)	unprognostic (2.63e-2)	unprognostic (1.23e-1)	unprognostic (1.84e-2)	unprognostic (5.33e-2)	unprognostic (8.28e-2)	unprognostic (2.10e-1)	prognostic unfavorable (8.85e-8)	unprognostic (3.29e-3)	unprognostic (7.80e-2)	unprognostic (2.08e-2)	prognostic unfavorable (2.17e-4)	15.2	3.8	4.5	11.6	5.3	6.4	26.8	5.1	5.2	19	39.4	3.6	20.4	4	40.3	15	23	16.1	23.4	30.9	4.8	4.3	4.1	1.4	11.7	4.4	5	5	13.3	2.5	0.8	3.1	8.7	4.7	19.8	10.2	11.8	4.7	38.4	32.2	3.8	10	75.9	5	6.5	17.2	6.1	4.8	0.4	6	11.2	2.5	33.9	20.9	0.2	6.5	23.4	0.6	4.4	0.1	0.8	2.5	5.6	4.9	22.8	22.2	19.7	0.1	25.8	27.8	10.1	6.1	0.2	0.3	0	5.6	37.2	3.2	0.5	2.3	6.5	9.2	0	4.7	0	5	0.2	14.5	13.5	0.1	10.3	3.6	8.5	11.9	33.8	20.4	0	0.1	0.1	23	0.8	0	3.1	1.6	0	3.1	0	6.7	0.1	2.3	0.3	0.1	2.4	8.9	0.5	6.3	5.3	4.2	13	23.4	12.9	7	5.8	10	2.4	1.8	0	3.5	31.3	8	6.3	0.3	23.4	0.1	0.6	0.1	0.1	0	0	0.1	0.2	0.1	0.1	4	4.4	0.2	6.5	0	0.8	4.5	5.3	5.1	5.2	4.8	4.3	5	5	4.7	4.8	11.9	4.3	0.5	13	5.7	20.7	2030.9	7.6	10.7	1.2	3.5	0	0.4	0	8.7	4.5	40.9	0	0	0.8	0.3	27.9	2.8	2.3	0	0.5	20.6	0	23.4	0	1.3	11.5	3.9	10.1	1	0	36.4	1.5	0	109.6	0.3	10.3	103.5	126	4.1	1.4	4	0.6	0	0	2.6	Cardiomyocytes
ATP2A2	ATP2B, DAR, SERCA2	ENSG00000174437	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2	P16615	12	110280756-110351093	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Calcium transport, Ion transport, Transport	Translocase	Disease mutation, Epilepsy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	5	heart muscle: 188.3;skeletal muscle: 319.7	Cell type enriched	Detected in all	12	Cardiomyocytes: 1592.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA062605	Enhanced								38000000			HPA062605: AB_2684805	unprognostic (4.81e-2)	unprognostic (2.16e-2)	unprognostic (1.87e-1)	unprognostic (3.41e-3)	unprognostic (2.50e-1)	unprognostic (3.98e-3)	unprognostic (1.91e-2)	unprognostic (6.20e-2)	unprognostic (4.69e-2)	unprognostic (2.42e-1)	unprognostic (1.20e-2)	unprognostic (1.00e-1)	unprognostic (3.47e-2)	unprognostic (1.36e-3)	unprognostic (2.26e-1)	unprognostic (5.62e-2)	unprognostic (9.93e-2)	8.4	8.8	7.3	8.5	14.5	5.7	7.5	7.4	20.8	8.2	9.6	8	8.3	7.3	9.4	10.3	24.1	9.4	9.3	188.3	10.1	5	6.7	11.8	8.9	5.6	5.6	13.1	8.5	7.6	8.7	6.1	8.1	10.2	13	11.2	22.3	18.3	9.6	319.7	9.3	9.3	14.3	7.4	5.4	7.9	11.9	7.1	3.1	12.6	51.3	12.7	13.4	11.4	0.8	2.2	0.2	4.4	1.7	1.7	0.7	35.5	70.9	35.9	28.8	23.9	30.6	51.8	44.3	55.8	45	30.3	51.2	37.9	43.9	37.5	42.1	34	52	59.4	70	51.2	36.3	29.7	38.3	28.4	29.9	40.6	43.7	37.1	32.1	49.4	57.1	55.4	43.3	34.7	23	44.6	21.5	36.6	34.1	23.6	27.1	40.9	36.5	35.9	24.9	32.3	36.2	22.2	73.4	38	28.5	55.8	45.8	25.9	34.2	61.6	23.6	37.2	41.7	22.4	27.7	33.8	44.2	53.8	49.2	38	18.9	47.2	0	1.9	0	1.7	4.4	0.9	0.7	1.3	1.1	1.9	0.8	1.3	1.2	0.2	1.7	2.3	2.2	1.2	0.7	7.3	14.5	7.4	20.8	10.1	5	5.6	13.1	10.2	7.1	41.7	53.9	23.1	78.3	101.7	60.4	1592.4	45.9	96.4	83	48.8	60.9	28	1.7	40.8	10.7	37.6	123.8	23.3	60.6	31.5	51.2	89.3	43.9	110.5	56	79.4	131.8	41.1	50.1	9	28.1	40.7	64.1	19	80.6	24	82.4	70.2	78.1	23.9	39	51.8	126	61.6	55.1	95.2	25.6	17	66.5	93.6	Cardiomyocytes
DES	CMD1I, CSM1, CSM2	ENSG00000175084	Desmin	P17661	2	219418377-219426739	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins		Muscle protein	Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease mutation, Limb-girdle muscular dystrophy, Myofibrillar myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 531.0;skeletal muscle: 600.8;smooth muscle: 439.9	Cell type enriched	Detected in many	12	Cardiomyocytes: 2379.6	Cancer enhanced	Detected in all		prostate cancer: 562.1	Not detected	Not detected			Group enriched	Detected in some	4	classical monocyte: 2.7;intermediate monocyte: 1.9;non-classical monocyte: 1.4	Lineage enriched	Detected in single	6	monocytes: 2.7	Cell line enhanced	Detected in some		HSkMC: 18.1;LHCN-M2: 36.0;NB-4: 9.4;RH-30: 83.8	Not detected	Not detected			Region enhanced	Detected in single		midbrain: 45.7	CAB000034, HPA018803	Enhanced		Supported	Intermediate filaments					1300000	Intermediate filaments		CAB000034: , HPA018803: AB_1847616	unprognostic (1.75e-1)	unprognostic (1.95e-3)	unprognostic (3.43e-2)	unprognostic (8.76e-2)	unprognostic (7.75e-3)	unprognostic (6.61e-3)	unprognostic (1.55e-1)	unprognostic (2.72e-2)	unprognostic (4.67e-1)	unprognostic (3.84e-2)	unprognostic (2.57e-1)	unprognostic (7.43e-2)	prognostic unfavorable (5.08e-4)	unprognostic (3.49e-2)	unprognostic (1.34e-1)	unprognostic (1.22e-1)	unprognostic (9.25e-3)	9.1	2.5	0.1	35.1	0.2	0.1	1.9	0.1	0.3	41.3	238.3	0.4	69.1	12.6	95.6	80.2	209.7	33	149.8	531	0.1	0.1	2.1	0.3	4.8	3	0.3	0.8	20.3	0.7	0	0.1	2.4	0.8	101	11.2	3.8	11.9	104.2	600.8	4.2	43.2	439.9	0.3	0.6	72.6	10.9	0	0	9.4	161.2	12.5	343.7	34.4	0	0.2	0.4	2.7	0	0	0.7	0	0	0	0	0	0.5	1.3	0	0	0	0	0.1	0	0	2.4	0.1	0	0	0	0	0	0	0	0	0	0	4.4	0	0.3	18.1	0	0	0	0	0	0	0.6	0	36	0	0	9.4	0.1	0	0	0	83.8	0.4	0	0	0	0.3	0	0	0	2.4	0	1.2	0	0	0	0.4	0	0	0	0	0	0.1	0	0	2.7	0	0	1.9	0	0	0	0	0.2	0	0	0	0.4	0	1.4	0	0	0.7	0.1	0.2	0.1	0.3	0.1	0.1	0.3	0.8	0.8	0	0	0	0	2.4	3.7	0	2379.6	0	0	0	0	0	2.2	0	0	70.8	4.5	0	0	0	3.6	31.7	3.6	0	0	4.8	0	0	0.6	0	43.3	26.7	0.4	11.8	0	0.5	0	0.8	0	47.4	0	0	45.3	204.9	1.8	1.7	8.5	7.1	0	0	0.4	Cardiomyocytes
NPPA	ANP, PND	ENSG00000175206	Natriuretic peptide A	P01160	1	11845709-11848345	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Hormone, Vasoactive, Vasodilator	Atrial fibrillation, Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	418	heart muscle: 1267.7	Cell type enriched	Detected in some	14450	Cardiomyocytes: 19644.9	Cancer enriched	Detected in some	9	glioma: 7.2	Not detected	Not detected			Cell type enhanced	Detected in single		memory B-cell: 1.3	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		SCLC-21H: 12.5;SH-SY5Y: 12.0	Region enriched	Detected in some	8	olfactory region: 28.1	Not detected	Not detected			HPA058269, HPA064007	Enhanced				Secreted to blood				190000			HPA058269: AB_2683660, HPA064007: 	unprognostic (1.27e-3)	unprognostic (3.12e-2)	unprognostic (2.15e-1)	unprognostic (1.30e-1)	unprognostic (1.94e-1)	unprognostic (1.95e-1)	unprognostic (2.02e-1)	unprognostic (2.01e-1)	unprognostic (1.48e-1)	unprognostic (3.25e-2)	unprognostic (9.72e-3)	unprognostic (2.21e-1)	unprognostic (5.93e-4)	unprognostic (2.31e-1)	unprognostic (1.59e-1)	unprognostic (1.20e-1)	unprognostic (6.70e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0.3	0.1	0	0.1	1267.7	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	1.7	0	0.1	0.1	0.1	0.1	0	0.1	0.6	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0	0.3	0.8	0	0.5	3	1.1	1.7	2.6	2.1	0	0	1.6	0.9	0	0	0	6.7	2.7	4.3	0.3	0	1.5	4	0	0	0	1	2.6	2.7	1.5	6.6	0	1.4	4.6	0	0	0	0	0.6	0	1.2	5.9	5.1	0	0.9	0.5	7.7	1.9	0.1	0.7	0.6	0.8	0.8	0	1.8	12.5	12	0.7	0	2.2	1.2	1.6	0.2	0.4	2.1	4.3	3.4	0.3	1.3	3.2	4.9	0.3	3.5	1.1	0	0.4	0	0.1	0.8	0.4	1.3	0	0	0	0	0.1	0.5	0.3	0	0.5	0	0	3	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	19644.9	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	Cardiomyocytes
C10orf71	FLJ45913	ENSG00000177354	Chromosome 10 open reading frame 71	Q711Q0	10	49299193-49327487	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	skeletal muscle: 104.2;tongue: 35.0	Cell type enriched	Detected in single	478	Cardiomyocytes: 47.8	Cancer enhanced	Detected in single		head and neck cancer: 0.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	21	K-562: 9.2;RH-30: 14.0	Not detected	Not detected			Not detected	Not detected			HPA057556			Approved	Nucleoplasm,Mitochondria						Nucleoplasm	Mitochondria	HPA057556: AB_2683467				unprognostic (1.25e-2)		unprognostic (3.97e-2)		unprognostic (4.16e-2)		unprognostic (5.58e-2)		unprognostic (1.66e-1)		unprognostic (1.17e-1)	unprognostic (1.81e-1)			2	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0	0	0	0.1	2	1.7	0.1	0	13.3	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0.1	3.3	15.3	0.1	0	0	0.3	0	0	1.1	0	104.2	0.1	0.1	0	0.1	0.1	0.1	0.2	0	0	0.5	35	3.9	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	9.2	0	0	0	0	0	0	0	0	0	14	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	47.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
PRSS42	TESSP2	ENSG00000178055	Serine protease 42	Q7Z5A4	3	46829542-46834095	Enzymes, Predicted secreted proteins	Differentiation, Spermatogenesis	Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at transcript level		Group enriched	Detected in some	5	heart muscle: 12.9;skeletal muscle: 19.2	Cell type enriched	Detected in single	4	Cardiomyocytes: 2.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 2.3;Daudi: 4.0;Karpas-707: 2.5;NTERA-2: 3.7									HPA046925	Uncertain				Secreted - unknown location							HPA046925: AB_10961401	unprognostic (6.53e-2)	unprognostic (2.72e-2)	unprognostic (3.57e-3)	unprognostic (9.14e-2)	unprognostic (3.26e-1)		unprognostic (2.37e-2)	unprognostic (1.85e-1)	unprognostic (6.54e-2)	unprognostic (4.26e-2)	unprognostic (1.14e-1)	unprognostic (1.12e-1)	unprognostic (1.45e-1)	unprognostic (1.09e-2)	unprognostic (1.38e-1)	unprognostic (1.62e-1)	unprognostic (7.98e-2)	0.2	0.1	0	0	0	0	0.2	0	0	0.6	0.2			0	0.2	3.4	0	0.2	0	12.9	0	0	1.3	0.5	0.2	0	0		0.2	0.2	1.6	0	0.1		0.4	0		0.3	0.2	19.2	0	0	0	0	0.4	0	0.7			0.8		0	0	0.6	0.4	0	0	0.1	0	0.6	0	0	0	0.1	0	0.8	0.2	1.6	0	0	0	0.7	0.2	2.3	4	0.4	0	0.1	0	0	0.2	1.4	0.1	0	0	0.2	0	0	0	0	0.5	0	0	0	0	0	0	0.1	2.5	0	0	0	0.4	3.7	0.5	0	1.3	0	0	0.1	0	0.6	0.5	0.5	0	0.3	1.2	0	0.5	0	1	0.7	0	0	0	0.3	0.9	0.1	0	0.3	0	0.1	0	0.3	0	0	0	0.6	0	0	0.4	0	0	0	0	0	0	0	0											0	0	0	0.2	0	0	2.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0.1	Cardiomyocytes
DAND5	CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3	ENSG00000179284	DAN domain BMP antagonist family member 5	Q8N907	19	12965159-12974762	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		blood: 5.3;heart muscle: 13.7	Cell type enriched	Detected in single	29	Cardiomyocytes: 13.8	Low cancer specificity	Detected in single			Low region specificity	Detected in some			Cell type enhanced	Detected in many		neutrophil: 5.3	Low lineage specificity	Detected in many			Cell line enriched	Detected in some	15	SH-SY5Y: 21.0	Low region specificity	Detected in all							HPA043493, HPA049472	Uncertain		Approved	Mitochondria	Secreted in other tissues					Mitochondria		HPA043493: AB_2732505, HPA049472: AB_2680781	unprognostic (1.18e-2)	unprognostic (4.63e-2)	unprognostic (7.51e-2)	unprognostic (4.63e-2)	unprognostic (3.82e-2)	unprognostic (8.71e-2)	unprognostic (2.29e-2)	unprognostic (3.18e-1)	unprognostic (5.95e-3)	unprognostic (7.27e-3)	unprognostic (8.17e-2)	unprognostic (2.15e-1)	unprognostic (2.48e-10)	unprognostic (4.43e-1)	unprognostic (2.48e-2)	unprognostic (6.77e-2)	unprognostic (1.37e-1)	0.2	2	0.9	0.9	2.5	3	0.4	1.4	1.4	0.2	3.6	2.1	0	0.4	0.4	0.4	0.3	0.1	0.7	13.7	0.4	0.3	0.1	0.1	0.2	0.3	0.5	0	0.4	0.4	0.4	0.2	0	3.8	0.2	0.5	3.6	2.6	0	0.2	0.7	2.5	0.4	1.6	0.1	0.7	0.8	0.3	0	0.5	0	0	0.3	0.2	1.6	1.4	5.3	0.6	1.4	1.2	0.3	0.4	0	0.1	0	0	0.1	0.1	0.1	0	0.1	0.1	0	0.2	0.2	0	0.1	0.1	0.3	0	0	0.2	0.1	0.4	0	0.7	0.3	0	0.1	0.2	0.2	0	0.3	0	0.2	0.1	0.8	0.4	1.3	0	0.5	0.3	0.1	0.2	0.1	0.3	0.2	0	0.3	0.2	0.1	1.1	21	0	0	0.2	0.2	0.2	0	0	0.2	0.3	0.1	0.2	0.5	0.1	0.1	0	0.3	0.1	2.7	0.6	1.3	0.7	0.4	0.6	0.9	0.4	0.4	0.2	1.6	0.7	1.2	5.3	1.4	0.3	1.4	0.2	0.3	0.9	2.5	1.4	0.8	0.4	0.3	0.5	0	3.8	0.3	0	0	0	0.2	0.1	0	13.8	0	0	0	0	0	0.2	0	0.1	0.1	0	0	0	0.3	0	0	0.2	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.5	0.1	0	0	0	0.4	0	0	0	0	0.3	0	0	0.1	0.1	Cardiomyocytes
FAM156B	TMEM29B	ENSG00000179304	Family with sequence similarity 156 member B	Q8NDB6	X	52891306-52908560	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		placenta: 34.3	Cell type enriched	Detected in some	7	Cardiomyocytes: 7.7	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all											HPA056640, HPA056643	Uncertain											HPA056640: AB_2683200, HPA056643: AB_2683201		unprognostic (2.91e-1)			unprognostic (1.31e-1)					unprognostic (2.66e-1)			unprognostic (3.24e-5)	unprognostic (2.97e-1)				6.4	7.4	6.5	10.9	6.9	5.2	7.9	13.7	12.3	4.6	5	5.6	13.9	5	8.8	9.3	4.6	8.7	5.4	6.4	10.1	5.7	5.9	4.9	5.3	3.8	4.7	11.4	7.7	5	3.9	13.9	34.3	5.6	6.2	4.4	7.2	6.1	9.8	5.1	20.6	4.8	7	5.5	7.6	4.5	4.6	2.4	3.5	7	3	4.7	5.9	5.1	1.1	8	1.2	7.3	3.1	2.6	3.3	3.7	7	4.6	6.6	5	4.2	13.5	3.9	6.1	5.9	4.2	3.5	3.7	3.3	2.8	11.6	4.9	4.8	7.9	6.2	1.7	1	8.8	2.4	13.6	14.1	17	2.2	2.2	9.8	6.5	6.7	5.4	8.8	5.1	9	2.6	2.1	7.7	8.5	5.2	12.5	5	6.1	12	3.5	4.8	5.6	7.1	4.8	4.4	5.2	3.3	8.9	4.3	10.8	5	5.8	4.3	3.1	3.5	6	4.2	4.7	6.7	6.2	4.4	9.6	1.9	0	4.6	1.2	1.2	7.3	1.8	1.1	0.7	1.2	8	1	2.6	0.6	1.1	3.1	6.8	4.5	2.4	3.3	6.5	6.9	13.7	12.3	10.1	5.7	4.7	11.4	5.6	2.4	0	0.6	0	0.1	0.1	0	7.7	0	0	1.2	0	0	0.3	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	1.1	0	0	0	Cardiomyocytes
NLRP8	CLR19.2, NALP8, NOD16, PAN4	ENSG00000179709	NLR family pyrin domain containing 8	Q86W28	19	55947832-55988629	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		blood: 1.7;breast: 1.9;heart muscle: 1.5	Cell type enriched	Detected in some	6	Cardiomyocytes: 10.6	Not detected	Not detected							Cell type enhanced	Detected in single		basophil: 1.7	Low lineage specificity	Detected in single			Not detected	Not detected							Not detected	Not detected			HPA056989	Uncertain											HPA056989: AB_2683301	unprognostic (2.43e-2)											unprognostic (3.35e-1)		unprognostic (3.13e-1)	unprognostic (6.96e-2)			0	0	0	0	0	0.2	1.9	0	0	0.1	0			0	0	0.4	0	0	0	1.5	0	0	0	0	0	0	0		0.1	0	0	0	0		0.9	0		0.8	0	0	0.2	0	0	0	0	0	1			0		0	0.1	0	0.7	0.3	1.7	0.2	0.4	0.3	0	0.1	0	0	0	0	0.4	0.2	0	0	0.2	0	0.2	0.2	0.2	0.2	0	0.1	0.2	0	0.4	0.1	0	0	0.2	0.6	0.4	0	0	0.2	0	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0.1	0.1	0.2	0.4	0	0.2	0	0.4	0.4	0	0	0.1	0	0.3	0.7	0.5	0	0.7	0.7	0.4	0.1	0.2	0	0	0.1	0.1	0.3	1.7	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0	0.7	0.3	0.3	0.8	0.4	0.1	0.3	0.1	0											0	0	0	0.1	0	0	10.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0.5	0	0.1	0	0	0	0.1	Cardiomyocytes
CHRM2		ENSG00000181072	Cholinergic receptor muscarinic 2	P08172	7	136868669-137020255	Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 25.5;heart muscle: 35.0;smooth muscle: 32.8	Cell type enriched	Detected in some	6	Cardiomyocytes: 45.4	Cancer enhanced	Detected in single		stomach cancer: 0.8	Region enhanced	Detected in many		pons and medulla: 15.7	Cell type enhanced	Detected in single		neutrophil: 1.3	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	5	fHDF/TERT166: 44.8	Low region specificity	Detected in many			Low region specificity	Detected in all			CAB022338, HPA029795	Approved											CAB022338: , HPA029795: AB_10601357			unprognostic (3.51e-2)	unprognostic (3.73e-4)	unprognostic (5.77e-2)			unprognostic (1.78e-2)		unprognostic (1.97e-1)	unprognostic (4.00e-1)	unprognostic (2.69e-1)		unprognostic (1.43e-2)	unprognostic (1.80e-1)		unprognostic (1.35e-3)	0.8	0.9	3.6	7.2	1.9	0.3	0.8	0.8	6	0.9	8.9	0	0	0.9	0.8	0.3	0.8	0.8	25.5	35	0.9	0.9	0.8	1.2	1	0.2	0.9	2.2	0.8	0.8	0.2	0.9	1.7	15.7	5.4	3.9	0	0.8	0.2	0.8	0.8	3.7	32.8	5	0.8	2.7	2.3	1.5	0	0.8	0	0.2	14	1.8	0	0.2	1.3	0.7	0	0	0	0	0	0	0	0	0	0	8.2	9.2	0.1	0	0	0	0	0	44.8	0	0	0	0	0	0	0	0	0	0	6.6	0	0	0	0	0	0	0.3	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0.2	0	0.4	0	0	0	0	0	0	0	0	1.3	0	0.7	0.2	0	0	3.6	1.9	0.8	6	0.9	0.9	0.9	2.2	15.7	1.5	0	0	0	0	0	4.9	45.4	0	0	0	0	2	0	0	0	8.2	0	0	0	0	0	0	0	0	0	0.1	0	0	2.5	0	5.9	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0.2	0	0	0	Cardiomyocytes
SLX1B	GIYD2, MGC5178	ENSG00000181625	SLX1 homolog B, structure-specific endonuclease subunit	Q9BQ83	16	29454501-29458219	Predicted intracellular proteins	DNA damage, DNA recombination, DNA repair	Endonuclease, Hydrolase, Nuclease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 26.5	Cell type enriched	Detected in some	6	Cardiomyocytes: 10.4	Not detected	Not detected							Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many											HPA047038	Uncertain		Approved	Nucleoplasm						Nucleoplasm		HPA047038: AB_2679913	unprognostic (2.93e-1)	unprognostic (1.11e-1)	unprognostic (2.16e-2)	unprognostic (5.12e-2)	unprognostic (7.05e-2)	unprognostic (1.78e-1)	unprognostic (7.20e-2)	unprognostic (2.72e-2)	unprognostic (2.35e-3)	unprognostic (3.63e-1)	unprognostic (1.22e-1)	unprognostic (3.64e-2)	unprognostic (2.51e-7)	unprognostic (4.84e-2)	unprognostic (1.96e-1)	unprognostic (4.44e-1)	unprognostic (5.25e-3)	4.6	2.9	0.2	3.9	0.5	8.8	4.9	2	2.7	5.6	6.6			14.1	5.4	2.7	3	4.4	1.1	2.2	0.4	0.5	3.3	11.1	5.7	3	0.6		4.2	3.1	3.4	2.2	5.4		4	4.6		8	5.4	11.2	5.7	13.4	2.9	1.8	6.3	4.7	0			6.1		6.6	5.7	3.9	3.2	20.8	26.5	24.7	3.7	6.5	6.7	6.8	5.9	15.4	0.7	3.2	4.6	21.2	6.4	15	14.6	12.4	1.6	10.5	17.3	5.6	4.5	2.3	2.6	5.7	9.2	3.5	1	4.3	7.1	3.1	9.2	9.9	7.2	2.9	6.1	6.6	9.6	6.5	9.2	16.2	20.4	3.7	7.1	6.8	9.7	1.3	7.2	1.3	15.4	8.6	7	12.2	15.5	12.3	4.2	2.5	14.8	2.7	30.2	1.4	2.4	1.4	4.1	10.8	4.9	1.5	2.9	1.1	3.2	20.1	11	5.4	5.5	2.1	3.3	24.7	26.5	2.8	20.7	0.8	3.2	2.5	2.8	20.8	2.5	1.2	1.6	14.8	3.7	11.9	1.2	6.5	6.7											0	0.3	0	0	0	0	10.4	0	0	0	0	0	1.4	0	0.6	0	0.1	1	0	1.3	0.6	0.4	0.2	0	0.5	1	0	0	0.6	1.2	0	0	0.2	0	1.8	0	0	0.8	0	0.4	0.3	0	0	0	0	0	0.1	1.1	0.9	0.1	0.1	Cardiomyocytes
ASB18		ENSG00000182177	Ankyrin repeat and SOCS box containing 18	Q6ZVZ8	2	236194872-236264409	Predicted intracellular proteins, Predicted membrane proteins	Ubl conjugation pathway			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	8	heart muscle: 9.8;skeletal muscle: 14.3	Cell type enriched	Detected in single	21	Cardiomyocytes: 5.0	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 1.9;CACO-2: 1.7;HEK 293: 2.4;K-562: 2.8;MCF7: 3.1;PC-3: 1.4;RH-30: 2.5;SiHa: 1.8	Low region specificity	Detected in many			Low region specificity	Detected in many																				unprognostic (1.12e-1)	unprognostic (7.33e-3)				unprognostic (3.07e-1)			unprognostic (1.78e-6)	unprognostic (4.75e-2)	unprognostic (3.22e-1)			0	0	0	0	1.5	0	0	0	0.3	0	0			0	0	0	0	0	0	9.8	0.1	0.1	0	0	0	0	0		0	0	0	0	0		0	0		0	0	14.3	0	0	0	0	0	0	0.7			0		0	0	0	0	0	0	0	0	0	0	0.7	0.3	0	0.3	0	0	1.9	0.1	0	0	0	1.7	0	0	0.2	0	0.5	0	0	0	0	0	2.4	0	0.9	0	0	0	0	0	0	0	0.2	0	0	0	2.8	0	0	3.1	0	0	0	0	1.4	0	2.5	0	0	0	0.1	0	1.8	0	0	0.1	0.1	0	1.4	0.6	0	0.1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	Cardiomyocytes
SLC8A1	NCX1	ENSG00000183023	Solute carrier family 8 member A1	P32418	2	40097270-40611053	FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Antiport, Calcium transport, Ion transport, Sodium transport, Transport	Calmodulin-binding	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 67.7	Cell type enriched	Detected in many	11	Cardiomyocytes: 601.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in some	4	neutrophil: 25.2	Lineage enriched	Detected in many	4	granulocytes: 25.2	Cell line enhanced	Detected in many		BJ: 15.4;fHDF/TERT166: 37.3;hTERT-HME1: 10.9	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB022694, HPA070007	Uncertain		Supported	Nucleoplasm,Plasma membrane	Intracellular and membrane					Nucleoplasm, Plasma membrane		CAB022694: , HPA070007: AB_2686227	unprognostic (2.46e-1)	unprognostic (1.33e-2)	unprognostic (1.42e-2)	unprognostic (7.57e-6)	unprognostic (1.56e-1)	unprognostic (3.94e-1)	unprognostic (2.28e-2)	unprognostic (4.60e-2)	unprognostic (1.31e-1)	unprognostic (7.71e-2)	unprognostic (1.21e-2)	unprognostic (1.07e-1)	unprognostic (3.66e-2)	unprognostic (7.04e-3)	unprognostic (3.93e-2)	unprognostic (5.46e-2)	unprognostic (6.77e-2)	3.9	2.9	7.7	4.4	14.3	1.4	2	3.5	15.3	5.5	7.3	1.8	7.1	3.3	12.2	3.9	4	3.9	5.3	67.7	7.7	6.6	11	2.2	3.7	2.5	5.2	8.2	2.1	1.5	1.1	1.9	6.8	7.6	12.2	3.4	1	1.5	17.2	1.5	2.1	3.6	20.5	2.8	4.4	2.5	1.4	2.5	0.1	1.6	0	1.3	9.8	2.8	0	2.4	25.2	6	0	0	0.5	1.5	1.2	1.1	0.1	1.7	3.6	0	15.4	6	5.1	3.3	0	2.5	0	1.2	37.3	5.5	0.6	0.3	2.5	5.3	0	2.1	0	0	0	0	0	0.2	2	0	5.9	10.9	2.3	0.4	0	0	0.2	6.5	0	0.4	0	0.8	0.1	2.1	4.1	8.1	0	1.8	0.2	1.7	0.3	0	0	0	5.6	0	0.3	5.2	4.8	0.1	0	1.6	0.8	0	0	0.8	0.9	0.7	0	4.9	0	0	5.1	0	0	0	0	2.4	0	0	0	25.2	0	6	0.1	0	0.5	7.7	14.3	3.5	15.3	7.7	6.6	5.2	8.2	7.6	2.5	3	3.2	2.9	0	1.1	50.8	601.5	2.5	0	1.2	33.2	3.9	0.4	0	0	0.8	3.3	0	0	0	1.4	4.8	0.1	0	0	28.3	0	0	20.3	56.6	0.7	0	46.7	1.7	1	0.6	35.9	0.1	0	7.8	0.1	6.9	12.9	19.6	0.2	0.4	2.8	0.9	0	0	0	Cardiomyocytes
NKX2-5	CSX, CSX1, NKX2.5, NKX2E, NKX4-1	ENSG00000183072	NK2 homeobox 5	P52952	5	173232109-173235357	Disease related genes, Predicted intracellular proteins, Transcription factors		Developmental protein, DNA-binding	Atrial septal defect, Congenital hypothyroidism, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	heart muscle: 95.6	Cell type enriched	Detected in some	32	Cardiomyocytes: 56.0	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 21.0;NTERA-2: 7.6;SK-MEL-30: 9.3;U-2 OS: 17.3;U-251 MG: 12.9	Not detected	Not detected			Not detected	Not detected			HPA065034			Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA065034: AB_2685409	unprognostic (3.81e-1)	unprognostic (8.53e-2)		unprognostic (2.62e-2)	unprognostic (9.57e-3)	unprognostic (3.22e-3)		unprognostic (6.63e-2)	unprognostic (1.57e-1)	unprognostic (2.72e-1)	unprognostic (2.31e-1)			unprognostic (5.80e-2)	unprognostic (2.19e-1)		unprognostic (1.77e-2)	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0.1	0	0	95.6	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	13.8	0	0.1	0	0	0.2	4.2	0.4	0	0	0	0	0	0	0	0.8	0	0	3	1.1	0.1	0	0	1.8	0	0	0	0	0	0	0	0	0	2.7	0	0	0	0	4.9	21	0	0.1	1.7	0	0	0	0	0.1	0.1	0	1.8	0	0.1	0	0	0	0	0	0	7.6	0	0	0	5.8	0	0	0	0.1	0.3	4.2	0	9.3	2.9	0	0	0	4	17.3	5.3	12.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	56	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	1.7	0.1	0.1	0	0	0	Cardiomyocytes
SCN5A	CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1	ENSG00000183873	Sodium voltage-gated channel alpha subunit 5	Q14524	3	38548057-38649673	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Sodium transport, Transport	Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel	Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	heart muscle: 67.3	Cell type enriched	Detected in some	5	Cardiomyocytes: 66.1	Low cancer specificity	Detected in some			Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	LHCN-M2: 22.0;RH-30: 18.3	Group enriched	Detected in some	5	amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0	Low region specificity	Detected in many			HPA063346			Supported	Nucleoplasm,Nucleoli,Plasma membrane						Plasma membrane	Nucleoplasm, Nucleoli	HPA063346: 	unprognostic (9.29e-4)	unprognostic (4.05e-2)	unprognostic (9.95e-2)	unprognostic (1.74e-1)	unprognostic (9.21e-2)	unprognostic (1.24e-2)	unprognostic (1.15e-1)	unprognostic (1.48e-1)	unprognostic (7.36e-2)	unprognostic (8.48e-2)	unprognostic (7.12e-3)	unprognostic (5.28e-2)	unprognostic (1.16e-4)	unprognostic (4.85e-3)	unprognostic (1.09e-1)	unprognostic (5.35e-2)	unprognostic (4.95e-3)	0.3	0.2	1.3	0.2	0.3	0.4	0.6	0.1	2.3	2	0.4	0	0.4	0.3	0.9	0.8	0.2	0.4	0.3	67.3	0.5	0.7	0.1	0.1	0.2	0.1	0.1	0.3	0.6	0.2	0.1	0.8	0.3	0	1.3	0.2	1.2	0.3	1.6	5.5	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0	0	0.3	0.1	0.1	0.8	1.1	0	0	0	0	0	0.4	0	0	0.1	0	0.5	0.1	0	0.1	0.8	0.4	0	0.1	0.3	2.7	0	0	0	0.9	0.9	2.7	0	0.4	0	1.2	0.7	0	0.1	0.1	0	0.1	0.5	0	0.5	0	1.7	3.6	0.4	0	0	22	1.1	0	0	2	0	0	0	18.3	0	0	2.4	0.3	2.4	0	0	0	0.7	0	0	4.4	0	4.5	0	0	0.1	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	1.3	0.3	0.1	2.3	0.5	0.7	0.1	0.3	0	0	0	0	0	1.1	0.2	3.1	66.1	0	0	0	0	13.7	0.1	0	0.1	1	0.4	0	0	0	0.2	0.3	0.3	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0.8	0.1	0	0	0	0.7	0	0.4	0.3	0.9	0	0	0	0	1	Cardiomyocytes
ACOT1	ACH2, CTE-1, LACH2	ENSG00000184227	Acyl-CoA thioesterase 1	Q86TX2	14	73537114-73543794	Enzymes, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Hydrolase, Serine esterase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		liver: 27.6	Cell type enriched	Detected in some	6	Cardiomyocytes: 44.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		Hep G2: 18.2;T-47d: 25.1									HPA043705	Approved		Approved	Mitochondria						Mitochondria		HPA043705: AB_2678626	unprognostic (4.74e-3)	unprognostic (3.81e-3)	unprognostic (7.65e-2)	unprognostic (8.66e-2)	unprognostic (1.22e-1)	unprognostic (1.29e-1)	unprognostic (4.54e-2)	unprognostic (1.29e-2)	unprognostic (1.53e-1)	unprognostic (1.73e-2)	unprognostic (1.84e-1)	unprognostic (4.16e-1)	prognostic favorable (5.09e-8)	unprognostic (1.35e-3)	unprognostic (4.60e-2)	unprognostic (1.75e-1)	unprognostic (1.43e-1)	8.5	7.2	5.1	3.7	3.9	1	13.7	2	7.7	3	5.8	4.1	0.9	5.3	6.8	8.8	2.7	3.4	1.8	11.3	4.3	3.6	16.4	27.6	9	0.9	3.2	6	4.5	1.4	2.9	0.9	4.1	5.6	5.5	3.4	2.4	2.7	6.1	10.7	3.8	12.9	13	1.9	1	3.4	2.7	2.4	0.9	1.8	5	1.9	5.6	1.7	3.8	5.7	1	1.7	4.2	6.3	3.1	4.2	5	1.9	0.1	9.9	6.1	0.1	1.3	5.4	4.5	8.2	1.9	2.1	0	0	3.6	0	2.5	0	0.9	2.2	2.3	1.6	2.7	1.2	18.2	9.6	0.1	3	7.9	0.4	3.6	0	0.1	2	0	0	0	3.5	1.6	0.3	0.5	1.9	0.6	1.9	5.1	3.9	0.1	4.4	4.7	2.3	3.8	4.2	12.4	6.8	0.4	25.1	6.2	2.2	2.5	3.2	2.3	0	0	0	1.3	3.6	0	4	0.1	1.3	1	6	1.7	4.9	3.8	5.5	4.7	5.7	2.6	4.8	5.3	0.2	4.2	1.5	3.2	6.3	3.1	5.1	3.9	2	7.7	4.3	3.6	3.2	6	5.6	2.4	0	2.7	0	0	0	0	44.7	0	0	0	0	0	0.6	0	0.5	0.4	0	0	0	7.2	0.2	0.3	0	0	0.6	0.8	0	0	0	0	0	0	0	1.7	0	0	0	1.7	0	0.4	0.8	0	0	0.5	0	0.2	0	0.7	0	0	0	Cardiomyocytes
DHRS7C	SDR32C2	ENSG00000184544	Dehydrogenase/reductase 7C	A6NNS2	17	9771434-9791297	Predicted intracellular proteins, Predicted secreted proteins		Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	21	heart muscle: 44.0;skeletal muscle: 87.4;tongue: 40.1	Cell type enriched	Detected in some	5	Cardiomyocytes: 62.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	28	BJ hTERT+: 4.5;HeLa: 1.1	Not detected	Not detected			Not detected	Not detected								Secreted in other tissues												unprognostic (6.83e-2)													0.1	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0.2	1.5	0	0	44	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0	2.7	0	87.4	0	0.1	0	0	0	0	0.1	0	0	0.2	40.1	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	62.1	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.8	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	Cardiomyocytes
NOMO2	NOMO, PM5	ENSG00000185164	NODAL modulator 2	Q5JPE7	16	18417325-18562211	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in some	14	Cardiomyocytes: 88.9	Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all											HPA046697, HPA061174	Approved											HPA046697: AB_2679758, HPA061174: AB_2684444	unprognostic (2.58e-3)	unprognostic (4.11e-3)	unprognostic (2.58e-2)	unprognostic (9.10e-2)	unprognostic (1.74e-1)	unprognostic (2.85e-2)	unprognostic (4.80e-2)	unprognostic (9.37e-2)	unprognostic (1.34e-1)	unprognostic (3.47e-2)	unprognostic (1.09e-2)	unprognostic (1.78e-1)	unprognostic (1.78e-3)	unprognostic (2.22e-1)	unprognostic (3.42e-2)	unprognostic (8.39e-2)	unprognostic (1.54e-2)	5.6	6	5	3.6	6.7	3.6	4.4	11	13.2	5.4	6.3			5	6	10.1	4.4	4.5	3.2	16	5.5	8.4	4.6	8.2	6.9	2.7	6		4.5	21.4	19.6	6.7	8.4		6.7	6.1		5.8	5.6	12.8	5.6	4.4	7	4.4	4.3	7.2	3.2			6.6		4.4	5.6	3.7	10.6	20.9	13.2	13	7.3	20.1	15.5	14	20	7.7	21.4	29.9	18.2	23.2	24.6	29.5	20.9	26.1	17.5	21.6	16.7	89.2	42.9	14.7	16.3	16.3	17.1	18.4	13	12.9	7.2	21.5	62.6	41.6	17.2	51.9	19.1	22.6	24.4	22.2	22.4	22.9	13.8	10	37.5	24.7	42.2	6.4	38.2	14.8	21.2	8.3	13.5	10.4	45	31.2	11.9	10.6	8.7	19.1	26	15.8	16.4	20.6	36.9	21.2	12.5	9.8	25.3	16.8	19.2	21.6	8.9	28.5	18	17.3	13.2	11.1	10.1	13.5	11.1	10.9	10.6	13.7	13.9	13	7.7	9.2	11.8	12.8	7.3	13	20.9	20.1	15.5											6	3.2	0	0.1	0.3	0.8	88.9	0	2.7	2.3	0	3.9	0.3	1.7	0	0.1	0.1	0	0	0.6	0.2	0.5	0.3	0	0.8	0.1	0	0	1.3	1.5	0	0	0	0	0	0	0.2	0.4	0	0.4	0	0.5	6.5	1	0.5	1.3	0.5	0.3	0	0.2	0.1	Cardiomyocytes
KLHL33		ENSG00000185271	Kelch like family member 33	A6NCF5	14	20425852-20436158	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in some	4	skeletal muscle: 39.2	Cell type enriched	Detected in single	215	Cardiomyocytes: 21.5	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	24	plasmacytoid DC: 9.3	Lineage enriched	Detected in single	24	dendritic cells: 9.3	Cell line enriched	Detected in some	9	REH: 9.5	Low region specificity	Detected in many							HPA049985, HPA056560	Enhanced											HPA049985: , HPA056560: AB_2683174	unprognostic (6.92e-2)	unprognostic (6.39e-2)	unprognostic (2.07e-1)	unprognostic (4.81e-1)	unprognostic (2.43e-1)	unprognostic (2.26e-1)	unprognostic (2.38e-3)	unprognostic (1.60e-1)	unprognostic (9.77e-2)	unprognostic (1.25e-1)	unprognostic (7.39e-2)	unprognostic (4.15e-2)	unprognostic (4.60e-2)	unprognostic (7.43e-3)	unprognostic (4.88e-3)	unprognostic (3.32e-5)	unprognostic (2.32e-1)	1.2	0.1	0.1	0.1	0.1	0	0.3	0.6	0.6	0.6	0.4	0.3	0.1	0	0.8	0.7	0.4	0.4	0.3	0.5	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.6	0.1	0.7	0.1	0.1	0.4	0.5	0	0.1	0.8	0.5	39.2	0	0.3	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	8.5	0.6	0.3	0.8	0.3	9.3	0.3	0.1	0.1	0.3	0.2	0.2	0	0.1	0	0	0.2	0.2	0.1	0	0.1	0.1	0.3	0.3	0.1	0.2	0.2	0.1	0.2	0	0	0.1	0.2	0	0.4	0.3	0.3	0.1	0.2	0.4	0.7	0	0	0	0	0.1	0.2	0.2	0.5	0	0	0.2	0.3	0.4	0.1	0	9.5	0.1	0.2	0	0.2	0.2	0.3	0	0.1	0.1	0.1	0.2	0.4	0.2	1	0.5	0.1	0.1	0.3	0.3	0.2	0.1	0.7	0.2	0.3	0.1	0	0.1	0.1	0.1	0.1	0.1	0.2	0	0.3	0.1	0.3	0.2	0.1	0	9.3	0	0.2	0.1	0.1	0.6	0.6	0.1	0.1	0.1	0.1	0.4	0.1	0	0	0	0	0	0	21.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
SRL		ENSG00000185739	Sarcalumenin	Q86TD4	16	4189374-4242080	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	17	heart muscle: 70.9;skeletal muscle: 104.1;tongue: 48.3	Cell type enriched	Detected in some	7	Cardiomyocytes: 216.0	Group enriched	Detected in some	5	head and neck cancer: 1.5;thyroid cancer: 5.9	Low region specificity	Detected in single			Cell type enhanced	Detected in some		basophil: 2.4	Low lineage specificity	Detected in single			Cell line enriched	Detected in single	13	HSkMC: 9.8					Low region specificity	Detected in some			HPA041535, HPA045520	Enhanced				Intracellular and membrane				26000			HPA041535: AB_2677538, HPA045520: AB_2679358	unprognostic (1.24e-2)	unprognostic (1.36e-2)	unprognostic (1.29e-1)	unprognostic (1.16e-2)	unprognostic (2.21e-1)	unprognostic (8.11e-2)	unprognostic (2.04e-7)	unprognostic (1.41e-1)	unprognostic (8.28e-2)	unprognostic (7.40e-4)	unprognostic (4.91e-2)	unprognostic (8.70e-2)	unprognostic (7.78e-4)	unprognostic (3.33e-2)	unprognostic (2.15e-1)	unprognostic (1.51e-3)	unprognostic (1.68e-4)	3.1	0.1	0.2	0.2	0.2	0	0.4	0.1	1	0.8	0.3	0	1.2	0.1	0.9	4.2	2.9	0.8	0.4	70.9	0.2	0.2	0.5	0.1	0.3	0.1	0.3	0.2	0.4	0.1	0.1	0.1	0.3	0.4	1.3	0.2	0.1	2.1	0.6	104.1	0.2	0.4	0.8	0.2	0.4	0.3	0.5	0.1	0.2	0.9	48.3	3.4	0.9	0.7	0.6	0.3	2.4	0.5	0.8	0.5	0.9	0	0.1	0	0	0	0	0	0	0.1	0	0.1	0.1	0.2	0.3	0	0	0	0	0	0	0	0	0.1	0.3	0.3	0.1	0	0.2	0.2	9.8	0	0	0	0	0.6	0.1	0.1	0.1	0	0.7	0	0.3	0	0	0	0.1	0.4	0	0.3	0	0.1	0	0	0.1	0	0.1	0.2	0.3	0	0	0	0.1	0	0.1	0.2	0.1	0	0.4	0	2.4	0.2	0.8	0.5	0.5	0.2	0.3	0.3	0.3	0.1	0.6	0.4	0.4	1.3	0.8	0.3	0.3	0.3	0.9	0.2	0.2	0.1	1	0.2	0.2	0.3	0.2	0.4	0.1	0	0	0	0	0.2	0.6	216	0	0	0	1.8	7.9	0	0	0	0	1.5	0	0	0	0	0.4	0.3	0	0	0	0	0	3.1	0.3	0	1.7	0	0	0	0	0.8	0.1	0	3.5	0	11.6	6.5	32	0	0.1	0.4	0	0	0	0	Cardiomyocytes
SHOX	GCFX, PHOG, SHOXY, SS	ENSG00000185960	Short stature homeobox	O15266	X	624344-659411	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding	Disease mutation, Dwarfism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 6.3;breast: 13.9	Cell type enriched	Detected in single	6	Cardiomyocytes: 1.4	Not detected	Not detected			Region enhanced	Detected in some		pons and medulla: 6.3	Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Group enriched	Detected in some	4	BJ: 19.5;BJ hTERT+: 9.0									HPA035141, HPA060931			Enhanced	Nucleoplasm,Vesicles						Nucleoplasm	Vesicles	HPA035141: AB_2674489, HPA060931: AB_2684388	unprognostic (7.51e-3)	unprognostic (1.99e-1)	unprognostic (3.08e-2)	unprognostic (2.23e-1)	unprognostic (4.00e-1)	unprognostic (6.82e-2)			unprognostic (2.45e-2)	unprognostic (2.34e-1)	unprognostic (9.24e-2)	unprognostic (9.95e-2)	unprognostic (5.67e-6)	unprognostic (1.99e-1)	unprognostic (1.71e-1)	unprognostic (9.14e-2)	unprognostic (1.38e-1)	3.8	1	0.3	0.7	0.3	3	13.9	1.8	0.8	0.3	0.4	0.2	0.2	1.4	0.3	0.6	0.3	0.4	0.4	0.4	0.7	0.3	0.3	0.3	0.3	0.6	0.3	1.4	0.3	0.9	0	0.3	4.8	6.3	0.8	0.3	0.2	1.4	0.2	2.8	1.4	1	0.2	0.4	1.6	0.4	0.4	0.2	0.2	0.5	0.2	0.2	0.3	0.3	2.2	1.9	5.5	1.8	2.5	1.5	0.8	0.1	0.2	0.1	0.2	0.2	0.1	3.2	19.5	9	2.9	3.2	0.3	0.3	0.3	0.1	0.4	0.8	0.3	0.2	0	1	0.2	0.1	0.1	1.3	0.1	0.1	0.1	0.4	0.6	0	0	0	0.1	0	0.2	0.2	0.8	0.1	0.2	0.1	0.2	0.1	0	0.4	0.1	0.3	0.2	0	0.2	0.2	0	0.1	0.1	0.1	0.2	0.6	0	0.1	0.3	0.2	0.1	0.1	0.9	0.1	0.3	0.1	0.2	0.1	5.5	1.8	1.8	1.4	1.1	1.5	1.6	1.1	1.2	0.5	2.2	1.5	1.5	5.2	2.5	1.5	1.9	1	0.8	0.3	0.3	1.8	0.4	0.7	0.3	0.3	1.4	6.3	0.2	0	0	0	0	0.1	0	1.4	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	Cardiomyocytes
FSD2	RP11-127F21, SPRYD1	ENSG00000186628	Fibronectin type III and SPRY domain containing 2	A1L4K1	15	82755362-82806070	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	13	heart muscle: 20.8;skeletal muscle: 54.0;tongue: 18.1	Cell type enriched	Detected in some	6	Cardiomyocytes: 70.6	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		U-266/70: 8.5	Low region specificity	Detected in some			Low region specificity	Detected in many			HPA046263			Approved	Cytosol						Cytosol		HPA046263: AB_2679604	unprognostic (2.80e-1)	unprognostic (3.54e-1)	unprognostic (6.63e-2)	unprognostic (6.30e-2)	unprognostic (7.71e-2)	unprognostic (1.83e-1)	unprognostic (5.97e-2)	unprognostic (7.66e-2)	unprognostic (1.07e-1)	unprognostic (9.37e-2)	unprognostic (3.05e-2)	unprognostic (2.21e-1)	unprognostic (1.07e-2)	unprognostic (1.27e-1)	unprognostic (8.03e-2)	unprognostic (1.68e-2)	unprognostic (1.59e-2)	1.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0	0	0.2	0.1	0.6	0.7	0.1	0	20.8	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.2	0.2	0	0	0.3	0	0.4	1	0	54	0.4	0.1	0	0.1	0.1	0.1	0.1	0	0	0.2	18.1	1.4	0	0.1	1.4	0.8	2.3	0.9	0.8	2.2	0.5	1.3	1.3	2	2.4	0	0	1.2	1.3	0	0	0	1.1	2.1	4.1	0.9	0	1.1	5	0	0	0.4	0.7	5.4	2.3	5.7	1.8	0	1.4	0.9	0.1	0.2	0	0.6	1.4	0	1.7	2	3.7	0	1.2	0.7	2.4	1.9	0.8	1.1	1.3	1.5	1	0.2	2.3	1.9	1.7	1	1	1.5	1	1.7	1.8	0.8	3	1.6	1.1	1.8	8.5	3.6	1.4	1.8	4.9	0.7	2.3	0.8	0.8	1	0.7	0.8	1.4	1.1	0.9	0.8	1.1	2.2	1.1	1.1	0.8	0.9	0.8	1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	2.1	0	1	0.3	2.6	70.6	2.5	0	1.2	0	5.9	0	0	0	1.6	0.6	0	0	0.3	0.1	0.2	0.3	1.1	0	0.2	11.1	1.2	0	0.8	1.8	0.3	0	0	0	0	0.3	0.1	0	0	0	3.6	0	0.3	0.7	0.2	0.5	0.2	0	0	0.3	Cardiomyocytes
IFNA2	IFN-alphaA, IFNA	ENSG00000188379	Interferon alpha 2	P01563	9	21384254-21385388	Predicted secreted proteins	Antiviral defense	Cytokine		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 1.6;brain: 1.3;lymphoid tissue: 1.1	Cell type enriched	Detected in single	20	Cardiomyocytes: 2.0	Not detected	Not detected			Low region specificity	Detected in some			Cell type enriched	Detected in single	17	eosinophil: 1.6	Lineage enriched	Detected in single	17	granulocytes: 1.6	Cell line enhanced	Detected in single		SuSa: 1.3									HPA047557	Uncertain				Secreted to blood			253000				HPA047557: AB_2680087																		0.1	0	0.8	0.1	1.3	0.8	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	1	0.4	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.4	1.1	0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	1.3	0.3	0.4	1	0.4	0.6	0.1	0.1	0.1	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
FITM2	C20orf142, dJ881L22.2, FIT2	ENSG00000197296	Fat storage inducing transmembrane protein 2	Q8N6M3	20	44302838-44311169	Predicted membrane proteins			Deafness, Disease mutation, Dystonia, Mental retardation	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	4	heart muscle: 56.7	Cell type enriched	Detected in many	9	Cardiomyocytes: 134.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (2.92e-2)	unprognostic (7.61e-2)	unprognostic (2.27e-2)	unprognostic (2.10e-3)	unprognostic (1.02e-1)	unprognostic (3.57e-3)	unprognostic (1.63e-2)	unprognostic (3.90e-2)	unprognostic (8.43e-2)	unprognostic (5.19e-2)	unprognostic (6.56e-3)	unprognostic (1.19e-1)	prognostic favorable (8.98e-12)	unprognostic (2.07e-1)	unprognostic (2.54e-1)	unprognostic (3.38e-3)	unprognostic (2.49e-3)	8.8	9.9	5	2.6	5.7	1.2	9.5	7.1	8.2	4	4.5	4.3	3.8	3.8	3.7	7.7	3.1	3.5	3.3	56.7	4.9	5.1	7.7	8	3.6	2	4.7	5.5	4.3	7.8	13	4.5	1.9	6.6	5.8	5.3	4.7	5.3	4.2	6.9	4.5	3.7	4.6	4.7	2.5	3.8	3.6	5.1	0.2	5.5	4.4	2.4	3.9	3.8	2	2.7	1.7	3	3.8	6.2	2.5	4.5	7	3	4.3	21.2	8.7	3	7.4	5.4	5.9	3.2	8.6	3.3	3.1	4.3	8.3	9.3	10.2	3.7	5	6.4	0.9	1.7	1	4.4	14.4	4.4	2	2.6	6.6	11.3	4.1	3.1	3.2	4.2	2	1.7	9.3	5.9	14.1	0.7	2.1	0.7	6.8	9.1	1.2	5.5	3.1	3.3	4.3	1.8	2.1	15.7	8.9	6.5	1.4	10.8	1.5	5.1	18.8	8.4	10.8	4.3	3.4	8.8	0.8	8.3	3.1	9.3	1.4	3	1.7	3.4	2.7	3.5	1.8	3.6	2.8	2.7	2	6.2	4.8	1.4	3.8	2.1	1.7	3.2	2.5	5	5.7	7.1	8.2	4.9	5.1	4.7	5.5	6.6	5.1	6	8.9	7.3	3.1	6.2	5.8	134	15.3	4	3.4	5.2	5.9	1.9	1.7	4.5	3.6	3.6	4.3	0	7.4	2.7	4.7	2.9	0	12.1	3	6.4	8.7	9.8	4	0.4	7.2	1.7	6.8	1.8	5.6	5.3	5.4	5.3	7.1	5.1	5.7	0	4.7	7.5	5.2	7	1.3	3.8	8	2	Cardiomyocytes
MYH6		ENSG00000197616	Myosin heavy chain 6	P13533	14	23381990-23408277	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin	Atrial septal defect, Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	36	heart muscle: 313.7	Cell type enriched	Detected in some	1060	Cardiomyocytes: 5369.5	Cancer enriched	Detected in single	5	testis cancer: 1.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	23	NTERA-2: 10.4	Not detected	Not detected			Not detected	Not detected			HPA001239, HPA001349, CAB075723, CAB075724, CAB075725	Enhanced								20000000			CAB075723: AB_2665728, CAB075724: AB_2665729, CAB075725: AB_2665730, HPA001239: AB_1079438, HPA001349: AB_1079437	unprognostic (2.09e-2)	unprognostic (8.53e-4)		unprognostic (1.80e-2)	unprognostic (2.99e-1)	unprognostic (1.66e-1)		unprognostic (2.09e-1)	unprognostic (1.66e-1)	unprognostic (5.73e-2)	unprognostic (1.44e-2)	unprognostic (5.34e-3)		unprognostic (6.90e-2)	unprognostic (1.42e-1)	unprognostic (1.85e-1)	unprognostic (1.22e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0	0.1	0.2	0.2	0	0.1	313.7	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0	0.1	0.1	0.1	0.1	0	0.1	0.2	0.2	8.6	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.5	0.7	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	10.4	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	5369.5	0	0	0	0	0	0	0	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	5.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.2	0	0	0	Cardiomyocytes
LHFPL5	DFNB67, dJ510O8.8, MGC33835, Tmhs	ENSG00000197753	LHFPL tetraspan subfamily member 5	Q8TAF8	6	35805293-35833874	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport		Deafness, Disease mutation, Non-syndromic deafness	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	bone marrow: 7.4;brain: 6.7;epididymis: 12.0;pancreas: 12.3	Cell type enriched	Detected in single	16	Cardiomyocytes: 13.0	Not detected	Not detected			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA055110	Uncertain											HPA055110: AB_2682697	unprognostic (2.35e-1)	unprognostic (6.45e-2)	unprognostic (2.41e-2)	unprognostic (1.22e-3)	unprognostic (1.96e-1)	unprognostic (1.78e-1)		unprognostic (4.89e-3)		unprognostic (2.96e-3)	unprognostic (2.46e-2)		unprognostic (1.47e-8)	unprognostic (5.53e-2)	unprognostic (1.70e-1)	unprognostic (2.15e-1)	unprognostic (1.41e-1)	0.5	0.5	3.9	1.2	4.1	7.4	0.5	0.4	5.8	0.4	0.4	0.2	0	0.9	0.9	12	0.3	0.3	0.7	0.3	3.5	2.8	0.4	0.4	0.3	1.5	1.2	6.7	0.6	12.3	0	2.2	0.6	2	0.6	0.3	0.2	1.1	0.1	0.6	2.3	0.8	0.1	0.6	1	0.5	0.8	0	0	0.8	0	0.4	0.3	0.4	1	0.3	1	0.8	0.5	0.9	0	1.5	1.9	3.6	2.2	0.6	1.7	3.2	2.5	0.9	0.4	1.1	2.1	2.2	3.6	1.9	1.3	2.3	2	0.6	1.4	0.9	1.8	2.9	3.8	5.6	1.9	0.1	1.7	2.6	1.4	0.7	0.7	1	3.1	0.5	3.4	2	7.2	2	1.2	2.3	1.8	2.4	0.9	1.5	2	1.6	1	1.2	3.3	3.3	2.2	1.6	1.9	1.1	2.5	3	1.3	3.6	2.4	2.1	3.3	1	4.1	3.4	2.8	1.1	2.4	1.5	1	0.3	0.2	0.9	0.6	0.5	0.5	0.5	0.3	0	1	0.6	0.8	0.9	0.5	0.8	0.3	0.4	0	3.9	4.1	0.4	5.8	3.5	2.8	1.2	6.7	2	0	0	0	0	0	0	0	13	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.8	0	0	0	0.1	0	0.1	0	0	0	Cardiomyocytes
NRAP		ENSG00000197893	Nebulin related anchoring protein	Q86VF7	10	113588716-113664127	Plasma proteins, Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	15	heart muscle: 74.1;skeletal muscle: 268.1;tongue: 82.3	Cell type enriched	Detected in some	147	Cardiomyocytes: 530.6	Group enriched	Detected in some	7	head and neck cancer: 8.2;prostate cancer: 3.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	4	OE19: 3.1	Low region specificity	Detected in some			Not detected	Not detected			HPA037953, HPA037954	Enhanced											HPA037953: AB_2675755, HPA037954: AB_10672394	unprognostic (1.13e-1)	unprognostic (2.95e-1)	unprognostic (3.61e-2)	unprognostic (2.05e-2)	unprognostic (5.75e-2)	unprognostic (1.97e-2)	unprognostic (1.25e-2)	unprognostic (3.03e-3)	unprognostic (3.72e-2)	unprognostic (4.20e-2)	unprognostic (6.40e-2)	unprognostic (2.88e-1)	unprognostic (5.39e-4)	unprognostic (8.21e-2)	unprognostic (1.16e-1)	unprognostic (3.16e-1)		5.1	0	0.1	0	0.1	0	0.1	0	0.3	0	0.1	0	0	0	0	9.4	5.8	0	0	74.1	0.1	0.1	0	0.1	0.1	0	0.1	0	0	0.1	0	0.1	0	0	2.3	0.1	0	4.2	0	268.1	0.1	0	0	0.1	0	0.1	0.1	0	0	1.8	82.3	7.8	0	0	0	0	0	0	0	0	0	0	0.4	0.3	0	0	0	0.1	0	0.1	0.1	0	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0.5	0	0.1	0	0.1	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0.7	3.1	0	0	0.4	0	0	0	0	0	0	0.1	0	0	0.5	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0.5	0	530.6	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	1	0	0	0	0	3.6	0	0	0	0	0	0	0	0	0.3	2.5	0.1	0	0	0.2	0	Cardiomyocytes
MB	PVALB	ENSG00000198125	Myoglobin	P02144	22	35606764-35637951	Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Transporters	Oxygen transport, Transport	Muscle protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	26	heart muscle: 366.6;skeletal muscle: 871.2;tongue: 310.7	Cell type enriched	Detected in many	38	Cardiomyocytes: 4117.3	Group enriched	Detected in many	7	breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4	Not detected	Not detected			Cell type enriched	Detected in single	6	NK-cell: 4.4	Lineage enriched	Detected in single	6	NK-cells: 4.4	Cell line enriched	Detected in some	4	SK-BR-3: 62.9	Not detected	Not detected							CAB000060, HPA003123	Enhanced							13500000	190000000			CAB000060: , HPA003123: AB_1079442	unprognostic (7.51e-2)	unprognostic (3.92e-3)	unprognostic (1.07e-1)	unprognostic (7.71e-2)	unprognostic (2.35e-1)	unprognostic (4.66e-3)	unprognostic (5.78e-3)	unprognostic (1.18e-1)	unprognostic (2.74e-1)	unprognostic (1.72e-1)	unprognostic (2.74e-3)	unprognostic (1.17e-2)	unprognostic (8.34e-2)	unprognostic (1.51e-2)	unprognostic (2.35e-1)	unprognostic (3.44e-3)	unprognostic (1.19e-2)	3.6	0.1	0.2	0.1	0.2	0	1.1	0.1	0.1	0	0.3	0	0	0	0	13	19.6	0.4	0	366.6	0.2	0.1	0.1	0.2	0.1	0	0.2	0	0.1	0.7	0	0.3	0.1	0	5	0.3	0	13	0	871.2	0.3	0.3	0	0.2	0.1	0.1	0.1	0	0	4.6	310.7	14.4	0.3	0.1	0.1	0.4	0.1	0	4.4	0.7	0	0.6	2.6	0	0	0	0	0	0	0	0.1	0	0	1.6	0.2	0	0.1	0.3	0.3	0	0	0	1.8	0.1	0	0.1	0	0	0	0.1	0	0	0.1	0	0	0	0	0.2	0.1	0	6.4	0	0.2	0	0.6	0.9	0.3	0.2	2.7	0	2.2	0.5	0	6.7	62.9	0	0.1	14	0	0.1	0.2	0.4	0.8	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0.1	0	0.7	0.4	0	0	0	0.1	4.4	0	0	0	0	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0	0	0	0	0	0	3.7	0.2	0	4117.3	0	20.1	3.4	0	0	0	0	3.6	20.4	0	1.6	0	0.2	0	0	28.6	0	0	0	0	11.1	0	0	52.6	0	0	11.8	0	109.2	0	0.4	2.9	0.7	0	0	0	1.9	0.4	0.6	0.1	0.2	0	2.6	8.4	Cardiomyocytes
MYL4	ALC1, AMLC, GT1, PRO1957	ENSG00000198336	Myosin light chain 4	P12829	17	47200446-47223679	Disease related genes, Plasma proteins, Predicted intracellular proteins		Motor protein, Muscle protein, Myosin	Atrial fibrillation, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	68	heart muscle: 712.3	Cell type enriched	Detected in many	5	Cardiomyocytes: 2384.1	Group enriched	Detected in some	7	testis cancer: 2.4;thyroid cancer: 11.7	Not detected	Not detected			Cell type enriched	Detected in single	11	plasmacytoid DC: 5.2	Lineage enriched	Detected in single	11	dendritic cells: 5.2	Cell line enriched	Detected in some	4	HEL: 109.9	Group enriched	Detected in many	6	amygdala: 25.9;cerebral cortex: 83.3;hippocampal formation: 27.8	Not detected	Not detected			HPA046859, HPA051884, HPA063034	Enhanced		Approved	Plasma membrane					140000	Plasma membrane		HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927	unprognostic (2.43e-2)	unprognostic (9.57e-2)	unprognostic (2.25e-1)	unprognostic (5.51e-2)	unprognostic (2.33e-1)	unprognostic (4.12e-3)	unprognostic (5.06e-3)	unprognostic (1.34e-1)	unprognostic (1.13e-1)	unprognostic (6.52e-2)	unprognostic (2.10e-2)	unprognostic (7.37e-2)	unprognostic (1.00e-6)	unprognostic (1.92e-4)	unprognostic (2.54e-1)	unprognostic (6.51e-3)	unprognostic (1.50e-1)	0.1	0	0	0.1	0	10.4	0.1	0	0.1	0	0	0.1	0	0	0.1	0.1	0.1	0	0	712.3	0	0	0	0	0.1	0.1	0	0.1	0.1	0.7	0	0	0.7	0.1	0	0	0.8	3.3	0	0.5	0	0	0.1	0	0.1	0.2	0.7	0	0.1	0.6	4.6	0.1	0.1	0.2	0.2	5.2	0	0.4	0	0	0.7	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0.3	0.1	0	0	0	0	0	0	0.5	0	109.9	0	0	0	0	0	4.5	0	0	0	0	0.2	0.3	26	0	0	0	1.9	0	0	0	0	0	2.6	0	0	0	0	0	0	0	0	5.2	0	0	0.9	0	0	0	0	0	0	2.6	0	0	0	0	0	0	0	0.4	0	0	0	0	0.4	0.2	0	0	0	0	0.1	5.2	0	0.7	0	0	0	0.1	0	0	0	0.1	0.1	0	3	0	0	0	0.7	4.5	2384.1	0	0	0	0	60.9	0.4	0	0	16.3	3	0.3	443.9	0	2.6	2.1	0	0	0	1.8	1.6	0	1.3	0	42.1	3.1	0	11.8	0	0	4.9	0.1	0	1.4	0	17	0	2	1.5	0.4	0.6	1.1	0	0	0	Cardiomyocytes
PLN	CMD1P, PLB	ENSG00000198523	Phospholamban	P26678	6	118548298-118560730	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters			Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	heart muscle: 337.5	Cell type enriched	Detected in some	8	Cardiomyocytes: 2230.5	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Cell type enhanced	Detected in some		eosinophil: 1.3;naive CD4 T-cell: 1.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		fHDF/TERT166: 1.3;Karpas-707: 1.6;NB-4: 1.8;SuSa: 1.7;U-2197: 1.3	Low region specificity	Detected in many			Low region specificity	Detected in all			CAB005597, HPA026900	Enhanced											CAB005597: AB_2252716, HPA026900: AB_1855314	unprognostic (2.49e-1)	unprognostic (5.67e-2)	unprognostic (1.96e-3)	unprognostic (4.81e-2)	unprognostic (1.20e-1)	unprognostic (5.54e-2)	unprognostic (2.35e-3)	unprognostic (4.66e-2)	unprognostic (3.97e-1)	unprognostic (8.98e-2)	unprognostic (8.98e-2)	unprognostic (3.28e-1)	prognostic unfavorable (4.11e-4)	unprognostic (2.98e-3)	unprognostic (1.80e-1)	unprognostic (2.11e-1)	prognostic unfavorable (5.59e-4)	9	1.8	0.4	2.7	0.5	0	5.4	0.4	0.6	22.3	22.2	0	9.8	2	21.1	22.3	27.3	11.6	29.8	337.5	0.4	0.5	6.4	0.4	5.3	0.8	0.7	1.4	18.6	0.5	0.1	0.4	0.1	1.4	14.4	3.9	0	1.6	6	68.4	1.5	14	30.8	1.2	0.6	6.5	12.3	0	0	2.8	23.7	0.8	32.2	6.6	0.3	0	1.3	0.4	0	1.4	0	0	0	0.3	0	0	0	0.9	0.2	0.1	0	0	0	0.2	0	0.1	1.3	0	0.2	0	0	0.3	0.6	0	0	0.5	0	0	0.1	0.2	0	0.3	0.5	0.2	0.1	0	0.2	0.2	1.6	0.1	0	0	1.8	0.1	0	0	0	0.1	1	0	0.7	0.2	0.8	0.4	0.1	0	1.7	0.4	0	0.5	0.3	0.2	1.3	0.3	0.2	0.3	0.4	0	1	0.1	0	0.4	1.3	0.1	0	0.3	0.1	0.4	0	0	0.3	1.4	0.4	0.3	0	0	0	0	0	0.4	0.5	0.4	0.6	0.4	0.5	0.7	1.4	1.4	0	0	0	0	0	3.8	1.6	2230.5	0	0	0	0	2	0	0	0	71.2	0.4	0	0	0	0	1.7	0.4	0	0	0.1	0	0	0	0	13.7	0.9	0.3	3.3	0	0	0	0.1	0	11	0	0.2	271.7	280.1	1.1	0.4	1.4	0	0	0	0.4	Cardiomyocytes
RYR2	ARVC2, ARVD2, VTSIP	ENSG00000198626	Ryanodine receptor 2	Q92736	1	237042205-237833988	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters	Calcium transport, Ion transport, Transport	Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor	Cardiomyopathy, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	heart muscle: 106.6	Cell type enriched	Detected in many	30	Cardiomyocytes: 1960.0	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HDLM-2: 7.8;HEK 293: 10.7;K-562: 3.3;NB-4: 2.7;NTERA-2: 4.0;U-937: 4.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA020028	Approved		Uncertain	Nucleoplasm,Plasma membrane,Cytosol						Nucleoplasm, Plasma membrane, Cytosol		HPA020028: AB_1856528	unprognostic (5.23e-3)	unprognostic (2.15e-2)	unprognostic (5.02e-4)	unprognostic (6.26e-2)	unprognostic (8.74e-2)	unprognostic (2.99e-3)	unprognostic (5.28e-2)	unprognostic (1.45e-3)	unprognostic (2.69e-2)	unprognostic (1.04e-1)	unprognostic (1.10e-1)	unprognostic (4.04e-2)	unprognostic (0.00e+0)	unprognostic (2.36e-2)	unprognostic (1.42e-1)	unprognostic (3.13e-2)	unprognostic (1.06e-2)	1.1	0.9	6.2	0.9	18.7	0.5	1.1	14.8	10.5	1.3	1.2	0	1.2	0.7	1.1	0.7	1.8	1	1.8	106.6	5.7	1.1	0.9	0.9	1.4	0.6	1	7.3	2.2	4.2	0.5	2	1.1	1.6	2	0.8	0.2	0.9	1.4	0.9	1	1	4.6	1	1	1.2	1.1	3	0	2.7	0	0.6	1.2	1	0	0	0	0	0	0.6	0	0	0	0	0.2	0	0	0	0	0	0	0	0.2	0	0.7	0.3	0	0	0.3	0.6	0	0	7.8	10.7	2.1	0.1	0	0	0	0	0	0.4	0	0	0	0	0	3.3	0.2	0	0	0	2.7	4	0.1	0.4	0	0.1	0.1	0	0	0.1	0.2	0	0	0.1	0.6	0	0	0	0	0.1	0	0	0	0	0	0.2	4.9	0	0	0	0	0.1	0	0.6	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	6.2	18.7	14.8	10.5	5.7	1.1	1	7.3	1.6	3	0	0.3	0	0	0.3	65.2	1960	0	1.4	2.3	1.8	9.8	0	0	0	15.8	1.5	0	0	2.5	0	2.1	0	0	0	0.1	1.6	3.4	1.3	0	10.2	1.1	0	8.5	0	0	1.5	0.3	0	0	0	4.7	0	18.6	3.2	0.9	0	0	0	0	0	Cardiomyocytes
MT-ND6	MTND6, NAD6, ND6	ENSG00000198695	Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6	P03923	MT	14149-14673	Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins	Electron transport, Respiratory chain, Transport	Translocase	Disease mutation, Dystonia, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 395.3;skeletal muscle: 593.2	Cell type enriched	Detected in many	16	Cardiomyocytes: 10763.4	Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		HeLa: 524.8	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (1.96e-1)	unprognostic (3.27e-1)	unprognostic (2.28e-1)	unprognostic (1.13e-1)	unprognostic (2.21e-1)	unprognostic (1.22e-2)	unprognostic (1.03e-3)	unprognostic (6.02e-3)	unprognostic (1.68e-2)	unprognostic (1.48e-1)	unprognostic (6.06e-3)	unprognostic (2.91e-1)	prognostic favorable (8.91e-6)	unprognostic (3.64e-2)	unprognostic (1.42e-2)	unprognostic (1.15e-2)	unprognostic (2.92e-2)	79.2	43.1	55.5	34.4	78.5	30.7	9.6	14.7	76.1	5.9	30.2			90.3	19.2	0	69.5	23.2	40.2	395.3	50.7	41.2	65.5	42.8	28.5	25.9	41.9		23.2	48	0	3.5	10.3		28	0.3		48.1	0	593.2	176.3	63.8	0	24.8	19.9	53.2	22.7			17.5		0	32.3	5.7	127.3	91.2	164.8	108.2	88.8	104.3	29.7	99.5	80.8	71.5	90.8	12	1.1	51.3	134.7	0.2	0.4	0.4	109.8	101.1	214.8	91.6	3.6	13.5	149	0.7	2.4	0.7	126.9	62	128.7	524.8	313.8	0.9	81.4	121.6	2	3.3	3.3	2.7	68.1	0.7	45	55.3	84.4	2.9	212.8	25	112.4	15.5	57.2	39.8	60.9	45.7	92.3	1.9	293.8	29.5	47.4	70.1	123.5	55.6	118.8	95.7	158.8	273.9	79.6	67.2	112.6	53.9	28.9	77.1	51.5	54	83.1	46.2	164.8	108.2	68.3	89.1	103.5	104.3	118.4	94.5	96.1	66.2	127.3	94.7	102.4	53.7	88.8	103.7	91.2	71.8	29.7											77.4	48.1	340.3	38	14.9	0	10763.4	298.1	156.6	138.8	122.1	0	0	14.9	22.5	5.1	82.2	98.6	584	30.5	0	11.3	44.8	92.7	656.7	0	0	29	406.4	492.6	24.4	57.8	31.8	32.1	42.3	60.4	0	23.3	63.7	42.5	111.6	0	58.2	27.7	25.6	53	17.9	0	156.7	77	76.6	Cardiomyocytes
MT-CO2	CO2, COX2, MTCO2	ENSG00000198712	Mitochondrially encoded cytochrome c oxidase II	P00403	MT	7586-8269	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Electron transport, Respiratory chain, Transport	Translocase	Disease mutation, Primary mitochondrial disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 489.9;skeletal muscle: 343.4	Cell type enriched	Detected in many	10	Cardiomyocytes: 412590.4	Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		HeLa: 1073.7	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB016243, HPA051505, HPA054758	Enhanced								1300000			CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595	unprognostic (2.67e-1)	unprognostic (5.72e-2)	unprognostic (4.57e-2)	unprognostic (5.31e-2)	unprognostic (2.77e-2)	unprognostic (1.96e-2)	prognostic favorable (2.89e-4)	unprognostic (1.06e-1)	unprognostic (3.39e-1)	unprognostic (2.72e-3)	prognostic favorable (7.10e-4)	unprognostic (1.25e-1)	unprognostic (9.30e-2)	unprognostic (3.05e-1)	unprognostic (1.70e-1)	unprognostic (9.50e-2)	unprognostic (3.72e-3)	54.6	64.8	149.7	21.7	194.8	30.2	45.5	48.9	99.5	27	106.9			73.6	23.8	46.3	35.8	25.1	23.7	252.1	151.9	112.4	158.4	173.8	22.7	22.8	154.6		21.2	46.4	50.4	22.5	41.4		38.2	106.4		61.7	56	343.4	56.4	51.1	40	77.8	25.9	68.5	28.2			23.3		29.5	29.9	16.2	379.8	278.1	489.9	409.1	220.4	273.9	181.4	111.2	179.1	238.3	230.3	487.6	188	175.6	145.1	117.7	82.5	124.6	192.6	251.5	232.6	121.5	213.4	84.9	422.7	31.5	298.5	111.8	180.1	161.5	166.8	1073.7	370.2	106.1	140.2	187.4	275.7	441.7	42.5	152.4	270.3	91.3	232.4	155.7	226.9	226	240.8	102.5	404.1	62.3	220.6	114	107.2	72.6	194.8	336.5	310.9	89.2	147.6	119.5	294.8	209.6	367.9	205.2	568.6	225.1	200	173.5	188.5	102	115.3	114.6	131.1	106.4	283.3	131.3	489.9	409.1	476	194.9	292.9	236.6	379.8	217.1	218.8	205.5	378.1	227.9	273.9	180.3	220.4	308.7	278.1	170.3	181.4											1343	1746.9	18282	6995.6	5999.6	0	412590.4	19500.5	2813.3	2462.5	17642.7	0	0	3143.4	3272.8	866	2789.7	27604.7	22029.3	4281.1	0	1817.5	4991	2029.2	43011.4	0	0	6162.7	12438.4	17929.8	4401	7095.7	4687.5	4875.7	4595.3	21499.4	0	3881.8	14501.3	4815.7	15512.8	0	6946.2	3920.2	6682.3	8100.4	5859.1	0	11198.1	21247.6	11593.6	Cardiomyocytes
MT-CYB	COB, CYTB, MTCYB, UQCR3	ENSG00000198727	Mitochondrially encoded cytochrome b	P00156	MT	14747-15887	Disease related genes, Predicted membrane proteins	Electron transport, Respiratory chain, Transport		Cardiomyopathy, Cataract, Deafness, Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 324.2;skeletal muscle: 302.1	Cell type enriched	Detected in many	4	Cardiomyocytes: 61379.6	Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		ASC diff: 490.3;HeLa: 493.3	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB032215, HPA068400, HPA074796	Approved		Supported	Mitochondria						Mitochondria		CAB032215: AB_2261378, HPA068400: AB_2685982, HPA074796: 	unprognostic (4.50e-1)	unprognostic (2.56e-1)	unprognostic (9.12e-2)	unprognostic (3.88e-2)	unprognostic (9.22e-2)	unprognostic (3.50e-1)	prognostic favorable (5.96e-4)	unprognostic (1.63e-2)	unprognostic (8.53e-2)	unprognostic (1.49e-2)	unprognostic (1.01e-3)	unprognostic (6.09e-2)	unprognostic (1.40e-1)	unprognostic (7.90e-3)	unprognostic (3.07e-1)	unprognostic (4.09e-2)	unprognostic (1.54e-2)	78	52.4	98.5	14.7	143.5	14.4	32.3	38.4	59.6	30.9	54			55.6	25	43.6	28	25	21.2	222.5	93.9	68	128.7	144.7	19.6	13.7	83.6		25.3	51.4	33.6	23.7	32.6		32.9	57.7		59.2	49.5	302.1	63.5	37.2	37.4	44.3	15.7	55.2	20.2			20.9		20.6	23.6	14.7	183.7	78.7	324.2	155.7	90	146.7	57.6	73.4	99.2	123	131.3	490.3	78.9	99.1	84.7	35.1	22.2	38.5	97.6	162.5	188.2	41.5	100.3	26.6	231.5	18.2	104.1	54.5	91.9	81.5	105.1	493.3	174	92.4	59	128.5	170.3	155.3	42	90.5	150.2	56.2	76.8	53.7	118.5	113.1	202.8	54.8	121.7	27.3	71.8	67.4	64.8	48.4	117.8	176.2	171.6	43.9	77.6	59	111.5	83.4	192.8	162.6	203.7	176.1	77.9	101.9	141.8	65	32.5	43.6	80.6	46.8	92	48.9	324.2	155.7	235.1	102.8	94.4	135.3	150.5	118.7	132	78	183.7	128.3	146.7	148	90	96.8	78.7	79.8	57.6											1101.8	1182.9	10535.1	6605.8	2949	0	61379.6	10280.2	2941.7	2205.5	7087.1	0	0	1833.6	2297.4	679	1928.7	15168.1	14904.3	3076	0	1463.9	4337.7	1777.7	14746	0	0	2756	7288.5	8580.4	3048.7	7355	2431.1	2478.3	3811.6	11241	0	2672.3	10113.2	5078	11513.5	0	5704.4	3210.7	4468.4	3767.8	2992.1	0	6827.7	9828	8723.5	Cardiomyocytes
LRRC10	HRLRRP, LRRC10A	ENSG00000198812	Leucine rich repeat containing 10	Q5BKY1	12	69608564-69611162	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	31	heart muscle: 42.5	Cell type enriched	Detected in single	323	Cardiomyocytes: 32.3	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HDLM-2: 2.5	Not detected	Not detected			Not detected	Not detected																				unprognostic (3.76e-4)										unprognostic (4.59e-1)			0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	42.5	0	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	1.3	1.1	1	0.5	0.4	0.8	0.1	0.1	0.5	0.6	0.6	0	0	0.5	0.2	0	1	0.4	0.3	0.3	1	0.3	0.1	0.2	0.7	0	0.1	0	2.5	0.7	0.5	0.7	0.6	0.1	0	0.8	0.2	0.7	0.6	0	0.9	0.4	0.5	0.6	0.1	0.1	0	0.8	0.4	0.2	0	0.4	0.9	0.1	0.1	0.8	1.3	0.8	0.9	0	0.1	0	0.7	0.3	0.1	0.4	0.2	0.8	0.5	0.4	0.6	0.4	0.8	1	1.3	0.1	0.4	0.5	0.4	0.6	0.2	0.5	0.7	0.5	0.6	0.1	1.3	0.8	0.7	1	0.4	0.3	1.1	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	32.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
DUSP27		ENSG00000198842	Dual specificity phosphatase 27, atypical	Q5VZP5	1	167094045-167129165	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	20	heart muscle: 46.8;skeletal muscle: 64.8;tongue: 18.2	Cell type enriched	Detected in some	10	Cardiomyocytes: 131.1	Group enriched	Detected in many	6	colorectal cancer: 12.8;stomach cancer: 3.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	RH-30: 18.0	Low region specificity	Detected in single			Not detected	Not detected			HPA012912			Approved	Nucleoplasm						Nucleoplasm		HPA012912: AB_2668767	unprognostic (1.26e-2)		unprognostic (1.74e-1)	unprognostic (1.44e-3)	unprognostic (1.22e-1)	unprognostic (2.10e-3)	unprognostic (4.65e-2)	unprognostic (1.53e-1)	unprognostic (8.19e-2)	unprognostic (1.07e-2)	unprognostic (1.48e-1)	unprognostic (2.44e-2)	unprognostic (1.15e-1)	unprognostic (2.72e-1)	unprognostic (7.65e-2)	unprognostic (8.23e-2)	unprognostic (3.39e-1)	2.1	0.1	0.1	0	0.1	0	0	0	0.3	0	0	0	0	0	0	1.5	1.1	0	0.1	46.8	0.2	0.1	0	0	0.1	0	0.1	0	0	0	0	0	0.9	0.1	0.8	0	0	0.9	0	64.8	0	0	0.1	0	0	0	0.2	0.1	0	0.5	18.2	0.8	0	0	0	0.3	0	0.1	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	1.8	0	0	0	0.2	0	0	0	18	0	0	0	0	0	0	0.2	0	3.2	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.2	0.2	0.1	0.1	0	0.1	0.1	0	0	0	0	0	0	131.1	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0.4	1	0	0	0	13.8	0	0	0	0	0	0	0	0	0	0	8.6	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	Cardiomyocytes
MT-ND4	LHON, MTND4, NAD4, ND4	ENSG00000198886	Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4	P03905	MT	10760-12137	Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins	Electron transport, Respiratory chain, Transport	Translocase	Disease mutation, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 392.9	Cell type enriched	Detected in many	4	Cardiomyocytes: 130137.0	Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		HeLa: 821.0	Low region specificity	Detected in all							HPA053928	Approved		Supported	Mitochondria						Mitochondria		HPA053928: AB_2682313	unprognostic (8.39e-2)	unprognostic (1.83e-1)	unprognostic (7.29e-2)	unprognostic (9.54e-2)	unprognostic (5.41e-2)	unprognostic (3.78e-2)	unprognostic (2.50e-3)	unprognostic (8.16e-2)	unprognostic (1.45e-1)	prognostic favorable (1.76e-4)	unprognostic (1.01e-2)	unprognostic (7.23e-2)	unprognostic (2.79e-2)	unprognostic (1.53e-1)	unprognostic (1.43e-1)	unprognostic (3.14e-2)	unprognostic (4.24e-2)	82.5	72.4	124.2	19.8	138.2	14.9	34.5	43.8	78.5	34.1	68.7			56.5	27.8	37.1	32.9	25.2	23.7	292.7	122.4	90.3	129.8	178.5	20.8	17.4	101.6		25.5	58.3	37.8	19.7	39.1		37.3	82.1		61.7	65.6	288.4	61.1	41	37.8	63.6	21.7	67.7	29.6			24.3		23.4	26	15.3	164.7	87.6	392.9	119.5	87.1	129.7	53	102.6	106.9	138.9	205.1	326.5	82.3	97.3	104.6	40	24.3	47.5	162.1	117.7	182.9	92.3	89.1	35.8	192.5	12.4	169.4	43.6	105.5	67.2	112.6	821	271.8	49.3	113.1	134	139.2	179.5	35.8	128.4	229.8	58.7	92.3	93.8	226.5	87.5	231.7	44.5	257	39.3	89.7	72.7	60.6	43.6	110.2	177.8	222.1	51.2	69.3	60.8	202.4	104.6	257.3	141.7	267.4	162.8	99.5	96.8	133.1	81	135.9	55.1	81.4	64.9	196.6	52.9	392.9	119.5	268.8	82.9	91.3	115.5	148	93	98.9	65.9	164.7	109.6	129.7	105.7	87.1	89	87.6	67.6	53											1179.2	1324.7	15760.8	7514.4	3912.5	0	130137	15452.1	2295.3	2103.1	12148.5	0	0	2064.1	2636.7	917	2449.9	17720.8	23127.3	3538.6	0	2017.3	5309	2067.8	31565.1	0	0	4902.7	11944.3	15339	4282.8	8180.5	3605.2	3603.6	4879.3	17860.7	0	3353.9	12846	5441.2	13683.6	0	6208.8	3859.5	7259.5	5529.7	4316.1	0	9799.9	18174.2	10097.1	Cardiomyocytes
MT-ND1	MTND1, NAD1, ND1	ENSG00000198888	Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1	P03886	MT	3307-4262	Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins	Electron transport, Respiratory chain, Transport	Translocase	Alzheimer disease, Amyloidosis, Diabetes mellitus, Disease mutation, Epilepsy, Leber hereditary optic neuropathy, MELAS syndrome, Neurodegeneration, Primary mitochondrial disease	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 314.4;skeletal muscle: 398.2	Cell type enriched	Detected in many	5	Cardiomyocytes: 72531.4	Low cancer specificity	Detected in all							Cell type enhanced	Detected in all		basophil: 314.4	Lineage enriched	Detected in all	5	granulocytes: 314.4	Cell line enhanced	Detected in all		HeLa: 673.1	Low region specificity	Detected in all							CAB033779, HPA066847	Approved											CAB033779: AB_2149736, HPA066847: 	prognostic favorable (3.63e-4)	unprognostic (3.55e-1)	unprognostic (3.77e-2)	unprognostic (3.65e-1)	unprognostic (3.50e-1)	unprognostic (1.28e-1)	unprognostic (1.95e-3)	unprognostic (5.84e-2)	unprognostic (1.06e-1)	unprognostic (5.05e-2)	prognostic favorable (3.26e-4)	unprognostic (8.67e-2)	unprognostic (8.66e-2)	unprognostic (3.24e-2)	unprognostic (1.42e-2)	unprognostic (3.99e-2)	unprognostic (2.85e-2)	83.5	48	118	15.2	136.1	17.7	31.8	45	85.9	19.6	58.3			40.2	16.3	43.4	30.7	16.7	17.6	223.1	106.1	74.3	96	104.7	20.5	12.1	101.8		14.2	48.2	35.1	14.3	32.2		26.6	58.6		71.2	48.4	398.2	75.4	33.3	24.6	55.2	16.7	45	29.8			13.8		17.1	19.9	9.4	60.8	32.2	314.4	54.4	35.8	46.4	19.5	101.9	104.3	85.6	77.9	325	59.2	110.1	88	26	24.4	25.8	181.3	111.3	125.2	56	66.3	24.8	68.2	9.4	53	49	89.2	73.5	139.3	673.1	257	69.8	65.9	137.7	140.2	144.8	37.8	54.6	99.7	26.2	36.7	64	78.3	72.4	140.2	53	273.1	22.9	64.3	78.6	55.9	38.9	67.2	135.5	165.5	35.6	56.7	48.8	78.1	85.3	108.9	69.7	228.7	137.9	81.8	73.9	104.2	73.1	86.9	53.5	58	55	116.9	22.3	314.4	54.4	103	25.7	31.4	37.3	54.3	30.8	34	20.6	60.8	41.1	46.4	157.8	35.8	32	32.2	22	19.5											1256.6	1138.7	6703.3	2831.5	2012.7	0	72531.4	10000	1801.4	2082.6	4374	0	0	875.4	1190.4	925.4	1519.1	10706.5	9881.7	3135.3	0	1058.8	2565.3	1330	13675.3	0	0	3018.7	7368.9	9328.1	4287.1	6527.3	2029.2	1420.6	1887.4	12938.3	0	1718	6638.7	3334.2	5210	0	6305.8	2437.5	5090.3	4626.8	1812.2	0	3284.5	11055	4223	Cardiomyocytes
MT-ATP6	ATP6, ATPase-6, MTATP6, RP, Su6m	ENSG00000198899	Mitochondrially encoded ATP synthase membrane subunit 6	P00846	MT	8527-9207	Disease related genes, Predicted membrane proteins	ATP synthesis, Hydrogen ion transport, Ion transport, Transport		Cardiomyopathy, Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, Neuropathy, Primary mitochondrial disease, Retinitis pigmentosa	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 419.0;skeletal muscle: 475.3	Cell type enriched	Detected in many	5	Cardiomyocytes: 108059.0	Low cancer specificity	Detected in all							Cell type enhanced	Detected in all		basophil: 419.0	Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		HeLa: 1186.6	Low region specificity	Detected in all																				unprognostic (2.97e-1)	unprognostic (4.16e-1)	unprognostic (1.86e-2)	unprognostic (4.55e-2)	unprognostic (8.45e-3)	unprognostic (1.66e-1)	prognostic favorable (3.79e-4)	unprognostic (6.47e-2)	unprognostic (2.39e-1)	unprognostic (1.44e-2)	prognostic favorable (7.64e-4)	unprognostic (6.01e-2)	unprognostic (4.64e-2)	unprognostic (1.46e-1)	unprognostic (1.37e-1)	unprognostic (3.56e-1)	unprognostic (2.52e-3)	85.2	89.2	126	25.1	159.3	20.1	29.6	45.2	81.2	20.1	60.3			75.6	23.5	30.9	42.8	19.8	24.6	309.5	122.3	90.2	154.4	166.8	18	19.3	102.8		26.5	54.7	36.2	22	34.1		37.6	59.4		66.8	35.6	475.3	62.5	52.6	27.9	61.3	20.7	58.4	27.7			22.4		18.6	23	15.7	110.2	58.9	419	88.2	72.3	90.5	35.3	100.8	166.4	116.2	182.2	221.8	50.9	75.9	148.7	27.1	20.1	34	195.6	110.9	179.7	63.2	80.2	31.2	219.8	12.1	116	37.3	128.3	105.3	157.3	1186.6	338.6	37.7	93.1	203.9	83	102.9	36.1	34.9	141.5	35.7	100.8	103.4	131.1	78.3	284	57.3	247.9	30.5	77.4	68.9	72.2	49.5	110.7	208.9	256	66.4	85.2	53.3	113.7	107.5	199.3	121.6	319.6	188.2	82	121.2	135.4	106.1	58	76.5	124.6	71.6	198.7	45.8	419	88.2	156.1	56.6	66.3	71.6	106	64.7	71.1	47.5	110.2	76.5	90.5	100.1	72.3	67.8	58.9	47.6	35.3											1381.7	1526	11633.9	5315.5	2578.7	0	108059	10741.3	2731.6	2651.3	6092.6	0	0	1593.2	1756.2	808.5	1505.8	13591.3	14997.7	2949.2	0	1371.6	3985.7	1952.8	21340.2	0	0	3847.9	7623.7	10387.2	3622.6	7103.8	2816.3	2404.1	3082.2	11928.5	0	2519.5	9780.9	4668.2	10316.3	0	6202.4	2943.8	6022.8	4841.7	2653	0	6498.2	11027.9	6485.3	Cardiomyocytes
RBM20		ENSG00000203867	RNA binding motif protein 20	Q5T481	10	110644397-110839469	Disease related genes, Predicted intracellular proteins	mRNA processing, mRNA splicing	RNA-binding	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 45.9;skeletal muscle: 20.9	Cell type enriched	Detected in some	8	Cardiomyocytes: 137.1	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 5.7;HEL: 4.8;K-562: 4.6;RH-30: 15.7;SH-SY5Y: 14.6;SuSa: 5.0;T-47d: 8.8	Region enhanced	Detected in some		olfactory region: 4.6	Not detected	Not detected			HPA035806, HPA070358	Approved		Approved	Nucleoplasm,Nucleoli,Golgi apparatus		Yes	No			Nucleoplasm, Nucleoli, Golgi apparatus		HPA035806: AB_10672097, HPA070358: 	unprognostic (2.43e-1)	unprognostic (8.24e-3)	unprognostic (5.81e-2)	unprognostic (1.27e-2)	unprognostic (1.03e-1)	unprognostic (2.03e-2)	unprognostic (2.75e-2)	unprognostic (5.47e-3)	unprognostic (1.33e-1)	unprognostic (2.78e-2)	unprognostic (4.14e-3)	unprognostic (1.44e-1)	unprognostic (2.39e-3)	unprognostic (3.34e-1)	unprognostic (3.35e-2)	unprognostic (1.20e-1)	unprognostic (6.46e-2)	1.7	0.1	0.4	0.6	1.9	0.1	2.2	0.5	1.5	0.9	2.6	1.3	0	0.2	2.5	7.5	3.6	1.9	2.3	45.9	0.6	0.2	1.1	0.1	0.5	0.1	0.3	1.3	2.4	13.7	0.9	1.2	1.4	1.4	1	0.5	4.3	6.3	0.7	20.9	0.7	1	2.1	0.6	0.1	0.6	0.9	1.4	0	0.7	3.4	0.5	1.8	3.2	0.1	0.2	0	0	0	0.5	0	0	1.5	0.5	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0	2.1	0.1	0.1	0	0	2.3	5.7	4.8	0	0	0	0	0.6	0.1	0	0	0	0	0	0	4.6	0	0.2	0	0	0	0.4	0	1.4	0	15.7	0	0	0	0.1	14.6	0.1	0	0.6	5	8.8	0	0	0.3	0.5	0	0	0.4	0.1	0.1	0	0	1	0	0	0	0	0	0.3	0	0	0	0	0.1	0.5	0.2	0	0	0	0.2	0	0	0.4	1.9	0.5	1.5	0.6	0.2	0.3	1.3	1.4	1.4	0	0	0	0.2	0.1	1.3	137.1	0	17.4	0	0	2	1	1.7	0	0.7	0.6	0.4	0	0.2	0.1	0.2	0	0	0	0.1	0	0	1.8	0	0.4	4	0	0	0	0.4	0	0	0	12.7	1.4	2.3	6.5	1.9	0	0.5	0	2.6	0	0	0.1	Cardiomyocytes
MUC19	FLJ35746	ENSG00000205592	Mucin 19, oligomeric		12	40393395-40570832	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	4	salivary gland: 22.6	Cell type enriched	Detected in single	6	Cardiomyocytes: 1.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	U-937: 8.9														Intracellular and membrane								unprognostic (7.80e-3)	unprognostic (2.84e-1)		unprognostic (1.69e-1)	unprognostic (2.53e-1)	unprognostic (4.25e-3)		unprognostic (8.16e-2)	unprognostic (1.27e-1)	unprognostic (5.45e-2)	unprognostic (8.63e-2)	unprognostic (6.99e-2)	unprognostic (8.64e-3)	unprognostic (2.57e-2)	unprognostic (1.60e-1)	unprognostic (2.12e-1)	unprognostic (7.35e-3)	0	0	0	0	0	0.9	0	0	0	0	0			0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		22.6	0	0	0	0	0	0	0	0	5.3			0		0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.6	0	0.1	0	0	0	0	0.3	0	0	0	0	0	0.3	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0.1	0.8	0	0.2	0	0	0	0	0	0	0	0	0	8.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0.2	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
TECRL	DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL	ENSG00000205678	Trans-2,3-enoyl-CoA reductase like	Q5HYJ1	4	64275257-64409468	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins		Oxidoreductase	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	heart muscle: 131.5	Cell type enriched	Detected in single	16229	Cardiomyocytes: 1622.9	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.3	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		OE19: 2.8	Low region specificity	Detected in single			Low region specificity	Detected in many																																	0.2	0.1	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	3.3	0.2	0	0	131.5	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0	0	19.8	0.1	0	0	0	0	0	0.1	0	0	0.2	1	0.1	0	0	0.2	0.2	1.3	0	0	0.3	0	0.9	0.9	0.6	1.1	0.5	0.2	0.3	1.1	0	0.1	0.2	1.1	0.7	0.5	0.3	0.3	0.6	0.5	0.3	0.1	0.4	0.5	0	0.7	1.4	1.4	0.2	1.2	0.6	0.1	0.5	0.2	0.3	1	0.2	0.3	0.7	1.1	0.2	0.2	0.5	0.8	0.7	2.8	0.2	0.5	0.8	0.4	2.5	0.5	0.2	0.6	0.5	0.1	0.1	1.4	0.4	0.5	0.7	1.1	0.8	0.7	0.8	1	0.2	0.7	0.5	0.8	0.6	0.6	0	0.2	0.3	0	0.2	0.1	0.1	0.1	0	0.2	0.2	0.2	1.3	0	0	0.2	0.1	0	0	0	0	0.1	0	0.1	0	0.1	0	0	0	0	0	0	0	0	1622.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
RAB12		ENSG00000206418	RAB12, member RAS oncogene family	Q6IQ22	18	8609445-8639381	Predicted intracellular proteins	Autophagy, Protein transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 96.4	Cell type enriched	Detected in many	4	Cardiomyocytes: 87.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040727	Approved		Approved	Vesicles						Vesicles		HPA040727: AB_10794858	unprognostic (7.92e-2)	unprognostic (4.11e-2)	unprognostic (1.05e-1)	unprognostic (1.72e-2)	unprognostic (1.53e-2)	unprognostic (1.47e-2)	unprognostic (1.25e-2)	unprognostic (2.77e-2)	unprognostic (1.11e-1)	unprognostic (1.29e-3)	unprognostic (2.67e-1)	unprognostic (5.72e-2)	unprognostic (2.02e-1)	unprognostic (1.63e-1)	unprognostic (1.46e-1)	unprognostic (1.61e-1)	unprognostic (9.11e-2)	20	16	18	10.2	18.3	7.2	15.6	23.5	22.1	17.2	16.8	13.8	9.2	7.3	18.5	12.3	17.3	13.4	11.2	45.6	16.2	16.2	18.4	20.7	15.8	12.5	13.7	17.8	19	7.5	10.4	12.7	17.6	15.3	15.3	10.5	13.7	10.1	18.6	96.4	18.1	10.3	25.4	12.2	16.3	10.8	8.3	10.6	7.7	12.1	21.2	11.9	19.4	20.2	3.2	4.1	7.7	5.1	3.9	3.1	1.3	11.6	6.9	8.1	8.5	24.2	20.6	4.5	15.9	21.9	18.2	21.4	9.4	10.8	4	15.5	19	13.6	7.4	9.4	17	22.1	1.6	7.6	3.4	7.4	9.8	22.5	4.5	3.6	20.3	24.1	13.3	17.1	18.8	21.9	3.6	5.2	5.8	17.6	12.6	5.1	4.5	5.2	40.4	6.6	3.6	19.7	3.8	17.7	15.7	13.5	9.6	12.1	16.5	19.9	12	4.8	6.9	18.3	21.1	12.3	21	24.1	3.9	2.2	3.4	15.8	4.2	13.4	7.7	2.2	2.4	2.1	3.6	3	3.2	2.3	2.5	1.8	3	3.1	3	4.1	3.9	5.1	4.1	2.5	1.3	18	18.3	23.5	22.1	16.2	16.2	13.7	17.8	15.3	10.6	11.9	17.1	3.4	1.7	5.8	14.8	87.9	2.5	10.7	13.6	3.5	5.9	1.4	3.3	2	0	7.4	1.6	0	1.2	1.1	5	3.2	5.8	15.3	1.5	11.1	5.2	19.6	13.9	0	3.1	6.9	3.3	2.8	2.8	14.3	2.5	0	4.2	4.9	6.7	0	5.2	1	1.5	7.3	0.9	2.5	2.3	3.5	Cardiomyocytes
SMCO1	C3orf43, DKFZp313B0440, FLJ41923	ENSG00000214097	Single-pass membrane protein with coiled-coil domains 1	Q147U7	3	196506877-196515366	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	22	heart muscle: 48.6;skeletal muscle: 57.8;tongue: 66.9	Cell type enriched	Detected in single	76	Cardiomyocytes: 71.8	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	5	NK-cell: 2.1	Lineage enriched	Detected in single	5	NK-cells: 2.1	Cell line enhanced	Detected in some		MCF7: 1.5;NTERA-2: 1.4;U-251 MG: 1.3	Not detected	Not detected			Low region specificity	Detected in all																unprognostic (4.86e-2)	unprognostic (1.62e-1)		unprognostic (1.51e-2)	unprognostic (6.08e-2)	unprognostic (1.72e-2)		unprognostic (1.73e-1)		unprognostic (3.25e-1)	unprognostic (1.64e-1)	unprognostic (1.94e-2)		unprognostic (2.95e-1)	unprognostic (2.72e-1)	unprognostic (3.07e-2)	unprognostic (2.88e-3)	0	0	0.1	0	0.1	0	0	0.1	0.1	0	0	0	0	0	0	1	1	0	0	48.6	0.1	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0.6	2.1	0	57.8	0	0	0	0	0	0	0.4	0	0	0.6	66.9	2.5	0	0	0	0	0.4	0	2.1	0	0	0.3	0	0.7	0	0	0	0.3	0	0.2	0	0.1	0.3	0.1	0	0.4	0.6	0.9	0.3	0.4	0	0	0.5	0	0	0	0.3	0	0.7	0.1	0	0.2	0.2	0	0.7	0.2	0.4	0.2	0.8	0.2	1.5	0.7	0.1	1.4	0	0	0	0.2	0	0.2	0	0.3	0.3	0.3	0.4	0	0.4	0.1	0	0	0.5	0	0	1.3	0.5	0.5	0.4	0	0.7	0.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.1	0	0	71.8	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.3	0	0	0	0	0	Cardiomyocytes
SCART1	CD163c-alpha	ENSG00000214279	Scavenger receptor family member expressed on T cells 1	Q4G0T1	10	133453928-133523558	Predicted membrane proteins	Immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 5.6	Cell type enriched	Detected in single	6	Cardiomyocytes: 5.6	Not detected	Not detected							Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Group enriched	Detected in some	5	HMC-1: 7.2;NB-4: 6.7;THP-1: 2.2;U-266/84: 7.3					Not detected	Not detected			HPA043101	Supported											HPA043101: AB_10797026	unprognostic (4.32e-2)	unprognostic (2.15e-2)	unprognostic (1.13e-2)	unprognostic (2.40e-2)	unprognostic (7.42e-2)	unprognostic (8.20e-4)	unprognostic (1.29e-3)	unprognostic (4.28e-3)	unprognostic (2.63e-2)	unprognostic (1.68e-1)	unprognostic (2.91e-1)	unprognostic (2.24e-2)	unprognostic (6.24e-5)	unprognostic (8.53e-2)	unprognostic (1.25e-1)	unprognostic (5.03e-2)	unprognostic (1.94e-1)	0.3	0.2	0	0.3	0.5	1.6	0	0.4	4.8	0.1	0.3	0.2	0	1.3	0.9	0	0.4	0	0.9	0	5.6		0.7	0.2	0.3	0	0	0	0	1.2	0	0	0.1	0.3	0.3	0	0.2	0.8	0.4	0.2	0.2	0.7	1.2	0	0.2	0	0.1	0	0	0	1.1	0.2	0.2	0	0.4	0.3	0.8	0.4	0.2	1.2	0	0.4	0.1	0	0	0	0.1	0.2	0.7	0.2	0	0	0	0	0.7	0.1	0.1	0.3	0.1	0.1	0.2	0	0.3	0.4	0.8	0.1	0	0	0.2	7.2	0	0.2	0.3	0	0	0.1	0	0.1	0	0.1	0.3	0.3	6.7	0.2	0.1	0	0.7	0.2	0	0	0	0	0.1	0.1	0	0	0.1	0	2.2	0	0.1	0.4	0	0.4	0.5	7.3	1.1	0	0	0.3	0.8	0.2	0.3	0.3	0.1	1.2	0.3	0.4	0.6	0.1	0.4	0.3	0.4	0.2	0.2	0.4	0.3	0.1	0											0	1	0	0	0	0	5.6	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
PPP1R3G		ENSG00000219607	Protein phosphatase 1 regulatory subunit 3G	B7ZBB8	6	5084581-5089487	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 8.3	Cell type enriched	Detected in some	5	Cardiomyocytes: 16.7	Cancer enhanced	Detected in many		liver cancer: 5.7					Group enriched	Detected in some	4	classical monocyte: 1.7;intermediate monocyte: 1.2;myeloid DC: 2.4;non-classical monocyte: 2.9	Group enriched	Detected in many	6	dendritic cells: 2.4;monocytes: 2.9	Cell line enhanced	Detected in some		EFO-21: 4.9;PC-3: 4.7;THP-1: 16.4;U-266/70: 2.9	Low region specificity	Detected in many			Not detected	Not detected			HPA056393	Uncertain											HPA056393: AB_2683115	unprognostic (1.99e-2)	unprognostic (5.50e-3)	unprognostic (2.10e-1)	unprognostic (5.29e-2)	unprognostic (1.70e-2)	unprognostic (1.38e-1)	unprognostic (6.56e-3)	unprognostic (8.64e-3)	unprognostic (1.81e-2)	unprognostic (2.98e-1)	unprognostic (1.04e-2)	unprognostic (3.71e-1)	unprognostic (7.60e-2)	unprognostic (1.33e-2)	unprognostic (5.56e-2)	unprognostic (3.17e-3)	unprognostic (1.27e-1)	1.9	3.5	3.3	0.6	4	0.1	1	0.1	2.3	2.1	1.7			0.4	1.2	1.9	2	1.1	0.6	8.3	1.8	1.4	0.8	6.4	0.4	0.7	2.4		1.7	0	0	0	1.3		2	0.8		0.4	3	0.9	0.9	0.5	0.9	0.1	5.3	0.5	0.3			0.1		0.5	3.2	2.2	0.3	2.4	0.4	2.9	0.3	0.2	0.5	0	0.3	0.1	0	1.9	1.2	0.1	0.3	0.5	0.3	0.4	0.1	0.3	0	4.9	0.7	0	0	0.1	0	0.7	0	0.1	0.1	0.5	0.5	0.2	0.2	0.1	0.1	0.1	0	0	0.8	0.1	0.1	0.1	0	0	0.2	0	0.9	0.1	0	4.7	0.1	0	0	0.4	0.5	0	0.1	0.6	0	0	0.4	0.1	16.4	0	0	0	1	0.6	2.9	2.3	0.1	0.9	0	0.1	0.4	1.7	0	0	1.2	0	0.3	0.2	0	2.4	0.2	0	0.1	0.3	0.3	2.9	0.1	0	0.5											0	0	0	0.4	0.5	0.7	16.7	0	0	0	3.5	0	0.7	0	0.2	0	1.7	0	0	0	0.3	3.7	0.3	0	0	3.5	0	1.2	0.6	1.9	0	0.9	1.9	0	1.8	0.3	0	0.4	1.9	2.8	1.2	0.1	0	1.4	0	0.2	0.3	0.7	0	0	0.8	Cardiomyocytes
MYBPHL		ENSG00000221986	Myosin binding protein H like	A2RUH7	1	109292365-109307041	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	46	heart muscle: 64.6	Cell type enriched	Detected in some	14	Cardiomyocytes: 139.3	Low cancer specificity	Detected in some			Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 2.4;Daudi: 1.5;Hep G2: 6.7;K-562: 1.7;RH-30: 3.9;THP-1: 1.5	Not detected	Not detected			Low region specificity	Detected in all			HPA077633			Approved	Vesicles						Vesicles		HPA077633: 	unprognostic (6.07e-3)	unprognostic (1.43e-1)	unprognostic (2.78e-1)	unprognostic (1.17e-2)	unprognostic (1.47e-1)	unprognostic (1.37e-1)	unprognostic (1.80e-2)	unprognostic (1.24e-2)	unprognostic (5.53e-2)	unprognostic (5.89e-1)	unprognostic (5.22e-3)	unprognostic (4.10e-1)	unprognostic (7.05e-9)	unprognostic (6.01e-2)	unprognostic (1.53e-1)	unprognostic (5.81e-2)	unprognostic (2.64e-1)	0	0	0.1	0	0.5	0	0	0.1	0.6	0	0	0.6	0	0	0	0.4	0.3	1.3	0	64.6	0.4	0.1	0	0	0.7	0	1.4	0.1	0	0	0	1.2	0	0.4	0	0	0.3	0	0	0.2	0	0	0	0.2	0	0.3	0.4	0.9	0	0	0	0	0.1	0	0	0.2	0	0.8	0	0	0.4	0.1	0	0.3	0	0	0	2.4	0	0	0	0	0.4	0	1.5	0.1	0	0	0	0	0.1	0	0	0.1	0	0	6.7	0	0	0	0.3	0.5	0	0	0	0	0	1.7	0	0.3	0	0	0	0	0	0	0	3.9	0	0	0.1	0.4	0.1	0.2	0.1	0.8	0.5	0	1.5	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0.8	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.4	0.1	0.5	0.1	0.6	0.4	0.1	1.4	0.1	0.4	0.9	0	3.2	0	0.1	0	1.1	139.3	0	0	1.2	0	5.9	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	1	0.2	0	0.7	0	9.8	0	0.3	0.3	0.3	0.1	0	0	0	0.5	Cardiomyocytes
RAB6C	WTH3	ENSG00000222014	RAB6C, member RAS oncogene family	Q9H0N0	2	129979664-129982738	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		parathyroid gland: 17.2	Cell type enriched	Detected in some	9	Cardiomyocytes: 8.7	Cancer enhanced	Detected in some		prostate cancer: 1.1	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	BEWO: 4.5;HMC-1: 4.0;REH: 9.3;T-47d: 5.8;U-266/70: 3.9									HPA059131	Uncertain		Uncertain	Golgi apparatus						Golgi apparatus		HPA059131: AB_2683916	unprognostic (3.84e-2)	unprognostic (5.77e-2)	unprognostic (1.02e-1)	unprognostic (1.07e-1)	unprognostic (2.54e-1)	unprognostic (8.62e-2)	unprognostic (1.83e-1)	unprognostic (1.98e-1)	unprognostic (1.38e-2)	unprognostic (1.50e-2)	unprognostic (1.28e-1)	unprognostic (2.44e-1)	unprognostic (1.33e-1)	unprognostic (4.48e-2)	unprognostic (6.04e-2)	unprognostic (1.24e-1)	unprognostic (4.78e-1)	1.7	3.3	5.1	1.4	6.2	1.1	9.9	1.3	10.3	7.6	2	4	1.3	1.1	3.3	1.4	2.2	1.6	1.5	1.5	7.6	5.3	1.4	3.8	1.2	1.2	5.2	4.9	1.5	4.2	17.2	1.6	2.8	8.6	7	1.3	2.1	2	2.8	1.7	1.2	4.4	1.3	5.3	2.7	1.3	4	1.5	0.8	1.5	0.9	1.3	1.2	1.5	0.2	0.3	0.8	0.5	0.6	0.9	0.3	0	0	0	0	0	0	4.5	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	4	0.1	0	0	0	0	0	0	0	0.1	0	0.7	0	0.1	0	0	0	9.3	0	0.9	0	0	0.1	0.8	0	0.8	0.2	1.1	5.8	0	0	0	0.7	0	0	3.9	0	0	0	0	0	0.8	0	0.4	0.9	0.4	0.3	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.2	0.6	0.5	0.2	0.4	0.3	5.1	6.2	1.3	10.3	7.6	5.3	5.2	4.9	8.6	1.5	0	0	0	0.2	0.7	0	8.7	0	0	0	0	0	0.5	0	0	0	0.4	0	0	0	0.9	0.4	0.7	0	0	0.2	0	0	0	0	0	0.3	0	0	0	0.2	0	0	0	0.7	0	0	0	0	0.5	0.8	1	0.5	0	0	0.3	Cardiomyocytes
MT-ATP8	A6L, ATP8, MTATP8	ENSG00000228253	Mitochondrially encoded ATP synthase membrane subunit 8	P03928	MT	8366-8572	Disease related genes, Predicted membrane proteins	ATP synthesis, Hydrogen ion transport, Ion transport, Transport		Cardiomyopathy, Disease mutation, Primary mitochondrial disease	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 959.7	Cell type enriched	Detected in many	31	Cardiomyocytes: 20663.1	Low cancer specificity	Detected in all							Cell type enhanced	Detected in all		basophil: 352.9	Lineage enriched	Detected in all	4	granulocytes: 352.9	Cell line enhanced	Detected in all		HeLa: 805.0																						unprognostic (1.54e-1)	unprognostic (4.12e-2)	unprognostic (3.95e-2)	unprognostic (2.56e-1)	unprognostic (3.07e-2)	unprognostic (1.17e-1)	prognostic favorable (7.56e-5)	unprognostic (5.17e-2)	unprognostic (6.61e-2)	unprognostic (2.52e-3)	unprognostic (8.26e-2)	unprognostic (1.30e-2)	unprognostic (1.10e-1)	unprognostic (1.31e-1)	unprognostic (2.76e-1)	unprognostic (2.62e-1)	unprognostic (1.63e-2)	257.8	128.5	111.1	33.5	124.1	20.5	31.2	42.1	82.1	14.9	78.9			115.5	23.9	11.6	31.6	14.4	19.9	203.6	108.7	78.8	151.5	165.2	16.9	18.5	88.8		24.3	56.4	22.8	21.1	27.7		44.2	38.7		65.2	25.7	959.7	33.1	91.5	14.2	52	19.3	67.4	26.1			23.2		11.8	19.6	15.4	87.7	58	352.9	78.1	75.9	79.1	24.2	189.4	69.9	228.3	43.4	248.7	39.8	112.1	398.9	23.6	18.1	31.7	81.2	127.3	485.5	99.6	85.8	69.2	326	14	131.5	28.5	214.5	91.1	367.2	805	183.1	45.4	213.8	314.4	85.5	69.8	40.2	34.6	254.6	25.8	193.9	194.4	154	55.5	101.3	125.2	315.4	50.2	106.8	50.5	103.4	111	102.1	133.6	189.5	71.8	129.8	151.3	140.3	147.4	378.1	136.9	449.1	377.2	88.4	195.8	194.6	182.8	104.4	174.8	277.5	87.1	380.3	53.6	352.9	78.1	97.9	49.4	68.6	73.5	87.7	55.9	58.5	47.2	87.3	68.9	79.1	49	75.9	68	58	44	24.2											175.7	127.6	194.5	6.6	10.3	0	20663.1	265	662.5	619.9	12.2	0	0	3.3	11.5	6	7.1	98.6	420.4	26.4	0	6.7	3.9	274.2	625.8	0	0	28	241.2	345.1	31.7	37.7	12.6	11.8	11.8	48.6	0	16.1	47	23.7	20.3	0	38.8	11.3	24.7	22.2	8	0	192.9	46.4	6.2	Cardiomyocytes
SBK3	SgK110	ENSG00000231274	SH3 domain binding kinase family member 3	P0C264	19	55540656-55545543	Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	heart muscle: 24.2	Cell type enriched	Detected in single	25	Cardiomyocytes: 2.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 9.4;CACO-2: 3.3;CAPAN-2: 5.6;NTERA-2: 2.5;RH-30: 4.1	Low region specificity	Detected in many			Not detected	Not detected			HPA078322			Approved	Mitochondria						Mitochondria		HPA078322: AB_2732379	unprognostic (2.15e-1)	unprognostic (1.99e-3)	unprognostic (2.71e-1)	unprognostic (1.39e-3)	unprognostic (7.52e-2)	unprognostic (2.83e-1)	unprognostic (5.47e-5)	unprognostic (4.64e-3)		unprognostic (7.24e-2)	unprognostic (1.65e-1)	unprognostic (3.38e-1)	unprognostic (3.08e-3)	unprognostic (1.21e-2)	unprognostic (4.92e-2)	unprognostic (2.41e-1)	unprognostic (1.79e-1)	2	0	0	0	0	0	0.2	0.1	0	0	0			0.2	0	0	1.7	0	0.1	24.2	0	0	0	0	0.1	0	0		0	0.2	0	0	0		0	0		0.1	0	1.9	0	0	0	0	0	0.2	0			0.1		0	0	0	0	0	0	0	0	0	0	0	9.4	0.8	0	0.1	0	0.2	0.2	0	0.1	0.3	3.3	5.6	0	0.2	0.2	0.2	0	0	0	0	0	0	0	0.9	1.8	0.4	0	0	0.1	0	0	0	0	0	0	2.2	0	0	1	0	0	2.5	0.1	0.6	0.2	4.1	0	0.1	0	0	0	0	0.2	0.1	0.1	0	0	0	0.2	1.3	0.4	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
MTRNR2L4		ENSG00000232196	MT-RNR2-like 4	P0CJ71	16	3370979-3372740	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in many	4	blood: 49.5;skeletal muscle: 52.2	Cell type enriched	Detected in some	24	Cardiomyocytes: 125.1	Not detected	Not detected			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 49.5	Lineage enriched	Detected in all	8	granulocytes: 49.5	Cell line enhanced	Detected in many		AN3-CA: 22.3;HaCaT: 23.3;HeLa: 31.2														Secreted to blood								unprognostic (8.53e-2)	unprognostic (1.10e-1)	unprognostic (1.44e-1)	unprognostic (1.80e-1)	unprognostic (1.05e-1)	unprognostic (3.66e-3)	unprognostic (1.58e-1)	unprognostic (1.37e-2)	unprognostic (2.26e-1)	unprognostic (1.71e-1)	unprognostic (6.81e-3)	unprognostic (1.65e-1)	unprognostic (2.79e-1)	unprognostic (1.19e-1)	unprognostic (9.27e-2)	unprognostic (1.90e-1)	unprognostic (1.65e-1)	2.5	10.3	3.5	1.3	4.4	0.9	1.2	2.7	6.6	1.5	2.2	0.5	0.3	3.4	1.6	0.9	1.5	2	1.7	11.7	2.3	1.2	5.8	2.5	1	0.3	6.3	4.8	5.8	9.7	0	3.1	1	2.5	1.7	1.1	1.2	2.7	3.3	52.2	1.2	3.6	2.1	1.5	1.1	3.1	2.3	3.1	0.3	2.6	1.1	0.8	1.5	1.3	5.4	3.8	49.5	6.4	2.5	2.5	5	6	4	1.2	22.3	0.5	0.7	6.9	3.3	0.1	0.4	0.3	1.8	13.1	4.5	6.7	0.2	0.1	23.3	0	0.2	0.2	3.4	2.2	4	31.2	16.2	0.1	1.3	10.9	0.4	0.3	0.1	0.2	0.5	0	0.5	3	6.3	0.7	1.3	2.8	10.5	1.8	0.2	0.8	5.2	3.2	4.1	0.9	4.6	2.7	6	2.1	5.3	8	0.4	7.4	10.1	2.9	7.2	6.4	8.3	2.3	3.3	1.1	4.2	4.9	10.3	1.6	12.1	6.4	19.1	1.4	3.7	1.7	4.2	1.9	1.9	3.1	5.4	2.1	2.5	49.5	2.5	3.6	3.8	2.1	5	3.5	4.4	2.7	5.5	2.3	1.2	6.3	4.8	2.5	3.1	0	0	0	2.4	0.1	0	125.1	5.1	0	0	1.8	0	0.1	3.3	0	0	0	0	0	0.2	0	0.2	1.6	0	0	0.1	0	0	0	0.3	0	0	0	1.7	0	0	0	0	0	0.4	0.3	0	0	1.7	0.5	0.2	0.3	0.1	0	0	1.4	Cardiomyocytes
UQCRHL		ENSG00000233954	Ubiquinol-cytochrome c reductase hinge protein like	A0A096LP55	1	15807169-15809348	Predicted intracellular proteins	Electron transport, Respiratory chain, Transport			Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	No human protein/transcript evidence		Group enriched	Detected in some	5	blood: 5.5;bone marrow: 2.2;epididymis: 1.6;skeletal muscle: 4.4;skin 1: 2.1	Cell type enriched	Detected in many	7	Cardiomyocytes: 418.0	Low cancer specificity	Detected in all							Cell type enhanced	Detected in many		neutrophil: 5.5	Low lineage specificity	Detected in all			Low cell line specificity	Detected in many											HPA042574	Approved											HPA042574: AB_10960998	unprognostic (8.91e-2)	unprognostic (1.05e-1)	unprognostic (1.81e-1)	unprognostic (3.70e-2)	unprognostic (3.19e-2)	unprognostic (7.10e-2)	unprognostic (4.01e-3)	unprognostic (4.83e-1)	unprognostic (6.76e-2)	unprognostic (6.46e-2)	unprognostic (4.60e-1)	unprognostic (9.67e-3)	unprognostic (9.76e-3)	unprognostic (2.71e-3)	unprognostic (1.16e-1)	unprognostic (9.70e-3)	unprognostic (1.02e-1)	0	0.1		0.2		2.2	0.4		0.4	0	0			0.2	0.4	1.6	0.1	0.4	0.4	0.1			0	0.4	0.2	0.2			0.5	0	0		0		0.1	0.1		0.5	0	4.4	2.1	0.4	0.1		0.6	0	0.5			0.2		0	0		1.5	1.2	5.5	1	1.3	1	0.5	0.7	0.5	3.2	3.3	0.8	0.9	1.2	0.6	0.3	0.1	0.3	0.7	2.5	1.2	0.9	0.5	0.9	1.3	0.6	0.5	0.7	2.2	0.4	1.1	1.9	0.5	0.7	0.9	1.5	0.6	1	0.4	0.3	1.2	0	1.6	1.1	2.4	0.2	1.9	0.4	1.5	1.6	0.4	1.3	1.1	0.7	1.1	0	1.7	2.7	1.8	1	2.1	0.8	0.7	0.9	2.7	0.5	2	1.1	1.2	0.8	2.3	0.9	1.3	1	2.1	0.9	3.6	1	0.9	0.8	0.7	0.6	1.1	0.6	0.8	0.6	1.5	1	1	5.5	1.3	0.7	1.2	0.5	0.5											0	0.6	37.2	21.8	0	3.8	418	28.1	0	1.2	8.7	5.9	20.5	19.9	1	2.4	12.3	7.7	0	0.6	18	10.8	25.1	2.3	21.7	18.5	1.6	7	17.8	58.5	2.7	10.3	0.8	0	0	14.1	3	0.7	0	11.7	6.1	7.3	6.5	1	3.2	14.6	0	19.7	4.5	17.7	24.4	Cardiomyocytes
KLHL41	KBTBD10, Krp1, SARCOSIN	ENSG00000239474	Kelch like family member 41	O60662	2	169509702-169526262	Disease related genes, Plasma proteins, Predicted intracellular proteins			Disease mutation, Nemaline myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	20	skeletal muscle: 564.4;tongue: 157.3	Cell type enriched	Detected in some	12	Cardiomyocytes: 97.4	Group enriched	Detected in some	9	head and neck cancer: 10.8;prostate cancer: 3.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	9	HSkMC: 12.8;LHCN-M2: 20.3;RH-30: 32.6	Not detected	Not detected			Low region specificity	Detected in single			HPA021165, HPA021753, HPA021760	Enhanced		Supported	Nucleoplasm,Plasma membrane,Cytosol						Cytosol	Nucleoplasm, Plasma membrane	HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091	unprognostic (2.44e-2)	unprognostic (6.12e-2)	unprognostic (9.01e-2)	unprognostic (2.94e-2)	unprognostic (2.90e-1)	unprognostic (1.36e-3)	unprognostic (2.05e-1)	unprognostic (5.46e-3)	unprognostic (1.88e-1)	unprognostic (5.38e-2)	unprognostic (6.65e-4)	unprognostic (9.64e-2)	unprognostic (1.50e-1)	unprognostic (1.69e-3)	unprognostic (1.19e-1)	unprognostic (1.12e-2)	unprognostic (1.52e-1)	12	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0	0	0.1	0.1	17.8	9.8	0.2	0.6	10.2	0.2	0.3	0.1	0.1	0.2	0.1	0.2	0	0.2	0.2	0.1	0.5	0.1	0	3.9	0.1	0	6.6	0.1	564.4	0.2	0.1	2.3	0.2	0.1	0.2	0.5	0	0	2	157.3	5	2.1	0.1	0.2	0.5	0	0.2	0	0.8	0	0	0.1	0	0.3	0.2	1.6	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	2.5	0	0	0	0.1	0.1	0	12.8	0.2	0.1	0	0.1	0	0.1	0	0	20.3	0	0	0	0	0	0.1	0	32.6	0	0.1	0	0.4	0	0	0	0.8	0	0	0	0	0.2	0.1	0.2	0	0	0.1	0	0	0	0	0	0	0	0.5	0.2	0	0.2	0.1	0	0	0	0.8	0.3	0	0	0	0.5	0	0	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0	0	0	0	0.3	0	0.2	0.1	2.2	97.4	0	4	3.4	0	7.9	0	0	0.4	3.7	0	0	0	0.5	0	0.3	0.4	0	0	0.2	0	1.2	0.6	0	2.1	0.9	0	0	0	0	0.7	0.7	0	1.1	0.2	5.7	0	0.6	3.3	0.5	0	0	0	0	0	Cardiomyocytes
MTRNR2L5		ENSG00000249860	MT-RNR2-like 5	P0CJ72	10	55599303-55600041	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		seminal vesicle: 7.0;skeletal muscle: 16.4;tongue: 6.6	Cell type enriched	Detected in single	42	Cardiomyocytes: 23.8	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in some		neutrophil: 1.8	Lineage enriched	Detected in single	4	granulocytes: 1.8	Cell line enhanced	Detected in some		HeLa: 1.7;Hep G2: 2.5;HL-60: 1.0														Secreted - unknown location																	unprognostic (2.11e-2)				unprognostic (1.20e-1)				0.4	1.8	1.5	1.2	2.5	0.2	0.4	0.4	2.3	0.4	0.6	0.4	0	0.5	0.4	1.3	0.4	0.4	0.6	0.5	1	0.5	0.9	0.4	0.4	0.3	1.4	0.6	0.4	0.7	0.1	0.8	0.1	0.6	0.4	0.3	0	4.7	7	16.4	0.4	0.8	0.5	0.4	0.4	0.5	0.5	0.9	0	0.4	6.6	0.3	1	0.4	0.2	0.1	1.8	0.4	0.1	0.1	0.1	0.3	0	0.3	0.3	0	0	0.5	0.6	0	0	0	0	0	0.3	0.4	0	0	0.8	0	0	0	0	0	0.7	1.7	2.5	0	1	0.4	0	0	0	0.8	0	0	0	0.7	0	0	0	0	0.7	0	0	0	0.2	0.3	0	0	0.5	0	0	0	0	0.2	0	0	0	0	0.8	0.4	0.4	0	0	0	0.2	0	0.5	0	1	0.4	0.2	0.1	0.1	0	0.1	0	0	0.1	0.2	0.1	0.1	1.8	0.1	0.1	0.1	0	0.1	1.5	2.5	0.4	2.3	1	0.5	1.4	0.6	0.6	0.9	0	0	0	0.1	0.6	0	23.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0	0	0	0	Cardiomyocytes
MTRNR2L8		ENSG00000255823	MT-RNR2-like 8	P0CJ75	11	10507887-10509189	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in all		blood: 329.5;skeletal muscle: 107.4	Cell type enriched	Detected in many	28	Cardiomyocytes: 28256.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in all	4	basophil: 89.7;eosinophil: 97.5;neutrophil: 329.5	Lineage enriched	Detected in all	8	granulocytes: 329.5	Cell line enhanced	Detected in many		HeLa: 192.6;Hep G2: 140.8														Secreted to blood								unprognostic (6.19e-2)	unprognostic (1.43e-1)	unprognostic (6.66e-2)	unprognostic (3.26e-2)	unprognostic (3.71e-2)	unprognostic (3.52e-2)	unprognostic (2.81e-2)	unprognostic (3.45e-2)	unprognostic (5.28e-2)	unprognostic (1.41e-1)	unprognostic (4.87e-2)	unprognostic (1.90e-1)	unprognostic (4.59e-2)	unprognostic (4.59e-2)	unprognostic (3.45e-2)	unprognostic (1.12e-1)	unprognostic (1.96e-2)	35.7	33.4	22.5	4.2	22.8	6.6	4.3	7.3	17.5	6.5	15.6	3.6	19.3	10.2	3.8	6.1	12.7	4.6	14.1	73.2	20.1	14.7	30.7	21.7	6.3	4	22	7.3	7	10.9	1.9	6.9	7	9	7.7	15.5	3.3	12.3	14.8	107.4	12	12.9	8.8	16.1	9.7	10.2	28.4	6.5	2.2	4.4	32.3	4.3	10	5.8	35.3	24.5	329.5	42.7	16.6	19	36.2	30.8	55.6	21.8	97.9	21.9	12	30.1	29.2	4.3	4.1	5.2	33.8	47.5	43.4	34.3	6.3	3.2	87.4	0.6	6.6	4.4	18.4	48.1	40.4	192.6	140.8	8.5	7.4	39	21.3	10.4	3.3	10	43.4	4	24.4	34.1	22.6	12.6	19.7	11.3	55.8	7.2	14.6	15.5	19.5	18.7	20.8	24.9	31.3	12.3	28	14.6	21.4	44.5	21.4	25.1	56.1	26.1	28.8	25.6	30.4	11.4	12.7	6	23	18.9	66.2	6.9	89.7	42.7	97.5	11.6	21	14.3	33.7	14.8	13	16.3	35.3	19	17.5	329.5	16.6	20.1	24.5	14.9	36.2	22.5	22.8	7.3	16.7	20.1	14.7	22	7.3	9	6.5	771.2	760.8	62	993.3	419	0	28256.5	137.6	867.3	881.5	54.1	0	5.8	61.3	0	12.2	397.4	0	140.2	0	5	628.6	627.3	501.1	277.9	11	0	0	103.2	108.7	41.9	60.7	803.5	686.7	0	0.3	0	0.1	0	42.1	73.2	0	64.7	701.4	22.4	27.9	427.3	9.4	68.2	0.6	948	Cardiomyocytes
MTRNR2L10		ENSG00000256045	MT-RNR2-like 10	P0CJ77	X	55181391-55182920	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		blood: 60.2	Cell type enriched	Detected in many	21	Cardiomyocytes: 8067.8	Low cancer specificity	Detected in single			Low region specificity	Detected in many			Group enriched	Detected in all	5	basophil: 16.9;eosinophil: 19.1;neutrophil: 60.2	Lineage enriched	Detected in all	9	granulocytes: 60.2	Group enriched	Detected in many	4	A549: 22.8;HeLa: 83.8;Hep G2: 71.6														Secreted to blood								unprognostic (4.42e-1)	unprognostic (3.04e-2)	unprognostic (1.15e-1)	unprognostic (5.10e-4)	unprognostic (1.59e-1)	unprognostic (1.27e-1)	unprognostic (1.71e-2)	unprognostic (8.42e-2)	unprognostic (1.58e-2)	unprognostic (9.01e-2)	unprognostic (5.26e-2)	unprognostic (1.22e-1)	unprognostic (3.01e-1)	unprognostic (6.28e-2)	unprognostic (2.97e-2)	unprognostic (4.99e-2)	unprognostic (3.97e-4)	4.2	3.8	3.2	0.6	4.6	0	1	1.3	4.4	1.2	4.5	1.2	0.6	0.6	1	4.7	2.2	1.5	1.5	19.8	4.1	2.2	14.3	8.5	2	5.1	2.6	0.6	1.2	2.4	0	2.5	1	2.7	1.1	8.4	0.6	3	0.6	16.9	1.1	1	2.6	2.1	1	1.1	3.7	1	0.6	1	1.6	1.7	1	1	6.1	3.9	60.2	6.9	3.5	3.4	7.4	1.3	22.8	0.3	6.5	0.5	0.3	1.6	2	0.1	0.1	0	1.4	3.3	3.1	0.4	0.1	0.2	4.8	0	0.1	0	0.9	4.7	1.5	83.8	71.6	0.1	0.5	0.8	0.8	0.3	0	0.2	5.6	0	2.4	2.7	1.8	0.2	8.4	0.4	3.6	0.1	0.1	1.8	1.2	1.3	1.4	0.5	13.9	0.3	1.3	0.6	0.5	2.2	3.2	1.9	2.7	3.3	2.4	0.5	0.8	0.2	0.6	0.3	0.2	1.5	0.6	0.5	16.9	6.9	19.1	1.5	3.8	1.8	5.8	2.4	2	3.2	6.1	3.1	3.4	60.2	3.5	3.5	3.9	2.4	7.4	3.2	4.6	1.3	4.4	4.1	2.2	2.6	0.6	2.7	1	0	0	8	376.7	7.2	0	8067.8	0	0	0	40.1	0	0.2	71.3	0	0.2	2.2	0	0	0	0.2	13.1	232.2	0	4.9	0.5	0	0	1.8	3.2	0.4	0.6	10.6	15.1	0	0	0	0	0	1.1	4.3	0	0	22.6	0.5	0.7	8	0.2	0	0	338.2	Cardiomyocytes
MTRNR2L3		ENSG00000256222	MT-RNR2-like 3	P0CJ70	20	57358442-57359980	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		skeletal muscle: 13.3	Cell type enriched	Detected in many	94	Cardiomyocytes: 2712.0	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in some		neutrophil: 3.7	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HeLa: 5.0;Hep G2: 1.6														Secreted - unknown location								unprognostic (1.55e-4)	unprognostic (2.65e-1)	unprognostic (2.59e-1)	unprognostic (8.34e-2)	unprognostic (2.64e-1)	unprognostic (1.80e-2)	unprognostic (9.44e-6)	unprognostic (2.56e-1)	unprognostic (6.68e-2)	unprognostic (5.35e-3)	unprognostic (1.52e-3)	unprognostic (7.52e-2)	unprognostic (5.36e-2)	unprognostic (4.37e-2)	unprognostic (2.44e-1)	unprognostic (1.18e-1)	unprognostic (2.94e-3)	0.8	1	2.9	0.3	2.4	2.4	0.5	1	3.6	0.7	0.9	0	2.5	0.6	0.5	1.4	0.7	0.5	1	1.3	2.5	0.7	1.2	1.1	0.4	0.5	2.1	2.7	0.8	1.2	0.2	0.5	0.3	2.4	0.5	0.9	0	2.4	1.1	13.3	1.1	0.5	0.5	1.7	0.4	0.9	1.2	2.7	0	0.6	0	0.3	0.3	0.6	1	0.8	3.7	0.7	0.1	1.3	0.4	0.3	0	0.2	0.9	0	0	0.1	0.3	0.1	0	0	0.2	0.3	0	0.1	0.2	0.2	0.4	0	0	0	0	0	0.2	5	1.6	0	0	0.3	0	0.3	0	0	0.5	0	0.6	0.1	0.2	0.1	0.5	0.3	0.6	0.2	0	0.2	0.4	0.1	0.2	0	0.1	0.4	0.1	0.2	0.2	0.6	0.2	0.3	0.5	0	0.4	0.1	0.1	0.1	0	0.1	0	0.1	0.3	0.1	0.7	0.7	1.1	0.8	0.2	0.6	0.4	0.5	0.5	0.8	1	1.3	0.5	3.7	0.1	0.6	0.2	0.7	0.4	2.9	2.4	1	3.6	2.5	0.7	2.1	2.7	2.4	2.7	0	0	0.9	28.7	2.9	0	2712	2.5	0	0	0	0	0.4	1.7	0	0	1.3	0	0	0	0.3	5.1	15	0	2.4	0.6	0	0	1.8	1.6	0.4	1.4	0.4	6.8	0	0	0	0	0	0.4	1.4	0	0	8.5	0.2	0.8	2.8	0.5	0	0	16.2	Cardiomyocytes
MTRNR2L1		ENSG00000256618	MT-RNR2-like 1	P0CJ68	17	22523111-22524663	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in all	4	blood: 249.5	Cell type enriched	Detected in many	13	Cardiomyocytes: 14115.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 249.5	Lineage enriched	Detected in all	7	granulocytes: 249.5	Cell line enhanced	Detected in all		HeLa: 188.9;Hep G2: 129.8														Secreted to blood								unprognostic (2.31e-2)	unprognostic (1.50e-1)	unprognostic (1.08e-1)	unprognostic (4.41e-3)	unprognostic (2.99e-2)	unprognostic (9.82e-3)	prognostic favorable (8.99e-4)	unprognostic (2.14e-1)	unprognostic (2.59e-2)	unprognostic (1.48e-2)	unprognostic (2.42e-2)	unprognostic (1.63e-2)	unprognostic (2.56e-2)	unprognostic (3.35e-2)	unprognostic (1.64e-1)	unprognostic (1.49e-2)	unprognostic (5.21e-3)	9.4	16.2	7.9	3.7	10	2.3	3	4	8.4	2.5	8.9	3.3	4.8	4.5	2.6	6.8	4.8	2.6	3.3	34.3	8.1	6.1	17.8	12.8	4.2	5.6	8.9	3	4.1	15	1.5	3.4	2.5	4.6	3.5	7.7	3.3	5.9	5	55.5	5.3	5.2	7.5	5.9	3.3	5.6	4.4	4	1.8	2.7	6.8	1.8	3.3	2.6	29.4	21.6	249.5	34.3	15	18.3	28.7	20.6	48.2	18.6	62.5	29.5	12.2	23.6	19.5	4.6	4.5	5.3	29.6	33.5	28.1	21.3	10	3.2	55	1.4	7	5.6	16.5	34.6	25.7	188.9	129.8	9.6	6	31	27.3	15.1	5	12.2	32.8	4.8	18.4	20.8	17.2	13.4	16.7	9.3	41.3	5.3	16.1	10.8	15.3	11.8	14.6	25.7	29.5	9.9	17.6	9.4	17.9	28.7	18.7	16.8	43	9.3	24.9	21	29.6	12	16	5.1	13.3	14.2	38	5.4	74.4	34.3	62.1	10.9	16.7	13.5	28.7	13.9	11.8	12.1	29.4	18.3	15.9	249.5	15	16.1	21.6	12.1	28.7	7.9	10	4	6.8	8.1	6.1	8.9	3	4.6	4	122.1	126.9	16.9	1081.8	75	0	14115	2.5	184.7	263.9	73.3	0	0.7	94.5	0.5	4.6	52.2	1.1	0	0.6	0.6	57.9	106.8	153.5	10.2	0.7	0	1.7	4.9	6.9	6.9	14.4	92.3	59.1	0	1.3	0	0.2	1.4	3.9	12.2	0	0	31.1	6.6	18.6	149.7	0.8	7.5	1.2	234.3	Cardiomyocytes
MTRNR2L7		ENSG00000256892	MT-RNR2-like 7	P0CJ74	10	37601440-37602974	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		blood: 2.1;heart muscle: 1.6;skeletal muscle: 1.9	Cell type enriched	Detected in single	277	Cardiomyocytes: 171.5	Not detected	Not detected							Cell type enhanced	Detected in some		neutrophil: 2.1	Lineage enriched	Detected in single	7	granulocytes: 2.1	Cell line enhanced	Detected in some		HeLa: 3.2;Hep G2: 1.6														Secreted - unknown location																	unprognostic (2.28e-1)				unprognostic (5.87e-2)				0.3	0.6	0.1	0	0.1	0.2	0.1	0.1	0.4	0.1	0.3			0	0.1	0.2	0.1	0.1	0	1.6	0.1	0.1	0.9	0.4	0.1	0	0.1		0.1	0.1	0	0.3	0		0.1	0.5		0.1	0	1.9	0.1	0.1	0	0.1	0.1	0.2	0.2			0.1		0	0.1	0.1	0.3	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0	0.2	0.4	0.3	0	0.3	0.2	0	0.1	0	0.7	0	0.6	0.1	0.2	0	0.5	0	0	0	0	0	0.9	3.2	1.6	0	0	0.3	0.3	0	0	0	0.1	0	0	0.2	0.2	0	0.2	0.1	0.7	0	0.5	0	0.1	0.3	0.5	0.4	0.3	0	0.2	0.8	0.1	0.1	0	0.1	0.3	0	0.1	0.1	0.1	0	0	0.2	0.2	0.1	0.8	0	1.2	0.2	0.6	0	0.1	0.1	0.3	0.1	0.1	0	0.3	0.2	0.2	2.1	0.2	0.1	0.2	0.1	0.2											0	0	0	0.6	0.1	0	171.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.6	Cardiomyocytes
MYZAP	GCOM1, Gup, Gup1, MYOZAP	ENSG00000263155	Myocardial zonula adherens protein	P0CAP1	15	57591941-57685364	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 132.6;smooth muscle: 52.2	Cell type enriched	Detected in many	16	Cardiomyocytes: 451.1	Low cancer specificity	Detected in many			Group enriched	Detected in many	5	cerebellum: 6.9;pons and medulla: 6.1	Cell type enhanced	Detected in some		naive B-cell: 6.7;naive CD4 T-cell: 3.6	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HEL: 52.3;hTERT-HME1: 9.6;HUVEC TERT2: 11.5;OE19: 18.4;RT4: 10.1;TIME: 12.3					Not detected	Not detected			HPA039827	Approved											HPA039827: AB_10673364	unprognostic (1.30e-2)	unprognostic (1.25e-1)	unprognostic (2.44e-1)	unprognostic (1.66e-1)	unprognostic (9.26e-3)	unprognostic (1.49e-1)	unprognostic (6.10e-3)	unprognostic (5.19e-2)	unprognostic (8.92e-2)	unprognostic (2.30e-2)	unprognostic (1.26e-1)	unprognostic (9.67e-2)	unprognostic (1.44e-1)	unprognostic (1.12e-1)	unprognostic (1.07e-1)	unprognostic (3.86e-2)	unprognostic (1.77e-2)	11.8	12.3	0.6	1.4	1.2	0.5	13	6.9	1	5.5	5.6	0.6	3.3	3.3	6.1	1.9	12.6	1.1	3.2	132.6	0.6	0.9	1.4	0.4	9.8	2.1	0.9	0.5	1.5	7.4	0	1	11.7	6.1	13	2.4	0	6.1	8.4	3.3	2.2	9.1	52.2	0.5	2.4	4.9	1.6	0.2	0.4	1	6.6	6.4	31.4	12.1	6.7	0.1	1	1.3	0	3.6	5	2.3	0.7	0	4.2	1	0	1.2	0.3	3.5	0.5	0.7	2.9	1.6	0	0.2	0	3.5	0.9	0	1.6	0.7	0	0.1	52.3	0.6	0	0.1	0	0	0	1.3	0.1	9.6	0	11.5	0	0.7	0	0.3	0.8	0	0	0	18.4	1	0	4.4	0.1	0	10.1	0	1.5	0.2	2.4	0	0.5	3.1	0	12.3	0	1	0.1	0	0	0	0	0.7	0	0	0	0.2	0	0	1	0	0.7	0.6	0	0.1	6.7	3.6	0	1	0	1.3	0	0.3	5	0.6	1.2	6.9	1	0.6	0.9	0.9	0.5	6.1	0.2	8.9	1.1	0	8.9	0	0.1	451.1	7.6	1.4	1.2	24.4	0	3.6	6.6	28.1	0.1	3.6	13.7	0	16.8	2.3	0	6	0	0	1.3	0	1.7	4.9	5.9	0.4	4.4	0	0	5.4	6.1	0.1	17.9	21	15.9	0	0	0	0.9	0	0.9	0	1	0	6	4.9	Cardiomyocytes
PPIAL4C		ENSG00000263464	Peptidylprolyl isomerase A like 4C	A0A0B4J2A2	1	149583865-149584464	Enzymes, Predicted intracellular proteins		Isomerase, Rotamase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		blood: 10.9;intestine: 5.5	Cell type enriched	Detected in single	16	Cardiomyocytes: 1.6	Not detected	Not detected							Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		NB-4: 14.4;THP-1: 16.9									HPA058345	Uncertain											HPA058345: AB_2683685	unprognostic (3.16e-1)	unprognostic (2.83e-2)			unprognostic (1.50e-2)	unprognostic (7.93e-2)		unprognostic (5.98e-2)	unprognostic (1.37e-1)	unprognostic (1.79e-1)				unprognostic (6.61e-2)			unprognostic (2.25e-1)	0	3.3		2.7		0.1	0		1.5	0	0.8			5.5	0.8	0	0	0	0	0			1	0	1	2.9			0.2	0	0.9		0.7		0.3	0		0	0	0.2	0.5	2.9	0		1.4	0.9	0			0		0.3	0		9.1	9.7	1.9	6	4.6	7.8	10.9	3.6	0.3	0.4	3.1	0.1	0.3	2	0.6	0.4	1	0.7	0	4.8	1.3	2.1	0	2.5	3.9	0	0.2	0.6	3.5	0	0.5	0	0	0.1	2	1.9	0.1	0.5	0.6	0.3	0	0	0.5	0.9	5.4	0.7	0.4	5.3	14.4	6.2	1	0.1	5.3	0	9	0.2	0	4	5.5	1.1	11.3	6.2	0.3	5.3	16.9	1.3	3.6	5.6	3.3	8.2	4.2	5.6	9.2	3.9	4.6	7.8	0.9	4.3	1.9	5.4	6	6	9.1	6.1	5.7	9.4	7.2	5	5.9	0	4.6	5.3	9.7	7.8	10.9											0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
MYH4	MYH2B, MyHC-2B, MyHC-IIb	ENSG00000264424	Myosin heavy chain 4	Q9Y623	17	10443290-10469559	Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	29	skeletal muscle: 15.1	Cell type enriched	Detected in single	25	Cardiomyocytes: 2.5	Cancer enriched	Detected in single	115	liver cancer: 9.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	25	OE19: 14.2	Not detected	Not detected			Not detected	Not detected			HPA001349	Supported								34000000			HPA001349: AB_1079437	unprognostic (3.27e-2)		unprognostic (2.94e-2)			unprognostic (4.94e-2)	unprognostic (1.69e-2)	unprognostic (4.72e-1)			unprognostic (1.37e-1)		unprognostic (3.32e-2)	unprognostic (1.21e-3)	unprognostic (3.52e-4)		unprognostic (9.97e-2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
PTGES3L		ENSG00000267060	Prostaglandin E synthase 3 like		17	42968088-42980433	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		heart muscle: 18.3;skeletal muscle: 61.3	Cell type enriched	Detected in some	5	Cardiomyocytes: 41.4	Low cancer specificity	Detected in some			Region enhanced	Detected in some		basal ganglia: 4.2	Cell type enriched	Detected in some	7	plasmacytoid DC: 8.9	Lineage enriched	Detected in many	7	dendritic cells: 8.9	Cell line enhanced	Detected in many		HMC-1: 8.9;RH-30: 8.7;THP-1: 22.7	Low region specificity	Detected in many			Low region specificity	Detected in all																unprognostic (1.83e-1)	unprognostic (1.64e-1)	unprognostic (9.77e-2)	unprognostic (6.61e-2)	unprognostic (7.45e-2)	unprognostic (4.66e-2)	unprognostic (2.36e-2)	unprognostic (1.31e-2)	unprognostic (1.24e-1)	unprognostic (6.23e-2)	unprognostic (2.80e-4)	unprognostic (9.24e-2)	unprognostic (3.03e-2)	unprognostic (1.40e-1)	unprognostic (3.10e-1)	unprognostic (6.25e-2)	unprognostic (4.08e-2)	0.5	0.2	0.7	0.8	4.2	1.1	0.5	0.3	1.2	1.3	5.1	0.2	0	0.6	3.5	2.2	2.2	1.1	3.3	18.3	0.5	0.7	0.2	0.1	0.4	0.5	0.6	0.7	0.6	0.2	0.2	0.4	0.2	0.3	1.8	1.5	1.5	1	2.2	61.3	0.5	1.2	10	0.2	0.3	1.7	0.6	0.1	0.4	0.4	13.6	0.6	4.7	1.3	0.7	8.9	1.3	0.3	0.6	0.3	0.8	0.7	0.6	1.9	3.6	0.1	0.3	1.6	1.3	0.8	1.1	0.6	1.5	0.7	0.6	0.5	0.5	1.1	1.4	1.5	1.4	1.7	0.5	0.6	5.2	3	3.1	0.1	0.8	8.9	0.7	1	2.4	1.7	0.7	0.3	3.3	1.8	1.6	3.4	1	3.2	2	2.1	2.8	0.5	1.3	8.7	0.7	2.1	1.4	1.7	5.9	1.6	3.2	2.6	2.1	1.7	22.7	0.7	1.9	1.8	0.6	1.2	3.9	2.5	0.9	0.3	0.9	0.7	1.3	0.3	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0.3	0.7	0.3	0.3	1.2	0.6	0.2	8.9	0.2	0.8	0.7	4.2	0.3	1.2	0.5	0.7	0.6	0.7	0.3	0.1	0	0	0.5	0.6	0	0.9	41.4	0	1.4	0	0	7.9	0.1	0	1.4	8.6	0.1	0.9	0	0.2	0.5	0.2	0.6	0	0	1	0	1.7	1.3	0	3.3	0.6	0.2	0	2.8	0.6	0.7	0.7	2.9	0.4	0.3	2.5	0	4.2	5.2	4.1	0	0.1	0	1	0.3	Cardiomyocytes
HSFX2		ENSG00000268738	Heat shock transcription factor family, X-linked 2	Q9UBD0	X	149592515-149594716	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	5	testis: 9.3	Cell type enriched	Detected in single	11	Cardiomyocytes: 1.1	Not detected	Not detected							Cell type enhanced	Detected in some		basophil: 1.7;naive CD4 T-cell: 1.8	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HaCaT: 2.7;hTCEpi: 3.4									HPA063040	Supported											HPA063040: AB_2732695					unprognostic (7.64e-2)					unprognostic (6.92e-3)				unprognostic (2.00e-1)				0	0		0		0	0.3		0.1	0	0			0	0	0	0	0.7	0	0			0	0.1	0.3	0.1			0.2	0	0.5		0.1		0.1	0.3		0.6	1.3	0.1	0.5	0	0.1		0	0	9.3			0		0	0.1		0.2	0.5	1.7	0.2	0.2	1.8	0.3	0.6	0	1.9	0.3	0	1.1	0.2	1	0.9	1.2	0.1	1.6	0	0.4	0	0	0	2.7	0	0.9	0.8	0	0.9	0.8	0	0.2	0.2	0.2	0.8	1.6	3.4	1.2	0	0.4	0	1	0	0	0	1	0.2	2.5	0.9	0.5	1.3	0.1	0	0.4	1.4	0.8	0	0.4	0	0.5	1.1	0.9	0.3	0.9	1.4	2.4	0	0.1	0	0.2	0	0.3	0.6	0.5	0.5	1.7	0.2	0	0.5	0	0	0	0.2	0	0.2	0.2	1.8	0.1	1.1	0.2	0.2	0.5	0	0.3											0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
MTRNR2L12		ENSG00000269028	MT-RNR2-like 12	P0DMP1	3	96617188-96618236	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in all	5	blood: 603.3	Cell type enriched	Detected in many	12	Cardiomyocytes: 31937.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 603.3	Lineage enriched	Detected in all	7	granulocytes: 603.3	Cell line enhanced	Detected in all		HeLa: 496.6														Secreted to blood								unprognostic (3.79e-2)	unprognostic (1.05e-1)	unprognostic (1.88e-2)	unprognostic (1.37e-1)	unprognostic (1.09e-1)	unprognostic (9.76e-3)	unprognostic (1.69e-3)	unprognostic (1.81e-2)	unprognostic (7.77e-2)	unprognostic (3.55e-2)	unprognostic (2.08e-2)	unprognostic (4.90e-2)	unprognostic (9.59e-3)	unprognostic (1.81e-2)	unprognostic (2.61e-1)	unprognostic (2.08e-1)	unprognostic (1.85e-2)	18	29.1	32.5	5.2	31	4.5	7.5	8.8	19.2	5.1	20.2	6.4	5.7	8.1	5.1	75.3	10.9	3.8	40.2	114.2	26.3	19.8	32.9	29.8	5.4	7.8	26.2	7.5	4.9	9.7	4.3	6.6	5	10.4	6.9	16.5	6.8	10.8	9.3	101.3	10.6	9.3	6.9	15.3	5.3	13.3	9.7	8.7	72.1	5.1	11	5.3	6	8.5	69.1	53.1	603.3	81.8	37.9	45.5	57.6	99.3	122.4	91.7	329	142.5	76.9	84.3	129.6	26.5	25	32.3	67.2	160.7	219.2	105.6	48.9	14.5	274.9	6.4	54.7	34.2	64.2	118.4	232.2	496.6	283	54.2	46	128.5	139.1	65.6	26.3	72.2	153.1	27.8	99.1	164.5	75.6	84.7	52	39.7	145.5	26.7	60.3	36.9	63.6	88.2	67.6	149.9	74	41.8	81.5	84.4	85.9	111.3	85.1	88.3	134.4	122.9	103.5	86	115.6	36.6	40.2	25.1	108.9	64.2	290.2	27.9	183.7	81.8	153.2	28.1	44	37	65.7	35.7	29.9	31.2	69.1	45.5	40.8	603.3	37.9	42.3	53.1	31.4	57.6	32.5	31	8.8	19	26.3	19.8	26.2	7.5	10.4	8.7	2513.2	2660	61.6	386.4	99.9	0	31937.7	112.1	2625.9	2640	80.3	0	6.1	53	0.7	11.2	82.6	5.6	163.5	1.6	7.5	167.2	335.7	1581.1	147.2	10.6	0	4.7	79.2	93.4	36.3	39.7	230.1	183.9	1	7.8	0	1.3	7	21.5	70	0	45.3	270.2	25.4	36.6	70.6	8.8	96.9	2.4	333.1	Cardiomyocytes
MTRNR2L11		ENSG00000270188	MT-RNR2-like 11	S4R3Y5	1	237943724-237945275	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	Evidence at transcript level		Group enriched	Detected in many	4	blood: 64.8;skeletal muscle: 46.5	Cell type enriched	Detected in many	26	Cardiomyocytes: 1023.1	Not detected	Not detected			Low region specificity	Detected in all			Cell type enriched	Detected in all	4	neutrophil: 64.8	Lineage enriched	Detected in all	9	granulocytes: 64.8	Cell line enhanced	Detected in many		HeLa: 66.8;Hep G2: 42.8														Secreted to blood												unprognostic (1.07e-1)					unprognostic (9.70e-2)			unprognostic (4.49e-2)	unprognostic (5.26e-2)				9.9	11.8	3.7	0.9	3.8	1.4	5.5	2.1	8.5	2	7	1.4	3.7	2.9	2	3.1	2	2	0.2	12.4	4.2	2.3	11.1	7.2	3	2.8	2.2	2.6	2	3.3	0	2	1.3	4.6	2.1	3.1	0.9	4.4	6.5	46.5	2	3.5	0.7	3.3	2	4.3	4	3	0.8	2	7.4	0.3	2	2	5.9	3.4	64.8	7	2.9	3.1	8.2	7.1	16.9	7.9	22.1	6.8	1.7	6.3	12	0.9	0.7	0.9	7.1	10.4	12.3	7.7	2.3	1.3	21.8	0.2	1.6	0.6	5.3	11.8	12.3	66.8	42.8	2.2	3.4	9.9	6.8	2.3	0.8	3	15.5	1	8	8.6	7.4	2	6.1	3.4	11.7	2.1	8.9	3.1	6.5	6.4	5	4.6	9.9	3	5.3	4.7	5.5	8.7	8.1	6.7	10.8	19.3	8.9	6.3	7.2	3.4	5.6	1.8	5	4.9	12.1	2.1	14.8	7	16.1	1.4	3.2	1.7	5.5	2.2	1.9	2.7	5.9	3.1	3.1	64.8	2.9	3.1	3.4	2	8.2	3.7	3.8	2.1	5.1	4.2	2.3	2.2	2.6	4.6	3	0	0	0	22.2	3.5	0	1023.1	0	0	0	12.2	0	0.1	39.7	0	0	2.2	0	0	0	0.1	2.4	23	0	1.3	0.1	0	0	1.3	0.3	0	0	2.4	8.5	0	0	0	0	0	0	1.7	0	0	3.1	0.3	0.2	3.4	0	0	0	20.9	Cardiomyocytes
MTRNR2L13		ENSG00000270394	MT-RNR2-like 13	S4R3P1	4	116298876-116300320	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in many		skeletal muscle: 11.5	Cell type enriched	Detected in some	39	Cardiomyocytes: 161.5	Not detected	Not detected			Low region specificity	Detected in many			Cell type enriched	Detected in some	5	neutrophil: 4.9	Lineage enriched	Detected in single	10	granulocytes: 4.9	Group enriched	Detected in some	5	HeLa: 8.3;Hep G2: 4.4														Secreted - unknown location												unprognostic (6.40e-2)					unprognostic (2.88e-1)			unprognostic (2.49e-1)	unprognostic (1.99e-1)				1.7	2.5	0.6	0.2	1.1	0.4	0.6	0.6	1.8	0.6	1.2	0	2.9	0.5	0.6	1	0.6	0.6	0.4	3.3	0.6	0.6	2.3	1.4	0.9	1.7	0.6	0.5	0.6	0.6	0	0.6	0.4	2.7	0.6	1.1	0.2	1.2	0.4	11.5	0.6	1	1.1	2.6	0.6	0.6	2	1.2	0	0.6	1.4	0.2	1	0.6	0.4	0.2	4.9	0.4	0.3	0.2	0.3	0.3	1.1	0.1	1.1	0.1	0.1	0.4	0.9	0	0	0	0.1	0.5	0.4	0.2	0	0	0.2	0	0	0	0.5	0.2	0.1	8.3	4.4	0.1	0.1	0.4	0.4	0	0.2	0	0.3	0	0.1	0	0	0	0.5	0.1	0.4	0	0.2	0.1	0.2	0.1	0.4	0.3	1.2	0.1	0.4	0.2	0.1	0.5	0.2	0.2	0.3	0	0.2	0	0.3	0	0	0	0.1	0.1	0.1	0	1	0.4	1	0.1	0.3	0.1	0.3	0.2	0.1	0.2	0.4	0.2	0.2	4.9	0.3	0.2	0.2	0	0.3	0.6	1.1	0.6	1.8	0.6	0.6	0.6	0.5	2.7	1.2	0	0	0	4.2	0.1	0	161.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	0	0	0	0	0	3.5	Cardiomyocytes
MTRNR2L6		ENSG00000270672	MT-RNR2-like 6	P0CJ73	7	142666272-142667718	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		blood: 81.7;skeletal muscle: 39.1	Cell type enriched	Detected in many	7	Cardiomyocytes: 849.8	Low cancer specificity	Detected in single			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 81.7	Lineage enriched	Detected in all	10	granulocytes: 81.7	Cell line enhanced	Detected in many		HeLa: 50.0;Hep G2: 44.1														Secreted to blood								unprognostic (5.34e-2)	unprognostic (1.34e-3)	unprognostic (3.80e-1)	unprognostic (4.45e-3)	unprognostic (1.33e-1)	unprognostic (2.89e-1)	unprognostic (1.40e-2)	unprognostic (3.49e-2)	unprognostic (1.30e-1)	unprognostic (1.10e-2)	unprognostic (6.02e-2)	unprognostic (1.04e-1)	unprognostic (3.69e-1)	unprognostic (3.03e-2)		unprognostic (2.66e-2)	unprognostic (8.07e-3)	3.4	8.2	1.4	0.8	2.3	0.1	1.1	1.2	5.5	1.1	3.9	1.5	0.8	1.1	1.1	0.8	1.7	1.1	0.8	17.9	6.1	1.4	7.3	4.7	1.1	5.9	2.2	3.9	1.1	2.2	0	1.1	0.8	4.5	1.1	2.3	0.8	2.5	0.8	39.1	1.5	2.6	0.8	3.5	1.1	2.2	1.7	1.8	0.8	1.5	0.8	0.8	1.8	1.1	8.4	4.2	81.7	8.2	4.7	3.9	9.5	5.6	9.6	3.3	22.6	3.8	2	5.5	6	0.5	0.6	1	3.1	10.3	4.9	8.2	1.1	0.5	19.9	0.1	1.1	0.5	3.1	3.7	6.8	50	44.1	1.2	1.4	7.3	3.4	1.4	0.5	1.6	12.7	0.5	6.1	5.8	7.3	1.8	3.1	2.8	15.2	1.2	3.1	1.1	4.5	2.8	3.7	3.9	8.3	2.2	8.2	1.6	3.8	11.5	4.9	5.3	9.6	6.9	6.5	6.6	7.8	2	2.9	1.3	3.1	3.9	8.7	1.6	20	8.2	21.6	2.4	4.9	2.4	8.4	2.9	2.9	4.1	7.7	3.2	3.9	81.7	4.7	4.4	4.2	3.1	9.5	1.4	2.3	1.2	2.9	6.1	1.4	2.2	3.9	4.5	1.8	35.7	50.8	1.4	7.4	5.7	0	849.8	0	75	127.4	31.4	0	0.5	38.1	0	0.3	1.5	0	23.3	0	0.6	7.1	3.3	51.1	1.9	0.5	0	0	0.6	0.6	0.6	2.3	14.5	3.3	0	0	0	0	0	0.4	4.9	0	0	4.7	0.3	2	3.9	0.2	1	0	3.7	Cardiomyocytes
AC051649.2		ENSG00000283787			11	1888577-1891895	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		blood: 7.0;skeletal muscle: 18.5	Cell type enriched	Detected in single	22	Cardiomyocytes: 2.2									Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		Daudi: 4.3;HDLM-2: 11.9;JURKAT: 2.7;Karpas-707: 8.1;NB-4: 3.3;U-937: 6.0					Low region specificity	Detected in many																																	0	4.9		3		4.5	0		0	0	0			0.3	0	0	0.1	0	0.3	0.2			0	0	0	3			0	0	0		0.3		0	0		0.7	0	18.5	6	0.6	0		4.5	0.8	0			0		0	0.2		1.6	2.8	7	3.1	1	1.9	4	0	0	0	0	0	0	0	0	0	0	0	0	0	4.3	0	0	0	0	0	0	0	11.9	0	0.1	0	0	0	0	0	0	0	0	0	0	0	2.7	0	8.1	0	0	0.7	3.3	0	0	0	0	0.2	1.2	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0.3	0	0	0	0	0.4	0	6	0	1.1	2.8	2.8	1.5	2.9	0.7	1.6	1.2	1.3	2.8	1.2	0.8	1.1	7	1	3.1	2.7	1.9	4											0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
TBCE	HRD, KCS, KCS1, pac2	ENSG00000284770	Tubulin folding cofactor E	Q15813	1	235367360-235452443	Disease related genes, Predicted intracellular proteins		Chaperone	Disease mutation, Dwarfism, Mental retardation, Neurodegeneration	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in single	141	Cardiomyocytes: 14.1									Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all											HPA026552, HPA026557	Approved											HPA026552: AB_1857797, HPA026557: AB_1857798																		5.2	6.6	4	4.3	5.9	3.4	3.1	9.4	6.9	3.8	5.6	5.6	3.6	6.2	7.3	3.4	8.5	2.5	5.8	9.2	4.3		6.7	7.2	3.5	4	3	4.5	4.1	10.5	2.6	8.7	4.9	11	4.5	3.7	6.2	7.8	2.7	15.5	6.5	4.6	3.6	4.4	3.1	5.6	5	3.8	3.6	10.7	5.7	5	6	3	1.8	5.3	1.5	6	2	2.4	1.8	12	14.6	11.3	7.5	7.8	8.8	12.7	13.7	5.2	11.7	14.7	12.9	10.3	9.3	25.9	4.5	10.1	8.1	9.9	6.7	9.9	15.8	19	9.1	9.3	11.5	11.4	15.2	7.1	9.4	6.1	9.3	9.7	7.3	5.8	15.8	33.5	6.1	11.5	5.9	9	7.4	19.6	25.9	3.3	8.9	15.9	19.1	11.4	8.7	9.4	8.9	9.9	10	12.9	7.9	17.6	15.9	9.5	10.8	8.3	14.3	13.6	10	18.4	10.7	10	10.8	16	0.6	3.7	1.5	2	6	2.3	0.8	1.8	2.4	5.3	1.8	1.2	2	0.3	2	3.2	1.9	1.2	1.8											0	0	0	0	0	0	14.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
